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ABSTRACT  
Background: Human papillomavirus (HPV) is primarily transmitted by unprotected sexual 
behaviours, and persistence of this virus is associated with HPV-related cancers of the cervix, 
anus, vulvar, oral cavity and penis.  Nigeria has one of the highest burdens of cervical cancer, 
but there is a paucity of data on other HPV-related cancers.  
Research objectives: To describe the epidemiology of HPV and the pattern of genital, oral and 
anal sexual intercourse and their association with the prevalence of genital, oral and anal HPV 
infections among adolescents and young adults and female sex workers (FSWs) (18-45 years) 
in Nigeria.  
Methods: First, a systematic review of reported oral and anal sex among heterosexual 
adolescents and adults in sub-Saharan Africa (SSA) was conducted. Second, a qualitative study 
that enrolled adolescent girls and young women in the community and in brothel-based FSW 
in Ibadan, Nigeria was conducted. The study used focus group discussions and in-depth 
interviews to collect data on definitions or meanings, attitudes and interpretations of 
different sexual behaviours. Third, a cross-sectional survey was conducted in Ibadan amongst 
girls and young women and FSWs to measure the prevalence and risk factors of oral, vulvar, 
cervical and anal HPV infections. Participants were interviewed, had a clinical examination 
and samples were collected for HPV genotyping.  Blood samples were also collected for 
human immunodeficiency virus testing.  
Results: The systematic review showed that oral and anal sex are commonly practiced in SSA, 
particularly among adolescents, young adults and FSWs. In the qualitative study, most 
participants had heard of oral and anal sex; more adolescents and FSWs had heard of these 
practices than adults. Local terminology/slang terms for oral and anal sex were acceptable to 
adolescents and FSWs but adults in the community often disapproved of these terms for 
framing interview questions. The most common motivations for practicing oral and anal sex 
were protection of sexual relationships and financial benefits. Concerns about these practices 
included fear of acquiring diseases and physical injury.  
For the prevalence survey, 310 women, and 315 FSWs participated.  Ever having practised 
oral sex was three times more frequently reported by FSWs than general population girls and 
women. Only one woman in the general population and eight FSWs had ever engaged in anal 
sex. The prevalences of any HPV genotypes were higher in FSWs than in general population 
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girls and women in the vulva (88% versus 69%), cervix (84% versus 60%), anal cavity (75% 
versus 57%) and oral cavity (24% versus 16%). The prevalence of HPV was significantly higher 
in adolescents and young adults than in adults in the cervix, vulvar and anal cavity in the two 
surveys.  In the adjusted model, there were higher odds of cervical HPV infection among 
women with concomitant vulvar (Adjusted odds ratio (aOR)= 12.85, 95% CI, 5.70-28.99), oral 
(aOR= 4.37, 95% CI, 1.50-12.71) and anal (aOR=3.48, 95%CI, 1.74-6.96) HPV infection while 
women with concomitant cervical (aOR=22.19, 95 %CI 7.85-62.72) and anal (aOR=6.68, 95% 
CI 2.44-18.26) HPV infections had higher odds of vulvar HPV infection. The odds of having anal 
HPV infection was associated with history of concomitant cervical (aOR=4.10, 95% CI, 1.85-
9.11) and vulvar (aOR=5.47, 95% CI, 2.11-14.20) HPV infection. Only the history of 
concomitant cervical HPV (aOR=4.81, 95% CI, 1.58-14.62) was associated with a higher odd of 
oral HPV.  Among the FSWs, history of concomitant vulvar HPV infection was associated with 
higher odds of cervical (aOR=16.60, 95% CI, 5.08-47.54) and anal (aOR=10.55, 95% CI, 3.67-
30.31 HPV infection, whereas history of concomitant cervical (aOR=6.48, 95% CI, 2.70-15.57) 
and anal (aOR=8.88, 95% CI, 3.66-23.28) HPV was associated with higher odds of vulvar HPV 
infections. The socio-demographic, behavioural and other biological factors that were 
associated with any HPV infections in specific anatomic sites are presented in the relevant 
chapters.  
Conclusion: Adolescents and adults, including FSWs in Ibadan, frequently engaged in different 
sexual behaviours, which might predispose them to sexually transmitted infections. HPV 
infection was found to be common among sexually active girls and women, with a higher 
prevalence among FSWs. 
5 | P a g e  
 
TABLE OF CONTENTS 
DECLARATION ............................................................................................................................................ 2 
ABSTRACT ................................................................................................................................................... 3 
LIST OF FIGURES ......................................................................................................................................... 7 
LIST OF TABLES ........................................................................................................................................... 8 
LIST OF ACRONYMS .................................................................................................................................. 10 
ACKNOWLEDGEMENTS ............................................................................................................................ 12 
CHAPTER 1: INTRODUCTION AND LITERATURE REVIEW ......................................................................... 14 
1.1. CLASSIFICATION OF HPV ....................................................................................................... 15 
1.2. NATURAL HISTORY AND PATHOGENESIS OF HPV INFECTION ............................................... 16 
1.3. PREVENTION AND SCREENING OF HPV INFECTION AND RELATED DISEASES ....................... 19 
1.4. EPIDEMIOLOGY OF HPV INFECTION ...................................................................................... 23 
1.5. RATIONALE FOR THE STUDIES IN THIS THESIS ...................................................................... 36 
1.6. AIMS AND OBJECTIVES .......................................................................................................... 37 
1.7. NIGERIAN CONTEXT AND STUDY SETTING ............................................................................ 38 
1.8. STRUCTURE OF THIS THESIS .................................................................................................. 40 
1.9. SCOPE OF WORK CONDUCTED BY THE PHD CANDIDATE ...................................................... 41 
2.0. SOURCE OF FUNDING ........................................................................................................... 42 
CHAPTER 2: LITERATURE REVIEW ON ORAL AND ANAL SEXUAL BEHAVIOURS ...................................... 43 
2.1. PREAMBLE ................................................................................................................................. 43 
2.2. COVER SHEET FOR THE SYSTEMATIC REVIEW MANUSCRIPT ..................................................... 46 
2.3. COPYRIGHT AGREEMENT ........................................................................................................... 47 
2.4.  REPORTED ORAL AND ANAL SEX AMONG ADOLESCENTS AND ADULTS REPORTING 
HETEROSEXUAL SEX IN SUB-SAHARAN AFRICA: A SYSTEMATIC REVIEW .......................................... 48 
2.5. SIGNIFICANCE OF THE SYSTEMATIC REVIEW FOR THE THESIS ................................................. 112 
CHAPTER 3: PERCEPTIONS, INTERPRETATIONS, TERMINOLOGIES, AND ATTITUDE OF ADOLESCENTS 
AND ADULTS TOWARDS HETEROSEXUAL ORAL AND ANAL SEX IN IBADAN, NIGERIA ......................... 113 
3.1. BACKGROUND INFORMATION ................................................................................................. 113 
3.2. METHODS ................................................................................................................................ 114 
3.3. RESULTS ................................................................................................................................... 123 
3.4. DISCUSSION ............................................................................................................................. 150 
3.5 CONCLUSION ............................................................................................................................ 154 
CHAPTER 4: EPIDEMIOLOGY OF ORO-GENITAL AND ANAL HUMAN PAPILLOMAVIRUS INFECTIONS 
AMONG SEXUALLY ACTIVE WOMEN IN IBADAN, NIGERIA ................................................................... 156 
4.1. BACKGROUND .......................................................................................................................... 156 
6 | P a g e  
 
4.2. METHODS ................................................................................................................................ 157 
4.3. RESULTS ................................................................................................................................... 173 
4.4. DISCUSSION ............................................................................................................................. 205 
CHAPTER 5: EPIDEMIOLOGY OF ORO-GENITAL AND ANAL HUMAN PAPILLOMAVIRUS INFECTIONS 
AMONG BROTHEL-BASED FEMALE SEX WORKERS IN IBADAN, NIGERIA .............................................. 213 
5.1. BACKGROUND .......................................................................................................................... 213 
5.2. METHODS ................................................................................................................................ 214 
5.3. RESULTS ................................................................................................................................... 228 
5.4. DISCUSSION ............................................................................................................................. 262 
5.5. CONCLUSION ........................................................................................................................... 267 
CHAPTER 6: DISCUSSION ........................................................................................................................ 268 
PREAMBLE ...................................................................................................................................... 268 
6.1. SUMMARY OF KEY FINDINGS OF THIS THESIS .......................................................................... 268 
6.2. STRENGTHS OF THE THESIS ..................................................................................................... 276 
6.3. LIMITATION OF THE RESEARCH FINDINGS ............................................................................... 277 
6.4. PUBLIC HEALTH IMPLICATIONS OF THE RESEARCH FINDINGS ................................................. 280 
6.5. RECOMMENDATIONS .............................................................................................................. 283 
6.6. CONCLUSION ........................................................................................................................... 285 
REFERENCES ........................................................................................................................................... 286 
ANNEXTURES .......................................................................................................................................... 319 
ANNEX 3.1: FGD TOPIC QUIDE QUESTIONS .................................................................................... 319 
ANNEX 3.2: IDI TOPIC QUIDE QUESTIONS ....................................................................................... 321 
ANNEX 3.3: INFORMATION SHEET AND INFORMED CONSENT FORM FOR FGD ............................. 323 
ANNEX 3.4: INFORMATION SHEET AND INFORMED CONSENT FORM FOR IDI ................................ 327 
ANNEX 3.5: ETHICAL APPROVALS ................................................................................................... 331 
ANNEX 4.1: INFORMATION SHEET AND INFORMED CONSENT FORM FOR CROSS-SECTIONAL STUDY
 ........................................................................................................................................................ 334 
ANNEX 4.2: RDT HIV SERIAL TESTING .............................................................................................. 339 
ANNEX 4.3: FEMALE CASE REPORT FORM ...................................................................................... 340 
ANNEX 5.1:  LIST OF MAPPED BROTHELS WITH NUMBER OF SELECTED PARTICIPANTS ................. 357 
ANNEX 5.2:  ADDITIONAL QUESTIONS FOR FEMALE SEX WORKERS ONLY ...................................... 358 
7 | P a g e  
 
LIST OF FIGURES 
Figure 1.1: Global burden of HPV and HPV-related diseases ............................................................... 14 
Figure 1.2: The map of Nigeria with 36 States and Federal Capital Territory; LGAs in Oyo state and 
Ibadan Metropolis ................................................................................................................................ 40 
Figure 1:3 PRISMA Flow for the systematic review .............................................................................. 57 
Figure 2.2: Prevalence of oral sex by study population ........................................................................ 83 
Figure 2.3: Prevalence of heterosexual anal sex by study population ................................................. 84 
Figure 4.1: Cadastral maps of the SHINI study sites at Ibadan North and Akinyele LGAs .................. 158 
Figure 4.2: Summary of the study procedure in the community ....................................................... 164 
Figure 4.3: Interpretation of HPV results on automated Seegene viewer software .......................... 166 
Figure 4.4: Conceptual Framework for the risk factor analysis of any HPV infection among females in 
the two communities in Ibadan, Nigeria ............................................................................................ 168 
Figure 4.5. Conceptual Framework for the risk factor analysis of oral sex among females in two 
communities in Ibadan ....................................................................................................................... 171 
Figure 4.6: Female participant enrolment flow for the community survey ....................................... 174 
Figure 4.7– Prevalence of specific HPV genotypes according to the four anatomical sites ............... 185 
Figure 4.8 – Prevalence of specific cervical HPV genotypes ............................................................... 186 
Figure 4.9– Prevalence of specific vulvar HPV genotypes .................................................................. 186 
Figure 4.10 – Prevalence of specific anal HPV genotypes .................................................................. 187 
Figure 4.11 – Prevalence of specific oral HPV genotypes ................................................................... 187 
Figure 5.1: summary of the study procedure in the community ....................................................... 218 
Figure 5.2: Conceptual Framework of the risk factor analysis for any HPV infection among female sex 
workers ............................................................................................................................................... 223 
Figure 5.3: Conceptual Framework of the risk factor analysis for oral sex among female sex workers
 ............................................................................................................................................................ 226 
Figure 5.4 Brothel-based female sex workers enrolment flow for the survey ................................... 228 
Figure 5.5– Prevalence of specific HPV genotypes according to the four anatomic sites .................. 240 
Figure 5.7 – Prevalence of specific vulvar HPV genotypes ................................................................. 241 
Figure 5.6 – Prevalence of specific cervical HPV genotypes ............................................................... 241 
Figure 5.8– Prevalence of specific anal HPV genotypes ..................................................................... 242 
Figure 5.9– Prevalence of specific oral HPV genotypes ...................................................................... 242 
Figure 6.1. Algorithm for Cervical cancer screening for low income countries .................................. 282 
8 | P a g e  
 
LIST OF TABLES 
Table 1.1. Broad classification of human papillomavirus by oncogenic risk and associated diseases 
according to the International Agency for Research on Cancer Education .......................................... 16 
Table 1.2: Characteristics of the three licensed HPV vaccines ............................................................. 20 
Table 1.3: Prevalence of cervical HPV among women ......................................................................... 28 
Table 1.4:  Prevalence of Oral HPV in men and women [2015-2019] .................................................. 30 
Table 1.5: Prevalence of Anal HPV in men and women (2014-2018] ................................................... 33 
Table 1.6: Prevalence of vulvar HPV in women (2012-2018] ............................................................... 34 
Table 2.1: Selected data from quantitative studies reporting on heterosexual oral and anal sex in 
sub-Saharan Africa by year of publication ........................................................................................... 58 
Table 2.2: Reported condom use during penetrative heterosexual sex (oral, anal and vaginal) ......... 85 
Table 2.3: Factors reported to be associated with engaging in heterosexual oral and anal sex among 
adolescents and adults in sub-Saharan Africa ...................................................................................... 89 
Table 2.4: Selected data from qualitative studies reporting on heterosexual oral and anal sex in sub-
Saharan Africa by year of publication .................................................................................................. 92 
Table 2.5: Assessment of  critical information on the design of quantitative studies ......................... 97 
Table 2.6: Assessment of  critical information on the design of qualitative studies .......................... 101 
Table 3. 1: Sampling matrix for the community FGDs, and selected socio-demographics of the 
participants ........................................................................................................................................ 120 
Table 3. 2: Sampling matrix for the community IDIs, and selected socio-demographics of the 
participants ........................................................................................................................................ 121 
Table 3.3: Sampling matrix for the brothel FGDs and IDIs, and selected socio-demographics of the 
participants ........................................................................................................................................ 122 
Table 4.1:  Table for sample size calculation ...................................................................................... 159 
Table 4.2:  Table for Power calculation .............................................................................................. 159 
Table 4.2:  Table for power calculation1 ............................................................................................. 160 
Table 4.3: Socio-demographic characteristics of sexually active females in two communities in 
Ibadan, Nigeria ................................................................................................................................... 175 
Table 4.4: Sexual relationships, partnerships and behaviours of sexually active females in two 
communities in Ibadan, Nigeria ......................................................................................................... 177 
Table 4.5: Relevant medical history and clinical and laboratory diagnosis among sexually active 
females in two communities in Ibadan, Nigeria ................................................................................. 179 
Table 4.6: Prevalence of Cervical, Vulvar, Anal and Oral Human papillomavirus infections among 
sexually active women from the general population in two communities in Ibadan, Nigeria (N=310)
 ............................................................................................................................................................ 182 
Table 4.7: Factors associated with cervical human papillomavirus infection among sexually active 
women from the general population in two communities in Ibadan, Nigeria ................................... 189 
Table 4.9: Factors associated with anal human papillomavirus infection among sexually active 
women from the general population in two communities in Ibadan, Nigeria ................................... 195 
Table 4.10: Factors associated with oral human papillomavirus infection among sexually active 
women from the general population in two communities in Ibadan, Nigeria ................................... 198 
Table 4.11: Proportion of HPV genotype specific concordance samples across the four anatomical 
sites of the cervix, vulvar, anal and oral cavities among sexually active women in two communities in 
Ibadan, Nigeria ................................................................................................................................... 201 
9 | P a g e  
 
Table 4.12: Pattern of HPV concordance by means of anatomical sites among females in Ibadan, 
Nigeria (n=310) ................................................................................................................................... 203 
Table 4.13 –Factors associated with previous report of any oral sex among sexually active women 
from the general population in two communities in Ibadan, Nigeria (N=310) .................................. 204 
Table 5.1: Socio-demographic characteristics of brothel-based female sex workers in Ibadan, Nigeria 
(N=315) ............................................................................................................................................... 229 
Table 5.2: Sexual relationships, Partnerships and Behaviours of brothel-based female sex workers in 
Ibadan, Nigeria (N=315) ..................................................................................................................... 231 
Table 5. 3: Relevant medical history and clinical and laboratory diagnosis of brothel-based female sex 
workers in Ibadan, Nigeria (N=315) .................................................................................................... 233 
Table 5.4: Information on sex work history of brothel-based female sex workers in Ibadan, Nigeria 
(N=315) ............................................................................................................................................... 234 
Table 5.5: Prevalence of Human papillomavirus infections among 315 brothel-based female sex 
workers in Ibadan, Nigeria ................................................................................................................. 237 
Table 5.6: Factors associated with cervical human papillomavirus infection among brothel-based 
female sex workers in Ibadan, Nigeria ............................................................................................... 244 
Table 5.7: Factors associated with vulvar human papillomavirus infection among brothel-based 
female sex workers in Ibadan, Nigeria ............................................................................................... 247 
Table 5.9: Factors associated with oral human papillomavirus infection among brothel-based female 
sex workers in Ibadan, Nigeria ........................................................................................................... 253 
Table 5.10: Proportion of HPV genotype specific concordance samples across the four anatomic sites 
of cervix, vulvar, anal and oral cavities among brothel-based female sex workers in Ibadan, Nigeria
 ............................................................................................................................................................ 256 
Table 5.12: Factors associated with ever gave oral sex among brothel-based female sex workers in 
Ibadan (N=315) ................................................................................................................................... 258 
Table 5.13: Factors associated with ever received oral sex among brothel-based female sex workers 
in Ibadan (N=315) ............................................................................................................................... 260 
10 | P a g e  
 
LIST OF ACRONYMS 
ACASI  Audio computer assisted and face-to-face interview 
AIDS  Acquired Immunodeficiency Diseases 
CA  California 
CASI  Computer assisted personal interviews 
CE-IVD  Certified in Europe for in-vitro diagnostics 
CIN  Cervical intraepithelial neoplasia 
DNA  Deoxyribonucleic acid 
EA  Enumeration area 
FDA  Food and drug administration 
FGD  Focus group discussion 
FSW  Female sex worker 
FTFI  Face-to-face interviews 
GCP  Good clinical practice 
GP  General Population 
HIV   Human Immunodeficiency Virus 
HPV  Human papillomavirus 
HR-HPV High-risk HPV   
HSV  Herpes simplex virus 
IARC  International Agency for Research on Cancer 
ICC  Intra-cluster correlation coefficient 
ICO  Catalan Institute of Oncology 
IBBSS  Integrated Biological and Behavioural Surveillance Surveys 
IDI  In-depth-interview 
KAP  Key Affected Population 
LGA  Local government areas 
LR-HPV Low-risk HPV 
LSHTM  London School of Hygiene and Tropical Medicine 
MOOSE Meta-analysis of Observational Studies in Epidemiology 
mRNA  Messenger ribonucleic acid 
MSM  Men that have sex with men 
MSW  Men who have sex with women 
NA  Not applicable 
NATSAL National Survey of Sexual Attitudes and Lifestyles 
PCR  Polymerase chain reaction 
PI  Principal Investigator 
PPS  Probability proportion to size 
11 | P a g e  
 
PRISMA Preferred Items for Reporting of Systematic Reviews and Meta-analyses 
RCT  Randomised Control Trial 
RDT  Rapid diagnostic test 
RNA  Riboxynucleic acid 
SAQ  Self-administered questionnaires 
SFH  Society for family health  
SHINI  Sexual Behaviour and HPV Infection in Nigerians in Ibadan 
SSA  Sub-Saharan Africa 
STI  sexually transmitted infection 
T-ACASI Telephone-and computer-assisted interviews 
TI  Telephone interviews with a human interviewer 
TLFB  Timeline-follow back assessments 
UI  University of Ibadan 
UK  United Kingdom 
USD  United State Dollars 
VIA  Visual inspection with acetic acid 
VILI  Visual inspection with Lugols Iodine 
VIN  Vulvar intraepithelial neoplasia 
WHO  World Health Organisation 
 
12 | P a g e  
 
ACKNOWLEDGEMENTS 
I wish to specially appreciate Professor Deborah Watson-Jones, who was kind to accept to be 
my main supervisor and mentored me throughout my research degree programme (PhD). I 
have benefitted immensely from her wealth of experience and contribution to my academic 
development, particularly, in my sojourn at the London School of Hygiene and Tropical 
Medicine, UK. I am grateful to Dr. Suzanna C. Francis, my co-supervisor, for her regular 
coaching, advice and supervision at every stage of my programme. I appreciate the effort of 
the statistics advisor Dr Kathy Baisley and other members of my PhD advisory committee that 
assisted me. My advisory committee panel are Professor Phillippe Mayaud (London School of 
Hygiene and Tropical Medicine, UK), Professor Kirstin Mitchel (University of Glasgow, 
Scotland), Dr. Aura Andreasen (Public Health England, UK) and Dr. Silvia de Sanjosé (PATH, 
Reproductive Health Global Program, Seattle, WA, USA). Dr. Miquel Pavon and his team at 
the Catalan Institute of Oncology Laboratory in Spain were wonderful.  
 
I thank the management of the University of Ibadan, Ibadan, Nigeria, for the award of a Staff 
Development Scholarship Grant to pursue my PhD programme. The award was in fulfilment 
of the promise made by the leadership of the University of Ibadan during the tenure of the 
11th Vice Chancellor – Professor Isaac Adewole, FAS, to support young academic staff for 
further training and research collaboration. I am glad to be one of the beneficiaries of this 
grant. Apart from initiating my interest, Professor Adewole while serving as the Minister of 
Health in Nigeria took time to supervise my field work in Nigeria. He also read through the 
thesis. When I had challenges of funding because of the demand of my research topic, 
Professor Abel Idowu Olayinka, FAS, the 12th Vice Chancellor provided resources to avoid 
premature termination of my programme. The positive disposition of the Provost, College of 
Medicine – Professor E. Olapade-Olaopa, the Chief Medical Director (Professor Temitope 
Alonge), University College Hospital, Ibadan, the Dean, Faculty of Clinical Sciences, and the 
Head of Department of Obstetrics and Gynaecology, and their predecessors towards my 
academic carrier is highly appreciated.  
 
Emeritus Professor Ebenezer Oluwole Akande, OON, encouraged me to pursue the PhD 
programme and wrote a letter of recommendation for me to process my admission. I 
acknowledge the pieces of advice given to me by my local advisors – Professor Ayodele Jegede 
13 | P a g e  
 
(Social scientist, University of Ibadan) and Professor Rasheed Bakare (Medical Microbiologist, 
University of Ibadan).  Professor Oladosu Ojengbede (Director, Centre for Population and 
Reproductive Health), Professor Adeyinka Aderinto (Former Deputy Vice-Chancellor 
Academic), Professor Rasak Alada (University of Ibadan) and Hajia Binta Adamu-Bello 
(Permanent Secretary, Federal Ministry of Health), for their gracious support to me during 
the program. I appreciate the encouragement given to me by Professors Suellen Miller 
(University of California, USA) and Amy Tsui (Johns Hopkins University, USA), Dr. Helen Kelly 
(London School of Hygiene and Tropical Medicine, UK), Dr. Gbolagade and Hannat Akintomide 
(London), Dr. Tunde Adedokun (University of Chicago, Illinois, USA), my teachers and 
colleagues in the department of Obstetrics and Gynaecology, University of Ibadan and 
University College Hospital. I thank the Director (Professor Catherine Falade) and the entire 
staff of Institute of Advanced Medical Research and [Training, College of Medicine, University 
of Ibadan for their show of love and support during the period when SHINI study was been 
conducted.  
 
I offer special gratitude to all the field subjects and gate-keepers who made the conduct of 
the study possible and stress free. I acknowledge the excellent work of my field workers and 
the cooperation of study participants who voluntary agreed to share their stories with us 
during the research.  
 
Finally, I wish to sincerely appreciate the understanding of my parents Alhaji L.A. Morhason-
Bello and Alhaja R.A. Morhason-Bello, and my siblings for showing maximum understanding 
during the period of my research degree programme. To my amiable wife, Khadijah Ekundayo, 
and my lovely children – Kaothar, Ibrahim and Idris, I appreciate your courage and resilience 
that you demonstrated while I was absent from my domestic duties due to the demand of my 
PhD programme.  
14 | P a g e  
 
CHAPTER 1: INTRODUCTION AND LITERATURE REVIEW 
Human papillomavirus (HPV) is a double stranded DNA virus from the alpha Papillomaviridae 
family. There are over 200 known genotypes of HPV, of which about 40 have a predilection 
for infecting epithelial and mucosa surfaces[1, 2] . The majority of HPV infections are 
asymptomatic and only a small proportion are associated with symptoms or disease, which 
can involve benign (verruca, warts and papillomas), premalignant or malignant lesions[1, 3]. 
Genital HPV infection is one of the most common sexually transmitted infections (STIs), and 
it can be transmitted through condomless vaginal, anal, and oral sexual intercourse [3, 4]. In 
addition, it is also transmitted through non-penetrative sexual behaviours and skin-to-skin 
contact[5].  
Worldwide, HPV-associated cancers are estimated to account for 4.5% of all cancers, with the 
highest burden occurring in developing countries [6, 7]. Specifically, HPV infection is 
associated with  99.0% of cervical cancer, 88.0% of anal cancer, 70.0% of vaginal cancers, 
50.0% of penile cancers, 43.0% of vulvar cancer and 25.6% of head and neck cancers (Figure 
1) [7].   










Sub-Saharan Africa has the highest burden of HPV-related cancer worldwide. According to a 
2019 HPV Information Centre report, the average age-standardised incidence rate of cervical 
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cancer per annum is highest in Africa (27.6/100,000 women/year) relative to other continents 
(10.2-11.9/100,000 women/year)[7]. Africa also has the highest average age-standardised 
cervical cancer associated mortality rate per annum of 20.0/100,000 women/year[7]. 
Countries in southern Africa have the highest average age-standardised incidence rate per 
annum of cervical cancer (43.1/100,000 women/year), followed by east African (40.1/100,000 
women/year) and west African (29.6/100,000 women/year) countries globally[7]. However, 
the average age-standardised cervical cancer associated mortality rate per annum is highest 
in eastern Africa (30.0/100,000 women/year), followed by western Africa (23.0/100,000 
women/year) and southern Africa (20.0/100,000 women/year)[7]. 
This chapter reviews the classification of HPV, natural history and pathogenesis of HPV, 
prevention and screening of HPV, epidemiology and risk factors of HPV, and present 
knowledge gaps. The rationale for studies in this thesis, the structure, aims and objectives of 
the thesis, the Nigerian context, and my role in the PhD are also described. 
1.1. CLASSIFICATION OF HPV  
The five evolutionary genera of HPV based on DNA sequence analysis are alpha, beta, gamma 
and Nu/Mu papillomaviruses. Of these, the largest group is the alpha HPV group [3, 4], which 
this thesis will focus on. HPV types are broadly classified into ‘high-risk’ (HR-HPV) or oncogenic 
and ‘low-risk’ or non-oncogenic types. The HR-HPV genotypes are associated with 
premalignant or malignant lesions while the low-risk (LR-HPV) genotypes are generally 
associated benign lesions like genital warts [8].  
The International Agency for Research on Cancer (IARC) has classified HPV genotypes based 
on epidemiological evidence of cancer risks as follows: ‘definitely carcinogenic to humans’ 
(group 1: 16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58 and 59); ‘probably carcinogenic to humans’ 
(group 2a: 68); ‘possibly carcinogenic to humans’ (group 2b: 26, 30, 34, 53, 55, 66, 67, 69, 70, 
71, 72, 73, 81, 82, 83, 84, IS39 and CP6108); and ‘not classifiable as to its carcinogenicity to 
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Table 1.1. Broad classification of human papillomavirus by oncogenic risk and associated 
diseases according to the International Agency for Research on Cancer Education[4]	
HUMAN PAPILLOMAVIRUS GENOTYPES ASSOCIATED DISEASE 
HR-HPV or oncogenic  HPV 16, 18, 31, 33, 35, 39, 45, 
51, 52, 56, 58, 59 
Cervical, anal, vaginal vulvar, 
penile, and oropharyngeal 
cancer and associated precursor 
lesions 
LR-HPV types HPV 6, 11 Genital warts, recurrent 
respiratory papillomatosis 
Probable carcinogenic HPV 68 Cervical cancer 
Possible carcinogenic HPV 5, 8 Squamous cell carcinoma of the 
skin in patients affected by 
epidermodysplasia 
verruciformis 
Possible carcinogenic HPV 26, 30, 34, 53, 66, 67, 69, 
70, 73, 82, 85 and 97 
Uncertain 
 
Table adapted from de Sanjosé et al 2018. The natural history of human papillomavirus infection. Best Practice 
& Research Clinical Obstetrics and Gynecology. 47:2-13 
 
1.2. NATURAL HISTORY AND PATHOGENESIS OF HPV INFECTION 
The highest incidence of HPV infection is around sexual debut and in young adults up to 30 
years of age. Thereafter, the risk generally declines with age [3, 4, 10, 11]. Some of the 
biological theories proposed for the high-risk of acquiring HPV infection among adolescents 
around their sexual debut include immaturity of the cervix including exposure of the columnar 
epithelium (ectopy) and insufficient production of cervical mucus within this age group [12, 
13]. Acquisition of new HPV infections is associated with the following factors: multiple sexual 
partners, acquisition of new sexual partners, presence of other STIs, marital status, male 
circumcision, condom use, immunosuppression, hormone contraceptives, use of drugs, 
smoking, alcohol consumption and dietary deficiency, amongst others [4, 10, 14].   
The pathogenesis of HPV infection involves incorporation of the viral particles into the host 
genome in the basal cell layer following disruption of epithelial or mucosa lining of ecto-
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endocervix or anorectal junctions [4, 15]. After viral incorporation, the oncoproteins E6 and 
E7 are expressed; both prevent cell apoptosis through inhibition of tumour suppressor genes 
(p53 and retinoblastoma (rb) genes)[1, 16]. This results in amplification of viral replication 
and uncontrolled division of infected cells[16]. Normally, the immune system prevents 
amplification and subsequent progression of HPV infection at the infected anatomic site[1]. 
If an HPV infection escapes host immune control, it can persist, causing dysplastic cellular 
changes of the infected basal cells [17].  
In the cervix, HPV infection occurs in the transformation zone – this is a junction between the 
columnar and squamous cell lining of the cervix and it is susceptible to dysplastic changes[18]. 
The squamocolumnar junction changes over the lifetime of a woman, and it depends on 
hormone status, oral contraceptive use, genital trauma and pregnancy[18]. A persistent HPV 
infection may progress from basal cell layer  to other cellular layers of the epithelial lining 
causing low, medium or high grade premalignant lesions[5]. HR-HPV infection can progress 
from low to high-grade lesions whereas LR-HPV infection is generally associated with low 
grade lesions [3-5]. Cervical premalignant lesions, also known as cervical intraepithelial 
lesions (CIN) on histology,  are classified into CIN 1, CIN 2 and CIN 3 based on the degree of 
cellular dysplasia of the epithelial lining [19]. CIN 1 refers to dysplasia that is confined to the 
basal one-third of the epithelial lining; CIN 2 is dysplasia that involves the basal two-thirds of 
the epithelial lining and CIN 3 is degree of dysplasia in more than two-thirds of the 
epithelium[19]. The time interval for developing these lesions from the point of HR-HPV 
acquisition can depend on other co-factors such as immunosuppression, other co-morbidities 
(e.g. HIV and STIs) and smoking, pregnancy, viral load, type of HR-HPV infection and age [5, 
20]. 
Each CIN stage can regress to earlier stages and to normal epithelium. The average probability 
of regression to normal epithelium is 55.0-57.0% for CIN 1, 43.0-62.4% for CIN 2 and 17.4-
32.0% for CIN 3 [20, 21]. Progression of untreated cervical premalignant lesions to invasive 
cancer is less than 1% for CIN 1, 1.5% for CIN 2 and 12% for CIN 3 [21, 22]. In 2018, a study in 
USA among 783 women with diagnosis of CIN 1, 2 and 3 reported higher rate of regression 
and remission, and lower rate of progression of premalignant lesions among young patients 
than older patients [20]. In the same study, a pooled estimate of a meta-analysis of seven 
studies that involved 3705 women was performed [20]. The result showed a similar outcome 
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of higher rates of regression among women that were less than 25 years (58.4%) compared 
with those that were 35 years and above (46.2%)[20]. 
In general, 80.0-90.0% of HPV infections (infections with a specific genotype) are cleared by 
the immune system [5, 23]. In healthy individuals, the majority of new cervical infections are 
cleared within a year and about 90.0% will resolve within 2 years [23]. Anal, vulvar and vaginal 
HPV infections appear to have similar rates of clearance to that of the cervical infections [23]. 
For example, a study in USA among 1568 heterosexual young women (13-21years) showed 
that the majority cleared anal HPV infections by the third year of detectable infection [24]. 
The authors suggested that the slow clearance rate might be due to viral shedding from other 
nearby infected anatomic sites such as the cervix or the vagina [24]. The clearance rate in the 
oral cavity is reported to be faster than cervical and other anogenital sites [25, 26].   Some 
studies have associated high clearance rates of HPV infection in the cervix, vulvar and oral 
cavity with women who are young [4, 27]. However, a few studies found no difference in 
clearance rates by age among people with anal HPV infection [24, 28]. 
The clearance of incident HPV infections is mediated by adaptive immunity in healthy 
individuals [17, 29]. T-cell mediated immune responses prevent further viral division and 
expression of oncoproteins[30] . An individual who clears a specific HPV infection is presumed 
to no longer be infected with that genotype. However, there is emerging evidence that 
clearance as defined by detection of a specific HPV genotype and then non-detection of that 
genotype at a subsequent visit may not represent complete clearance of that specific HPV 
infection [17, 29]. Asymptomatic HPV infection may be present as low viral copies that cannot 
be detected [17, 29].  It is therefore plausible that a proportion of HPV infections defined as 
cleared may be in a latency phase [17, 29, 31].  For example, animal molecular model studies 
with cottontail rabbit papillomavirus and rabbit oral papillomavirus models showed that HPV 
infection could remain latent without evidence of clinical infection [29, 32].  
Similarly, latent HPV infection has been reported in subjects with normal laryngeal epithelia 
who are in remission from recurrent respiratory papillomatosis [29, 33]. Reactivation of HPV 
infections has been found to occur with immunosuppression such as HIV infection, steroid 
use, pregnancy, ultraviolent light and mechanical stimulation [4, 17, 29, 34]. As mentioned 
above, HPV infections may escape the body’s immune response and can become persistent 
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[35]. Persistent HPV infection is the cause of anogenital warts, respiratory papillomatosis, and 
cervical cancer, and it also causes some anal, vulva, penile and oropharyngeal cancers [6, 36, 
37].   The persistence of HR-HPV genotypes can result in premalignant and malignant lesions 
over 10-20 years [4, 38].  There is no uniform operational definition of persistent infection; 
some studies defined this as the presence of the same genotype of HPV 12 months after the 
first detection or two visits of 6 months apart after the first detection [4, 24, 39-42]. A repeat 
HPV test at 12 months is recommended for those who have previously been HPV positive with 
negative cervical cytology as a screening guideline [4].   It is unclear whether persistence is 
due to reinfection of the same genotype after clearance or reactivation of a latent subclinical 
infection or continuous detection of the same type [29, 43].  Some of the factors associated 
with persistence of HPV infection in epidemiological studies are immunosuppression, 
smoking, hormonal contraceptives and the presence of other STIs [6, 7]. 
Generally, most of the natural history-related information relates to the cervical HPV 
infection but there is emerging evidence that suggests that anal, vulvar, vaginal, and oral HPV 
infections might have similar oncogenic potentials as cervical HPV infections [4, 6, 44-46]. HR-
HPV infections of anogenital sites and oral cavities in men and women may persist and 
undergo malignant transformation. However, there are still some unanswered questions 
pertaining to HPV acquisition, clearance and persistence at these non-cervical sites [44]. Of 
all the HPV types, HPV 16 has the strongest association with HPV-related cancers [1, 10]. In 
non-cervical sites, similar types and strains of HPV have been isolated, and HPV 16 remains 
the most likely to cause cancer [3, 47]. However, some LR-HPV types have been associated 
with some penile cancers [3, 48].   
1.3. PREVENTION AND SCREENING OF HPV INFECTION AND RELATED 
DISEASES  
1.3.1. Primary prevention with HPV vaccination 
There are three licensed prophylactic HPV vaccines: Cervarix® (GlaxoSmithKline Biologicals, 
Rixensart, Belgium) protects against HPV 16 and 18; Gardasil® (Merck and Co, Inc., 
Whitehouse Station, NJ, USA) protects against HPV 6, 11, 16 and 18, and Gardasil®9 (Merck 
and Co, Inc., Whitehouse Station, NJ, USA) protects against HPV 6, 11, 16, 18, 31, 33, 45, 52 
and 58. These vaccines have been  approved by the US Food and Drug Administration (FDA) 
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to primarily prevent HPV infections in boys and girls [2]. Routine HPV vaccine is part of the 
global strategy to eliminate cervical cancer[49] [50]. The maximum benefit of HPV vaccination 
is attained when it is administered before sexual debut and exposure to HPV infection.  
Adapted from the Centers for Disease Control, USA (https://www.cdc.gov/hpv/hcp/schedules-
recommendations.html) 
The 2030 target resolution established at the 2018 World Health Assembly was for the 
member countries to achieve a national coverage of 90.0% of two doses of HPV vaccination 
for girls aged 15 years[50]. However, a global HPV vaccine coverage review (2014-2016) of 51 
countries showed that 27.0% of those with 80.0% coverage were from high-income countries, 
and another 25.0% of  countries that had introduced HPV vaccination had less than 50.0% 
coverage[52]. Out of seven African countries that have introduced national HPV vaccination 
programme, only two countries (Rwanda and Seychelles) had 90.0% national HPV vaccine 
coverage[52]. There is also increasing demand for a gender-neutral HPV vaccination in high 
income countries [53-55], which advocates for equitable access to HPV vaccine coverage 
through the inclusion of boys. Some researchers believe that a gender-neutral vaccine 
coverage policy will speed up herd immunity, reduce the burden of HPV-related diseases in 
men and women, and possibly eliminate transmission of HPV infection [53, 54]. Other 
Table 1.2: Characteristics of the three licensed HPV vaccines [51] 
VARIABLE GARDASIL® CERVARIX® GARDASIL®9 






Merck and Co, Inc., 
Whitehouse Station, 
NJ, USA 













HPV genotypes  6, 11, 16 and 18 16 and 18 6, 11, 16, 18, 31, 33, 
45, 52 and 58 
FDA approval date 2006 2008 2014 
Recommended dose 2 2 3 
Recommended 
dosing schedule 
0, 6-12 months 0, 6-12 months 0, 1-2, 6 months 
Prevention benefits Mostly cervical 




vaginal, and anal 
cancers, and warts 
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researchers believe that HPV vaccination of girls only is cost efficient and may also protect 
boys from the infection[56]. 
1.3.2.  Screening for premalignant lesions 
Cytological screening for premalignant lesions along with treatment of detected lesions is an 
effective secondary prevention intervention for cancer of the cervix as it significantly reduces 
disease incidence and associated mortality [23, 57]. According to the 2019 HPV Information 
Centre report, implementation of population level cytological screening (using Papanicolaou 
(Pap) smears) for sexually active women is available in Europe, North America, most of 
Oceania and Asian countries, and a few countries in Africa, as part of their national cervical 
cancer screening programmes [7].  According to the same report, a large number of other 
countries in Asia and Africa still engage in opportunistic Pap smear screening for eligible 
women[7].  The Pap smear screening test has a high specificity (96.0–100%) and low to 
moderate sensitivity (40.0-60.0%) for detection of premalignant lesions (CIN 2 and CIN 3) [57-
60].  
Though cytological screening for premalignant lesions of anal and vulvar regions could also 
reasonably predict the respective cancers risks at these sites, the cost effectiveness of this 
approach at the population level is unclear [61-63]. Key affected populations such as men that 
have sex with men (MSM) and women that engage in anal sex are offered anal Pap screening 
as part of STI screening guidelines by some health organisations in the USA, Europe and 
Australia [64]. The sensitivity of anal Pap smear to detect premalignant anal lesions among 
MSM is 47.0-70.0%, and it increases when anal Pap smears are complemented with HPV 
genotyping and serial anoscopy [64, 65].  Presently there is no acceptable screening strategy 
for oral cancer.  
Visual inspection with acetic acid (VIA), visual inspection with Lugols iodine (VILI) and HPV 
testing have been recommended by the World Health Organisation (WHO) as alternative 
cervical cancer screening methods to Pap smears for developing countries [66]. These 
methods are relatively cheap and are easier to interpret than Pap smears. VIA and VILI are 
used as part of the “screen-and-treat” treatment strategy for premalignant lesions [66]. Both 
methods have high sensitivity but lower specificity compared to the Pap smear[66].  
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1.3.3. HPV DNA detection for clinical use 
HPV DNA detection methods are used for clinical and research purposes. Molecular 
techniques using nucleic probe technology are the only feasible methods to detect HPV [67, 
68]. HPV DNA detection offers more information on persistence and clearance of infections 
and allows for monitoring of women with abnormal cytology who have negative 
colposcopy/biopsy findings [67, 68]. Therefore, HPV screening is useful for clinical decision-
making and follow-up of patients, as well as for clinical research and epidemiological 
studies[67].  In 2017, a systematic review on cost-effectiveness of  cervical cancer screening 
methods in low and middle-income countries showed that HPV testing is more cost efficient 
than VIA and Pap smear screening [69].  
Broadly, there are three molecular techniques for detecting HPV: nucleic acid hybridization 
assays; signal amplification assays; and nucleic-acid amplification assays [23, 67, 68]. Nucleic 
acid hybridization methods include Southern blot, in-situ hybridization and Dot blot 
hybridization. Although nucleic acid hybridization provides good quality results, it is 
technically cumbersome, time-consuming and requires a large amount of purified nucleic acid 
for HPV genome analysis [67, 68]. These issues coupled with low sensitivity make it less 
attractive as a screening method to detect premalignant lesions.  
 
The signal amplification assays are automated methods that can distinguish between high 
and low risk genotypes, but they cannot distinguish between or provide results for individual 
HPV genotypes [67, 68, 70]. These techniques serve as a complementary screening method 
to Pap smear or VIA/VILI to detect HR-HPV infections associated with premalignant and 
malignant lesions of the cervix as a point of care diagnostic method [71]. Examples of 
commercial signal amplification assays include Hybrid Capture® 2 (Qiagen Corporation, 
Gaithersburg, MD, USA) and Cervista® HPV (Hologic, Inc., Bedford, MA, USA) [71]. Signal 
amplification assays have higher sensitivity and lower false positive results compared with 
other molecular techniques. Hybrid Capture 2 is recommended for detection of oncogenic 
HPV infections in genital and non-genital sites [71].  The Care HPV test kit (QIAGEN, 
Gaithersburg, MD) is a simplified and rapid technology of the Hybrid Capture kit that has been 
shown to be very efficient as a point of 
 care test in many low-middle income countries including in Africa [72-74]. Other point of care 
screening tests for HPV detection include OncoE6 and Xpert HPV test (GeneXpert; Cepheid, 
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Sunnyvale, CA) assays [68]. Both Care HPV and Xpert HPV tests can detect 14 high-risk HPV 
genotypes [75-77]. 
1.3.4. HPV DNA detection for research use 
The nucleic acid amplification assays use polymerase chain reaction (PCR)-based techniques. 
These are highly sensitive and specific, can detect individual genotype specific result within a 
sample and have the lowest risk of contamination [67, 68]. These PCR-based techniques are 
generally used for research purposes and can be expensive for population screening 
programmes. There are various modifications of the conventional PCR technique to improve 
the quality of genotyping, reduce turnaround time and minimize errors[68]. Some of the 
examples of PCR based techniques include real-time PCR, Abbott real-time PCR, COBAS® 4800 
HPV test (Roche Molecular Systems, Pleasanton, CA, USA), CLARTW Human Papillomavirus 2 
(Genomica, Madrid, Spain),  PapilloCheck®, Anyplex™ II HPV28 assay (Seegene, Seoul, South 
Korea) and the Linear Array® HPV Genotyping assay (Roche Molecular Diagnostics, 
Pleasanton, CA, USA)[68]. These techniques vary in the number of individual genotypes they 
can detect. For example, the PapilloCheck® assay detects 24 HPV genotypes while the Roche 
Linear Array® assay detects 37 HPV genotypes in a single reaction [68, 78]. 
More novel techniques are being developed that can identify the virus and are able to 
determine biomarkers of progression of HPV infection at any anatomic site [67, 68].  These 
techniques involve detection of HPV mRNA and E6/E7 onco-proteins; the biomarkers for 
persistence of HPV infection. However, many of these techniques are still undergoing 
validation [67, 68].  
1.4. EPIDEMIOLOGY OF HPV INFECTION  
1.4.1. Prevalence of HPV infection and associated risk factors  
Prevalence of Cervical HPV Infection 
The WHO estimated that approximately 291 million women are infected with HPV at any 
given point in time [66]. According to the 2019 HPV Information Centre report, the range of 
the global prevalence of cervical HPV infection was 6.3-29.7% in cytologically normal women 
with variations across continents; the highest estimates ranged between 20.6-37.3% in sub-
Saharan Africa and the Americas[7]. In the same report, cervical HPV prevalence was highest 
among women that were less than 25 years and it declined with age except in Africa, Asia and 
Oceania, which have a second peak prevalence among women that are 50 years and above[7].  
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In the last five years (2014-2019), there were more published articles on the prevalence of 
cervical HPV among healthy populations from Asia [79-85] and South America [86-89] than 
other continents. The continent with the fewest published articles was Africa [90, 91] [Table 
1]. Most studies reported prevalence of any HPV infections alone in the cervix while others 
included prevalence of HR, type specific genotypes and multiple HPV infections in their results 
[85, 92]. Generally, prevalence of cervical HPV infection among the general population has 
not changed markedly in the last decade. A study from South America reported an unusually 
high prevalence of 74.0% among indigenous women in the northern part of the Venezuelan 
Amazonas State [86]. The unusual high prevalence was thought to be due to high burden of 
anaemia and intestinal helminthiasis in the population, which could potentially reduce 
clearance of HPV infection [86].  
Generally, a high prevalence of cervical HPV infection was more commonly reported among 
female sex workers (FSWs) and other high-risk women than amongst women in the general 
population [93-96]. FSWs engage in multiple sexual partnerships, condomless sex, and 
intravaginal cleaning practices before or after sexual acts [93, 97-99]. All of these behaviours 
increase the risk of contracting STIs, including HIV and HPV infections. 
Prevalence of Oral HPV Infection 
The reported prevalence of oral HPV infection ranges from 0-20.7% in women among healthy 
populations worldwide [26, 100-107]; however, data for oral HPV in sub-Saharan Africa (SSA) 
are few. According to a systematic review published in 2018 on the prevalence of oral HPV 
among healthy populations of men and women, only five out of the 63 studies reviewed were 
from South Africa [26]. In this review, the average global prevalence of oral HPV was 7.7% 
(95%CI 6.8-8.6) with variations across the continents; the reported prevalences were higher 
in South America (12.4%), Europe (9.9%) and North America (7.7%) than Africa (7.0%), 
Oceania (4.6%) and Asia (2.6%). The reported average prevalence of oral HPV was higher in 
men (9.3%) than women (5.5%), and HPV 16 was the most prevalent genotype [26]. The 
observed gender difference in the reported prevalence of oral HPV might be due to a higher 
prevalence of multiple sexual partnerships in men, or because cunnilingus transmits HPV 
infection to the oral cavity more efficiently than fellatio [108-110].  FSWs and women who 
engaged in illicit drug use also had higher a prevalence of oral HPV infection compared with 
women in the general population [26, 105]. 
25 | P a g e  
 
Other risk factors associated with oral HPV infection apart from oral sex include being HIV 
positive, HPV infection at other sites, having partners with abnormal cervical cytology or 
cancer, age at sexual initiation and alcohol consumption [111]. A few studies found a higher 
prevalence of oral HPV infection in heterosexual men than in homosexual men [112]. The 
plausible explanation is the increased risk of oral HPV infection from genital mucosa of a 
female partner compared to the keratinised skin surfaces of the penile shaft [113, 114].   
Prevalence of Anal HPV Infection 
There are more studies on anal HPV infections among MSM in high-income countries than 
among heterosexual men and women.  In 2019, a systematic review of 1805 HIV-negative 
men who have sex with women (MSW), 924 HIV-positive MSW, 8213 HIV-negative MSM and 
12758 HIV-positive MSM reported an average prevalence of any anal HPV of 47.0% in HIV-
negative MSM and 12.0% in MSW[115]. Similarly, anal HPV infection was 79.0% and 43.0% in 
HIV-positive MSM and MSW, respectively [115]. In the same review, higher proportions of 
MSM had anal HPV 16 infections than the MSW population [115]. In another systematic 
review (2015), the prevalence of HR anal HPV infection was 4.0-22.0% among HIV negative 
women with no other HPV related pathology and 23.0-36.0% in those with HPV-related 
pathology of cervix, vulva and vagina [116].  
Most studies that reported on the prevalence of anal HPV infection in SSA were conducted 
among MSM [117-119].  The prevalence of anal HPV ranged from 40.6-91.1% among MSM 
with a higher prevalence among those with HIV infection relative to the HIV negative 
population of MSM [118, 120, 121]. However, there is a paucity of data on the prevalence of 
anal HPV infection among healthy heterosexual men and women in SSA. Two Zimbabwean 
studies separately reported a prevalence of 44.0% [122] and 48.0% [123] of anal HPV infection 
among HIV positive and negative women respectively. A South African study found that 79.0% 
of HIV positive men had anal HPV and about a third of them had multiple HPV genotypes 
[124].  
Available data on gender differences of anal HPV infections showed mixed results. A number 
of studies found a higher prevalence of anal HPV infection in women than men, and this has 
been associated with receptive anal sex by women and possibly as result of viral shedding 
from other HPV infected genital sites [122, 125]. A Zimbabwean study showed that 60.3% of 
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women and 20.4% of men had anal HPV infections in a cohort of people living with HIV in the 
community [122]. Another study from Brazil found that 71.3% of men and 67.1% of women 
had an anal HPV infection [125]. Some risk factors associated with acquisition of anal HPV 
infections include history of anal sex including digito-anal contact, a high number of lifetime 
anal sex acts, the presence of HPV in other genital sites, early sexual initiation, use of barrier 
methods and immunosuppression [125-127]. Detection of multiple anal HPV genotypes was 
also associated with having a high number of sexual partners [115]. However, the presence 
of a CD4 count in excess of 500 in HIV positive women is protective against multiple anal HPV 
infection [128].  
Prevalence of Vulvar HPV Infection 
Although several studies have linked HPV infection with vulvar intraepithelial neoplasia (VIN) 
and vulvar cancer, the data on the prevalence of vulvar HPV infections among healthy 
populations of women are limited worldwide [7, 129, 130]. A study demonstrated that vulvar 
samples can produce good quality HPV DNA for easy detection [131]. For example, a study in 
the USA compared HPV detection rates from the vulvar and cervical samples in women 
referred for colposcopy [131]. The results showed similar pick-up rates between vulvar and 
cervical samples for any HPV (82.4% vs 87.5%) and at least one oncogenic HPV genotype 
(72.1% vs 73.6%)[131]. Another study that used residual vulvar-vaginal swab samples of 
adolescents and young adults that were recruited for the National Chlamydia Screening 
Programme or Prevention of Pelvic Infection trial in the UK to investigate the prevalence of 
HPV at vulvar-vaginal site [132]. The prevalence of HR-HPV in the vulvar-vaginal samples was 
higher in participants aged 16-24 years (34.6%) than in 13-15year old adolescents (22.6%). In 
the same study, the prevalence of HPV 16 and 18 increased by age from 20.0% in 14 years to 
a peak of 39.0% at 19 years[132].  
A Chinese study among 2,327 women (18-55 years) showed that the prevalence of any vulvar 
HPV, HR-HPV and LR-HPV were 13.3%, 12.8% and 0.8%, respectively [133]. HPV 52 was the 
most common genotype detected (4.4%). In this same study, women living in urban settings 
who had a high number of lifetime sexual partners in the past year, or who had ever used a 
towel supplied by a hotel had a higher odd of having a vulvar HPV infection than those without 
using towel [133].  
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Penile HPV Infection 
Most studies reporting the prevalence of penile HPV infections were conducted among MSM, 
and they were largely from high-income countries [7, 134-136]. A meta-analysis of penile HPV 
infection involving 14,800 participants from 23 countries reported a wide range of prevalence 
figures from 1.0-84.0% and 2.0-93.0% among LR and HR men, respectively [136]. Another 
meta-analysis in 2018 that included 18,106 participants from studies that were published in 
English and Spanish language reported a prevalence range of 35.0-64.0%  for any HPV and 
26.0-45.0% for HR-HPV[135].  
In SSA, a systematic review involving 9342 men reported an average pooled prevalence of 
penile HPV infection of 78.2% among HIV positive and 49.4% among HIV negative men [137].  
The most common HR-HPV genotypes were 16, 52 and 58.   Similar to other reviews, there 
were higher odds of penile HPV infections among uncircumcised men than among 
circumcised men [134, 138]. The biological explanation for the increased risk of HPV infection 
among uncircumcised participants is the high likelihood of HPV acquisition through the moist 
mucosa underneath the prepuce compared with acquisition through the keratinised scar of 
the circumcised area [136, 137]. A higher prevalence of HPV infections was reported among 
MSMs compared to heterosexual men, younger compared to older populations, men with 
higher numbers of lifetime sexual partners, men who engaged in  inconsistent condom use, 
men who reported bathing less frequently and men engaging in illicit substance use [135] 
[138]. Some studies have also shown that the prevalence of penile HPV infection can also be 
associated with the method of sample collection [139, 140]. Collection of samples from the 
penile shaft, coronal sulcus and glans provides a better yield of DNA and prevalence of HPV 
than samples collected from the penile urethral meatus alone[139].  
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					 	  Table 1.3: Prevalence of cervical HPV among women [2015-2019]	
















Wolday 2018 2008-2009 AFRICA 
[Ethiopia] 
Cross-sectional PCR  ≥40 Women in the clinic 141 48.9 
Fowotade 2018 NS AFRICA 
[Nigeria] 
Cross-sectional Serology (IgG & 
IgM) 
 Volunteer women 
in the clinic 
90 20.01 
Nejo 2018 2014-2015 AFRICA 
[Nigeria] 




Okunade 2017 NS AFRICA 
[Nigeria] 
Cross-sectional PCR 20-63 Women in the 
community/clinic 
200 36.52 
Ardhaoul 2016 2012-2013 AFRICA 
[Tunisia] 




Yuan 2019 2019 ASIA  
[China] 
Hospital records GenoArray kit 21-29 Women with 
normal cytology 
9945 13.51 
Liu 2019 2013-2016 ASIA [China] Hospital records Linked Biotech HPV 
kit 
≥15 Women attending 
gynaecology clinic 
19700 16.31 
Ge 2019 2016-2017 ASIA [China] Cross-sectional TellgenplexTM HPV 
DNA Test 




Thapa 2018 2011 ASIA  
[India] 












Sainei 2018 2016-2017 ASIA 
[Malaysia] 
Cross-sectional PCR 18-70 Volunteer healthy 




Mirbahari 2018 2015-2017 ASIA 
 [Iran] 




Aziz 2018 2014-2016 ASIA 
 [Pakistan] 




Zhong 2018 2010-2015 ASIA 
 [China] 

















Seneldir 2019 2013-2015 EUROPE 
[Turkey] 
Hospital records Cervista HPV HR & 
HPV 16/18 
18-75 Women with 
normal cytology 
922 18.72 















 1- overall/any HPV prevalence; 2 – any HR-HPV; 3 - information on HPV prevalence by methods of sample collection; NS – Not stated; PCR – Polymerase 
Chain Reaction; 4 – 21-30 years; 5 – 31-65years
Kovachev 2018 2012-2016 EUROPE 
[Bulgaria] 
Cross-sectional PCR – GenoFlow 
HPV Array  
15-55 Volunteer women 
in the community 
5277 29.81 
Bretagne 2018 2008-2017 EUROPE 
[France] 
Cross-sectional Hybrid Capture®  Volunteer women 











Lee 2018 2014-2015 NORTH 
AMERICA 
[USA] 
Cross-sectional PCR 21-65 Women in the 
communityAMI 
730 34.82 





PCR    21-304 
31-655 
Women in the 
community/clinic 







Cross-sectional SPF 10 PCR LiPA25 12-53 Women in the 
community/clinic 
228 74.01 
Teixeira 2018 2014-2015 SOUTH 
AMERICA 
[Brazil] 
Cross-sectional BD OnclarityTM HPV 
Assay 
≥18 Women living with 








Cross-sectional  PCR ≥18 Volunteer healthy 
women in the 
community/clinic 
397 63.62 
Vergara 2017 2014-2016 SOUTH 
AMERICA 
[Chile] 
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Tam et al 2018 1995-2017 Global data Systematic review PCR NS Men and women 56,600 M: 9.3
1 
F: 5.51 
Shigeishi 2016 2012-2015 Global Systematic review 
20 studies PCR & 9 
studies used 
qualitative methods 




Chikandiwa 20183,4 2012 AFRICA [SouthAfrica] Cross-sectional Roche Linear Array ≥18 
Men in the 
community/clinic 181 0.6-1.8
1 
Wang 2019 2016 ASIA [Taiwan] Cross-sectional EasyChip genotyping array 20-70 
















Bumrungthai 2019 NS ASIA  [Thailand] Cross-sectional PCR 1-60 











Healthy control men 
and women in the 
community/clinic 
 3.21 









Ciccarese 2017  EUROPE [Genoa] Cross-sectional PCR 18-82 






31 | P a g e  
 
Drago 2018 2015-2017 EUROPE  [Italy] 
Review of medical 
records PCR  
Men and women in 
the community/clinic 274 32.8
1 
Lupato 2017 2014-2015 EUROPE  [Italy] Cross-sectional PCR 18-35 










Cross-sectional PCR 18-25 University students M:67 F:57 4.0
1 
Dalla 2016 NS EUROPE [Austria] Cross-sectional PCR 18-20 
Adolescents & adults 
in the community 310 18.1
1 
Grun 2015 2013-2014 EUROPE [Sweden] Cross-sectional PCR 15-23 
Adolescents & young 






Tatar 2015 2004-2013 EUROPE [Hungary] Medical records PCR 16-82 
Men and women in 
the community/clinic 209 5.7
1 









Winer 2018 2011-2012 NORTH AMERICA [USA] Cohort PCR 30-50 
Women in the 
community/clinic 403 20.6
1 
Orosco 2016 2009-2012 NORTH AMERICA [USA] NHANSE survey Roche Linear Array 18-69 






D’Souza 2016 2010-2012 NORTH AMERICA [USA] 
Randomised 
Controlled Trial PCR 18-25 
Adolescents & young 










Cross-sectional PCR 15-71 
Adolescents & adult 
women in the 
community 
390 14.01 
Chatuverdi 2015 2009-2012 NORTH AMERICA [USA] NHANES survey Roche Linear Array 14-69 
Adolescents & adults 
in the community 9480 
M:10.51 
F:3.11 
Bui 2015 2013 NORTH AMERICA [USA] Cross-sectional PCR 18-45 
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1- overall/any HPV prevalence; 2 – any HR-HPV;	3- HIV positive population; 4– compared two methods of oral sampling; PCR – Polymerase Chain Reaction; NS – 
Not stated; 
Beachler 2015 2010-2011 NORTH AMERICA [USA] Cohort Roche Linear Array  
Men and women in 







Cross-sectional Roche Linear Array ≥18 Men and women in the community/clinic 104 8.7
1 



















2015 NS AUSTRALIA Cross-sectional PCR NS 
Adolescents & adults 
in the community 234 3.2
1 
33 | P a g e  
 
Table 1.5: Prevalence of Anal HPV in men and women (2014-2018] 
 
1- overall/any HPV prevalence; 2- HIV positive population; 3 – any HR-HPV; PCR – Polymerase Chain Reaction; NS – Not stated 
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 [France] 
Cohort Roche Linear 
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Smelov 2018 2006-2009 EUROPE [Russia] Cross-
sectional 





Posso 2018 2005-2010 SOUTH AMERICA 
[Mexico] 


















Table 1.6: Prevalence of vulvar HPV in women (2012-2018] 
 























Wei 2018 2014 ASIA 
[China] 






Sahasrabuddhe 2014  
NS 
USA Medical records PCR Median 
age 28.0 






Howell-Jones 2012 2008 UK Cross-sectional  Roche Linear 
Array 
< 25.0 Women recruited 
for STI screening 
3829 34.6
2 
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1.4.2. Association between HPV infection and the changing pattern of sexual 
behaviours 
In the past two decades, there has been a rising global prevalence, as well as incidence, of 
HPV infections and HPV-related cancers in genital and non-genital anatomic sites [7, 141, 
142]. This is believed to be due to changing sexual behaviours among general and key affected 
populations, including earlier sexual debut, increased number of multiple partners, and 
increased oral and anal sexual intercourse [6, 143, 144]. Similarly, studies have highlighted 
the role of oral and anal sex in the increasing incidence and prevalence of other STIs in the 
oro-pharynx and in the anus [145-147]. 
Available data from the United Kingdom, United States of America, Australia and Europe have 
shown that oral and anal sexual behaviours are increasingly reported together with vaginal 
sex among adolescents and young adults, FSWs and other key affected populations [148-154]. 
For example, Mercer et al compared trends of oral and anal sex in the UK general population 
using the National Survey of Sexual Attitudes and Lifestyles (Natsal 1, 2, and 3) datasets 
among 16-44 year old from 1990 – 2012[155].  The reported prevalence of any anal sex within 
the past year among women was 6.5% between 1990-1991 (Natsal 1), 11.3% between 1999-
2001 (Natsal 2), and 15.1% between 2010-2012 (Natsal 3)[155]. The proportion of women 
that had oral sex in the preceding year also increased from 65.6% in the first survey to 76.8% 
in the second survey, and 75% in the last survey [155]. The proportion of men who have 
performed oral sex in the last year was 69.7% in Natsal 1, 77.9% in Natsal 2 and 77.1% in 
Natsal 3, while the proportion of men who received oral sex was 7% in Natsal 1, 12.2% in 
Natsal 2 and 17% in Natsal 3[155].  
There is emerging evidence that sexual behaviours may also be changing in SSA that could, in 
turn, increase the incidence of HPV infections in oral and anal anatomic sites as well as in 
cervical and penile sites. Although a systematic review on anal sex showed that anal sex is 
being practiced among youth in SSA, information on anal sex among adult populations 
reporting heterosexual anal sex has not been systematically reviewed [156].  It is also not very 
clear how oral sexual practices among adolescents and adults are being investigated and 
reported in the sub-region.   This thesis presents a systematic review on the reported oral and 
anal sex among adolescents and adults reporting heterosexual sex in SSA that shows that 
these behaviours are commonly reported among men and women[157]. In brief, the 
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prevalence of having ever practiced oral sex ranged from 1.7% to 47.2% and having ever 
practiced anal sex ranged from 0.3% to 46.5%. Higher prevalences of both sexual behaviours 
were reported among key affected populations such as FSW and also amongst men in the 
general population compared with women in the general population[157]. 
1.5. RATIONALE FOR THE STUDIES IN THIS THESIS 
Although the prevalence of cervical HPV is high in SSA, there is a paucity of robust data on the 
prevalence of HPV in other genital and non-genital sites among healthy adolescents and adult 
women in the general population and among FSWs, particularly in West African countries 
such as Nigeria. The prevalence of reported oral and anal sex in SSA among people practicing 
heterosexual sex is unknown. Another critical gap is the lack of published qualitative studies 
on oral and anal sexual behaviours among men and women in the general and key affected 
populations in Nigeria, a country that is characterised by complex socio-cultural beliefs and 
practices. In addition, the association between oral and anal sexual behaviours and HPV 
infections in the general populations or in FSWs, has not been well explored in the West 
African sub-region. These gaps make it difficult to understand the importance of these 
changing sexual behaviours on the burden of HPV infections and HPV-associated cancers in 
the sub-region.  
Presently, there are no nationally representative data on the HPV-related cancer burden in 
Nigeria but estimates from extrapolation of local studies show that the country has one of 
the highest burdens of cervical cancer in the world, after eastern and southern African 
countries.  It is estimated that 14,943 new cervical cancer cases and 10,403 related deaths 
occur each year in Nigeria, accounting for 27.2% of cervical cases and 20.0%  of cervical cancer 
deaths in West Africa[7]. A study in Nigeria reported that the age-standardized incidence rates 
per annum for some HPV attributable cancers among women are as follows: 28.3 per 100,000 
for cervical cancers, 0.6 per 100,000 for anal cancers, 0.5 per 100,00 for vulvar cancers and 0-
0.3% per 100,000 for oropharyngeal cancers[158]. The crude death rate in 2012 attributable 
to cervical cancer was 17.1 per 100,000 [7, 159]. There are no published data on crude death 
rates for vulvar, vaginal, anal or oropharyngeal cancers in Nigeria.   
In the past two decades, studies on HPV infections among Nigerian women were generally 
limited to the cervix. The reported prevalences of cervical HPV infections ranged between 
3.5%-37.0% [91, 160-163]. The results from these studies varied according to HIV status, the 
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DNA techniques that were used, and age; the highest prevalence of HPV occurred among the 
younger populations. Despite the reported oral and anal sexual behaviours among adolescent 
girls and women in Nigeria, there are no published data on the prevalence of oral, anal or 
vulvar HPV infections.  
In order to fully understand the impact of changing sexual behaviours on the prevalence of 
HPV infections in Nigeria, it is important to learn about the socio-cultural interpretations of 
sexual behaviours, which are often considered to be a very sensitive topic of discussion in the 
community. Information on terminologies or colloquial terms as well as perception and 
meaning of oral and anal sexual behaviours among people practicing heterosexual sex are not 
well documented in Nigeria or West Africa. 
The Sexual Behaviour and HPV Infection in Nigerians in Ibadan (SHINI) study presented in this 
thesis aims to address these gaps by seeking to understand the epidemiology of HPV 
infections in genital, oral and anal niches and their association with sexual behaviours among 
women in the community and brothels in Ibadan, Nigeria. This research has the potential to 
fill a critical gap in scientific knowledge and influence policy and programming in the country, 
as well as in SSA through sharing of findings with the appropriate authorities. The study will 
provide information on the prevalence of HPV infections in sexually active adolescents and 
adults.  It will also generate data on sexual behaviours and associated risks of HPV infection 
in the community. 
1.6. AIMS AND OBJECTIVES 
The aim of this thesis is to describe the epidemiology of HPV infections and the patterns of 
genital, oral and anal sexual intercourse associated with prevalence of genital, oral and anal 
HPV infections among sexually active older adolescents (≥18 years) and adults and FSWs aged 
18-45 years in Ibadan, Nigeria.  
The specific objectives are to: 
1. explore knowledge, socio-cultural interpretation and different ways of learning sexual 
behaviours among older adolescents and adults in the community, and among FSWs 
in Ibadan; 
2. describe attitudes, motivations, potential health risks and stigma associated with 
engaging in oral and anal sexual behaviours among older adolescents and adults in the 
community, and FSWs in Ibadan; 
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3. determine the prevalence of oral, genital (cervical and vulvar) and anal HPV infections 
among older adolescents, adult females in the community and FSWs in Ibadan; 
4. determine the risk factors associated with any HPV infection in each of the anatomic 
sites (cervix, oral cavity, vulvar and anal cavity) among older adolescents and adult 
females in the community, and FSWs in Ibadan; and 
5. examine the concordance of HPV genotype-specific infections in different anatomical 





1.7. NIGERIAN CONTEXT AND STUDY SETTING 
Nigeria, with an estimated population of 201 million, is the most populous country in Africa, 
and more than half of its population is less than 40 years of age[164]. Nigeria operates a 
presidential system of government comprising of the Federal, State and Local government 
authorities. The country has 36 states and 774 local government areas (LGAs) for 
administrative and political purposes. Each LGA is headed by a chairman that is usually elected 
for a term of three years in accordance with the Nigerian constitution, and in absence of an 
elected chairman, a caretaker committee is appointed by the Governor of the state before 
election is conducted.  Each community within an LGA has a traditional ruler or village head 
that oversees daily activities of the community with his chiefs. In addition, each community 
has a representative on the social mobilization sub-committee at the LGA. The committee 
acts as liaison and advisory body on health-related issues including conduct of scientific 
research in the community.  There are over 500 languages in Nigeria and the major ethnic 
groups are Hausa, Yoruba and Igbo accounting for 25.0%, 21.0% and 18.0%, respectively[165]. 
The main religions are Christianity, Islam and Traditional African religion[164]. The country is 
largely patrilineal, particularly in rural communities[166, 167]. 
Nigeria, with a gross national income per capita of 5,360 United States Dollars (USD), has an 
average life expectancy at birth of 55 years for males and 56 years for females [168]. Nigeria 
has never achieved the minimum required spending on health of 15.0% set by the UN [168, 
169]. The country has three levels of health systems: the primary level controlled by the Local 
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Government, the secondary level controlled by the State Government, and the  tertiary level 
controlled by the Federal Government [169]. Nigeria currently has 29,854 primary health 
care, 3,768 secondary health care and 47 tertiary health care facilities[170]. About 73.0% of 
these health facilities are owned by the government, 12.0% are owned by the private sector, 
14.0% are owned by both government and private sectors and 1.0% are faith based 
organisations[170].  Although the country has a National Health Insurance scheme, this only 
covers approximately 5.0% of the population [171, 172]. The healthcare system is therefore 
largely driven by out-of-pocket expenses. Screening for non-communicable diseases including 
cancer is usually performed without clear national guidelines[172]. Traditional healthcare in 
the community is a recognized alternative form of healthcare that involves the use of locally 
made herbs and incantations.  
Nigeria currently ranks fourth among countries with people living with HIV infection after 
India, South Africa and Mozambique. The acquisition of HIV  infection in Nigeria is largely 
driven by heterosexual vaginal sex among general and key affected populations[173]. It is not 
known what proportion of new cases of HIV and STI in Nigeria may be due to condomless 
heterosexual oral and anal sexual practices [174-176].  
The Nigerian constitution forbids sex in exchange for money or favours, and any business that 
may be associated with it[177].   FSWs suffer discriminations and abuse from people in the 
community [178]. In spite of legal restrictions, the Federal Ministry of Health and some 
international donor agencies routinely collect health related data from FSWs and other key 
affected population groups [179]. Government and donor agencies also offer interventions to 
minimize health risks among FSWs and in the community[180, 181]. For instance, Nigeria has 
conducted three Integrated Biological and Behavioural Surveillance Surveys (IBBSS) in 2007, 
2010 and 2014 among MSM, FSWs, people who inject drugs and other high-risk groups in the 
country, such as transport workers, officers, men of the Armed Forces and the Police [180]. 
Several HIV prevention programmes such as HIV counselling and testing, negotiation skills for 
condom use and access to anti-retroviral drugs are being supported by the Federal 
Government of Nigeria and their partners for FSWs and other key affected population 
groups[182]. 
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The SHINI study was conducted in Ibadan metropolis. Ibadan is the commercial and the 
political capital city of Oyo state, which is located in the southwestern region of Nigeria. Oyo 
state has 33 LGAs councils. At the time of the 2006 Nigerian census, Ibadan had a population 
of 2,550,593 with a population growth rate of 2.35 %[183]. Administratively, the metropolis 
has 11 LGAs councils consisting of five urban LGAs in the city (Ibadan North, Ibadan North-
East, Ibadan South-East, Ibadan South-West and Ibadan North-West)  and 6 peri-urban LGAs 
(Akinyele, Lagelu, Egbeda, Ona-Ara, Oluyole and Ido) [184]. Two Nigerian premier tertiary 
institutions – the University of Ibadan and the University College Hospital – are located in the 
metropolis.  
Figure 1.2: The map of Nigeria with 36 States and Federal Capital Territory; LGAs in Oyo state 










1.8. STRUCTURE OF THIS THESIS 
This thesis consists of six chapters. This introductory chapter has introduced the topic of HPV, 
along with its natural history, pathogenesis of infections, screening and detection strategies, 
epidemiology, and related morbidities in the oral and anogenital sites. It has also described 
the current gaps in knowledge and outlined the aims and objectives of the PhD thesis.  
Chapter 2 will systematically review the published literature on the prevalence of reported 
oral and anal sex in sub-Saharan Africa. This systematic review has been published in the 
Reproductive Health Journal.  
 
Five urban LGAs in Ibadan (red) surrounded by Six 
peri-urban LGAs 
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Chapter 3 will describe a qualitative formative study to (explore knowledge and perceptions, 
interpretations, local terminologies, motivations and potential health risks associated with 
heterosexual oral and anal sexual behaviours) carried out among older female adolescents 
(≥18 years) and adults in the community and among brothel workers in Ibadan. This chapter 
will present the methods, results and a brief discussion. Results from this study were used to 
develop the questionnaires for the studies described in Chapters 4 and 5. 
Chapter 4 will present the cross-sectional study to determine the prevalence of and risk 
factors for HPV infections in the cervix, oral cavity, vulvar and anal canal among older 
adolescents/young adults in Ibadan. This chapter will present the methods, results and a brief 
discussion of the results. 
Chapter 5 will present the cross-sectional study (which will determine the prevalence of and 
risk factors for HPV infections in the cervix, oral cavity, vulvar and anal canal) carried out 
among brothel workers in Ibadan. This chapter will present the methods, results and a brief 
discussion of the results. 
In Chapter 6, the results of chapters 3, 4 and 5 will be discussed, including the strengths and 
limitations of the research. This chapter will conclude with recommendations for future 
studies and programmes, as well as a discussion of areas for future research.  
1.9. SCOPE OF WORK CONDUCTED BY THE PHD CANDIDATE 
This section describes the role of the PhD candidate Imran Morhason-Bello (IMB) and others 
in different aspects of this research work. IMB led the draft of the systematic review protocol 
and the design of the data extraction tool, registered the protocol in the Prospero database, 
conducted the literature search, screened and retrieved titles and abstracts with another 
reviewer, extracted and synthesized the data, and wrote the first draft of the manuscript 
(Chapter 2). Professor Deborah Watson-Jones (DWJ) and Dr. Suzanna C. Francis (SCF), IMB’s 
PhD supervisors, supervised the design and development of the systematic review protocol, 
literature search, data extraction and synthesis and reviewed and comments on drafts of the 
manuscript.  
 
With regards to the field research work, IMB conceptualized the study idea with DWJ and SCF. 
He drafted the study protocol and data collection tools and developed the field procedures 
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manual with the guidance and support of DWJ, SCF and the PhD advisory committee 
members. IMB managed the fieldwork and led and coordinated all field activities from Ibadan. 
These activities involved the recruitment of field staff, the training of staff, and the daily 
coordination of the fieldwork for both the qualitative and the cross-sectional studies. For the 
qualitative study, IMB coded the transcripts with two other independent researchers 
experienced in the use of Nvivo software (QSR International Pty Ltd. Cardigan UK). The final 
analysis of the qualitative data and the report writing was performed by IMB and supervised 
by IMB’s PhD supervisors and advisors.  
With regards to the cross-sectional study, the HPV genotyping was conducted at the Catalan 
Institute of Oncology (ICO), Spain, by a team of laboratory scientists led by Dr Miquel Pavon. 
IMB visited the ICO laboratory to observe how the genital, oral and anal samples were 
analysed. IMB led on the cleaning of the data with one of the data analysts that performed 
double data entry.  IMB wrote the do-files and carried out the statistical analysis, generated 
results and wrote the thesis under the supervision by DWJ and SF, and advisors. Dr. Kathy 
Baisley supervised the statistical components of the field work. 
 
 
2.0. SOURCE OF FUNDING 
The management of University of Ibadan, Nigeria, funded IMB’s research degree programme 
(salary and school fees), and the research work as part of the capacity building programme 
for young academics employed by the institution
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CHAPTER 2:	 LITERATURE REVIEW ON ORAL AND ANAL SEXUAL 
BEHAVIOURS	
2.1. PREAMBLE 
According to the WHO , the global burden of STI is very high,  compromising the quality of life, 
including sexual and reproductive health, of a large number of people worldwide [185]. 
Current estimates indicate more than one million people acquire an STI every day, primarily 
from penetrative (vaginal, oral and anal sex) and non-penetrative (masturbation) sexual 
contacts [185, 186]. Sexual behaviours among adolescents and adults need to be properly 
understood in order to appreciate the burden of associated health risks such as STIs and other 
associated morbidities, such as cancers, globally. Although a review from SSA synthesised 
information among young people reporting heterosexual anal sex, there are no such reports 
on oral sex [156]. In addition, published information on oral and anal sex among adults in 
heterosexual relationships has not been systematically reviewed and synthesised among 
studies carried out in SSA.  
Collection of data on sexual behaviours is complex due to the sensitive nature of the subject 
[187-189]. Over the years, some researchers have tried to improve on the quality of 
information collected by using simple and clear definitions for different sexual behaviours. 
The aim was to improve comprehension and elicit correct responses from participants 
without any emotional harm [188, 190]. Clear definitions of sexual behaviours improve the 
ability to  compare data making it possible to generalise findings [188].  In addition, 
information on the roles played by individuals during sexual activities should be collected for 
proper profiling of risks that might be associated with such behaviours [185].  
The methodology used to collect data during sexual behaviour research can also determine 
the quality of information that is collected [189, 191, 192]. Examples of data collection 
methods that are commonly used include audio computer assisted self-interviews (ACASI), 
computer assisted personal interviews (CASI), face-to-face interviews (FTFI), self-
administered questionnaires (SAQ), telephone-and computer-assisted interviews (T-ACASI), 
telephone interviews with a human interviewer (TI), timeline-follow back assessments (TLFB), 
and use of diary self-completed methods[192]. Each of these methods has its own strengths 
and weaknesses. For example, data collection of sexual behaviours with interview methods 
44 | P a g e  
 
(FTFI and ACASIs) are more closely associated with recall and social desirability bias than the 
daily self-completed diaries, particularly when questions are asked on duration of sexual acts 
and number of sexual partners [193, 194]. Among different interview methods, FTFI is more 
closely associated with social desirability bias and under-reporting of sexual behaviours than 
ACASI methods[195]. 
Comparatively, in heterosexual relationships, there is more information on vaginal than oral 
and anal sexual behaviours for risk factor for STIs and other associated morbidities, especially 
among people engaging in heterosexual sex [190]. Apart from the general risks associated 
with condomless penile-vaginal sex, the health risks associated with oral and anal sexual 
behaviours also depend on the role of individual during sexual act. For example, receptive 
anal sex is riskier than insertive anal sex in acquisition of HIV and other STIs [196]. However, 
the risks associated with condomless oral sex are slightly different; the role of giving oral sex 
appear to be riskier than receiving oral sex[197]. It is important to collect detailed information 
that will not only record the sexual act but also document potential risks that might be 
associated with such behaviour [190, 198]. Such information will also provide insight into the 
burden of STIs, including HPV, in the community and assist policy makers and programmers 
to design relevant interventions that will aid prevention and treatment [190]. Whilst high 
quality data on oral and anal sexual behaviours are available in high-income countries such as 
the United Kingdom, United States and Australia [199-201], the quality of data in SSA are 
unknown.  
This chapter presents a systematic review of published scientific articles in SSA on oral and 
anal sex among men and women that are reporting heterosexual sex. The review reports a 
range of prevalence values across different population groups, identifies associated risk 
factors, describes interpretations of oral and anal sex, assesses the quality of published 
papers, identifies gaps, and makes recommendations to improve the quality of future 
research from SSA on oral and anal sexual behaviours. This systematic review was carried out 
before the SHINI study was conducted with the aim to synthesize the published data on oral 
and anal sexual behaviours, the main exposures for HPV infection. 
The systematic review was presented by IMB as a poster presentation at the 30th International 
Papillomavirus Society Conference in 2015 at Lisbon, Portugal.  
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The full manuscript was published in the Reproductive Health Journal in 2019. IMB developed 
the initial concept for this review, conducted the literature search, registered the review in 
Prospero databased, screened the titles and abstracts with another person, extracted the 
data, wrote the first draft and submitted to the Reproductive health journal. Each step was 
supervised by DWJ and SCF.   
  
46 | P a g e  
 






















47 | P a g e  
 
2.3. COPYRIGHT AGREEMENT 
Open Access 
This article is distributed under the terms of the Creative Commons Attribution 4.0 
International License (http://creativecommons.org/licenses/by/4.0/), which permits 
unrestricted use, distribution, and reproduction in any medium, provided you give 
appropriate credit to the original author(s) and the source, provide a link to the Creative 
Commons license, and indicate if changes were made. The Creative Commons Public Domain 
Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the 
data made available in this article, unless otherwise stated
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2.4.  REPORTED ORAL AND ANAL SEX AMONG ADOLESCENTS AND ADULTS 
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ABSTRACT  
Background: Oral and anal sexual behaviours are increasingly reported among adolescents 
and adults reporting heterosexual sex in peer-reviewed journals in high income countries, but 
less is known about these behaviours in low and middle-income countries, especially in sub-
Saharan Africa. The aim of this systematic review is to describe the prevalence of, and 
motivations for, oral and anal sex among adolescents and adults reporting heterosexual sex 
in sub-Saharan Africa. 
Methods: A systematic review of published articles that reported oral and or anal sex in sub-
Saharan Africa was conducted from seven databases up to and including 30th August 2018.  
Results: Of 13,592 articles, 103 met the inclusion criteria. The prevalence of reporting ever 
practising oral sex among adolescents, university students and a combined population of 
adolescents/adults ranged from 1.7-26.6%, 5.0-46.4% and 3.0-47.2% respectively. Similarly, 
prevalences of reported ever practising anal sex ranged from 6.4-12.4% among adolescents, 
0.3-46.5% among university students and 4.3-37.8% amongst combined population of 
adolescents and adults. Higher prevalences of oral and anal sex were reported among 
populations at high-risk for sexually transmitted infections and HIV and university students 
and, in most studies, both behaviours were more commonly reported by males than females. 
Heterosexual oral and anal sexual acts were associated with some high-risk behaviours such 
as inconsistent condom use and multiple sexual partners.  
Conclusion: Reported oral and anal sex between men and women are prevalent behaviours 
in sub-Saharan Africa. Health professionals and policy makers should be aware of these 
behaviours and their potential associated health risks.  
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PLAIN ENGLISH SUMMARY 
Oral and anal sexual acts are increasingly reported in peer reviewed journals, especially 
among adolescents and young adults in high income countries. These behaviours are 
associated with negative health outcomes such as STIs. Oral and anal sex may be important 
unrecognised modes of transmission for STIs, contributing to onward transmission. In 
addition, STIs in the oropharynx and anus may result in poor health outcomes such as oral 
and anal cancers; however, oral and anal sex are not always regarded as ‘hetero-normative 
sexual intercourse’, and are often disregarded by researchers, programmers and policy 
makers. Importantly, both sexual acts are sometimes perceived by some people to be safer 
than vaginal sex against pregnancy and STIs, and are associated with lower reported use of 
condoms to prevent HIV and STIs. 
We conducted a systematic review of published scientific papers reporting these behaviours 
in SSA between 1946 and 30th August 2018. We investigated the prevalences of oral and anal 
sex, and factors that influenced these behaviours.  
Our findings showed that oral and anal sex were commonly reported among adolescents and 
adults as well as FSWs. We found that more boys/men reported oral and anal sex than 
girls/women in most of the studies, and that a substantial number of those engaging in oral 
and anal sex did not use barrier methods during those sexual acts. 
In summary, oral and anal sexual behaviours are commonly reported in sub-Saharan Africa 
among people reporting heterosexual sex. While testing for oropharyngeal and anal 
infections may not be feasible in resource-constrained settings, these data are important for 
researchers, programmers and policy makers to raise awareness of these potential modes of 
STI transmission. Information about the risk of STI transmission for oral and anal sex should 
be included in information, education and counselling programmes for both general and key 
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BACKGROUND INFORMATION 
Condomless heterosexual oral and anal intercourse have been associated with extragenital 
STIs such as Chlamydia trachomatis, Neisseria gonorrhoea, syphilis, hepatitis, herpes simplex 
virus (HSV) and HPV infections in the anal and oropharyngeal niches [202-207]. Although oral 
and anal STIs are frequently asymptomatic they remain an important source of onward 
transmission [202-204, 206]. Clinical sequelae of oral and anal STIs include pain, anal 
discharge, ulcerative proctitis, and HPV-associated premalignant lesions and cancers [203, 
204, 207, 208]. The comparative risk of HIV infection transmission between condomless anal 
sex and vaginal sex is higher than oral sex, and the risk is higher among those engaging in 
receptive anal sex than insertive anal sex when other HIV prevention methods, such as anti-
retroviral treatment or preexposure prophylaxis, are not used[209, 210].  
Several studies have reported a higher prevalence of oral and penile-anal sex among key 
affected populations’ such as FSWs [211, 212], MSM[213], entertainment outlet workers, long 
distance drivers, and people who inject drugs, compared to general populations [214]. Most 
studies report low or inconsistent condom use during oral and anal sex. For example, in Lima, 
Peru (2010), 98.4% of FSWs aged 18-26 years had performed oral sex in their lifetime and only 
20.0% reported condom use during the sexual act [212]. Another study in Peru (2013) showed 
that 21.2% of FSWs performed oral sex with clients in the previous month, and only 37.6% 
used condoms consistently while performing oral sex[215]. A study conducted in India (2009-
2010) reported that 12.3 % of 18-60 year old FSWs engaged in receptive penile-anal 
intercourse in the past six months, and only 48.4% used condoms consistently[216]. In the 
Netherlands (2016), the prevalence of anal sex in the past 6 months among FSWs aged 18 
years and above was 20.0%, and only 31.0% of these FSWs always used condoms with 
clients[217]. In the USA, a systematic review of anal sex that included published articles 
between 1987-2013 reported that the prevalence of anal sex among FSWs ranged between 
0-18.0% and that 14.0-82.0% of these FSWs always used condoms during anal sex [218]. 
Oral and anal sexual behaviours are increasingly reported among adolescents and adults 
reporting heterosexual sex in the general population in both developed and developing 
countries [219-222]. For example, data from the Australian national surveys in 2001-2002 
(aged 16-59 years) and 2012-2013 (aged 16-69 years) showed a moderate increase in the 
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prevalence of reported oral and penile-anal sex over time in both genders [219, 223]. In the 
United States, similar findings of increased prevalence of penile-anal sex was reported from 
three waves of the National Survey of Family Growth [224]. Reported penile-anal sex with the 
opposite sex increased from 34.0% in 2002 to 37.0% in 2006-2010 and 37.7% in 2011-2015 
among men (15-44years) [224], whereas the proportion of reported anal sex among women 
increased from 30% in the first survey to 31.6% in the second and 33.3% in the third 
survey[224]. There were no significant changes in the prevalence of reported oral sex over 
the same period in both men and women[224]. However, a sub-analysis of the wave 2 and 3 
of the National Survey of Family Growth on reported oral sex among young adults aged 15-
24 years showed different patterns of change between men and women [225]. The 
prevalence of young men that gave and received  oral sex increased from 53.9% to 55.4% and 
62.9% to 64.6%, respectively, but the prevalence of ever giving  and receiving oral sex 
decreased from 59.6% to 58.6% and 62.2% to 60.4% among young women over the same 
period[225].  
In SSA, many studies reporting sexual behaviours in heterosexual relationships have focused 
on penile-vaginal sex and associated negative health outcomes [226-229]. This has influenced 
sexual health policies and programmes in many countries within the region [230, 231]. The 
role of heterosexual oral and anal sexual acts within the spectrum of sexual behaviours needs 
to be documented within the region in order to appreciate their potential impacts on STI 
transmission and other associated morbidities such as oral and anal cancers. A systematic 
review of the prevalence of, and motivations for, practising heterosexual oral and penile-anal 
sex and the cultural interpretations of these behaviours in SSA was conducted. 
 
METHODS 
This review was conducted in accordance with Preferred Items for Reporting of Systematic 
Reviews and Meta-analyses (PRISMA) and Meta-analysis of Observational Studies in 
Epidemiology (MOOSE) guidelines [232, 233]. The protocol was registered in PROSPERO 
database with registration number CRD42015025311[234].  
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Search strategy 
The search was conducted in English using seven databases: Medline; Embase; African-Wide 
Information; Cinahl; Global Health; Scopus; and Popline databases. We used medical subject 
headings (MeSH) and text words related to oral and anal sex for the search. The terms used 
for oral sex were oral (sex OR sexual behaviour OR sexual practices), cunnilingus, oral vaginal 
contact, fellatio, oral penile contact, anilingus, and oral anal contact. The search terms for 
anal sex included anal (anus OR anal cavity) sex OR anal (sexual behaviour OR sexual practice) 
or ano-genital (sex OR intercourse). The search was restricted to SSA by using “AND” before 
adding different search terms for sub-regions (West Africa OR East Africa OR Central Africa 
OR Southern Africa), and by specific country names. Multi-continent studies that had separate 
data from any country in SSA were also considered. The search included published articles 
from 1946 up to and including the final search of 30th August 2018. Manual searches of 
bibliographies of relevant publications on the subject were conducted. All titles retrieved 
from the search were compiled and reviewed with Endnote X 8.0 (Thompson Reuters) by one 
author (IMB); duplications were removed using the Endnote automated system and through 
a manual check.  
Eligibility criteria 
The eligibility criteria were determined apriori in the registered protocol [234], and only 
published original research articles that reported on oral or anal sex with a partner of the 
opposite sex in adolescents and adults in SSA were considered. The review excluded articles 
that focused exclusively on non-consensual heterosexual intercourse and MSM, even if men 
reported sex with both men and women. Commentaries or review articles, letter to editors, 
editorials, case series and case reports were also excluded. Oral sex was defined as oral 
contact with the vulva and or vagina (cunnilingus) or penile shaft (fellatio) or anus (analingus). 
Anal sex was defined as penetration (insertion) of a man’s penis into the woman’s anus or, 
for women, reception of the penile shaft into the woman’s anus.  
Two authors (IMB, SK) independently screened the titles and abstracts using the eligibility 
criteria. Thereafter, the full-text of selected articles were independently reviewed again by 
IMB and SK. Discrepancies at each stage of the review were resolved through discussion and 
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consensus. DWJ and SCF served as arbitrators for cases that could not be resolved by 
discussion. 
Data extraction 
Data were extracted by IMB into pre-specified data extraction form prepared in Microsoft 
Excel 2010, and verified by SK. The data extracted included the authors’ and journals’ names, 
sampling methods, study location, definition of oral and anal sex, and prevalence/proportion 
of those that reported oral and anal sex, including reasons/motivations and risk factors 
associated with these behaviours. Prevalence was defined as the proportion of those that 
reported oral/anal sex divided by the total number of individuals in the study population. 
For reporting periods, studies that used “ever had” or “ever experienced” or “life-time 
experience” for oral and or anal sex were classified as “ever practiced”. Other specific look-
back reporting periods recorded were “past 12 months”, “past 3 months”, “past 1 month”, 
“last sexual act” and the “first sexual act”. Studies that used any form of random sampling 
were classified as “probability sampling” while others that used non-probability techniques 
were categorised as “convenience”, “snowball”, or “venue-based” or “volunteer” sampling. 
Studies that had participants with increased risk of STI were categorised as key affected 
populations (e.g. FSWs, HIV positive men and women, recreational facility workers such as 
bar and guesthouse workers, long distance truck drivers and participants described as “high-
risk” in the methods sections of eligible publications). 
Assessment of quality of eligible studies 
Separate risk of bias tools were used to assess the quality of papers reporting quantitative 
and qualitative data. For papers reporting quantitative data, a validated tool for observational 
studies was modified (supplementary figure 3) [235] by developing a list of methodological 
features of the eligible studies that could bias the prevalence and risk factor estimates for oral 
and anal sex. For each study, documentation of the following items were assessed to classify 
the study as being either at lower or higher risk of bias: description of study population 
(Yes/No); type of sampling techniques (probability sampling [Yes] or non-probability 
sampling/not reported [No]); response rate (Yes/No); eligibility criteria (Yes/No); definition of 
oral sex (Yes/No); definition of anal sex (Yes/No); sexual behaviour roles reported as 
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giving/insertive or receptive/received (Yes/No); risk factor estimates controlled for potential 
confounders (Yes/No); and inclusion of a statement on the ethical approval (Yes/No). For 
papers reporting qualitative data, a critical appraisal skill programme tool was used for 
qualitative studies (supplementary figure 4) [236]. Each tool has ten fields for assessment; 
studies with five or more “Yes” fields were considered to be of lower risk of bias.  
Data synthesis 
Due to the heterogeneity in study populations, study design, sampling strategy, and 
definitions of exposure of interest in the eligible studies, a descriptive analysis of both 
quantitative and qualitative studies were performed without providing a pooled estimate by 
meta-analysis. In the descriptive analysis, data were disaggregated by exposure of interest 
(oral sex, anal sex or both), gender, population category (key affected or general population), 
country locations and regions. The prevalence of outcomes (oral and anal sex) and risk factors 
for oral and anal sex in quantitative studies were presented. Minitab 18.0 statistical software 
(Minitab, Inc.) was used to graphically present individual value plots of the prevalence of oral 
and anal sex by sub-region, study population, population category and risk of bias to visualise 
the range in reported prevalence compared by population type, geographical area and risk of 
bias. Key findings from qualitative studies were summarised and categorised into the 
following themes: cultural meaning; interpretations; and reported personal experiences. 
 
RESULTS 
Out of the 13,592 articles retrieved, 155 full-text articles were reviewed and 103 were 
included in the descriptive analysis of heterosexual oral and or anal sexual behaviours (Figure 
2.1). Among the 103 articles reviewed, 38 reported on both oral and anal sex [174, 175, 237-
273], 53 reported on anal sex only [274-325] , and 12 reported on oral sex only [176, 326-
336]. One Nigerian publication out of the 38 articles reported the prevalence of oral and anal 
sex as a combined outcome[245]. Six articles were mixed methods studies (a study each from 
Ethiopia, Kenya, Nigeria, Tanzania, Zambia and another was conducted in Kenya and Rwanda) 
[241, 266, 270, 290, 320, 333]. Fifty-nine studies were from Southern Africa, 38 were from 
East Africa, 20 were from West Africa and four were from Central Africa (Table 2.1). 
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Only nine quantitative studies presented the operational definitions of reported oral sex [239, 
240, 252, 254, 266, 271-273, 336] and six studies presented operational definitions of 
reported anal sex[240, 252, 254, 266, 273, 290] in the methods section of the papers. For oral 
sex, definitions included oral stimulation of either the external female genitalia (i.e. clitoris, 
vulva and vagina) or the penis [239]; ejaculation during oral stimulation of the male 
genitalia[240]; contact between the mouth and penis or vagina or anus [254]; and putting 
one’s mouth on their partner’s penis or vagina or letting their partner put his or her mouth 
on one’s penis or vagina [252]. For anal sex, definitions included were ejaculation during anal 
sex [240]; introduction of the penis into the anus or back passage of the partner [254, 266, 
273, 290]; and putting the penis into the partner’s anus or letting the partner insert his penis 
to her anus[252]. 
Twelve out of 13 articles presented qualitative data investigating motivations, cultural 
interpretations and personal experiences of anal sex [266, 290, 300-304, 320, 322-325] (Table 
1). Of these, seven studies (two from South Africa [300, 301] and three from Tanzania[303, 
304, 324], and two multi-country studies conducted in Kenya, Tanzania and Uganda [302] and 
Uganda, South Africa and Zimbabwe [323]) used qualitative methods only. Six qualitative 
studies each on anal sex were conducted among key affected populations [290, 302-304, 324, 
333] and general populations [266, 300, 301, 320, 322, 323]. No studies included adolescents. 
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Figure 1:3 PRISMA Flow for the systematic review 
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Table 2.1: Selected data from quantitative studies reporting on heterosexual oral and anal sex in sub-Saharan Africa by year of publication 
GP – General Population; KAP - Key Affected Population.  
M – Male; F – Female; X – Not reported; Kig – Kigali; Mom – Mombasa; NS – Not stated; Pry - Primary; Sec –Secondary; RCT – Randomised Control Trial; Ref – References; ¥ - Okafor et al 
reported proportion of boys and girls that had practiced oral and heterosexual anal sex as a single outcome. 
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The majority of the studies (90 out of 103) focused on participants aged 10 to 49 years 
(Supplementary table 1). Eleven out of 91 studies included only adolescents (aged ≤19 
years)[175, 242, 247, 248, 254-256, 327]. Seven studies did not indicate the study population 
age [237, 281, 300-302]. Overall, 46  studies included both male and females [174-176, 237, 
239-248, 251-256, 259, 264-266, 268, 270, 273, 278, 280, 284, 287, 292, 294, 301, 302, 311, 
314, 320, 326-329, 334], 51 studies included women/girls only [238, 249, 250, 257, 258, 260-
263, 267, 269, 271, 272, 274, 276, 277, 279, 281-283, 285-291, 296-299, 305, 306, 309, 310, 
312, 313, 315-319, 321, 332, 333, 335], and eight studies included men/boys only [275, 293, 
295, 307, 308, 330, 331, 336].  
 
Reported condom use during heterosexual oral and anal sex 
Condom use was reported in 19 studies during heterosexual anal sex [240, 241, 252, 253, 256, 
259, 261, 262, 273, 275, 277, 279, 284, 287, 290, 306, 312, 313, 315, 320], five studies during 
oral sex [240, 252, 253, 256, 261], and 29 studies for combined vaginal, oral and anal sexual 
experience [175, 242, 254, 257, 258, 260, 262, 263, 265, 267-269, 276, 280, 282, 285, 288, 
292, 297, 298, 305, 307, 311, 316-319, 335]. (Table 2.2). 
Four (three from South Africa and one from East Africa) out of six studies that reported 
condomless anal sex were among key affected populations[253, 277, 287, 290], and one study 
was a general population study in South Africa[277]. Condomless oral sex was also reported 
in a study among HIV positive men and women in South Africa[253]. Reported condom use 
tended to be higher during heterosexual anal sex than during oral sex, and was more 
frequently reported among key affected populations than general populations during 
heterosexual anal sex. The range of any condom use during oral sex was 1.7-16.5% among 
three general population studies [240, 252, 256]. Of these, consistent condom use during oral 
sex was reported by 13.2% of Nigerian and 16.5% of Zimbabwean students [240], and by 
12.2% of high school students in Ethiopia [252]. A study in South Africa showed that 54.8% of 
FSWs reported consistent condom use during oral sex [261].  
The range of any condom use during heterosexual anal sex was 6.7-73.1% among eight 
general population studies [240, 241, 252, 256, 259, 273, 277, 320]. Consistent condom use 
during anal sex was reported by 22.5% and 27.5% of Nigerian and Zimbabwean students 
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respectively [240], 26.1% of Ethiopian high school students [252] and 36.4% of adolescents 
and young adults in Tanzania[320]. Among five key affected population studies, the range of 
condom use during heterosexual anal sex was 13.2.0-67.0% [261, 275, 279, 284, 312]. Two of 
these studies reported consistent condom use of 45.0% among Kenyan FSWs with their clients 
[279] and 50% among HIV positive women in a South African city [261]. The range of 
condomless heterosexual anal sex among four key affected population studies was 7.0-54.3% 
[253, 279, 287, 290]. 
Prevalence of reported oral sex 
Only six (two from South Africa and one each from Nigeria, Rwanda, Zambia and Zimbabwe) 
out of the 51 oral sex studies described the prevalence of reported oral sex as either giving or 
receiving oral sex [238, 239, 241, 269, 271, 272]. Most studies that reported on prevalence of 
oral sex were from the South African region, among adolescents and young adults, and key 
affected populations (Figure 2.2 and Table 2.1). 
Reported prevalence of ever practiced oral sex 
Twenty-eight general population studies reported on the prevalence of ever practising oral 
sex (Table 2.1), of which only two studies (Nigeria and Zambia) described the prevalence of 
giving and receiving oral sex separately[241, 271]. However, the Zambian study combined 
these data by gender[241]. Of the remaining 26 general population studies reporting oral sex 
prevalence, 14 described this by gender: five among adolescents and adults [250, 263, 265, 
273, 326]; four among adolescents[247, 248, 254, 335]; two studies among adult women 
[260, 332]; two studies among university students [243, 266]; and one study among adult men 
only [330]. Men/boys tended to report a higher prevalence of ever practising oral sex 
compared to women/girls across these populations. For example, 26.2% of boys reported 
ever practising oral sex compared to 8.1% of girls in a cross-sectional study in South 
Africa[247], and 22.8% of males reported ever practising oral sex compared to 18.2% of 
female South African university students [243]. The range of reported oral sex prevalence in 
the remaining studies was 5.0-46.4% among university students[237, 240, 264, 268]; 1.7-
26.6% among adolescents[175, 255, 256, 327]; 3.0-47.2% among a combined population of 
adolescents and adults [174, 176, 252, 328], and 1.7-40.8% in three studies among adult 
populations [330-332]. In all but adult populations, higher prevalences of ever practicing oral 
sex were recorded after the year 2000 compared to before 2000. Studies conducted among 
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university students reported a relatively high prevalence of oral sex compared with other 
groups within the general population. 
Ten studies amongst key affected populations described the prevalence of ever practising oral 
sex [238, 244, 249, 257, 261, 270, 329, 331, 333, 336]. Three studies were among FSWs, of 
which only one Rwandan study described prevalence of giving and receiving oral sex 
separately[238, 257, 333]. The Rwandan study showed that 1.8% and 0.5% of FSWs reported 
that they ever received or gave oral sex respectively[238]. Prevalence of having ever practiced 
oral sex in the other two studies among FSWs were 9.0% in Kenya [333] and 24.1% in South 
Africa[257]. The prevalences of ever having practiced oral sex in two Nigerian studies were 
reported to be 1.5% among adult men and women in the general community [270] and 13.3% 
among HIV positive men and women [244]. In Ghana, 42.3% of ‘women considered to be at 
risk of STIs’ (working in food and recreational facilities) ever practiced oral sex[249]. Three 
studies from South Africa reported on the prevalence of ever practising oral sex among key 
affected populations[261, 329, 336]. One study showed that a higher proportion of HIV 
positive men (79.4%) in the community/clinic reported ever practising oral sex than HIV 
positive women (76.5%)[329] while the two other studies reported that the prevalence of 
ever having practiced oral sex was 13.9%[257] among HIV positive women [261] and 15.0% 
among HIV positive adult men [336] in the community. 
Prevalence of oral sex by other reporting periods 
Data on the prevalence of oral sex using other reporting periods came from 11 general 
population studies [242, 251, 252, 254, 256, 258, 259, 262, 269, 272, 334]. Three of these 
studies found that men/boys generally reported a higher prevalence of oral sex than 
women/girls. For example, any oral sex in the past three months was reported by 29.0% and 
21.0% of 18-34 year old Kenyan men and women respectively [251], and by 4.8% and 2.8% of 
12-15 year old South African boys and girls respectively [254]. In contrast, a Tanzanian study 
showed that having had oral sex during their first sexual experience was reported by 39.0% 
and 40.0% of primary school boys and girls, respectively[242]. Among a combined population 
of adolescents and adults in Addis Ababa, the prevalence of reported oral sex in the past 12 
months among the 5.4% of the study population that had ever practiced oral sex was 51.6% 
[252]. Two South African studies reported the prevalence of oral sex in the past three months 
as 8.0% among girls/women above 16 years[258] and 19.9% among women aged 18 years 
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and above[262]. Reported prevalence of oral sex in the past six months ranged between 
32.9% and 40.0% among adult men and women with their casual and steady partners, 
respectively in Soweto[259], 13.4% among women in rural Mopani District[269], and 6.2% of 
men and 8.7% of women in Cape Town[334]. Finally, 22.8% and 21.0% of pregnant and 
postpartum women in Cape Town described either giving or receiving oral sex in the past 12 
months respectively [272]. 
Among four key affected population studies, two studies among HIV positive men and women 
described the prevalence of reported oral sex in the past three months to be 11.0% in 
KwaZulu-Natal and 13.4% in Mpumalanga in South Africa [246, 253]. A third study among 
FSWs and their clients in Harare, Zimbabwe, described higher reporting by men of receiving 
oral sex from FSWs during their last sexual act than by FSWs giving oral sex during their last 
sexual encounters (10.0% vs 1.0%)[239]. In the same study, 4.0% and 1.0% of men and FSWs 
respectively reported giving/receiving oral sex during their last sexual act [239]. Another study 
among FSWs from South Africa, Uganda and Benin reported that the prevalence of oral sex in 
the past month with clients was 8.3% [267].  
Factors associated with engaging in oral sex 
Eight studies investigated factors associated with reported oral sex (Table 2.3). Five of these 
studies reported unadjusted estimates [248, 251, 254, 256, 333]. In 2000, a study in Kenya 
found that older FSWs were less likely to have ever engaged in oral sex than younger FSW 
[333]. In 2012, another study in Kenya showed that men tended to report oral sex in the past 
3 months more than women (29.0% vs 21.0%) [251]. Similarly, adolescent boys in Tanzania 
were more likely to report ever practicing oral sex compared with adolescent girls (9.4% vs 
5.8%) [248]. In Nigeria, girls were more likely to report oral sex as their last sexual act 
compared with boys (23.5% vs 15.1%)[256]. Girls in South Africa aged 12-15 years who were 
“currently dating” compared to girls that were not currently dating were more likely to have 
reported ever having oral sex with their partners (8.1% versus 0.6%) and also having oral sex 
in the last three months (6.5% versus 0%,) [254]. Similar results on dating status were also 
reported among boys (20.2% versus 8.1%)[254]. 
Two studies from Ethiopia and a study from Malawi reported adjusted estimates for the 
association between potential risk factors and reported oral sex [252, 266, 331].  A study 
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among 3543 adolescents in high schools in Ethiopia showed that reporting oral sex was 
associated with having an illiterate mother, being younger (15-16 years compared to 17 years 
and older), being female, having a perception of oral sexual activity in peers, having a positive 
attitude to oral sex, and low self-esteem [252]. Of the 5.4% who reported ever having had 
oral sex, 13.5% had initiated oral sex before the age of 10 years [252]. Another Ethiopian study 
found that among university students, ever having practised oral sex was associated with: the 
male gender; being a first year undergraduate; being a student in faculties of business and 
economics, technology, humanities, social sciences and education; living off campus; 
belonging to the Protestant Christian denomination; and having boy/girlfriends[266]. A study 
among Malawian men that reported ever practicing oral sex had three times the odds of ever 
using condoms, two times odds of spending money in the last three months, and having a 
higher number of lifetime sexual partners than men with no history of oral sex [331]. 
Motivations for engaging in oral sex 
Only one study reported on motivations for engaging in oral sex. This study was conducted 
among Ethiopian school boys and girls aged 15-24 years in Addis Ababa [252].  The main 
motivations reported by participants were preventing pregnancy (95.9%), minimizing risk of 
HIV acquisition (86.5%), preserving virginity (85.8%) and reducing the risk of STIs (80.4%). Of 
those having oral sex within the past 12 months, 48.0% had received a gift in exchange for 
practising oral sex.  
Prevalence of reported heterosexual anal sex 
Sixty-five out of 82 studies distinguished the prevalence of reported anal sex into ‘insertive’ 
by male participants or ‘receptive’ by female participants[238, 239, 242, 243, 246-251, 254, 
256-258, 260-267, 269, 271-277, 279-299, 305-313, 315-319, 321]. Most studies that 
described anal sex were from Southern and East African countries, among adolescents and 
young adults, and key affected populations (Figure 2.3 and Table 2.1). We used the same 
reporting periods as we did for oral sex in presenting prevalences of heterosexual anal sex in 
different populations. 
Reported prevalence of ever practiced heterosexual anal sex 
Fifty-one out of 82 studies reported on the prevalence of ever practising heterosexual anal 
sex. Twenty-three out of 51 studies were conducted among key affected populations [238, 
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244, 249, 257, 261, 270, 274-276, 279, 282, 289, 293, 305-308, 310, 312, 314, 317, 318]. 
Seventeen of the 28 general population studies described reported prevalence of receptive 
or insertive heterosexual anal sex separately [243, 247, 248, 250, 254, 260, 263-266, 271, 273, 
295-297, 309, 313]. Of these, seven studies were among adolescents and adults[250, 260, 
265, 273, 295, 296, 313], five studies were conducted among adolescents only in 
schools/communities (South Africa [247, 254, 297], Tanzania[248] and Mozambique[263]), 
three studies among university students in South Africa [243, 264, 266] and two studies 
among adult women[271, 309]. In seven studies, the proportion of boys that reported ever-
practising heterosexual insertive anal sex was higher than the proportion of girls that reported 
ever engaging in receptive anal sex [243, 247, 248, 254, 265, 266, 273]. For example, in 
Tanzania, 8.5% and 5.4% of boys and girls reported ever having insertive or receptive anal sex, 
respectively [248]. In South Africa, 10.8% and 8.4% of male and female university students 
reported ever engaging in insertive or receptive anal sex, respectively [243]. In the three 
studies that were conducted among girls/women only, the reported prevalence of receptive 
anal sex among adolescents and adults was 34.8% in Tanzania[250] and 7.7-11.3% in South 
Africa[295], and in a study from South Africa a prevalence of 1.5-1.9% was reported among 
adult women[260].  
In the remaining 11 general population studies that reported the prevalence of ever having 
practiced anal sex among boys/men and girls/women, three were among university students 
[237, 240, 268] and four studies each were among adolescents and adults in 
schools/community [174, 241, 252, 278] or adolescents in schools [175, 255, 256, 280]. The 
reported prevalence of ever practising anal sex among university students in Nigeria ranged 
between 0.3-4.4% [237, 268]. In another similar study,  35.2% among university students in 
Zimbabwe, and 46.4% among university students in Nigeria reported ever practising anal sex  
[240]. Studies that combined adolescent and adult populations reported prevalences 
between 4.3-34.8% from Zambia, South Africa, Nigeria and Ethiopia [174, 241, 252, 278]. 
Studies amongst adolescents in schools/communities showed that the prevalence of ever 
practicing anal sex was 6.7-12.4% in Nigeria[175, 256], 2.4-3.8% in South Africa[280] and 6.4% 
in Tanzania[255]. 
In key affected populations, the reported prevalence of ever practising receptive heterosexual 
anal sex in nine different studies among FSWs was 2.3-42.8% in Rwanda[238], 
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Cameroun[310], Uganda[318], Kenya[274, 279, 289] and South Africa[257, 276, 306]; 42.0% 
among male truck drivers in South Africa[275]; 25.4% among men attending bars/night clubs 
in South Africa [293]; 11.5% [249],  2.4% [282] and 0.4% [305] among women working in food 
and recreational facilities in Ghana, Tanzania and Kenya respectively. Other reported 
prevalences of anal sex were 3.3-17.1% among HIV positive men and women in Nigeria [244] 
and South Africa[261], 5.7-72.0% among adult men and women in community/clinics in 
Nigeria[270] and Cameroun[314], 11.7-20.0% among adult men only in Nigeria[308] and 
Angola[307], and 13.4% among adolescents and adults women in South Africa[317]. 
Prevalence of heterosexual anal sex by other reporting periods 
Six key affected population studies reported specifically on insertive or receptive anal sex 
within the past three months [246, 253, 283, 284, 290, 291]. Higher prevalences of insertive 
anal sex in the past three months were reported by men compared to receptive anal sex 
reported by women among key affected populations [246, 284]. Similarly, two key affected 
population studies in South Africa (one study each among HIV positive men and women[246] 
and adult men and women[284]) showed higher prevalences among men that reported 
practising insertive anal than women that engaged in receptive anal sex. Three other studies 
among HIV positive men and women in Kenya, South Africa and Zimbabwe described the 
prevalence of heterosexual anal sex in the past three months to be 18.0%[283], 7.7%[253] 
and 4.8%[291] respectively. 
Four studies among key affected populations presented prevalences of anal sex in the past 
month [267, 281, 287, 292]. One study compared prevalences of anal sex in the past month 
by method of data collection and found that women in food and recreational centres in 
Tanzania reported a higher prevalence of anal sex using daily diaries (2.1%) to record their 
sexual behaviours compared to face-to-face interviews (1.4%) [281]. The other two studies 
from South Africa reported the prevalence of insertive anal sex in the past month among men 
attending bars/night clubs and men patronising alcohol drinking points to be 15.0% [287] and 
10.6% respectively[292]. In the same studies, 11.0% of women in bars/night clubs[287] and 
6.9% women at alcohol drinking points reported receiving anal sex in the past month[292]. 
Another study reported that 2.2% of FSWs in South Africa, Uganda and republic of Benin 
received anal sex in the past month [267]. Other reporting periods used to describe 
prevalence for anal sex among key affected populations were the past 12 months in 3 studies 
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(two from Tanzania and Cote-d’ivoire)[311, 320, 321], and during the most recent sexual acts 
in 2 studies from Zimbabwe[239] and the Central African Republic [319]. 
Seven general population studies, including six from South Africa, reported on insertive or 
receptive anal sex in the past three months[251, 254, 258, 262, 277, 298, 299]. The range of 
reported prevalence of receptive anal sex in three studies among South African women was 
5.6-20.3%[262, 277, 298]. Two studies among adolescents and adults reported a prevalence 
of 2-3.0%[258, 299]. In the same country, a study showed that 1.1% of girls reported receptive 
anal sex while 7.4% of boys reported insertive anal sex during the same period[254]. A Kenyan 
study showed that 25.0% men reported insertive anal sex while 21.0% women reported 
receptive anal sex in the preceding three months[251].  
Twelve studies used different reporting periods (past 12 months[252, 272, 315], past six 
months[259, 269, 294], past month[285, 286, 288], during first sexual act[242] and last sexual 
act  [256, 316]) . Within these reporting periods, the highest reported prevalence of anal sex 
was 57.1% among anal sex experienced Ethiopian high school students in the past 12 
months[252], 9.2% among South African young men and women in the past six months[259], 
7.8% of South African adult women in the past month[288] and 5.6% of Nigerian boys during 
their last sexual act [256]. 
Factors associated with engaging in anal sex 
Eight studies explored factors associated with practising heterosexual anal sex (Table 2.3). 
Two of the three studies that presented unadjusted estimates showed that the reported 
prevalence of heterosexual anal sex was associated with type of sexual relationship [254, 
289]. A study amongst South African adolescents found that the prevalence of having ever 
practised heterosexual anal sex was higher among ‘currently dating’ girls (3.3% vs 0%) and 
boys (15.6% vs 6.0%) than those with ‘no dating partners’[254]. A similar result was also 
described in the same study among boys that reported prevalence of anal sex act in the past 
three months[254]. In Kenya the frequency of anal sex in past month among FSWs was higher 
among those with regular and casual partners than those with a primary partner only [289]. 
In the same study, the frequency of condom use among FSWs was lower during anal sex than 
during vaginal sex (data not shown). Unlike the general gender pattern observed in other 
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studies, women in Kenya reported a higher prevalence of heterosexual anal sex than men 
(25.0% vs 16.0%) [251]. 
Five studies reported adjusted estimates on factors associated with reported anal sex [252, 
266, 284, 287, 290]: A Kenyan study among FSWs showed that the odds of reporting 
heterosexual anal sex was about four times higher among those with current genital 
symptoms versus no genital symptoms, three times higher with inconsistent condom use 
during last sexual act compared to those reporting consistent condom use, two times higher 
in those with at least five years of sex experience compared to those with more than five 
years, six times higher with inconsistence condom use with casual partners than those that 
used condoms, and higher in those with a higher number of sexual partners than those with 
a lower number [290]. A study among FSWs in Rwanda found that inconsistent condom use 
with casual sex partners (adjusted odds ratio (AOR)=5.9) and a higher number of sexual 
partners (AOR=4.3) were also identified as risk factors for reporting heterosexual anal sex 
[290]. In addition, the odds ratio for those with regular use of alcohol before sex was about 
three times associated with reporting anal sex than FSWs that those that did not regularly use 
alcohol before sex. A study among men and women attending bars/night clubs in South Africa 
found the following factors to be associated with reported anal sex in the past month: 
younger age, having casual sexual partners compared to regular partners, having sex with 
only one sexual partner compared to having multiple recent sexual partners, and meeting 
their sexual partners in shebeens (alcohol drinking venues) in the past month [287].  
Other risk factors associated with engaging in heterosexual anal sex that were reported 
among men and women in the community and special treatment clinics in South Africa 
included the following[284]: never using condoms, previous transactional sex, cannabis use 
in the past three months, having been previously tested for HIV, and being HIV positive. Being 
older, married or living with a partner and previous condomless vaginal intercourse reduced 
the risk of reporting anal sex. Factors associated with ever practising heterosexual anal sex 
among Ethiopian school boys and girls included younger age, being a boy, having a positive 
attitude towards anal sex, having low aspirations for college education, having low self-
esteem, having a perception of peer engagement in anal sex, and having an illiterate mother 
or father [252]. However, adolescents living with both parents were less likely to engage in 
anal sex [252]. In another Ethiopian study, university students reporting ever having had anal 
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sex experience was associated with enrolment in non-medical university faculties compared 
with students enrolled in a medical faculty[266]. In the same study, university students that 
had ever married were more likely to report previous anal sex experience than single 
students[266]. 
Motivations for engaging in anal sex 
A study in Ethiopia described the motivations for engaging in anal sex among school-attending 
boys and girls aged 15-24 years [252]. The motivations included minimizing the risk of 
pregnancy (92.1%), preserving virginity (85.5%), minimising the risk of STIs (82.9%), and 
minimising risk of acquiring HIV (77.6%). Other motivations reported were desire by the 
sexual partner, increasing sexual pleasure, and self-preference for anal sex. Amongst the 
57.0% who had reported engaging in anal sex in the previous 12 months, 52.3% had received 
money or gifts for engaging in anal sex. 
Four studies (two from Tanzania [303, 304], one from South Africa [300]and one multi-site 
study from Kenya, Tanzania and Uganda [302]) explored motivations for engaging in anal sex 
using qualitative research. Their findings showed that motivations differed between men and 
women (Table 1). Reasons mentioned by women were preserving their virginity, to promote 
a sexual relationship or to avoid a domestic quarrel, to prevent pregnancy, as an alternative 
during menstruation or during pregnancy or when there is evidence of a sexually transmitted 
infection, and in exchange for money[301, 302]. Motivations reported by men included 
adventure, influence from their peers, to avoid unwanted pregnancy, to enjoy enhanced 
sexual pleasure and to show sexual supremacy over women [304].  
Cultural meaning, interpretations and personal experiences of anal sex 
Twelve qualitative studies explored interpretations of anal sex (Table 2.4). Five qualitative 
studies reported on the culture of silence and reluctance to openly discuss heterosexual anal 
sex [290, 300, 303, 322, 323]. For example, a study in rural South Africa among men and 
women found that some participants considered heterosexual anal sex to be too sensitive for 
discussion and some even expressed shock or disappointment and threatened to abandon a 
focus group discussion when it was brought up for discussion by the facilitator [301]. In the 
same study, men were reported to be more willing to discuss anal sex than women. In another 
study in Kenya, men in two counties reported that they were reluctant to discuss anal sex 
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among themselves as it was regarded as a cultural taboo to claim knowledge of, or practice, 
anal sex in their community[302].  
Two studies (Rwanda and South Africa) reported that women, including FSWs, perceived anal 
sex as punishment, and they only engaged in it to avoid quarrel from their partners/clients  
and for financial benefits[290, 300]. Other reasons mentioned by participants for engaging in 
anal sex included adventure, and coercion [300, 320, 324, 325]. There was some evidence of 
misunderstanding the definition of anal sex; for example, one South African study reported 
that participants in rural part of Soweto believed anal sex to mean “penile-vaginal penetration 
from behind” [300]. In several other studies, interviewees believed that anal sex is “foreign” 
to the African culture [266, 290, 301] or that it is exclusively practiced by men who have sex 
with men [301]. Some believed anal sex is safer than penile-vaginal sex [320, 324]. 
Seven qualitative studies presented personal experiences of men and women about 
heterosexual anal sex [290, 300, 301, 303, 304, 320, 324]. Findings from three studies showed 
that men expressed more desire for anal sex than women as they often regarded the act as a 
sign of manhood, and women were reported not to be receptive to openly discussing or 
demanding anal sex [300, 303, 324]. Tanzanian and South African studies reported that both 
men and women sometimes used proxy names such as slang or colloquial terms to describe 
anal sex [301, 304].  A study among FSWs in Kigali reported extreme resentment towards 
clients who asked for anal sex as they regarded the practice to be uncomfortable, emotionally 
painful and associated with STIs and faecal and urinary incontinence[290]. However, some 
young women in Tanzania said that anal sex was more acceptable and enjoyable when 
performed with “jelly” lubricants [320]. 
Assessment of quality of studies 
The detailed assessment of risk of bias are presented in Table 2.5. Overall, 53 out of 94 
quantitative studies assessed had low risk of bias in their methods: 51 of these described 
heterosexual anal sex [242, 252, 254-257, 259, 260, 262, 264-267, 269-276, 279, 280, 282-
284, 286-288, 290-293, 295, 296, 298, 299, 307-312, 315-321] while 24 studies described oral 
sex [176, 242, 252, 254-260, 262, 264-267, 269-273, 331, 332, 335, 336]. The majority of 
articles assessed to be low risk were from Southern and Eastern Africa. Most studies with a 
high risk of bias used convenience sampling techniques to recruit study participants, had 
82 | P a g e  
 
unclear eligibility criteria, did not include operational definitions of outcome measures in the 
methods, did not control for potential confounders, presented the prevalence of oral or anal 
sex by the reported sexual behaviour role, or gave no indication as to whether ethical 
approvals were obtained (data not shown – Supplementary table 3). All of the nine qualitative 
studies assessed had low risk of bias (Table 2.6). 
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Multiple data points for author and year in the same study by: Educational level – primary & secondary - (Matasha et al 1998); Gender – male & female -  (Wilson et al 1989; Matasha et al 
1998; Tengia-Kessy et al 1998; Nicholas et al 2004; Operario et al 2007; Pluddemann et al 2008; Kazaura et al 2009; Chege et al 2012; Gever et al 2013; Vogt et al 2013; and Folayan et al 
2014); Mbulawa et al 2014; Ybara et al 2018; Range value - the reported range of prevalence - (Kerwin et al 2014); Reporting periods – used more than one reporting periods - (Gever et al 
2013; Cherie et al 2012 and Folayan et al 2014); Sexual partners – casual & steady partners - (Anderson et al 2009); Study sites – multiple study sites -  (Akande 1994; Nell et al 2011); Okafor 
et al 2005 was excluded in this graph because it presented combined prevalence of oral and anal sex as a single estimate point. FSWs: Female sex workers; KAP: Key affected population. Status 
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Multiple data points for author and year in the same study by: Data collection methods – Methods of interview used - (Allen et al 2007; van der Est et al 2009; Mensch 
et al 2011); Educational level – primary & secondary -  (Matasha et al 1998); Gender – male & female - (Operario et al 2007; Folayan et al 2014) Study site (Akande 
1994; Abdool Karim et al 2010; Veldhuijezn et al 2011; AbdulKarim et al 2011; Nell et al 2011; Palanee-Philips et al 2015); Sexual partners - casual & steady partners - 
(Anderson et al 2009; Jemmot et al 2014); Reporting period - used more than one reporting periods -  (Cherie et al 2012; Gever et al 2013; Folayan et al 2014 Okafor et 
al 2005 was excluded in this graph because it presented combined prevalence of oral and anal sex as a single estimate point. FSWs: Female sex workers; KAP: Key 
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Table 2.2: Reported condom use during penetrative heterosexual sex (oral, anal and vaginal)  
 
Author, Year (population 
category) 
Report on condom use during heterosexual sexual act 
Anal sex (n= 19 studies) Oral sex (n= 5 studies) All penetrative sexual activities including oral or anal sex (n= 29 studies) 
Katsivo, 1991(KAP) NA NA None of the participants used condom for any sexual acts 
Akande, 1994 (GP) 
22.5% Nigerian and 27.5% 
Zimbabwean often used condom 
during anal sex 
13.2% Nigerian and 16.5% 
Zimbabwean often used condom 
during oral sex 
NA 
Cossa et al 1994 (GP) NA NA Only 0.3% of women reported that their partner ever used condom 
Feldman et al 1997 (GP) 14.3% of boys and girls reported condom use during anal sex NA NA 
Abdool karim et al 1998 
Women that were <25years old used 
condom in 63.4% while those that 
were ≥ 25years old used condom 
during 57.1% of anal sexual acts 
NA NA 
Matasha et al 1998 (GP) NA NA 33% used condom for sexual activity 
van Damme et al 2002 
(KAP) NA NA 
67% vs 66% of participants in intervention group 
and control group respectively used condom for ≥ 
50 sexual acts with clients 
12% vs 6% of participants in intervention group 
and control group respectively used condom for ≥ 
50 sexual acts with sexual partners 
Ramjee et al 2002 (KAP) 23% of men reported using condom during anal sex NA NA 
Kalichman et al 2004 (GP) 89% of women reported not using condom during anal sex   NA 
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Dunkle et al 2005 (KAP) NA NA 
49.8% used male condom for 50-75% of their 
sexual acts while 34.6% reported using condom 
for > 75% of their sexual acts 
Schwandt et al 2006 (KAP) 
45% of FSW reported consistent 
condom use during anal sex with their 
clients NA NA 
26.7% of FSW reported never using 
condom for anal sex with their clients 
Jaspan et al 2007 (GP) NA NA 
33% vs 26% reported ever using condom during 
sexual act when interviewed by paper or PDA 
respectively 
Operario et al 2007 (GP) NA NA 
27.6% of girls with both parents alive compared to 
25.4% of girls with one or both parents deceased 
always used condom in the past 12 months 
41.2% of boys with both parents alive compared 
to 36.9% of boys with one or both parents 
deceased always used condom in the past 12 
months 
Watson-Jones et al 2007 
(KAP) NA NA 30% reported condom use during the last sex 
Bing et al 2008 (KAP) NA NA 
Condom use was 45.2% with girlfriends, 40.8% 
with occasional partners and 60.6% with 
commercial partners during anal or vaginal sex 
Skoler-Karpoff et al 2008 
(GP) NA NA 34% used condom during the sexual act 
Kalichman et al 2009 (KAP) 
Men and women used condom during 
67% and 50% of anal sex acts 
respectively 
NA NA 
Andersson et al 2009 (GP) 
The mean condom use during anal sex 
was 49.5% for steady partners and 
73.1% for casual/anonymous partners 
NA NA 
Bamidele et al 2009 (GP) NA NA 40% used condom during last sexual activity 
Abdool Karim et al 2010 
(GP) NA NA 
22.8% living in rural centres and 42.8% living in 
urban communities always used condom 
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Ambaw et al 2010 (GP) NA NA 
46.6% of the sexually experienced participants 
reported ever using condom during their sexual 
acts 
Kalichman et al 2011 (KAP) 8% of men and 7% of women reported anal sex without condom NA NA 
Mensch et al 2011 (GP) NA NA 
25.2% and 24.5% of participants interviewed by 
ACASI and FTFI respectively reported using 
condom always during sexual activity 
Nel et al 2011 (GP) NA NA 
44.5% of participants in Madibeng and 43.5% 
participants in Mbekweni used condom during last 
sexual act 
Veldhuijenzn et al 2011 
(KAP) 
24% and 21% of women never used 
condom with regular and casual 
partners for anal sex respectively 
NA NA 
Cherie et al 2012 (GP) 
26.1% of boys and girls reported 
consistent condom use during anal 
sex 
12.2% of boys and girls reported 
consistent condom use during oral 
sex 
NA 
Guedou et al 2012 (KAP) NA NA 77.7% of participant reported using condom during their last sexual act 
van-Loggerenberg et al 
2012 (KAP) 
50% consistently used condom during 
anal sex 
54.8% consistently used condom 
during oral sex NA 
Clain et al 2012 (KAP) NA NA 
Reported consistent condom use between 
Shebeen and non- Shebeen patrons’ that are men 
were 19% and 23% with primary partners, and 
38% and 29% respectively for casual partners. 
Reported consistent condom use between 
Shebeen and non- Shebeen patrons’ that are 
women were 23% and 29% with primary partners, 
and 29% and 9% respectively for casual partners. 
Peltzer 2012 (KAP) 54.3% of men and women reported never using condom for anal sex 
65% of men and women reported 
never using condom for oral sex NA 
Gaffoor et al 2013 (GP) NA NA 47.5% used condom during last sexual activity 
Gevers et al 2013 (GP) NA NA 73.9% and 50% condom use at the last sexual activity among girls and boys respectively 
Lambdin et al 2013 (KAP) NA NA   
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55% of men vs 69% of women reported condom 
use at last sexual act. 
Asekun-Olarinmoye et al 
2014 (GP) NA NA 
54% of participants always use condom during 
sexual act. 
Folayan et al 2014 (GP) 6.7% of boys and girls reported condom use during anal sex 
1.7% of boys and girls reported 
condom use during oral sex NA 
Githuka et al 2014 (KAP) 13.2% women reported condom use at the last anal sex     
Thurton et al 2014 (GP) NA NA 5% of participants reported using condom in the past 6 months for sexual acts. 
Anyanwu et al 2015 (GP) 20.6% always and 9.8% sometimes use condom during anal sex. NA NA 
Noguchi et al 2015 (GP) NA NA 74.6% reported condom use during the last sexual act. 
Animasahun et al 2016 (GP) NA NA 47.4% used condom during sexual acts. 
Dubbink et al 2016 (GP) NA NA 36.2% used condom during the last sexual act. 
McLellan-Lemal et al 2016 
(GP) 
2.9% of women reported condom use 
during anal sex in the past 12 months NA NA 
Teasdale et al 2016 (GP) NA NA 70.5% of participants used condom during last sexual act. 
Giorgio et al 2017 (KAP) NA NA 58.7% reported inconsistent condom use in the past 3 months. 
Hladik et al 2017 (KAP) NA NA 32% reported condom use in last sexual act. 
Longo et al 2017 (KAP) NA NA 36% reported condom use in the last 3 months. 
Shayo et al 2017 (GP) 
36.4% of participants always use 
condom during female anal sex, and 
25% used condom during the last 
female anal sex. 
NA NA 
Ybarra et al 2018 (GP) 
36.7% of those that ever-had anal sex 
reported using condom half of time or 
less while 63.3% used condom more 
than half of the time 
NA NA 
 
GP – General population; KAP – Key affected population; NA – Not available
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(no of individuals) 
Test of 
association 
Reported associated risk factor for 
Oral sex 
Summary of results 
 Gathece et al 
2000; 
Kenya 
 FSW (322)  Unadjusted, 
Chi Square 
 Age  Older respondents were more likely to engage in oral sex (X2 =18.847, 
p=0.002) 
Kazaura et al 






gender  Male vs female (9.4% vs 5.8% p=0.07) 
Chege et al 2012; 
Kenya 
  





gender  Male vs female (29% vs 21%, p=0.03) 









type of sexual relationship by 
gender 
For Girls 
In the past 3months: currently dating vs not currently dating (6.5% vs 0%; 
p<0.01) 
Ever practiced: currently dating vs not currently dating (8.1% vs 0.6%; p<0.01) 
 
For Boys 
In the past 3months: currently dating vs not currently dating (7.8% vs 2.0%; 
p<0.06 
Ever practiced: currently dating vs not currently dating (20.2% vs 8.1%; p=0.01) 
Folayan et al 






Gender female vs male (23.5% vs 15.1%, p=0.01)  
 Ambaw et al 
2010; Ethiopia 





 Gender; level of education; 
faculty; place of residence; 
marital status 
 Male (AOR=1.6, 95%CI1.02-2.57); protestant (AOR=0.59, 95%CI 0.39-0.9); year 
one student (AOR=2.14, 95%CI1.23-3.66); business and economics faculty 
(AOR=5.47, 95%CI3.09-9.67), technology faculty (AOR=6.23, 95%CI3.32-11.67), 
humanities faculty (AOR=3.15, 95%CI1.92-5.18), social sciences faculty 
(AOR=2.96, 95%CI1.61-5.42) and education faculty (AOR=3.91, 95%CI2.01-
7.61); out of campus (AOR=1.85, 95%CI1.09-3.14); have boy/girlfriend 
(AOR=1.81, 95%CI1.17-2.8) 
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age; gender; attitude to oral 
sex; aspiration for college 
education; self-esteem; 
maternal education; partner 
education; perception of peer 
oral sexual activity and living 
arrangement 
Younger age (AOR=3.2, 95%CI 1.9-5.3);  female (AOR=1.3, 95%CI 1.1-2.2); 
positive attitude to oral sex (AOR=2.3, 95%CI 1.7-4.5); low aspiration to attend 
college education (AOR=3.1, 95%CI=2.8-5.9); low self-esteem (AOR=2.1, 95%CI 
1.7-3.9); illiterate mother (AOR=11.5, 95%CI 6.4-18.5); illiterate father 
(AOR=1.4, 95%CI 0.9-3.2); friends that engage in oral sex (AOR=5.7, 95%CI 3.6-
11.2); living with both parents (AOR=0.4, 95%CI 0.2-0.9)  
Kerwin et al 2014; 
Malawi [100] 





no of lifetime sex partners; ever 
used condom for oral sex; 
history of spending in the past 
3months 
higher total lifetime sex partner (AOR=1.04, 95%CI 1.02-1.06); ever used 
condom (AOR=3.16, 95%CI 1.47-6.8); history of spending in the last 3months 




(no of individuals) 
Test of 
association 
Reported associated risk factor 
for Anal sex 
Summary of results 
Chege et al 2012; 
Kenya  





Gender female vs male (25% vs 16%, p=0.03) 
Gever et al 2013; 








type of sexual relationship by 
gender 
For Girls 
In the past 3months: currently dating vs not currently dating (2.4% vs 0%, 
p=0.09) 
Ever practiced: currently dating vs not currently dating (3.3% vs 0%, p=0.04) 
 
For Boys 
In the past 3months: currently dating vs not currently dating (13.3% vs 2.0%, 
p<0.01) 
Ever practiced: currently dating vs not currently dating (15.6% vs 6.0%, p=0.01)  
Priddy 2011; 
Kenya   
FSW (200) Unadjusted, 
Chi Square 
type of sexual relationship regular vs casual vs primary (35% vs 29% vs 9%, p<0.01) 
  
Kalichman et al 
2009; South 
Africa  
Adult men and 
women in 
community /clinic  





age; sexual relationship; history 
of condom use; history of STI; 
transactional sex; alcohol and 
cannabis abuse use in past 3 
months; HIV test and status; 
number of sexual partners  
Older age (AOR=0.97, 95%CI 0.96-0.98); married/living with partner 
(AOR=0.62, 0.5-0.77); never used condom (AOR=1.79, 1.49-2.17); history of STI 
(AOR=1.64, 1.46-1.85); received gift for sex (AOR=1.77, 1.57-1.99); given gift 
for sex (AOR=1.7, 1.51-1.9); alcohol use in past 3 months (AOR=2.16, 1.77-
2.63); cannabis use in past 3months (AOR=1.97, 1.62-2.4); had HIV test 
(AOR=1.44, 1.19-1.73); test HIV positive (AOR=2.62, 1.89-3.63); increased 
number of sexual partners (AOR=1.26, 1.2-1.32); unprotected vaginal 
intercourse (AOR=0.97, 0.94-0.98); previous vaginal intercourse with condom 
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(AOR=1.04, 1.03-1.05); increasing percentage condom use during vaginal 
intercourse (AOR=5.61, 4.27-7.37) 
 Ambaw et al 
2010; Ethiopia 





 Faculty; marital status  Business and economics faculty (AOR=6.3, 95%CI2.64-15.05), technology 
faculty (AOR=7.5, 95%CI2.96-18.99), humanities faculty (AOR=4.59, 95%CI2.19-
10.05), social sciences law faculty(AOR=3.02, 95%CI1.15-7.94) and education 
faculty (AOR=5.85, 95%CI2.26-15.1); ever married (AOR=4.06, 95%CI1.53-
10.79) 
Veldhuijzen et al 
2011; Rwanda 
and Kenya  
FSW  





inconsistent condom use; 
number of sexual partner; 
alcohol use before sex; year of 
sex work and history of genital 
symptoms 
For the Kigali cohorts - inconsistent condom use with casual partner (AOR=5.9, 
95%CI 1.4-24.7); had more than 5 sexual partners in last week (AOR=4.34, 
95%CI 1.52-12.36); regular use of alcohol before sex (AOR=2.83, 95%CI 1.37-
5.84).                             
For Mombasa cohorts - more than 5 years of sex work (AOR=2.44, 95%CI 1.22-
4.89); inconsistent condom use with casual partner or client (AOR=2.1, 95%CI 
1.10-4.20); condom not used in the last sex (AOR=3.40, 95%CI 1.70-6.80); had 
more than 5 sexual partners in last week (AOR=2.20, 95%CI 1.10-4.30); had 
genital symptoms (AOR=3.60, 95%CI 1.70-7.90). 
Kalichman et al 
2011; South 
Africa [ 






age; education; type of sexual 
relationship; meeting sexual 
partner in Shebeen in past 
months 
Age (AOR=0.97, 95%CI 0.96-0.98); primary sexual partner (AOR=1.56, 1.19-
2.05); casual sexual partner (AOR=2.33, 1.92-2.83); meeting sexual partner in 
Shebeen (drinking spot) in the past month (AOR=1.81, 95%CI 1.47-2.22)   








age; gender; attitude to oral 
sex; aspiration for college 
education; self-esteem; 
maternal education; partner 
education; perception of peer 
oral/anal sexual activity and 
living arrangement 
Younger age (AOR=1.7, 95%CI 1.3-3.1), female (AOR=2.9, 1.6-4.7), having 
positive attitude towards anal sex (AOR=6.2, 95%CI 3.8-12.4), having low 
aspiration for college education (AOR=4.2, 95%CI 2.8-8.1), having low self-
esteem (AOR=1.6, 95%CI 1.2-3.1); illiterate mother (AOR=11.6, 95%CI 7.8-
19.6); illiterate father (AOR=7.8, 95%CI 5.3-14.9); friends that engage in 
oral/anal sex (AOR=9.7, 95%CI 5.4-17.7); living with both parents (AOR=0.4, 
95%CI 0.2-0.9) 
AOR – Adjusted odds ratio; CI – Confidence interval; M – Male; F – Female
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Table 2.4: Selected data from qualitative studies reporting on heterosexual oral and anal sex in sub-Saharan Africa by year of publication 
 









Summary of Key findings on oral sex 
Assessment 
of risk of bias 










FSW (KAP) F: 30.5 
 Participants said that there was no need to use 
condom during oral sex because they felt that oral sex 
is "safer" than vaginal sex. 
 high-risk of 
bias 









Summary of Key findings on Anal sex 
Assessment 
of risk of bias 












Some of the local terminologies of anal sex that were 
mentioned by participants included: "pata pata", 
"matanyula" and "dog style". Participants had open 
discussions on anal sex. They mentioned 
pornographic films and television as sources of 
information of anal sex. The reported reasons for 
engaging in anal sex that were discussed included: a 
form of partner punishment and coercion, sexual 
experimentation and partner desire or pleasure. 
Some of the misconceptions that emerged during 
discussion were: anal sex is safer than penile-vaginal 
sex, anal sex was regarded as a form of contraception 
and it could prevent STIs/HIVs. 
low risk of 
bias 













 M and F:18-40 
Participants were uncomfortable with "anal sex" as a 
question. They preferred anal sex to be referred to as 
"sex at a place where wastes (faeces) comes out" or 
"sex at backside". Some referred to anal sex as "doggy 
style". They described anal sex as "homosexual do". 
 low risk of 
bias 
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sampling; 11 Focus 
group discussions 
Adult men 




Participants were reluctant to talk about anal sex. 
They largely used proxy names in Zulu to describe 
anal sex. There was poor understanding about the 
meaning of anal sex. They expressed shock and 
disbelief when the facilitator told them the meaning 
of anal sex as “having sex in the faecal passage". 
Some participants felt that anal sex is practiced only 
by MSM. They expressed shock and disbelief when 
the facilitator told them the meaning of anal sex as 
“having sex in the feacal passage".  Some participant 
felt that anal sex is practiced only by MSM. 
low risk of bias 










 M and F: 17-45 
 Participants interpreted sexual intercourse to mean 
heterosexual and vaginal sex. They believed only 
"whites" (ferenges) accept anal sex as a form of sexual 
intercourse 









sampling; 7 Focus 
group discussions 
and 4 In-depth 
interviews 
FSW in Kigali 
only (KAP) 
F; 22-30 
Some FSWs had strong negative perceptions about 
clients requesting anal sex. They believed that anal 
sex was mostly requested by non-Rwandans. The 
most common reported reason for engaging in anal 
sex was a financial incentive. Some participants said 
that anal sex practices are associated with alcohol 
use. Some FSWs reported that their clients do not use 
condoms for anal sex. 
low risk of bias 








sampling; 40 Focus 
group discussions 
and 54 In-depth 
interviews 
Adult men 
and women in 
community/cl
inics (KAP) 
M and F; NS 
Participants demonstrated a good knowledge of anal 
sex, but they were reluctant to discuss their personal 
experiences. They also regarded anal sex as a taboo. 
Reported reasons for engaging in anal sex that were 
discussed included: preserving virginity, 
contraception, financial incentives, as an alternative 
low risk of bias 
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when vaginal sex was not feasible (e.g. pregnancy and 
menstruation), to satisfy their male partner's 
pleasure, adventure and novelty. Participants had the 
misconception that anal sex is safer than vaginal sex, 
is associated with lesser risk of HIV/STIs and hence 
there is no reason to use condoms. 




sampling; 3 Focus 
group discussions 
and 30 In-depth 
interviews 
FSW (KAP) F; 20-40 
Participants had open discussion about anal sex 
including their personal experiences with clients. The 
main reported reason for engaging anal sex was 
receiving higher financial incentives than for penile-
vaginal sex. Clients paid more for requesting 
unprotected anal sex.  
low risk of bias 
 






sampling; 24 Focus 
group discussions 
and 81 In-depth 
interviews 
 Adult men 
and women in 
community 
(KAP) 
 M and F; NS 
Truck drivers and their female partners said 
heterosexual anal sex is increasingly being practiced 
in Tanzania. Reasons for engaging in anal sex by men 
included: seeking better sexual pleasure than vaginal 
sex, to avoid pregnancy, to prove to their female 
partners that they are sexually strong and for sexual 
adventure. Women mentioned receiving greater 
financial gains with anal sex compared to vaginal sex, 
that anal sex helped to retain their sexual partners, 
that it could prevent pregnancy, was an alternative 
during menstruation and fattening their buttocks to 
improve their beauty to suitors as reasons for 
practicing anal sex. Both men and women said a 
barrier method is not needed during anal sex because 
the sexual act is safer than vaginal sex, sexual 
pleasure will be reduced and there is a fear of losing 
the condom inside the anus. 
 low risk of 
bias 
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sampling; 4 Focus 
group discussions 
and 16 In-depth 
interviews 
Adult men 




There was culture of silence about anal sex and 
participants used proxy names for the practice. 
Participants believed that anal sex was mostly 
practiced by foreigners, young people, FSWs and 
Arabs.  Reported reasons for engaging in anal sex that 
were described by participants included: adventure, 
'trending', financial incentives and male partner 
desire. Women felt that anal sex was associated with 
delivery complications, and anal incontinence.  Male 
participants reported that engaging in anal sex could 
cause blockage of the anus and urinary system, and 
cancer. Both male and female participants believed 
that anal sex is risky and there was a need to use 
condom during anal  sexual act.  
low risk of bias 















Some participants expressed "shock", "disbelief", 
"disgust", "embarrassment" and "denial" about anal 
sex. some believed that anal sex should not be openly 
discussed. There were misconceptions that the back 
side vaginal sex and anal sex were the same sexual act 
by the participants until it was explained by the 
researcher with annotated diagram. A number of 
participants preferred to use alternative name for 
anal sex e.g. "hidden part", "down there" and "where 
faeces comes out". Women reported engaging in anal 
sex in order to satisfy their partners' sexual pleasure/ 
They considered anal sex to be safer than vaginal sex 
and as an alternative sexual act when vaginal sex was 
not feasible. Some engaged in anal sex for better 
financial gains. 
 low risk of 
bias 
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 Snow ball 
Sampling; 18 In-
depth interviews 
 FSW (KAP)  F:18-39 
Participants engaged in anal sex with their clients for 
financial gains, for personal sexual pleasure, due to 
coercion by clients and to satisfy their lovers (husband 
or boyfriends). 
 low risk of 
bias 






sampling; 20 Focus 
group discussions 
 Adolescent 





 Heterosexual anal sex was perceived to be more 
culturally acceptable especially among the younger 
population and it is regarded as part of love making. 
Some women said men force them to practice anal 
sex against their wish while other women engage in 
anal sex to protect their sexual relationships. Some 
women suffered discrimination among their peers for 
refusing anal sex. A number of participants believed 
that anal sex is safe without using any barrier 
methods. Lubricants such as "jelly" were believed to 
enhance anal sex pleasure and to minimise risk of 
injury. 




GP – General Population; KAP: Key Affected Population; M – Male; F – Female; FSW – Female sex worker; NS – Not stated; Yrs – Years
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Table 2.5: Assessment of  critical information on the design of quantitative studies 
 










in methods (anal sex) 
Definition of 
Exposure/outcome 




behaviour role  
(anal sex) 
Prevalence of 
outcome by sexual 







Soyinka 1979 Yes Yes NR Yes No No No No No No 
Van de Perre et al 1985 Yes Yes Yes No No No Yes Yes No No 
Wilson et al 1989 Yes No Yes No No No Yes Yes No No 
Katsivo et al Yes No Yes No No NA Yes NA NA No 
Akande 1994 Yes No Yes Yes No No No No No No 
Cossa et al 1994 Yes Yes Yes No No No Yes No No No 
Feldman et al 1997 Yes No No Yes No No No Yes NA No 
Abdool Karim et al 1998 Yes No Yes NR No NA Yes NA NA No 
Matasha et al 1998 Yes Yes Yes Yes No No Yes No No Yes 
Tengia-Kessy et al 1998 Yes Yes Yes Yes NA No NA No No No 
Fawole et al 1999 Yes No No No NA No NA No No No 
Sallah et al 1999 Yes Yes Yes Yes No NA Yes No NA Yes 
Fonk et al 2000 Yes Yes Yes No No NA Yes NA No Yes 
Gathece et al 2000 Yes No Yes No NA No NA No Yes No 
Okesola et al 2000 Yes No No No NA No NA No No No 
van Dammee et al 2002 Yes Yes Yes Yes No NA Yes No No Yes 
Ramjee et al 2002 Yes Yes Yes No No NA Yes NA No Yes 
Kalichman et al 2004 Yes No No No No NA Yes NA No No 
Nicholas 2004 Yes No Yes No No No Yes No No No 
NNoruka et al 2005 Yes No No No No No No No No No 
Okafor et al 2005¥ Yes Yes Yes Yes No No No No No No 
Mpofu et al 2006 Yes No Yes Yes Yes NA No NA No No 
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Schwandt et al 2006 Yes Yes Yes Yes No NA Yes No Yes Yes 
Dunkle et al 2005 Yes Yes Yes No No No Yes No No Yes 
Jaspan et al 2007 Yes Yes Yes No No NA Yes NA No Yes 
Allen et al 2007 Yes No Yes Yes No NA Yes NA No Yes 
Operario et al 2007 Yes Yes Yes Yes No No Yes No NA Yes 
Watson-Jones et al 2007 Yes Yes Yes No No NA Yes NA No Yes 
Adoga et al 2009 Yes Yes Yes No No NA Yes NA NA Yes 
Cornman et al 2008 Yes Yes No No No No Yes No No Yes 
Bing et al 2008 Yes Yes Yes Yes No NA Yes NA No Yes 
Grijsen et al 2008 Yes Yes Yes No Yes NA Yes NA Yes Yes 
Morhason-Bello et al 2008 Yes Yes Yes Yes No No No No No Yes 
Pluddemann et al 2008 Yes No No Yes No No Yes No Yes Yes 
Skoler-Karpoff et al 2008 Yes Yes Yes No No No Yes No No Yes 
Andersson et al 2009 Yes No Yes No No No No No Yes Yes 
Bamidele et al 2009 Yes Yes Yes Yes   No No No No No 
Kalichman et al 2009 Yes Yes Yes No No NA Yes NA Yes Yes 
Kazaura et al 2009 Yes No Yes Yes No No Yes No No Yes 
van der Elst et al 2009 Yes Yes Yes Yes No NA Yes NA No Yes 
Abdool karim et al 2010 Yes No Yes No No NA Yes NA No Yes 
Abdool Karim et al 2011 Yes Yes Yes No No NA Yes NA No Yes 
Ambaw et al 2010 Yes Yes Yes Yes Yes Yes No No Yes Yes 
Opoku 2010 Yes No Yes No No No Yes No No No 
Kalichman et al 2011 Yes Yes Yes No Yes NA Yes NA Yes Yes 
Maswanya et al 2011 Yes Yes Yes Yes No No Yes No No No 
Mensch et al 2011 Yes Yes Yes No Yes NA Yes NA No Yes 
Priddy et al 2011 Yes No Yes No No NA Yes NA No Yes 
Nel et al 2011 Yes Yes Yes No No No Yes No No Yes 
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Venkatesh et al 2011 Yes Yes Yes No No NA Yes NA No Yes 
Veldhuijezn et al 2011 Yes No Yes No Yes NA Yes NA Yes Yes 
Clain et al 2012 Yes Yes Yes Yes No NA Yes NA Yes Yes 
Chege et al 2012 Yes No Yes No No No Yes No NA Yes 
Cherie et al 2012 Yes Yes Yes Yes Yes Yes No No Yes Yes 
Guedou et al 2012 Yes Yes Yes Yes No No Yes No No Yes 
Loggerenberg et al 2012 Yes No Yes No No No Yes No No Yes 
Peltzer 2012 Yes Yes Yes No No No No No No Yes 
Gaffoor et al 2013 Yes Yes Yes No No No Yes No No Yes 
Gray et al 2013 Yes No Yes No No NA Yes NA No Yes 
Guffey et al 2014 Yes Yes Yes Yes No NA Yes NA No Yes 
Essomna et al 2013 Yes No Yes No No NA Yes NA No Yes 
Gevers et al 2013 Yes Yes Yes Yes Yes Yes Yes No Yes Yes 
Kakoko 2013 Yes No Yes Yes No No No No NA Yes 
Lambdin et al 2013 Yes Yes Yes No No NA Yes NA NA Yes 
Scott-Sheldon et al 2013 Yes Yes Yes No Yes NA Yes NA No Yes 
Vogt et al 2013 Yes No Yes No NA Yes NA NA NA Yes 
Asekun-Olarinmoye et al 2014 Yes Yes Yes Yes No No No No No Yes 
Davidson et al 2014 Yes No Yes No NA No NA No NA Yes 
Folayan et al 2014 Yes Yes Yes Yes No No NA No Yes Yes 
Githuka et al 2014 Yes Yes Yes Yes Yes NA Yes NA NA Yes 
Jemmott et al 2014 Yes Yes Yes Yes Yes NA Yes NA No Yes 
Kerwin et al 2014 Yes No Yes Yes NA No No NA Yes Yes 
Mbulawa et al 2014 Yes No Yes No NA NA NA No No Yes 
Meque et al 2014 Yes No Yes Yes NA Yes NA No Yes Yes 
Anyanwu et al 2015 Yes Yes Yes No No NA Yes NA NA Yes 
Noguchi et al 2015 Yes Yes Yes No No NA Yes NA Yes Yes 
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Palanee-Phillips et al 2015 Yes Yes Yes No No No Yes NA No Yes 
Thurston et al 2014 Yes Yes Yes No No No Yes NA Yes No 
Animasahun et al 2016 Yes Yes Yes Yes NA No NA No NA Yes 
Arulogun et al 2016 Yes Yes Yes Yes NA No NA No NA Yes 
Dubbink et al 2016 Yes Yes Yes Yes Yes Yes Yes Yes NA Yes 
Lawan et al 2016 Yes Yes Yes Yes No No Yes No NA Yes 
Luma et al 2016 Yes Yes Yes No No No No NA NA Yes 
McLellan-Lemal et al 2016 Yes Yes Yes No No No Yes NA No Yes 
Teasdale et al 2016 Yes Yes Yes Yes No NA Yes NA NA Yes 
Dareng et al 2017 Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes 
Giorgio et al 2017 Yes Yes Yes No No No Yes NA NA Yes 
Hladik et al 2017 Yes Yes Yes No No NA Yes NA NA Yes 
Longo et al 2017 Yes Yes Yes No No NA Yes NA NA Yes 
Shayo et al 2017 Yes Yes Yes Yes Yes NA Yes NA Yes Yes 
Chikandiwa et al 2018 Yes Yes Yes Yes No No Yes Yes NA Yes 
Davey et al 2018 Yes Yes Yes Yes Yes Yes Yes Yes NA Yes 
Maheu-Giroux et al 2018 Yes Yes Yes No Yes NA Yes NA NA Yes 
Ybarra et al 2018 Yes Yes Yes Yes Yes Yes Yes No NA Yes 
 
CD: Cannot determine; NA: Not Applicable; NR: Not reported. Study population(Yes – provides information on study population); Response rate (Yes=the response rate was 
indicated ihe manuscript); Eligibility criteria (Yes=The inclusion and or exclusion criteria was described in the manuscript); Sampling technique (Yes=There was a description of 
sampling method in the manuscript); Definition of exposure (Yes=There was a description of operational definition of outcome measure – oral or anal sex in the manuscript); 
Prevalence of outcome  by sexual behaviour role (Yes=The prevalence (proportion) of outcome was presented for insertive or receptive sexual behaviour role in the manuscript); 
Confounders/Riskfactors measured (Yes=The confounders were stated and presented in the analysis); Ethical approval (Yes=A statement on ethical approval was described in 
the manuscript); No=Absence of any of the assessment indicators in the manuscript that was reviewed.
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Table 2.6: Assessment of  critical information on the design of qualitative studies 
 






















Stadler et al 2007 Yes Yes Yes CT CT Yes No CT Yes Yes low risk of bias 
Mavhu et al 2008 Yes Yes Yes CT CT No Yes CT CT Yes low risk of bias 
Ndinda et al 2008 Yes Yes Yes Yes Yes Yes No Yes Yes Yes low risk of bias 
Veldhuijezn et al 2011 Yes Yes Yes CT CT No Yes CT CT Yes low risk of bias 
Duby et al 2014 Yes Yes Yes Yes Yes CT No Yes Yes Yes low risk of bias 
Beckham et al 2015 CT Yes Yes Yes Yes CT Yes Yes Yes Yes low risk of bias 
Matenga et al 2015 Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes low risk of bias 
Wamoyi et al 2015 Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes low risk of bias 
Duby et al 2016 Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes low risk of bias 
Mazeingia et al 2017 Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes low risk of bias 
Mtenga et al 2017 Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes low risk of bias 
Shayo et al 2017 Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes low risk of bias 
 
CT: cannot be determined; Aim (Yes=The aim or objective of the study was described in the manuscript); Method (Yes=The correct method of analysis was used and 
described in the manuscript); Study design appropriate (Yes = Assessment whether the study design was correctly described in the manuscript); Recruitment appropriate 
(Yes=A detailed description of the process of recruitment of participants); Data collection (Yes= A description of the process of data collection in the manuscript); Researcher 
and participant relationship (Yes=There was information on the role and or relationship of researcher and participant in a section of the manuscript); Ethical consideration 
(Yes=a description of ethical approval and other related statements in the manuscript); Data analysis sufficient (Yes=A description of analysis methods including description 
of clear outcomes and methods of data synthesis); Findings clearly discussed (Yes=A clear summary of outcomes/themes on different aspects of oral and or anal sexual 
behaviours including information on how the themes were formed from the analysis); Signficance of the study (Yes=A summary of clear message of the manuscript as it 
relates to oral and or anal sexual behaviour); No=lack of information of any of the key indicators that were assessed. Reviewers comments = overall assessment
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DISCUSSION 
This is the first systematic review of reported prevalence of oral and anal sex among 
adolescents and adults reporting heterosexual sex in SSA. The review showed a large range 
of reported prevalences for both behaviours. Generally, the range of prevalences were similar 
among key affected and general populations. However, reported prevalences of oral and anal 
sex among FSWs and university students tended to be higher than in other population groups 
of adolescents and adults. In addition, reported prevalences of both oral and anal sex tended 
to be higher among males than females. Few studies reported the use of condoms or other 
barrier methods with oral and anal sex with a number of them reporting low or inconsistent 
condom use during oral and anal sex. Factors associated with these behaviours showed that 
those who engaged in oral and anal sex often also engaged in other high-risk activities such 
as having frequent and multiple sexual partners, illegal substance or alcohol use, and 
inconsistent condom use. Oral and anal sex are important modes of transmission for STIs, and 
these data are vital for understanding sexual behaviours in populations at high risk for STIs 
including HIV, oral and anal cancers.  
Findings from three qualitative studies provided possible explanations for engaging in 
unprotected anal sex [300, 302, 303] including that it was regarded as less risky than vaginal 
sex and could prevent STIs, including HIV. Anal sex was also associated with an exchange of 
money or gifts among FSWs. Studies from the USA also showed that the belief that oral sex is 
without health risk, and subjects not regarding oral and anal sex as “having sex” are 
perceptions that might have accounted for low condom use [337, 338]. Qualitative research 
also illustrated a culture of silence in discussing anal sex, and many of those that discussed it 
expressed shock and disbelief that such sexual acts existed within heterosexual relationships. 
This, combined with the belief by some boys/men that performing heterosexual anal sex 
demonstrates a supremacy over girls/women, may further create a culture of secrecy, shame, 
and transgression. Indeed, women reported coercion for anal sex and a perception that men 
engaged in it to punish them. In such an environment, discussion about safety and condom 
use may be undermined, and strategies for STI control may be challenging. More research is 
needed to further understand motivations for and meaning of engaging in oral and anal sex 
in SSA, as well as opportunities and challenges for addressing violence, safety and STI/HIV 
risk. 
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The comparatively higher prevalences of oral and anal sex among some key affected 
populations compared to general populations in this review has also been widely reported in 
high-income countries. Some studies among key affected populations suggested that these 
behaviours were associated with increased use of alcohol and substance abuse during sexual 
activity, increased frequency of sexual acts and multiple sexual partners [339-343]. Men who 
engaged in anal sex with FSWs were more likely to have consumed alcohol and to be a 
frequent customer[339]. Apart from these reasons, it has also been reported that FSWs 
engaged more in oral and anal sex to satisfy their clients’ requests and for financial gain [339, 
344]. This was corroborated by two qualitative studies included in this review where FSWs 
reported economic gain as the main reason for engaging in anal sex [290, 303]. Adolescents 
in Ethiopia also reported receiving gifts or money for practicing oral and anal sex[252].  
High prevalences of oral and anal sex were observed among university students, and this is 
similar to findings from studies in high-income countries. In the UK NATSAL survey, young 
people were more likely to report oral and anal sex than older adults, irrespective of gender 
[222]. The increased reporting of oral and anal sex among young people has been associated 
with changing perception of sexual activity among younger generations and the influence of 
social media, including pornography, amongst others [345-348]. An Australian study that was 
conducted among young people found that previous anal sex experience was associated with 
frequent use of pornography[348]. It will be important that adolescent health providers are 
aware that these behaviours are now being practiced by young people across the continent, 
and education programmes will need to be tailored to addressing the risks associated with 
these behaviours and how these can be prevented.  
Although routine testing for oropharyngeal and anal infections is recommended in high-
income countries for sexually active MSM[349, 350], some argue that exclusion of sexually 
active women with history of receptive oral and anal sex from routine testing will lead to 
missed opportunities for early detection of STIs and the prevention of onward transmission 
[349, 350]. The cost-effectiveness of routine testing for asymptomatic pharyngeal and anal 
infection is unclear[350]. A routine testing strategy is not yet a feasible option for people 
reporting heterosexual oral and anal sex in SSA. However, raising awareness on the risk of 
contracting STIs during condomless oral and anal sex through information, education and 
counselling programmes could be a practicable strategy in the region. It is also imperative 
104 | P a g e  
 
that policy makers in the region expand the concept of hetero-normative sexual acts to 
include oral and anal sex.  
The higher prevalence of reported oral and anal sex by males in this review should be 
interpreted within a context of reporting bias. Studies in SSA and other regions have shown 
that during self-reported sexual behaviour interviews, males tend to report a higher number 
of sexual partners, non-marital partners and concurrent relationships than females, and 
females may under-report numbers of sexual partnerships [351-353]. Reporting differences 
by gender may also vary according to the specific sexual behaviour. Available evidence from 
population studies in the UK and USA showed that more men or boys reported receiving oral 
sex than women or girls in heterosexual relationship [222, 354]. In the same report, more girls 
were reported to give oral sex than boys. Some researchers argued that gender differences 
in the reporting of sexual activity might be influenced by the perception of sexual pleasure, 
health risks and beliefs[355, 356]. A qualitative study further showed that men preferred to 
receive oral sex from their partners  than to give oral sex to their partners because they 
perceived receiving oral sex to be less risky and giving oral sex  to be a dirty and dangerous 
practice[357].  
The strengths of this review are the range of prevalences across geographic sub-regions, 
populations and ages within SSA. However, there are a number of limitations. There were 
very few population-based estimates of the oral and anal sex prevalence such as prevalences 
reported in the population-based studies in the UK and Australia [219, 222]. Instead, there 
was a wide range of prevalences of oral and anal sex observed in various population sub-
groups which are unlikely to be generalizable. In addition, there were several methodological 
weaknesses in the studies reviewed including inconsistent operational definitions of oral and 
anal sex. Furthermore, studies also used different reporting periods, making it challenging to 
pool and compare results across population sub-groups and settings in SSA.  
In addition to reporting gender bias discussed above, there is likely to be under-reporting of 
these sensitive behaviours due to social desirability bias, especially for heterosexual anal sex, 
since this practice is not well accepted in some communities [301, 302, 358]. Many studies 
were assessed as having a high-risk of bias and did not provide information on how their 
sample sizes were determined. Lastly, restricting our inclusion criteria to only published, peer 
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reviewed articles, limiting our search to seven databases, and exclusion of MSM that also 
engaged in heterosexual oral and anal sex could have resulted in our missing other studies 
that reported on oral and anal sex in the region.  
CONCLUSION  
In summary, oral and anal sex are commonly practiced among adolescents and adults 
reporting heterosexual sex in SSA, often without condom use. Future sexual reproductive 
health research investigating risks for STIs should incorporate questions on oral and anal sex 
using clear definitions of these behaviours. Well powered and rigorous population-based 
study designs similar to studies in the United Kingdom and Australia [219, 222] are needed to 
understand population estimates of these behaviours, their associated morbidities, and 
changes in sexual behaviour trends over time. Researchers should also consider using 
qualitative research methods, complimentary tools such as pictures/drawings and other 
visual aids to elicit more accurate responses from participants[358]. Accurate data are needed 
to inform reproductive and sexual health policies, and information on oral and anal sex and 
their health risks should be included in information, education and counselling messages for 
both the key affected and general populations. 
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Multiple data points for the same author and year referred to disaggregated data by: Educational level (Matasha et al 1998); Gender (Wilson et al 1989; Matasha et al 1998; Tengia-Kessy et 
al 1998; Nicholas et al 2004; Operario et al 2007; Pluddemann et al 2008; Kazaura et al 2009; Chege et al 2012; Gever et al 2013; Vogt et al 2013; and Folayan et al 2014); Mbulawa et al 2014; 
Ybara et al 2018;  Range value (Kerwin et al 2014); Reporting periods (Gever et al 2013; Cherie et al 2012 and Folayan et al 2014); Sexual partners (Anderson et al 2009); Study sites (Akande 
1994; Nell et al 2011); A study by Okafor et al 2005 that presented combined prevalence of oral and anal sex as a single estimate point was excluded in this graph. FSWs: Female sex workers; 
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Multiple data points for the same author and year referred to disaggregated data by: Educational level (Matasha et al 1998); Gender (Wilson et al 1989; Matasha et al 1998; Tengia-Kessy et 
al 1998; Nicholas et al 2004; Operario et al 2007; Pluddemann et al 2008; Kazaura et al 2009; Chege et al 2012; Gever et al 2013; Vogt et al 2013; and Folayan et al 2014); Mbulawa et al 2014; 
Ybara et al 2018;  Range value (Kerwin et al 2014); Reporting periods (Gever et al 2013; Cherie et al 2012 and Folayan et al 2014); Sexual partners (Anderson et al 2009); Study sites (Akande 
1994; Nell et al 2011); A study by Okafor et al 2005 that presented combined prevalence of oral and anal sex as a single estimate point was excluded in this graph. FSWs: Female sex workers; 
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Multiple data points for the same author and year referred to disaggregated data by: Educational level (Matasha et al 1998); Gender (Wilson et al 1989; Matasha et al 1998; Tengia-Kessy et 
al 1998; Nicholas et al 2004; Operario et al 2007; Pluddemann et al 2008; Kazaura et al 2009; Chege et al 2012; Gever et al 2013; Vogt et al 2013; and Folayan et al 2014); Mbulawa et al 2014; 
Ybara et al 2018;  Range value (Kerwin et al 2014); Reporting periods (Gever et al 2013; Cherie et al 2012 and Folayan et al 2014); Sexual partners (Anderson et al 2009); Study sites (Akande 
1994; Nell et al 2011); A study by Okafor et al 2005 that presented combined prevalence of oral and anal sex as a single estimate point was excluded in this graph. FSWs: Female sex workers; 
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Multiple data points for the same author and year referred to disaggregated data by: Data collection methods (Allen et al 2007; van der Est et al 2009; Mensch et al 2011); Educational level 
(Matasha et al 1998); Gender (Operario et al 2007; Folayan et al 2014) Study site (Akande 1994; Abdool Karim et al 2010; Veldhuijezn et al 2011; AbdulKarim et al 2011; Nell et al 2011; 
Palanee-Philips et al 2015); Sexual partners (Anderson et al 2009; Jemmot et al 2014);  Reporting period (Cherie et al 2012; Gever et al 2013; Folayan et al 2014); A study by Okafor et al 2005 
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Multiple data points for the same author and year referred to disaggregated data by: Data collection methods (Allen et al 2007; van der Est et al 2009; Mensch et al 2011); Educational level 
(Matasha et al 1998); Gender (Operario et al 2007; Folayan et al 2014) Study site (Akande 1994; Abdool Karim et al 2010; Veldhuijezn et al 2011; AbdulKarim et al 2011; Nell et al 2011; 
Palanee-Philips et al 2015); Sexual partners (Anderson et al 2009; Jemmot et al 2014);  Reporting period (Cherie et al 2012; Gever et al 2013; Folayan et al 2014); A study by Okafor et al 2005 
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2.5. SIGNIFICANCE OF THE SYSTEMATIC REVIEW FOR THE THESIS 
The outcome of this systematic review shows that oral and anal sexual behaviours are 
common, but data collected are difficult to synthesise and interpret because of the 
heterogenous design of published studies. For example, most published studies from Nigeria 
in this review did not provide a clear definition of oral and anal sexual behaviours. It is 
therefore difficult to ascertain whether participants understood the questions that were 
asked on oral and anal sexual practices, and how their response varied across different 
populations. Apart from the possibility of incorrect interpretation of questions, lack of 
operational definitions of these sexual behaviours may also make comparisons of research 
findings across studies challenging. Despite these limitations, some studies provided clear 
definitions of oral and anal sex including sexual behaviour roles and associated risk factors, 
which served as a useful guide for the design of tools on sexual behaviours for the qualitative 
and quantitative aspects of SHINI study. Furthermore, it was also clear from this review that 
oral and anal sexual behaviours have local or colloquial terms which might connote different 
meaning or elicit varied responses, and interpretations of these terms sometimes shape 
people’s attitude in the community. This explored in more detail among the SHINI study 
population with formative qualitative research in Chapter 3. 
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CHAPTER 3: PERCEPTIONS, INTERPRETATIONS, TERMINOLOGIES, AND 
ATTITUDE OF ADOLESCENTS AND ADULTS TOWARDS HETEROSEXUAL 
ORAL AND ANAL SEX IN IBADAN, NIGERIA 
3.1.	BACKGROUND INFORMATION 
Emerging data from SSA described in the systematic review in Chapter 2 showed that 
heterosexual oral and anal sex behaviours are common among men and women in the 
general population and in key affected populations such as FSWs, long distance drivers and 
women working in bars and entertainment centres [157, 252, 282, 320, 331].  However, there 
are limited qualitative research publications that seek to understand knowledge, perceptions 
and interpretations of these sexual behaviours in SSA.  Although there were virtually no 
published qualitative data on oral sex in SSA,  there were some qualitative studies published 
on heterosexual anal sex, mostly from Southern [301, 322, 323] and East African countries 
[302, 304, 320]. None of the qualitative studies on oral and anal sex in the systematic review 
was conducted in Nigeria. The qualitative studies generally focused on understanding 
terminologies, perceptions, and interpretations of anal sex [301, 304, 322, 323]. For example, 
anal sex  was misunderstood by people in some communities to be vaginal sex from 
behind[301], or was perceived to be foreign to African culture and to be exclusive to 
homosexuals[301, 304]. In five qualitative studies [290, 300, 303, 322, 323], anal sex was 
considered to be too sensitive a topic to be mentioned openly, and individuals involved in 
such practices often use slang words or other terminologies to describe it. 
The systematic review in Chapter 2 also documented a few studies that provided clear 
definitions of oral and anal sex; the majority of studies did not[157]. However, it is not clear 
from the review whether participants preferred the use of simple definitions or local or 
colloquial names or slang terms for oral and anal sex. It is important to use appropriate 
terminologies to frame questions in order to elicit correct response from participants without 
causing any provocation or embarrassment [358]. Given that sexual behaviours are not 
openly discussed and have many local terminologies, there is also the risk that individuals will 
misunderstand questions that are asked regarding these sexual behaviours [358-360]. As part 
of this PhD, qualitative research was conducted amongst different groups of people in some 
communities in Ibadan, Nigeria to prepare for cross-sectional surveys to document the 
114 | P a g e  
 
prevalence of and risk factors for HPV infection in adolescent and adult females and FSWs. 
Specifically, this qualitative study explored knowledge and perceptions, interpretations, local 
terminologies, motivations and beliefs around potential health risks associated with different 
types of sexual behaviours, with specific attention on heterosexual oral and anal sex. 
3.2. METHODS 
The formative qualitative research presented in this chapter was designed to help develop a 
culturally acceptable questionnaire tool that could be used in the SHINI cross-sectional study 
presented in Chapters 4 and 5.   
3.2.1 Study design and population 
The qualitative study used focus group discussion (FGD) and in-depth interview (IDI) data 
collection techniques to obtain information from male and female older adolescents (≥18 
years) and adults in the community and brothels in Ibadan metropolis. The younger 
adolescents (<18 years) were excluded because of the logistic challenge of securing consent 
from a minor and ethical implication to the study. The FGDs were conducted to initiate 
discussions about knowledge, definitions/meanings, and motivations for different sexual 
behaviours among homogenous participants (Annex 3.1 – topic guides for the FGD). 
Specifically, the FGDs explored participants’ perceptions of oral and anal sex including 
motivations, meanings, interpretations, associated stigma, and perceived health related 
problems associated with these sexual acts. The IDIs sought information on personal 
experiences of participants concerning oral and anal sex, including motivations for engaging 
in these sexual acts and any perceived associated health risks (Annex 3.2 – topic guides for 
the IDI).  
Two urban LGAs, Ibadan Southwest and Ibadan Southeast, were purposively selected for the 
qualitative research because of the relatively high population of youths aged 18 years and 
above and adults up to 45 years of age the presence of social activity points such as hotels, 
bars, pub and clubs, cinema houses and brothels. A list of mapped brothels was provided by 
the Society for Family Health (SFH), a non-governmental organization that has been 
conducting reproductive health programmes among FSWs for decades 
(http://www.sfhnigeria.org).  Out of the mapped brothels, the four brothels with the highest 
number of FSWs were selected from two LGAs.  
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The study purposively selected male and female adolescents and adults in the community as 
a sample from the general population and brothel-based FSWs (18-45 years) as a sample of 
the key affected population group. The general population sample consist of two age groups: 
(i) adolescents and young adults (18-25 years) and (ii) older adults (26-45 years).  
3.2.2 Study procedures 
3.2.2.1 Recruitment of study participants for Focus Group Discussion 
Potential participants among the general population and FSWs were recruited separately by 
gender-matched trained research assistants. The FGD participants from the general 
population were recruited in the community from tertiary educational establishments, 
vocational centers, youth clubs, markets, artisan people and other institutions/facilities in 
both LGAs to provide a wide perspective on the research topic. Research assistants informed 
potential participants about the objectives of the study and this was corroborated with an 
information leaflet that explained the aims and procedures of the study.  The contact details 
of potential FGD and IDI participants that agreed to join the study were recorded for follow-
up.  
In each LGA, separate FGDs were conducted for male and female participants in the general 
populations. Within each gender sub-group, separate FGDs were conducted for the married 
and unmarried participants. There were also separate FGDs for participants that spoke English 
or spoke only Yoruba (Table 3.1).   The average number of participants per session of FGD was 
6-10 people. 
The FSWs living and/or working in the selected brothels were invited to take part in one of 
two FGDs (one in each LGA) (Table 3.3).  The map of local brothels provided by the Society for 
Family Health was updated by two teams of volunteer brothel gatekeepers and an Assistant 
Director in the Oyo State Ministry of Health who coordinated public health interventions in 
the key affected populations.  Two members of the research team visited the selected 
brothels and met with the managers and the chairladies of the FSWs working in the brothels 
to discuss the research objectives. The brothel manager or chairlady endorsed the letter of 
invitation to conduct the study in their brothel. After securing written approval from the 
brothel leadership, the female research assistants individually discussed the objectives of the 
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study with the FSWs and also gave out study information leaflets. Those that agreed to 
participate were enrolled in the study.  
3.2.2.2 Recruitment of study participants for In-depth Interviews 
Participants among the general population and FSWs that participated in FGDs and other 
interested people in the community and brothels who were willing to discuss the research 
topic further were invited for IDIs. They were informed that they would be asked about their 
sexual behaviours.  The potential participants were individually informed about the IDI stage 
of the study, and each of them was given an information leaflet about the study to ensure 
that they had a clear understanding of the study and of their participation in it.  Thereafter, 
those willing to participate were scheduled for the interview by a gender matched research 
assistant. 
The IDI participants in the general population were recruited from the two LGAs and the 
recruitment covered gender, age-group, marital status and educational status. The interview 
was conducted in English or Yoruba. The detail of the sampling matrix for the recruitment of 
study participants is in tables 3.2 and 3.3. 
3.2.3. Design of Topic Guides, Training and Data Collection Process 
3.2.3.1. Research Team, Training and Pilot study 
The principal investigator (IMB) developed topic guides for FGDs and IDIs following a review 
of the literature on different sexual behaviours including oral and anal sex. The design of the 
topic guides was supervised by KM, DWJ and SCF. The topic guides (Annexes 3.1 and 3.2) 
covered knowledge of different sexual behaviours, including oral and anal sexual acts, 
motivations, terminologies, interpretations, and experiences of practicing vaginal, oral and 
anal sexual acts. Information on stigma and health risks associated with these sexual 
behaviours was also discussed. Six research assistants (three male and three female) who had 
tertiary education, who spoke English, Yoruba and ‘pidgin’ English fluently, and who had 
previous experience in social science research were engaged to serve as recruiters, 
moderators or interviewers as well as note-keepers 
Before the data was collected, IMB and a social scientist in Nigeria conducted a week of 
intensive training on qualitative research for the research assistants. The training involved 
didactic lectures, interactive discussions and role play scenarios on how to conduct FGDs and 
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IDIs using the topic guides.  A pilot study was conducted at Yemetu community to pre-test the 
topic guides to elicit information on the study objectives. One FGD and two IDIs were 
conducted.  IMB reviewed the three pilot study transcripts to assess whether all the key issues 
in the topic guides were covered. A one-day follow-up meeting was held with the research 
team by IMB to discuss feedback from the pilot tests and to finalise the strategy for the 
conduction of the qualitative study.  
3.2.3.2. Data Collection Process 
During FGDs, a trained gender-matched moderator and a note-taker facilitated the sessions. 
Written, informed consent was obtained from individual potential participants before each 
session began (Annexes 3.3 and 3.4 – Consent for the qualitative study). The consent form 
also covered permission to record and analyse results and to publish the research findings. 
After a brief introduction, participants that gave consent to participate in the study were 
assigned numbers for identification (R1, R2…Rn).  The moderator began with setting the stage 
by providing some ground rules, including telling participants that no comments or expressed 
views would be taken as a right or a wrong response. Most FGDs were conducted in English. 
Participants with no formal education were grouped together and their FGDs were conducted 
in Yoruba while the FGDs among FSWs were conducted in “pidgin” English.  
The moderator introduced each issue in the topic guides for discussion, allowing participants 
to present their views openly and ensured that no participant dominated the session. Each 
participant was encouraged to express his/her views freely. Participants were assured that 
the information provided by them would not be used against them and their identity would 
not be revealed at any stage of the research process. The moderator probed for specific issues 
that were not covered by participants. Demographic data pertaining to each of the 
participants were collected individually at the end of each FGD session.  
IDIs were conducted in the participant’s preferred venue. A gender matched research 
assistant conducted each interview. The choice of language that was used to conduct an IDI 
was dictated by the participant’s preference. The transcript and recording of individual 
participants was identified by their age and marital status.  Each FGD session and each IDI was 
audio-recorded and these generally lasted between 40-65 minutes. The note taker 
documented the key findings from each FGD and IDI session, including the non-verbal cues 
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that were observed. The data collection took place between 22nd August 2016 and 14th 
December 2016. 
3.2.4. Data management and analysis 
All data collected (electronic and hard copy) were kept in a locked cabinet inside IMB’s office. 
Audio files were transcribed verbatim and this was supported with information from field 
notes by IMB and two hired research assistants. Yoruba language and “pidgin” English 
transcripts were translated to by the two hired research assistants who had many years’ 
experience in translating Yoruba to English. Data quality checks were done through reading 
of all transcripts by IMB. KM and AJ read some randomly selected transcripts of FGD and IDI. 
The data were imported into Nvivo 11.0 Pro software (QSR International Pty Ltd. Cardigan 
UK) for coding. 
At the first stage, three coders (IMB and two other independent persons experienced in Nvivo 
software (QSR International Pty Ltd. Cardigan UK) for coding) generated the preliminary 
(parent) codes for review and discussion. Two experienced qualitative researchers (KM and 
AJ) reviewed the codes and offered suggestions to improve on the emerging parent codes. 
IMB and two other coders generated child codes from further reading of transcripts and 
discussions. Information from the memos of the FGDs and IDIs and the reflective diaries of 
coding were used to further refine the emergent themes through an iterative and inductive 
process[361]. The links between emerged themes were explored to reveal contextual 
meaning of the final themes that were identified. The analysis was conducted using a 
thematic content analysis framework[362]. The identified themes from the FGDs and IDIs 
were summarized with headings and key messages were amplified using direct quotes from 
the study participants. The descriptive statistics of the participants were presented.  
3.2.4 Ethical considerations 
Ethical approvals for the study were obtained from the ethical committees of the London 
School of Hygiene and Tropical Medicine, London (LSHTM 9736-3); the University of 
Ibadan/the University College Hospital, Ibadan (UI/EC/16/005); and the Oyo State 
Government (AD13/479/712) in Nigeria (Annex 3.5). The research assistants explained the 
objectives of the study to the potential participants and gave each of them a copy of the 
information leaflet. Written consent was obtained before data collection and a witnessed 
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consent was obtained from those that could not read or write (illiterate) (Annexes 3.3 and 
3.4). The witness was selected by individual participants. Participants were assured of 
confidentiality, and each of them was given condoms, a toothbrush, toothpaste and a bar of 
bathing soap as well as light refreshments at the end of the FGD or IDI session. 
120 | P a g e  
 
Table 3. 1: Sampling matrix for the community FGDs, and selected socio-demographics of the participants 
 
FGD -focus group discussion; IDI- In-depth-interview; LGA – Local government area; Adolescent and young adult population – 18-25 years; Adult population – 
26-45years; One FGD was conducted for each population group




Population sub-group Gender Mean age in years 
(range)  
 
Total number of 
participants 
Southeast LGA FGDs Formal 
education 
Adolescent and young adult 
(unmarried) 
Male 20.9 (18 – 25) 8 
Female 20.8 (19 – 25) 6 
Adults (married) Male 34.8 (28 – 42) 8 
Female 37.3 (28 – 45) 7 
No formal 
education 
Adolescent and young adult 
(unmarried) 
Male 21.9 (18 – 25) 9 
Female 20.9 (18 – 24) 7 
Adults (married) Male 40.4 (32 – 45) 8 
Female 38.2 (30 – 45) 10 
Southwest LGA FGDs Formal 
education 
Adolescent and young adult 
(unmarried) 
Male 19.7 (18 – 22) 7 
Female 19.3 (18 – 25) 10 
Adults (married) Male 41.1 (33 – 45) 7 
Female 40.4 (33 – 45) 8 
Formal 
education 
Adolescent and young adult 
(unmarried) 
Male 20.8 (18 – 25) 6 
Female 22.0 (20 – 24) 7 
Adults (married) Male 36.6 (26 – 45) 10 
Female 37.8 (28 – 45) 10 
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Table 3. 2: Sampling matrix for the community IDIs, and selected socio-demographics of the participants 
 
 
FGD -focus group discussion; IDI- In-depth-interview; LGA – Local government area; Adolescent and young adult population – 18-25 years; Adult population – 
26-45years




Population sub-group Gender Age or Mean age in 
years (range) 
Total number of 
participants 
Southeast LGA IDIs Formal 
education 
Adolescent and young adult 
(unmarried) 
Male 22.0 (19 – 24) 3 
Female 20.0 1 
Adults (married) Male 34.0 (28 – 42) 3 
Female 33.0 (30 – 36) 2 
No formal 
education 
Adolescent and young adult 
(unmarried) 
Male 21.7 (18 – 24) 3 
Female 21.0 (19 – 23) 2 
Adults (married) Male 37.7 (28 – 45) 3 
Female 36.0 (32 – 40) 2 
Southwest LGA IDIs Formal 
education 
Adolescent and young adult 
(unmarried) 
Male 20.7 (18 – 22) 3 
Female 22.0 1 
Adults (married) Male 33.7 (31 – 37) 3 
Female 43.0 (40 – 45) 3 
No formal 
education 
Adolescent and young adult 
(unmarried) 
Male 22.7 (21 – 25) 3 
Female 23.7 (23 – 24) 3 
Adults (married) Male 32.7 (29 – 36) 3 
Female 30.0 1 
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FGD -focus group discussion; IDI- In-depth-interview; LGA – Local government area; NA – Not available (Declined to give her age).  
1-single – 6FSWs and 3 ; 2-single;3-single-6 FSWs and divorced – 2 FSWs; 4-single- 2FSWs and divorced – 1FSW




Mean age in years (range) Total number of 
participants 
Southeast LGA  FGD Married 30.0 1 
Unmarried1 26.3 (20 – 34) 9 
IDI Married 32.0 1 
Unmarried2 35.0 1 
Southwest LGA FGD Married 30.0 1 
Unmarried3 26.6 (21 – 29) 8 
IDI Married NA - 
Unmarried4 26.3 (23 – 29) 3 
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3.3. RESULTS  
3.3.1 Sociodemographic characteristics of participants 
A total of 18 FGDs and 44 IDIs were conducted in the two LGAs: 16 FGDs (128 participants) 
and 39 IDIs were among the general population; and two FGDs (19 participants) and five IDIs 
were conducted among the FSWs (Table 3.1, 3.2, 3.3).  Of the eight FGDs conducted among 
adolescents and young adults who were unmarried, four each were conducted among male 
and females. Another four FGDs each were conducted among married men and women.  
Nineteen adolescents and young adults had IDIs, twelve were males while seven were 
females. Twelve married men and eight married women were interviewed. Fourteen 
participants in the FGD were also recruited for the IDIs (12 in the general population – 8 
females and 4 males – and two among the FSWs).  The summary description of selected socio-
demographics are presented in tables 3.1, 3.2 and 3.3 
3.3.2 Knowledge of oral and anal sexual practice 
3.3.2.1. Knowledge of oral sex  
Most of the FGD and IDI participants had heard about oral sex; however, not all of them were 
able to give accurate and complete definitions of the behaviour. Generally, most participants 
described oral sex as a form of sexual activity involving the use of the mouth and/or tongue. 
The most common description of oral sex given by both male and female participants was 
oral stimulation of the penile shaft by a female.  
During one of the FGDs, a young man gave a complete definition of oral sex as follows: 
“what I knew of oral sex is when a man or woman is using their tongue or mouth to 
stimulate either the vulva or vagina or penis. This is my own understanding” 
[Unmarried male adolescent with no formal education, Ibadan southwest FGD, aged 
18 years, R3] 
 
A male adolescent gave this explanation when he was asked to explain the meaning of oral 
sex: 
 “I will say oral sex is like having sex, it is like hmm, a guy is having sex with a girl by using 
his mouth or lips to lick the vagina” [Unmarried male adolescent with formal education, 
Ibadan southwest IDI, aged 18 years] 
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Most participants described oral sex from the perspective of heterosexual relationships. 
Some participants described oral sex as ejaculation of seminal fluid into the mouth of a 
woman, the exchange of open mouth-to-mouth kisses (deep kisses) between two lovers, 
breast fondling with the mouth, or licking of the anal verge of a sexual partner (“rimming”). 
There was also a description by two participants that oral sex can be an “unprotected penile-
vaginal sex” or the exchange of erotic messages between two sexual partners during a 
telephone conversation.  
Few participants mentioned that men and women who are involved in same sex relationships 
could also practice oral sex. In one FGD, a married man explained that oral sex could be 
practiced between women that are in the same sexual relationships.   
 “Oral sex means that some could use their tongue, insert it into the vagina or the 
vulva of the baby (“loving woman or lady”) and start licking the vulva. It could be man 
to woman, woman to woman, and that’s when they say that the person is having oral 
sex [Married man with formal education, Ibadan southeast FGD, aged 45 years, R1] 
Oral sex was also regarded as a modern method of foreplay before engaging in penile-vaginal 
sex. A female participant described oral sex as part of the initial “romance” before penile-
vaginal sex. 
“For a female, who is also not in the mood when she and her boyfriend are together, 
in this case, when they are romancing themselves, the man will put his mouth on the 
woman’s vagina to make her to be in the mood, then he might also put her breast in 
his mouth and suck it” [Unmarried female adolescent with no formal education, 
Ibadan southeast FGD, aged 18 years, R3] 
 
A married man compared how couples in former and modern times engaged in sex. He 
believed that couples nowadays engaged in oral sex as a form of foreplay to stimulate 
themselves to achieve orgasm.   
 “In the olden days, the husband will just lie on top of the wife during sex and there 
will be no adjustment until they are through. But nowadays, the husband can tell the 
wife to first stimulate his penis with her mouth before inserting it into her vagina, and 
he will enjoy it until he ejaculates” [Married male adult with no formal education, 
Ibadan southeast FGD, aged 43 years, R7].  
 
125 | P a g e  
 
During one of the FGDs among the FSWs, a participant gave insights into how oral sex is 
performed. She described oral sex as the licking or sucking of the male or female’s genital 
organs.  
“Oral sex involves licking and/or sucking of a vagina and licking of the penis…” [Female 
sex worker, Ibadan southeast FGD, aged 29 years, R1] 
 
Another FSW gave a detailed description of the way oral sex should be performed on a male 
sexual partner to give him maximum pleasure and enhance orgasm, and possibly to avoid 
injury during the process.  
“you hold the prick (penis) and put it inside your mouth, you suck it, you make sure 
that your teeth is not biting the prick (penis) because if you are biting the prick (penis) 
the guy will not enjoy it.  Just make sure that you suck the prick (penis) with your 
tongue and your lips so that the guy will enjoy it” [Female sex worker, Ibadan 
southeast IDI, aged 27 years] 
 
3.3.2.2. Sources of information on oral sex 
Both adolescents and adults and sex workers openly shared information about where they 
learnt oral sex for the first time. The most frequently mentioned sources of information of 
oral sex by participants from the general population were watching movies including ‘porn’, 
followed by learning from sexual partners. This is in contrast to most FSWs, who said they 
learnt oral sex from their sexual partners followed by watching ‘porn’ movies. Other sources 
of information that were mentioned included school mates, neighbourhood friends, personal 
adventures, musical videos and other social media platforms. According to one married 
woman during a FGD, some people watched sexually explicit movies that contained oral sex 
at some point in their lives. She described how her husband used a ‘porn’ movie at home to 
convince her to learn about oral sex.  
 “We all learnt oral sex from blue film.  We have been watching such movies inside. 
My husband bought one blue (pornographic) film, and said you, you will just sleep 
"borogidi" (like log of wood) (*laughs by all participants*). He said you will just sleep 
and your body will not move. so, he brought one blue film. When I watched the film, 
I screamed, said ehnnn!!! I cannot even do it and I don't want to see this film inside 
my house again. I saw a lot of oral sex, like a lady sucking the penis of a man and 
thereafter, two men were sucking her at the same time, one was sucking her breast 
and another sucking her genitals (*laughs by everyone*) …” [Married female adult 
with formal education, Ibadan southwest FGD, aged 39 years, R3] 
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At one of the IDI sessions, a FSW explained how she learnt oral sex through a customer’s 
request and through discussions with her friends.  oral sex is performed because of the 
financial benefits. 
 “I learnt about oral sex from friends and from my customers; some men do come here 
and request for oral sex.  You will do it for them based on the money you are looking 
for” [Female sex worker, Ibadan southeast IDI, aged 23 years] 
 
A married woman also shared a similar experience of learning oral sex from a a friend 
that narrated her experience with her sexual partner. 
“ I heard about it from a friend that we were together, she has a boyfriend, they both 
went out, when they came back, she says the film she watched today  is quite surprising, 
that his sperm didn’t come out after the sex and he asked her to put his manhood in her 
mouth and be sucking it…” [Married female adult with no formal education, Ibadan 
southeast IDI, aged 40 years] 
 
A sex worker described an unusual source of information for learning sexual behaviour; 
that there is a possibility of people divulging previous sexual practices during a brawl to 
make jest of each other. A sex worker shared her experience as follows:  
“I learnt about oral sex when I became mature. I started watching films like blue 
films on the television. However, I started to see and hear about it when I joined 
this business. I heard about it when there was a misunderstanding between two 
jolly friends. They were accusing each other of engaging in oral practice while I 
was in Lagos”. [Female sex worker, Ibadan southwest IDI, aged 35 years,]  
 
There were a few participants, mostly during FGDs among adolescents with no formal 
education, that had not heard or learnt about oral sex. For example, a female adolescent said 
that “I have not heard of oral sex before” and another female adolescent said that “I have not 
been taught on how to perform oral sex”. Both responses elicited laughter from other 
participants. 
3.3.2.3. Knowledge of anal sex 
Knowledge was assessed by asking participants to define the term anal sex according to their 
own understanding. Although not all participants had heard about anal sex, most were able 
to define anal sex as a form of sexual intercourse that involves the anus or anal cavity. Male 
adolescents, young adults and the FSWs were able to offer a more comprehensive 
explanation of the meaning of anal sex compared with adult participants. Some participants 
127 | P a g e  
 
described anal sex as a sexual relationship that is more common among MSM, as described 
by an adolescent in an FGD.   
“Anal sex basically happens among men to men, it is more common among men who 
used to have sex with men. They must perform anal sex to satisfy themselves” 
[Unmarried male adolescent with no formal education, Ibadan southeast FGD, aged 
18 years, R3] 
 
At the same FGD session, another participant corroborated that since men do not have a 
vaginal opening, they can only engage in anal sex between themselves.  
“A man can insert his penis into the anus of another man since there is no vagina.” 
[Unmarried male adolescent with no formal education, Ibadan southeast FGD, aged 
19 years, R2] 
 
However, other participants felt that anal sexual acts are usually practiced between men and 
women. A more detailed explanation of anal sex was given by some participants as a penile-
anal sex between two men or a man and woman or oral-anal sex between two women. Anal 
sex was also described as ‘penile-vaginal sex’ from behind the woman.  
Some participants were aware that anal sex could happen in both same-sex and heterosexual 
relationships. For example, a married man correctly defined anal sex to be penile penetration 
of the anal canal of a man or a woman.  
“..the anal simply means when the man’s penis is erect, you insert it into the anus of 
either a man or woman….”[Married male adult with formal education, Ibadan 
southeast  FGD, aged 33 years, R8] 
 
Another woman gave a similar description of anal sex based on hearsay from other people.  
“..they said a man will put his penis at the anus of maybe a man or a woman, so they 
would now put the penis inside the anus..” [Married female adult with formal 
education, Ibadan southeast FGD, aged 44 years, R3]. 
 
Some adolescents and young adults during one of the discussions echoed that anal sex is 
practiced among people that are involved in homosexual and heterosexual relationships. 
Some adolescents described heterosexual penile-anal sex to be more pleasurable than penile-
vaginal sex. Male adolescents felt that anal sex is pleasant while the females felt otherwise. 
This perspective was summarised by a young man during a FGD.   
 “from my own view, I think anal sex means having sex through the anus and it is very 
common to people that are called gay. Some guys do practice anal sex with some 
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ladies because I think they enjoyed it more than vaginal sex [Unmarried male young 
adult with formal education, Ibadan southwest FGD, aged 22 years, R4]. 
 
A married female participant said: 
“The experience I saw was in the pornographic films when the man inserted his penis 
into the anus of the woman and started having sex. I cannot say how they enjoyed 
themselves [Married female with no formal education, Ibadan southeast FGD, aged 
45 years, R4]. 
 
Some adolescents and young adults with no formal education believed that it was impossible 
for anyone to insert a penis into the anus of another person, describing such sexual acts as 
“barbaric” or unacceptable.  
 
3.3.2.4. Sources of information on anal sex 
In a similar way to how participants described learning about oral sex, most participants 
reported learning about anal sex from watching pornography movies and other sexually 
explicit movies, personal adventure, sexual partners and friends. Adolescents and young adult 
participants mentioned pornographic movies (“porn”) and other media platforms more often 
than older adult participants. Most FSWs learnt about anal sex when they joined the sex work 
business or from clients that requested anal sex. Unlike the adolescents/young adults, the 
adult participants did not freely share their source of information on anal sex. An adolescent 
described how they used to learn different sexual behaviours, including penile-anal sex, from 
watching pornographic movies. She also added that these movies might have accounted for 
the changing sexual behaviours between the older people and young people.  
 “..Before now, during the time of our mothers and fathers, they don’t engage in such 
(anal sex), but now that everybody is now watching blue film, and they see how 
everything is done, they also want to do the same.….” [Unmarried female young adult 
with no formal education, Ibadan southeast FGD, aged 20 years, R3] 
 
A man also shared the influence of pornography as a source of learning anal sex during an 
interview. He considered watching pornographic films as a negative influence on the sexual 
habits of people. 
“…70% are due to negative influence, I used to watch pornography videos. I developed 
much interest in these sexual activities (oral and anal sex), which is not good at all, and 
it is against the will of God, so watching pornography video is dangerous” [Married male 
adult with formal education, IDI, aged 28 years] 
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A male adult participant described that he heard about anal sex while trying to settle a quarrel 
between two young boys in the community. 
“Concerning the male to male sex, something happened to one of my people, a boy 
called another boy for sex but the other boy disagreed leading to a serious 
disagreement. The matter was taken to the landlord association meeting. The boys 
were warned seriously not to try anything funny again”.  [Married male adult with no 
formal education, Ibadan southeast FGD, aged 35 years, R3] 
 
Unlike the general population participants, most FSWs learnt anal sex from their clients at the 
brothel. Most sex workers said that they had had clients or boyfriends (non-fee-paying 
partners) requesting anal sex. According to a sex worker:  
 “I have one customer that said that he used to have a friend that “fuck” (have sex 
with) him from the anus. He used to pay me well for anal sex but he is a man but wears 
a woman clothes” [Female sex worker, Ibadan southeast FGD, aged 20 years, R2] 
 
A sex worker described the way she first heard of anal sex after joining the sex work business:  
“Yes, of course. Some people will come and request that they want to have it through 
the anus. In fact, I have never heard of it before until when I found myself in this job…” 
[Female sex worker, Ibadan southwest FGD, aged 33 years, R4] 
 
 
3.3.3. Local names and slang terms for oral and anal sex 
3.3.3.1. Local names and slang terms for oral sex 
The general population participants and FSWs mentioned several local names or slang terms 
that are used to describe oral sex. These terminologies were broadly categorised into three 
types, based on the type of oral sexual practice that is performed. Some terms were used 
when a man gives oral sex to a woman, i.e. when a man/boy uses his tongue, mouth, or lips 
to touch or stimulate the external genitals of a woman/girl. Examples that were mentioned 
included ‘lick plate’, ‘clean up’, ‘wash wash’ and ‘go south’. Another set of terms described 
oral sex that is given by a woman or girl to a man or boy i.e. when a woman uses her tongue 
or mouth to touch or lick or suck the penis. These slang terms were ‘blow job (BJ)’, ‘chop or 
eat banana or plantain (‘dodo’), ‘eating carrot’, ‘hold microphone to sing’, ‘licking soft sweet 
stick’, ‘lollipop’, ‘suck straw’ and ‘gbe se enu’ (put it in your mouth). The third category were 
oral sex terms that could be used interchangeably to describe oral sex that is given by 
man/boy or woman/girl, and these included ‘sucking’, ‘sukky’, ‘kiss it’, ‘ice cream’, ‘yoghurt’ 
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and ‘collabo’. The most frequently mentioned oral sex slang term was ‘blow job’ by both the 
male and the female participants. The adolescent male participants and female sex workers 
mentioned more oral sex slang words than the female general population participants. Most 
female participants were not interested in discussing oral sex slang words, with some of them 
showing signs of resentment while others were reluctant when the moderator prompted 
them to give examples. They felt that slang terms were not nice words for describing oral sex. 
 
Adolescents reported often using slang terms to conceal their discussions in the community, 
especially in the presence of parents or guardians. For example, a male adolescent participant 
mentioned some of the common oral sex slang words and also added that these are 
sometimes used to conceal their discussion about oral sex from adults.  
“there is something we call blow job. It means using the mouth to stimulate to help 
somebody reach climax, to help somebody reach orgasm. if you really want to code it 
and you don’t want somebody to know what you are talking about, you can call it BJ, 
yeah, through “BJ” [Unmarried male adolescent with formal education, Ibadan 
southeast FGD, aged 18 years, R3] 
 
3.3.3.2. Local names or slang terms for anal sex 
The participants listed some of the common local names or slang words that are used to 
describe anal sex in the community, including ‘back side’, ‘bend down and sow’, ‘backyard 
sex’, ‘chopping from the back’, ‘daudau’ (penile thrusting from behind), ‘doggy style’, ‘gba 
eyin wole’ (penetration from behind), ‘hanging up’, ‘load from the back’, ‘monkey style’, 
‘olosho’ ( sex worker’s style), ‘room’, ‘reedemed’, ‘sex through yansh’, ‘shoki’, ‘smash from 
the back’, ‘table sex’, ‘touching of toe’, ‘wheel barrow’ and ‘yodi (project out your buttock or 
anus)’. Participants did not categorise penile-anal sex slang terms between homosexual and 
heterosexual relationships even when they were prompted. Participants did not mention 
slang terms to describe oral-anal sex (rimming) by participants. 
 
Generally, anal sex slang words were more frequently used by the adolescents and young 
adults than by the older adults and also by boys/men more than girls/women, and by 
unmarried more than married participants. The most frequently mentioned slang words to 
describe anal sex among the general population participants were ‘backside’, and ‘bend and 
sow’. Anal sex terms were reported as being used to communicate among people in the same 
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circle (i.e. share a common social status). For example, a young adult participant described 
how people used to describe an anal sex experience:  
 “People often used the expression that "I entered through the back" to refer to anal 
sex” [Unmarried male young adult with formal education, Ibadan southeast FGD, aged 
25 years, R4] 
 
An adult participant offered a detailed explanation of “entering through the back”.  He 
differentiated a penile-anal sex from a penile-vaginal sex from behind a woman. The man also 
advised that “bakashi” (buttocks) could be used to avoid confusing anal sex with vaginal sex.  
He explained further as follows: 
 “….. what I see about those who go through the back is that for instance, [it is not just 
back], it is the anus, yes, because if it is back, it can be the vagina also, but it is not the 
vagina we are talking about. We are talking about the place through which the woman 
defaecates. The man can also say that I gave her from the “bakashi” (buttocks)...” 
[Married male adult with no formal education, Ibadan southwest FGD, aged 43 years, 
R7] 
 
Participants also discussed some native Yoruba language slang words to describe anal sex. For 
example, a male participant used a Yoruba term to describe the anal canal as a room (‘mogba 
oju ibuwo’ meaning ‘I entered through the opening door’) to enter.  
“You see if we are talking about anal sex, we can call it monkey style, monkey style, 
that was even common some 20 years ago or more than that, if it is through the place 
where the woman excretes, they can say that, mogba oju ibuwo (enter a room), there 
is no one that does not know”[Married male adult with no formal education, Ibadan 
southwest FGD, aged 35 years, R8]. 
 
The description of the anus as a room was described during one of the FGD sessions among 
adolescents and adults. An adolescent female participant corroborated that anal sex slang 
terms can be likened to a room.  
“When men are discussing among themselves someone can say something like “for 
me I enter through the anus”. Another person can say “for me I entered through the 
back, "I entered through the room" or "went in through the backyard” [Unmarried 
female with no formal education, Ibadan southeast FGD, aged 18 years, R3]. 
 
 
3.3.4 Reasons for using slang terms to describe oral and anal sex 
Participants gave different reasons for using slang terms to describe oral and anal sex among 
themselves in the community.  
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3.3.4.1. Communication between friends 
The most common reason for using slang words was to communicate among a group of 
people. The male adolescents and young adults mostly preferred to use these terms among 
their cliques. The slang terms were used to tease people about previous sexual activity, to 
mock ladies that offended them, to display that they were modern or to cover up discussions 
about oral or anal sex when an older person was around such as their parents or guardians. 
For example, a young man explained that slang words could be used between friends freely 
and their parents would not understand the content of their discussion. 
 “I think oral sex, if you are in the presence of your parent, the slang term can be used 
as a cover up when my friends are with me and we want to talk about a girl. What I 
am trying to say is that there is no way I can say that I have licked that girl's plate and 
my parent will understand” [Unmarried male with formal education, Ibadan 
southwest FGD, aged 18 years, R3] 
 
An adult participant also added the use of slang words among friends and peers to share their 
previous sexual experience.  
“Let’s say a man has already had done something with a lady, then maybe you want 
to explain what happened between each other to one of your friends. You may say 
that the lady that is going has already eaten my banana” [Married male adult with 
formal education, Ibadan southeast FGD, aged 33 years, R8] 
 
Most FSWs communicate with their male clients during sexual negotiation with slangs. A sex 
worker gave an example of how clients used slang words to request for oral sex.  
“Some customers will tell you that I want to do clean-up, meaning the type of oral sex 
where a man licks up a woman’s vulva or vagina. Some will say I want to suck you” 
[Female sex worker, Ibadan southeast FGD, aged 21 years, R4] 
 
Other reasons for using oral sex slang terms include discussion about sexual practices at social 
gatherings and when friends are teasing each other regarding their previous sexual practices.  
 
3.3.4.2. Show sexual superiority and dexterity 
Some participants were of the opinion that male adolescents and young adults usually use 
slang words to discuss their sexual experience. They also used slang words to show-off to 
friends when describing their oral and anal sex practice with their female sexual partners or 
girlfriends.  A young adult male participant summarised the way his colleagues used slang 
words to demonstrate their sexual power and control over their female friends in the 
community.  
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 “Guys like to discuss if they had sex with a lady, they considered it to be a pride in 
their environment. i.e. the lady that sees herself as the biggest girl... So, when a guy is 
able to have sex with such a girl, the guy will say, I was able to ‘nail’ that lady, last 
night. In fact, she gave me BJ (Blow Job). [Unmarried male adolescent with formal 
education, Ibadan southeast FGD, aged 18 years, R3]. 
 
3.3.4.3. Profiling of the brothel clients and people in the community 
The ability to use and understand the slang terms for different sexual acts including oral and 
anal sex is one of the tools that sex workers usually used to differentiate the old from the new 
customers. The frequent customers of sex workers were called “roskos” while the new 
customers were called “magas”.  According to them, new customers were usually billed 
higher than regular customers. A sex worker offered her own understanding of how clients 
are profiled in the brothel. 
 “Customers that are frequent in the hotel will know and understand slang terms for 
different sexual styles. There is no way you wouldn’t know them in the hotel unless 
you don’t come around” [Female sex worker, Ibadan southeast FGD, aged 29 years, 
R5] 
 
Another FSW added that the use of slang terms is also common among students and clubbers.  
 “I for one, if I hear anybody outside saying he wants to suck or washy-washy, skirt and 
blouse, plate etc., I will know easily that the person belongs to our team. I will 
understand without any problem because an outsider may not know that (slang 
terms), except the clubbers. Some students and clubbers are in the same business 
……Also, you know that I can’t just get home now and tell my sister that I want to wash; 
she will only tell me to go and wash either plate or cloth because she will not 
understand it” [Female sex worker, Ibadan southwest FGD, aged 22 years, R1] 
 
3.3.5. Perceptions and attitude towards using oral and anal sex slang terms 
There was a sharp contrast in perspectives among participants on the use of slang or local 
names to describe types of sexual activities in the community  
 
3.3.5.1. Slang terms are not acceptable 
Adult participants considered the use of slang or local names to describe sexual acts as ‘very 
embarrassing’. They warned that such terminologies should not be used at all among religious 
or decent people. Participants also explained that oral or anal sex slang terms might be 
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considered offensive to hear. Some participants categorically stated it was not acceptable in 
the community to openly use ‘offensive’ slang terms to describe a subject that is already 
considered sensitive in the community. For example, a female participant added that oral and 
anal sex slang words would sound embarrassing to people:  
“the slang for oral and anal sex just sounds embarrassing. People can even ask that 
what kind of slang terms are these? [Married female adult with formal education, 
Ibadan southwest FGD, aged 36 years, R5]. 
 
Adding to the debate of disapproval of slang term in the community, a married man described 
oral and anal sex slang terms as indecent and that these words are commonly used by ‘rascals’ 
and men of high socio-economic class.  
 “Slang words are not for only rascal, there are some big men, they love speaking all 
these foul things, they don't care, they believe they are catching their fun. It is not only 
the illiterates that say all rubbish things, even some elite are saying it. But for me, 
whether we like it or not, slang are things that are not acceptable in the whole 
community” [Married male adult with formal education, Ibadan southwest FGD, aged 
39 years, R3].  
 
There was also a concern that the religious people in the community might not be favourably 
disposed to the use of slang terms to describe oral and anal sexual acts. A male participant 
said: 
“Sex slang term will be offensive in the midst of the religious people; you cannot utter 
all those sex slang words in Church or Mosque. But in the midst of the people of the 
same set mind, you can say whatever you want to say at times, even at the influence 
of alcohol, you are free, you will be saying many things” [Married male with formal 
education, Ibadan southeast FGD, aged 33 years, R8].  
Some participants warned against using slang words to describe oral and anal sex in the 
community. They observed that this might elicit negative response from some people in the 
community. A participant said her friends usually get uncomfortable discussing sex with slang 
terms: 
“I have a friend that whenever she hears those slang terms about sex, she feels 
irritated and she is even beside me. She feels irritated. She doesn’t like those names 
like sucking the man’s dick (penile shaft).” [Unmarried female with formal education, 
Ibadan southeast FGD, aged 18 years, R6]. 
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There was also a concern that sexually related slang terms could potentially promote 
immorality especially among young people. 
” Sex related slang words are not at acceptable all because it is something that is very 
bad in the society and most of the younger ones must not be aware of these names. 
It has even become more rampant in our society that it can” [Unmarried male 
adolescent with no formal education, Ibadan southeast FGD, aged 19 years, R7] 
 
3.3.5.2. Oral and anal sex slang terms are acceptable to the young people and sex workers 
Most educated adolescents and young adults did not have any objection to use of slang words 
to describe sexual activities including oral and anal sex. They considered slang words as a 
modern method of communication or expression. Some participants believed that students, 
clubbers, ‘big-men’ in the society and FSWs commonly used slang word because they found 
it to be interesting.  
During FGD, some participants maintained that the use of slang words is acceptable 
particularly among those that understand its meaning. According to a young adult participant: 
“Nowadays slang word are very common and if it is used it will not be a strange thing” 
[Unmarried male adolescent with no formal education, Ibadan southeast FGD, 19 
years, R4] 
 
Acceptability of sexually related slang words in the brothel was discussed; participants felt 
that everyone would accept it. For example, a sex worker said: 
 “people use them (sexually related slang) on a daily basis. Customers ask for it now” 
[Female sex worker, Ibadan southeast FGD, aged 29 years, R5]. 
 
3.3.5.3. Slang word may not give clear meaning and interpretation  
Generally, most participants agreed that the use of slang words could sometimes be very 
confusing to those that are not familiar to such terms. They cited examples of some slang 
words that are used to describe sexual activity which might connote another meaning. For 
example, a woman during FGD warned that “yodi” in Yoruba, a known slang word for anal sex 
could also suggest presence of haemorrhoids: 
"Yodi - projecting of the buttock or anus - is a common slang term that has different 
meaning. It can mean pile (haemorrhoids) and it can also mean big buttocks.  So do 
not use the slang term” [Married female adult with formal education, Ibadan 
southwest FGD, aged 44 years, R1].  
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During another FGD, a man explained that the meaning of slang terms for different sexual 
activities is not universal but specific for certain groups of people. This would require anyone 
that is interested to learn the meaning of such slang terms to join the clique. A youth during 
FGD said: 
“You see people have different caucus, and their peculiar slang words, no matter how 
wayward the person is, they will not get what you are saying, the way my friends and 
I will describe the vagina is different from what others will say in their own caucus, if 
there are people who don’t know us, they won’t understand and it is the same reason 
outsiders will not understand” [Unmarried male adult with no formal education,  
Ibadan southwest FGD, aged 25 years, R4] 
Although most adolescents and young adults and FSWs knew the meaning of different slang 
words for oral and anal sex, they advised against using such words to frame research 
questions about oral or anal sex.  They believed that slang words could be ambiguous, might 
not elicit appropriate responses, and might provoke negative responses from 
interviewees/participants. However, most participants were of the view that the use of simple 
definitions to describe oral and anal sex would be well accepted in the community. A female 
adolescent participant summarised as follow: 
 “I think if you use oral sex, I think everybody knows what oral sex is, everybody knows 
what sex is rather, so if you use oral sex, it would be more understanding than talking 
about blow job. What is the meaning of blow job? You will be looking at the 
questionnaire as if the questionnaire should give you the answer itself. However, if 
you use oral sex, they will be like ok, it oral sex. You will try and meditate on it and get 
the answer but if you use these slang words, it may not easy for people to understand 
the message being passed across” [Unmarried female with formal education Ibadan 
southeast FGD, aged 21 years, R4].  
3.3.6. Motivation for engaging in oral and anal sexual practice 
3.3.6.1. Protection of the sexual relationship 
Both the general population participants and the FSWs highlighted the importance of 
protecting sexual relationships as a motivator for engaging in oral and anal sex. Women/girls 
among the general population and the FSWs explained that they engaged in oral and anal sex 
to satisfy the request of their sexual partners or clients. This was to prevent them from losing 
their partners to other competitors.  Some participants further added that they sometimes 
pretend to enjoy the practice for their sexual partners, despite their internal disgust, or that 
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they practiced oral and anal sex to satisfy their partner’s request.  The pretence and 
acceptance of partners’ requests for oral and anal sex were mostly discussed by the 
unmarried women and sex workers. For example, a female young adult explained that the 
fear of losing a lover might be a strong motivator for learning about and engaging in oral and 
anal sex: 
“Maybe you are in love with someone, this is what he wants (oral or anal sex) and it is 
something you can’t do no matter what, but because you don’t want him to break up 
with you, the fear of breaking up and losing him will make you do that thing” 
[Unmarried female young adult with formal education, Ibadan southeast FGD, aged 
19 years, R5]  
 
Another female participant noted that women were usually at the receiving end of accepting 
their partners’ requests. She portrayed women in sexual relationships as the weaker sex that 
needed to accept the sexual requests of her partners in order to keep the relationships.  
 “the reason why some people engage in oral or anal sex is that due to the kind of love 
they have for the person they are dating even if they don’t like doing it, they will 
because they don’t want to lose the guy” [Unmarried female adolescent with no 
formal education, Ibadan southwest FGD, aged 18 years, R3].  
 
There was a sex worker that shared her experience of anal sex during an interview; she 
recounted how she endured the severe pain in order to allow her sexual partner to have 
penile-anal sex with her.  
 “in the process of having fun (vaginal sex) with my guy, he requested for anal sex, and 
I said no problem.  We used lubricants with all other things we know in the process, 
but I had to endure the pain to satisfy him ” [Female sex worker, Ibadan southeast IDI, 
aged 27 years] 
 
Another FSW narrated that some of her colleagues would do anything possible to satisfy their 
clients: 
“Some customers will come and ask you for a sexual style, but if you cannot give such 
style to them, they will go to another person that can easily render such a good service 
to them”. [Female sex worker, Ibadan southeast FGD, aged 29 years, R5]  
 
Whereas, some married women rejected their husbands’ request for oral and anal sex 
because of the fear of contracting infections or diseases. 
“So as far as I am concern, I don't engage oral sex because even though my husband 
wants it. I don't accept it from him because he might have other women outside. He 
138 | P a g e  
 
always asked me to suck him, but I usually refuse because I don't want to contact any 
disease from him” [Married female adult with formal education, Ibadan southwest 
FGD, aged 36 years, R5]. 
 
 
3.3.6.2. Financial benefit 
Financial benefit was another theme that was discussed as one of the drivers for engaging in 
oral and anal sex among general populations and FSWs. Sex workers mentioned financial 
reasons more than the general population participants. The desire for money to survive and 
to be able to attend to personal and family needs were the major drivers among sex workers. 
Most sex workers observed that they made more money from oral and anal sex than vaginal 
sex. According to a FSW, the price of engaging in oral or anal sex with a customer at the 
brothel is about ten times the price for vaginal sex:    
“if a customer requested from me (oral and anal sex), I tell him to pay 10,000 Naira 
(28USD). If he rejects my price, I will rather tell him to pay 500-1,000 Naira (1.4-
2.8USD) to have the normal vaginal sex from the frontal side. I heard that they 
normally pay 10,000-15,000 Naira (28-41.7USD) for anal sex”. [Female sex worker, 
Ibadan southeast FGD, aged 30 years, R7]. 
 
Some FSWs also accused their clients of tempting them with money to accept their requests 
for oral or anal sex. A participant shared her personal experience of how a customer offered 
her a huge sum of money to accept his request for oral sex that was difficult to decline. The 
participant experienced guilty feelings but was consoled by her friend that she should 
consider the financial benefit. 
“My first experience was when a customer requested for oral sex. I initially declined by 
telling him that I’ve never done it before. Then, he said he was going to give me good 
money if I could cooperate with him. He was the one that taught me….I discussed the 
different styles I had with the man with my friends. I also discussed the pleasure and my 
fear…. But they (my friends) said ‘forget about it’... it is about money”. [Female sex 
worker, Ibadan southeast IDI, aged 25 years].  
 
 
Oral and anal sex was also described as a form of transactional sex in the general population 
in Nigeria. Some participants believed that the rich men lure young girls with money in order 
to engage in oral and anal sex with them. A female participant in the general population 
summarised how girls engaged in transactional sex. 
“Some people do engage in oral sex and anal sex because of money, and when these 
so-called rich men want to enjoy themselves, they will ask our teenage girls to do 
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something like this. These girls are usually from broken homes. Poverty is real in our 
country. Anything they ask them to do, they will do it just to get money to survive 
themselves” [Married female adult with formal education, Ibadan southeast FGD, 
aged 44 years, R3]  
 
However, there was a different perspective during a discussion. A male participant explained 
that some people engaged in anal sex in order to gain spiritual power to protect their wealth. 
“some are using that thing (anal sex) to protect their wealth” [Married male adult with 
formal education, Ibadan southeast FGD, aged 34 years, R2] 
 
 
3.3.6.3. Oral and anal sex as an alternative to vaginal sex 
The discourse that people engaged in oral and anal sex as an alternative to vaginal sex brought 
out different perspectives and interpretations from the participants. Most adolescents and 
young adults observed that some of their colleagues had sexual partners that usually engaged 
in oral and anal sex instead of vaginal sex in order to protect the virginity of female partners 
and avoid the embarrassment of unwanted pregnancy.   
“I think anal and oral sex is safer because if you are not really ready to marry, you can 
have an oral and anal sex. You cannot get an unwanted pregnancy from anal or oral 
sex” [Unmarried male young adult with formal education, Ibadan southeast FGD, aged 
25 years, R4] 
 
A married woman shared her personal experience regarding how she engaged in oral sex to 
prevent unwanted pregnancy as a young lady for six years before marriage. 
 “Concerning oral sex, let me talk about myself.  Before I got married, I dated a man 
for six years and anything we did, there was no condom. The man will tell me that I 
should lick him - the penis, just for me to avoid pregnancy.  I dated the man for good 
six years without pregnancy. This was what I did before I got married” [Married female 
adult with formal education, Ibadan southwest FGD, aged 33 years, R2] 
 
Another woman shared her personal experience of using oral sex as a form of family planning 
in her marriage. 
Oral sex, we have it more than vagina sex. The reason is that I don’t want to get 
pregnant.  You know I told you before that I don’t do family planning, we don’t do 
anything.  My husband prefers flesh to flesh.  He does not like to use condom. So the 
only way to satisfy him sexually and prevent unwanted pregnancy is to give him oral 
sex” [Married female adult with formal education, Ibadan southeast IDI, aged 36 years] 
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Most participants suggested that since penile-vaginal sex is not feasible during menstruation, 
people would engage in alternative sexual acts.  For example, a female participant said: 
“with what I have watched maybe when the lady is in her menstruation period, they 
do oral sex” [Unmarried female young adult with no formal education, Ibadan 
southwest FGD, aged 22 years] 
 
According to another male participant, a woman could engage in anal sex during her 
menstrual period. 
“Anal sex can also be done when a female is menstruating” [Unmarried male 
adolescent with no formal education, Ibadan southeast FGD, aged 18 years, R7].  
 
 
3.3.6.4. Better sexual pleasure 
There was a general belief across the population groups that some people practice oral or 
anal sex to improve their sexual pleasure. According to some participants, oral sex could easily 
make a man and woman achieve orgasm to achieve satisfactory sexual pleasure. Similarly, 
participants also felt that some men preferred penile-anal sex to penile-vaginal sex because 
it provided more sexual pleasure. They explained that men who engaged in penile-anal sex 
usually achieved better sexual pleasure due to the tight anal opening compared with penile-
vaginal sex penetration.  
“What I see to that is that there are some women that no matter how long you have 
sex with them through the vagina, they (women) won’t feel it like having sex through 
the anus. The way we do is that we are going to dip our manhood into the anus but 
that is tighter than the vagina. I have experienced it before” [Unmarried male adult 
with no formal education, Ibadan southeast FGD aged 21 years, R1] 
 
An adolescent explained that, if the vaginal opening is wide, men with a smaller penile shaft 
would prefer to have penile-anal sex compared with penile-vaginal sex to achieve better 
sexual pleasure.  
“if the vagina of a woman is too wide, the man with a small penis cannot enjoy it. He 
has to resort to anal sex as an alternative [Unmarried male adolescent with no formal 
education Ibadan southeast FGD, aged 18 years, R1] 
 
A married woman described oral sex as a good foreplay before penile-vaginal sex.  She 
explained that oral sex increases sexual urge, drive and performance during vaginal sex. 
“I think they (men) derive pleasure and enjoyment. when they do such (oral sex), the 
urge will arouse, and they will be able to perform very well (vagina sex) either with 
their husband or with the wife. I think enjoyment, pleasure and urge that they derive 
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from oral sex is the magic” [Married female adult with formal education, Ibadan 




This theme gave insight into how people engaged in oral or anal sex to satisfy their curiosity 
or to learn or try a new form of sexual behaviour. Adolescents and young adults highlighted 
adventure as a possible motivation for learning oral and anal sex. Participants also felt that 
oral and anal sexual behaviours were part of civilisation and modernity. 
 A married woman said: 
“Before someone start to engage in something (oral or anal sex) to the extent of 
enjoying it, it is civilization that brings about it before he/she see it as a thing of 
enjoyment” [Married female adult with no formal education, Ibadan southeast FGD, 
aged 30 years, R6] 
 
An unmarried female adolescent emphasised that some people engaged in oral or anal sex to 
test what they have learnt about these sexual behaviours:  
 “some people may want to practice oral or anal sex because they have heard of it, so 
they will want to have it with their partner, so as times goes on, they will start doing 
it” [Unmarried female with formal education, Ibadan southwest FGD, 18 years, R8]. 
 
Some participants suggested that peer influence was one of the major drivers for their 
previous experiences of oral or anal sex. A married man explained that he was stimulated to 
learn about oral and anal sex out of shared curiosity.   
“The number one reason why people are engaging in oral or anal sex is because of 
what they have seen or learnt about it. Even you may have dreamt it (…..). Even if your 
friend tells you that this was the style of sex I had with the lady I met yesterday, you 
will have it in mind that anytime that I want to have sex with a lady, I must use this 
style too” [Married male adult with formal education, Ibadan southeast FGD, aged 33 
years, R8]. 
 
A sex worker also explained how she was motivated to try penile-anal sex by watching a porn 
movie and subsequent encouragement by her boyfriend to try new sexual styles.  
“when my guy and I wanted to have sex, we watched blue film (porn movie).  He can 
say, can you do this style?  We sometimes engaged in betting to practice sexual style 
we have watched on blue film including anal sex” [Female sex worker, Ibadan 
southeast IDI, aged 23 years] 
 
142 | P a g e  
 
3.3.6.6. Other Motivations for oral and anal sex 
Other reasons for engaging in oral or anal sex that were highlighted by the participants 
included: under the influence an excessive consumption of alcohol, illegal substance abuse, 
during sexual assault, and as a form of punishment to women.  
 
 
3.3.7. Concerns associated with oral and anal sexual practices  
Participants expressed different opinions regarding their concerns about oral and anal sexual 
behaviours. These concerns were based on hearsay, personal and general feelings, and from 
previous experiences. Participants with no previous experience spoke about hearsay and 
personal feelings to present their thoughts. Most of these participants presented their views 
as disadvantages of oral and anal sex compared to vaginal sex or as reasons why they have 
not engaged in oral or anal sexual acts. Another set of participants described their concerns 
from their previous experiences of oral or anal sex. The emerging themes from different 
discussions and interviews across the general population groups and FSWs were broadly 
categorized as follows: health risk concerns, stigmatization, religious teachings concerns, and 
personal displeasure concerns. Health risk concerns was further categorized into two sub-
themes: risk of infection and disease, and physical injury and pain. 
 
3.3.7.1 Health Risk Concerns  
3.3.7.1.1 Infection and disease  
The most feared risk by participants was acquisition or transmission of infections during oral or 
anal sex.  Most participants believed that both oral and anal sex were risky and gave different 
examples to support their views.  The anal cavity was considered an unclean place and a 
reservoir for different infections. They expressed concerns that condomless penile-anal sex 
would expose both partners to different infections. There was also a concern about recurrent 
urethral infections in men who engaged in condomless anal sex.  
For example, a married woman described condomless anal sex to be unsafe and that it could 
cause serious urethral infections to men: 
“anal sex is not safe because there might be remnant of feaces and the man will now 
go in through the anus and you know the penis is open outside. By the time the penis 
enters anus, faecal materials could block the penile opening and the urethral pipe. 
This could result in a disease affecting prostate gland. It could also cause urinary 
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infections. The person will not be able to urinate frequently, and they might be 
bleeding from urethral opening. If catheter is passed into the penis, bloody urine may 
come out. This is not any enjoyment. The enjoyment of one day could be a cause of 
death” [Married female adult with formal education, Ibadan southeast FGD, aged 44 
years, R3].   
 
The risk of sexually transmitted infections such as human immunodeficiency virus and human 
papillomavirus was highlighted as a possible risk from penile-anal sex. According to a female 
adolescent participant, 
“the disadvantage is that, for a man that has anal sex with different women, he can 
contract the disease, AIDS. He could contract HIV from there, he could contract HPV 
that you are talking about……” [Unmarried female young adult with formal education, 
Ibadan southwest aged 25 years, R2]. 
  
A sex worker stated that men could contract a urethral infection while women might be prone 
to the risk of cross-infection from the anal cavity into the vagina. She explained that penile 
thrusting during anal sex could cause urethral and vaginal infections. She counselled that men 
should always wash their penile shaft with water and use antibiotics with their partner after 
anal sex to prevent infection.  
 “you know that waste product comes out from our bum-bum (anus).  I’m very sure that 
if you insert your finger, it must come out with faeces. If a penis now enters the anus 
while thrusting, it could have contacted so many diseases inside. If care is not taking the 
person will come back and fuck you (vagina sex) again with that same penis. You will 
have problem because the disease is already in his body and he will transmit it to you. 
When my guy and I had anal sex, he removed the penis immediately and that ended the 
sex session. We later went to take our shower and took drugs”. [Female sex worker, 
Ibadan southeast IDI, aged 27 years]   
 
Oral sex was also perceived to be risky. Generally, women were thought to be at high risk of 
infection from licking an ‘unhygienic penis’, inadvertent swallowing of seminal fluids that could 
be a vehicle for pathogens, and the possible trauma to their mouth. Men could acquire infection 
from trauma to their mouth or penile shaft during oral sex. 
For example, a female adolescent gave examples of different types of infections that could be 
acquired during oral sex as HIV and HPV. She said risk could occur when a woman/girl is giving 
oral sex to a man/boy. 
“ the disadvantage is that, for a woman who sucks a man’s penis and the sperm enters 
her mouth, she doesn’t know if the man already has any disease.. if the man has any 
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disease like HIV, or HPV so the woman will contact disease from there” [Unmarried 
female with no formal education Ibadan southeast FGD R2, aged 21 years]. 
 
A woman mentioned that oral sex could also cause other problems, apart from the risk of HIV 
infection: 
“There are many diseases you can contract through oral sex. For example, if someone 
suck in sperm and allow it to enter your stomach and blood, you can contract HIV 
infection, cough related diseases or body swelling and egress of water from other parts 
her body” [Married female adult with no formal education, Ibadan southeast IDI, aged 
40 years] 
 
Some participants associated oral sex with the risk of mouth odour and mouth cancer.  For 
example, a sex worker highlighted the possible risk of mouth cancer from giving oral sex.  
“We have been taught on different diseases that come up as a result of kissing the pussy 
(vagina) or “kinikan-kinikan” (something like that). Example of such is cancer. We in our 
circle make jest of customers that come for “wash-wash”/ clean-up (oral sex) to ridicule 
them”. [Female. Sex worker, Ibadan southwest FGD, aged 21 years, R8]   
 
There were concerns by some participants that people could contract an unknown or strange 
disease that may be difficult to treat as a result of frequent oral sex. A FSW said that the fear of 
contracting a disease would discourage her from considering financial benefit from oral sex:  
“I don’t like oral sex because you wouldn’t know the kind of disease the man is having 
in his penis and you are sucking for the purpose of money. At the end, you are attacked 
with disease that the money collected may not be able to treat. So, who is losing?”. 
[Female sex worker, Ibadan southwest IDI, aged 35 years]   
 
However, some participants in the general population believed oral sex to be safe. They 
rationalized that oral sex is not a known risk factor for acquiring HIV infection, unlike condoms 
bursting during vaginal sex or the use of contaminated sharp objects such as needles.  A 
participant described her perception as follows:  
“Sucking doesn’t allow one to contact HIV. Condoms too burst at times and if the person 
is HIV positive, you wouldn’t know now especially because of drugs they use now. So, 
avoiding bad condoms, sharp objects and a host of others prevent us from contacting 
HIV. There are no other ways of contracting again”. [Married female adult with no 
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3.3.7.1.2. Physical injury and pain 
Participants associated different injuries with anal and oral sex. Receptive anal sex by women 
was associated with faecal incontinence. Most FSWs expressed fear of having faecal 
incontinence with associated embarrassment, shame and a large financial cost to manage the 
condition.  
“If you have sex with a lady with infection, you might contact the disease. For the anal 
sex, it will get to a point that the anus will start leaking as if it’s menstruation thereby 
leaving the anus wide open while it secretes water…. Those are the disadvantages”. 
[Female sex worker, Ibadan southeast FGD, aged 29 years, R5] 
 
Another sex worker recounted the counselling she received from her doctor to dissuade her 
from practicing anal sex. According to her narration, the doctor told her that penile thrusting 
during anal sex could damage her anal sphincter.   
 “I could remember that a friend of mine who was indulging in anal sex usually gets wet 
whenever she sat down. Then, my doctor used to tell me that our anus contains a “small 
ball” (sphincter) and that when the small ball bursts, the person gets wet whenever she 
sits down”. [Female sex worker, Ibadan southwest FGD, aged 33 years, R4]  
 
The fear that there might be no competent expert to manage faecal incontinence in Nigeria 
further reinforced the concern of participants against anal sexual practice. A sex worker 
explained:   
“that means you want to kill me! White men have treatment for anal sex and Nigeria 
does not have that. I don’t want to have a leaking buttock and I’m not ready for the use 
of diaper for the rest of my life”. [Female sex worker, Ibadan southwest IDI, aged 32 
years] 
 
The risk of penile shaft injury during penile-anal sex was also highlighted. They explained that 
penile shaft injury could occur during penetration of anal canal. For example, a married man 
explained further: 
“Another thing a man uses his penis to penetrate the anus of a woman; his penis is 
bound to sustain wounds. You cannot compare the wideness of anus to vagina. The 
vagina will expand; the anus will not expand like the vagina. It is not so elastic 
compared to vagina. When you have a very big rod (penis), you will have wound. You 
will disturb yourself and you will disturb the person too. All these cause injury [Married 
male adult with formal education, Ibadan southeast aged 40 years, R7] 
 
Most participants, particularly female participants and FSWs described anal sex pain as 
“excruciating”. Some participants compared the pain experienced during anal sex with 
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childbirth pain, while others said the pain was just unbearable.  A young adult woman while 
narrating her previous anal sex experience said she had to discontinue dating her boyfriend 
because of unbearable pain from his frequent request of penile-anal sex. She took her decision 
to quit the relationship despite threats by her boyfriend.  
 “… I have to back out of the relationship because if he wanted to kill me. It happens 
that he loves to have sex with me through the anus, and the day he tried it, it was very 
painful. Therefore, I told him that I will not be able to do this again, that was the reason 
why I back out. He told me that do I want him to start going to other ladies? Although 
I was not ready to lose him, but I tried it with him again, but the pain I experienced 
was just too much to bear. I have to tell him that I won’t be able to do such with him 
again” [Unmarried female young adult with no formal education, Ibadan southwest 
FGD, aged 21 years, R6] 
 
A FSW narrated the painful distress she experienced during her first penile-anal sex.  
“Anal is very painful. I have tried it once. When I wanted to do it then, I screamed, and 
faeces came out through my anus. In short, that is why I said I don’t like it, it’s painful. 
It is very painful, and I can’t do it”. [Female sex worker, Ibadan southeast IDI, aged 23 
years]  
 
Participants highlighted injuries that are associated with oral sex. The FSWs ascribed the risk 
of injury during oral sex to the rough attitude of male clients. They observed that some of 
their clients, in an attempt to fully enjoy their money, would insert their penile shaft deep 
into women’s throats, which would sometimes choke them and could have some other health 
risks.  
“I think so, because if you suck some guys there are some little sperm that will be 
entering your mouth. Some guys like inserting their ‘dick’ (penis) inside your mouth so 
that you won’t be able to talk. Assuming you are holding and sucking penis, you will be 
able to spit sperm out. Some guys will insert penis strongly that their sperms go directly 
inside of your throat. I think there is a risk because you wouldn’t know what the person 
is bringing from his house to the brothel. If he wants to fuck (have sex with) you, you 
will give him condom. The sperm will be inside the condom and it will not have any 
contact with you, but if you are sucking him, the sperm will be coming out little by little 
into your mouth”.  [Female sex worker, Ibadan southeast IDI, aged 27 years]   
 
According to some participants, malalignment of teeth of the person giving oral sex could 
cause injury to the person receiving oral sex. For example, a married man said that a man 
could be injured on his penile shaft if the woman giving oral sex has a misaligned set of teeth.  
“For oral sex, one may be unfortunate to meet a lady with a set of teeth that is 
misarranged and when she tampers with that penis it can definitely cause injury”. 
[Married male adult with formal education, Ibadan southeast FGD, aged 33 years, R8]  
147 | P a g e  
 
  
3.3.7.2. Stigmatization concern 
Stigmatisation from friends, relatives and community members to people that practiced oral 
or anal sex was another major issue of concern. Both the general population participants and 
FSWs believed that oral and anal sexual practices are not acceptable in the community. They 
felt that the negative reaction in the community might be due to the perception that oral and 
anal sex are alien in their culture. Some adolescent participants explained further that anyone 
caught engaging in anal sex could suffer abuse and different forms of discrimination. For 
example, a female adolescent said that some people could be isolated and hated for their 
action.  
“If there are people like that are engaging in such things like oral or anal sex that 
people may develop hatred for them because it’s not really normal; people may 
develop hatred for them, they might want to abstain from them and might not want 
to have anything to do with this person so that’s it” [Unmarried female adolescent 
with formal education, Ibadan southwest FGD, aged 18 years, R10]. 
 
A young adult female said that people practicing oral or anal sex could suffer from guilty 
feelings and personal frustration due to fear of reprimand from the community members.  
 “if such a thing happened the person that engaged in this kind of act (oral or anal sex), 
and she knows that some people were aware of what she was doing, so when she 
passed by without people abusing her, even from her heart she will feel guilty in her 
that she is a prostitute and start blaming herself that why was she into such act? that 
she shouldn’t have done this kind of a thing with the guy” [Unmarried female young 
adult with no formal education, Ibadan southwest FGD, aged 23 years, R4].  
      
The same fear of stigmatisation could also occur among sex workers in the brothel. A 
participant explained that it would be a difficult task for anyone to openly admit that they 
practiced oral or anal sex in the brothel. She added that this might be the reason why some 
sex workers would bluntly deny practising oral and anal sex in public. 
“they will not accept oral or anal sex in public. I don’t do it and some people will say it is 
not good. what is the rationale in getting involved in oral or anal sex? It is very common 
here to suck penis or suck vagina…. nobody will come outside here and say, she just had 
oral or anal sex now. They don’t accept things like that because of stigmatization. …. 
there is no way you can discuss such (oral and anal sex) with a family member. A family 
or friend cannot yield to that kind of sexual practice. Even, if one practices it indoor; you 
will deny it outside that God forbids that I suck a man or a woman”. [Female sex worker, 
Ibadan southwest FGD, aged 33 years, R4]  
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There were discussions by some participants that the fear of previous verbal abuse or public 
ridicule by people encouraged the culture of silence about discussing oral or anal sexual 
behaviours. However, a few participants said they would not mind discussing their sexual 
behaviours including oral and anal sex. A FSW during an IDI said that she could confidently 
discuss her oral and anal sex experience with trusted confidants to avoid risk of public disgrace: 
“I shared my experience with my best friend and not everybody. You see, in this our job, 
it is good to always have someone that you can confide in. The reason is that if you 
discuss your matter with everyone, they will use that medium to insult you here. Some 
may be indulging in oral and anal sex, but they will not come to the public to say that. 
Therefore, I only know of myself, I don’t know of others”. [Female sex worker, Ibadan 
southwest IDI, aged 32 years]  
 
3.3.7.3. Religious teachings concerns 
The religious interpretation of oral and anal sex and associated concerns was another broad 
thematic issue that was discussed mostly among the general population participants. 
Participants discussed the perspectives of the three major religions in Nigeria on the two 
sexual behaviours and the implications on their personal life. The three major religions 
(Christianity, Islam and Traditional) were said to be against oral and anal sexual practices. 
Some participants described anal sexual practices as “satanic” and ungodly. These negative 
interpretations make open discussion on any of these two sexual practices very sensitive, if 
not impossible, in the midst of the followers of these religions. For example, a man was 
emphatic that all the three religions considered oral and anal sex to be unacceptable 
behaviours. 
“Without deceiving ourselves among the three religions oral and anal sex practices are 
not acceptable in our country” [Married male adult with no formal education, Ibadan 
southeast FGD, aged 45 years, R6] 
 
Another man, during the same FGD, explained further that the three religions condemned 
these sexual acts and the followers of these faiths would not want to associate with anyone 
that engaged in oral or anal sex:  
“All the three religions in Nigeria, they all consider people who engaged in such acts 
as devilish people because if you look at it too, it is not acceptable. So, the three 
religious bodies will totally condemn the act too; they dislike people who engage in 
such acts” [Married male with no formal education Ibadan southeast FGD, aged 45 
years, R3]. 
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In one of the discussion sessions, a female young adult said that the mere mentioning of oral 
and anal sex could be irritating to the people that are very religious. 
 “some that are religious, if they hear such thing (oral or anal sex), it always sounds so 
irritating to them...” [Unmarried female young adult with no formal education, Ibadan 
southwest FGD, aged 22 years, R5]  
 
3.3.7.4. Personal displeasure concerns 
Some participants expressed their personal displeasure about oral and anal sexual practices. 
The personal displeasure was described as ‘disgusting’ or ‘irritating’ or ‘to make them vomit’ 
and ‘not enjoyable’. Most of the participants that raised this as a major concern were male 
and female adults and female adolescents/young adults during the discussions and 
interviews. An adult summarised his personal view on oral and anal sex as follows: 
 “there is no enjoyment in both anal and oral sex, it is irritating to me because it is very 
bad, and God is against” [Married male adult with no formal education, Ibadan 
southeast FGD, aged 45 years, R8]. 
 
A female young adult participant suggested that the risk of the inadvertent swallowing of 
seminal fluid could be irritating to a woman. 
 “I want to mention that oral sex has a lot of disadvantages because by the time the 
man wants to ejaculate there is no way the lady would not feel irritated and this could 
provoke vomiting” [Unmarried female young adult with no formal education, Ibadan 
southwest FGD, aged 21 years, R6] 
 
Another woman also said that she could not engage in oral or anal sex with her husband under 
any reason because these sexual acts were disgusting to her. A few FSWs also amplified the 
personal displeasure discourse on oral and anal sex. A sex worker, while expressing her 
displeasure, said that she could not be lured with money to allow oral or anal sex by her 
clients.  
“as for me, I don’t indulge in oral sex because it irritates me and I’m always afraid 
of contracting disease. I have been so guided by this thought to the extent that I 
don’t practice it with my boyfriend. Also, I’m always of the view that I don’t know 
the destination of the sperm in case I swallowed it in my body. I don’t know how 
white people do theirs, whether they swallow sperm or not. If you attempt 
offering me 10,000 naira (28USD), I will not do it at all because it irritates me” 
[Female sex worker, Ibadan southwest FGD, aged 32 years, R8] 
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3.4. DISCUSSION 
This is the first formative qualitative study that explores the perspectives of adolescents and 
adults among the general population and brothel-based FSWs regarding oral and anal sexual 
behaviours in West Africa. The study provided a mixed pattern of perspectives on the 
knowledge and perceptions, interpretations, and attitude towards oral and anal sexual 
behaviours in the community. Although the study participants had heard of oral and anal 
sexual behaviours, adolescents/young adults and FSWs demonstrated better knowledge 
about these practices compared with older adults from the general population. There was 
better knowledge about oral sex than about anal sex, particularly, on the description of 
different slang words or local names. The participants, especially the adolescents/young 
adults and FSWs, were a bit more comfortable discussing oral sex than anal sex. The sources 
of information on both sexual behaviours were similar; most participants learnt these 
behaviours from watching sexually explicit movies including pornography and from their 
sexual partners. There was a general perception by participants that the use of slang words 
to describe oral and anal sex may be misleading, especially when it is used to frame research 
questions for an interview. However, the views on the acceptability of using slang terms in 
the community to describe sexual behaviours differed across population groups; only 
adolescents/young adults and FSWs would readily accept slang/colloquial terminologies for 
oral and anal sexual behaviours. Although the emerging themes regarding the motivations for 
and the health risk concerns of practicing oral and anal sex were similar, there were subtle 
differences in these themes between participants from the general population and the FSWs. 
 
In this study, adolescents/young adults and FSWs engaged in more robust discussions on the 
meaning of oral and anal sex than adults from the general population. This might reflect the 
changing sexual behaviours that are being reported among the young people and the key 
affected populations. The increasing liberal access to sexually explicit movies on different 
platforms could have possibly provided a higher exposure to these behaviours in young 
people than the adults [363-365].  It is not surprising that the most frequently mentioned 
source of information of oral and anal sex in this study was watching pornographic movies. In 
spite of the knowledge of oral and anal sex by many participants, some of them gave incorrect 
definitions for these sexual behaviours. For example, oral sex was defined by some 
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participants as an exchange of erotic messages between lovers or condomless penile-vaginal 
sex. Similarly, anal sex was referred to by some as penile-vaginal sex from behind. The 
misconceptions about the definitions and the lack of knowledge of oral and anal sexual 
behaviours by some participants suggest that researchers may need to consider this while 
designing their studies to avoid eliciting incorrect responses. Asking direct question about oral 
and anal sex might not convey the intended meaning to the participants unless these 
terminologies are clearly defined. 
 
The significance of using a clear definition of oral and anal sex for framing research questions 
was unanimous among the participants despite the observed differences on the acceptability 
of using slang words to describe both sexual behaviours. The danger of incorrect 
interpretation of questions and the fear of negative reactions from the people when oral or 
anal sex slang terms or colloquial terminologies are used were emphasized during the 
discussions and interviews. Some of these slang terms were considered vulgar and 
unacceptable in the community. Findings from similar studies from some Southern African 
countries also highlighted the risk of poor comprehension and misinterpretation of research 
questions that are framed with local terminologies or slang [304, 358]. According to the VOICE 
D study, a qualitative study that highlighted the challenges associated with socio-cultural 
differences in the translation of penile-vaginal sex among 88 women from South Africa, 
Uganda and Zimbabwe [358], use of local terms or slang words alone could change the 
meaning of the questions that the researcher intended to ask. Other issues that were 
emphasized in the VOICE D study to improve the quality of research instruments for data 
collection on sexual behaviours and better comprehension of questions included translation 
and back translation of questions, use of culturally acceptable terms for definition and the 
use of visual aids such as diagrams/sketches, particularly for people with low literacy levels 
[358].  
 
Although the use of oral and anal sex slang terms may not be useful to conduct research, slang 
word is a sub-culture phenomenon which borders on identity as evidenced in this study[358]. 
People who use slang words have something in common and they understand such language 
within their clique[366]. This may be the reason why the adolescents/young adults and FSWs 
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would readily accept slang words as a means of communication and openly discuss their 
experience of oral and anal sex at ease. Some sex workers shared their experience on how 
they profiled customers to negotiate the price of sex. Customers that communicated and 
understood the slang terms for different sexual behaviours, including oral and anal sex, were 
usually charged less than those that were naïve to such methods of communication.  
 
The discourse on the motivations for practicing oral and anal sex by people were similar to 
previous qualitative studies conducted among adolescent and adult women in Tanzania, USA 
and Canada [304, 367-369]. The four major motivating factors that emerged from our study 
were protection of sexual relationships, financial benefits, to improve sexual pleasure, and 
adventure. Gender and age groups of participants in the community determined how they 
talked about each of the four themes on the motivation for oral and anal sex. The discourse 
on the protection of sexual relationships as a motivator for engaging in oral and anal sex came 
out loudly among the unmarried adolescents/young adults and FSWs. Apart from the risk of 
losing sexual partners to other individuals, the need to protect sexual relationships by women 
might be a reflection of the submissive role that they are expected to play in a patriarchal 
society and financial dependency [370].  
The FSWs gave a deeper insight into the role of financial inducement to encourage people to 
accept oral and anal sex than women in the general population. They explained the huge 
financial price that is often placed on oral and anal sex by customers to incentivised them to 
allow oral and anal sex before vaginal sex, even when they despise it. A qualitative study in 
South Africa also showed that FSWs will negotiate for high price from clients to allow  
condomless sex or oral or anal sex[371]. In Ethiopia, FSWs (18-39 years) reported that they 
engaged in anal sex with fees paying clients when need money for personal needs, out of 
coercion from clients, particularly when they are both drunk and to practice it for the fun of 
it[372].    Men/boys emphasised the need to improve sexual pleasure and adventure as the 
possible motivators for engaging oral and anal sex. This finding is consistent with the results 
of a qualitative study among long-distance drivers in the Morogoro region of Tanzania that 
found where most truck drivers mentioned better sexual pleasure with anal sex than vaginal 
sex as their main motivational reason [324]. In same study, the women would practice anal 
sex provided the male partner is willing to pay money [324]. Oral sex was perceived as an 
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effective foreplay act that hastened orgasm while penile-anal sex was believed to offer 
enhanced sexual pleasure at penetration. 
 
The fear of acquiring infections and other diseases, physical injury, stigmatization, and 
breaching the religious teachings, as well as personal disapproval were the key concerns 
raised against oral and anal sexual practice. Although the opinions of most participants did 
not differ on these perceived risks, the adolescents/young adults and sex workers spoke more 
than the adults about the risk of infection and stigmatization. Participants associated a risk of 
acquiring sexually transmitted infections such as HIV and human papillomavirus with both 
oral and anal sex. Oral sex was also reported to be associated with the risk of cancer. The fear 
of stigma and the breaching of religious teachings might be responsible for the culture of 
silence around oral and anal sexual practice. Even in the brothels where discussions about 
sexual practices appeared to be more acceptable than in the community, some sex workers 
sometimes denied practicing oral and anal sex when an unfamiliar person requested it or 
asked about it. 
 
The strength of this qualitative study includes the enrolment of different population groups 
that that had different sexual relationships and experiences within the community. The 
triangulation of the focus group discussions and in-depth interview data make the research 
findings robust on these emerging sexual behaviours. The study also provided the opportunity 
to seek the input of people in the community in the preparatory stages of the survey design. 
The study participants made recommendations as to how the questions about oral and anal 
sex should be framed to enhance acceptability and clarity.  
 
There are a number of potential study limitations. There is a risk of social desirability bias due 
to the sensitive nature of oral and anal sex in the community. It was difficult to fully discern 
the impact of negative reactions from people on their reported perceptions of oral and anal 
sex during the discussions and interviews. The fear of negative reactions, including the risk of 
stigma, may have resulted in some participants limiting the depth of information that they 
wanted to share. The study did not include other population groups such as men that have 
sex with men, lesbians, bisexuals, long-distance drivers, people working at bars or 
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entertainment venues, and street-based sexual workers who may have different perspectives 
about oral and anal sex. The study did not capture boys and girls aged10 to 17 years in the 
community, this omission makes it difficult to understand the full range of perspectives of 
adolescents on different sexual behaviours. There could also be a risk of contamination from 
information collected from participants that were recruited for both FGD and IDI. For 
example, it is plausible that some participants might have used some information from their 
interaction and experience with other participants during FGDs to respond to questions 
during the IDIs. 
 
3.5 CONCLUSION 
This formative study provides insights on different aspects of oral and anal sex among 
adolescents and adults in the general and key affected populations. The focus of this study 
covered critical aspects of oral and anal sexual behaviours that need to be understood in any 
given community, particularly, when related scientific research is being contemplated. 
Although oral and anal sex were known as specific sexual behaviours, they were still 
considered sensitive topics by the participants. The use of clear and culturally acceptable 
definitions of oral and anal sex instead of slang or colloquial terms was advised whenever the 
research questions are to be designed to improve the quality of responses and cooperation 
of people in the community. The perceived motivation for and against the practice of oral and 
anal sex were similar to findings in a number of previous studies.  
 
This formative research provides a useful guide on how oral and anal sex questions were 
framed during the SHINI cross-sectional study that are presented in Chapters 5 and 6. For 
example, slang terms of oral and anal sex were not used in the design of questions for the 
cross-sectional study questionnaire. Information on attitudes of the people in the community 
towards both behaviours helped during the training of the interviewers for SHINI survey. 
Briefly, the research assistants were trained to stick by the clear definition of oral and anal 
sex in the case report forms, avoid judgmental attitudes during the interviews, and respect 
the views or responses of participants on each question. Furthermore, questions on oral and 
anal sex were asked towards the end of the interview when interviewers would have possibly 
secured the confidence of the participants. It is recommended that policy makers and other 
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stakeholders should initiate interventions to prevent or minimise risk associated with sexual 
risk behaviours that were expressed by participants.  The intervention could be in form of 
health education/mass mobilisation, and introduction of sexual and reproductive health 
programme such as barrier contraception for prevention and treatment of any health-related 
challenges including STIs.  Introduction of programmes that promote gender equity and 
rights, particularly, among adolescents and young people in the society will help to minimise 
gender imbalance on sexual and reproductive health and all forms of violence against women.
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CHAPTER 4: EPIDEMIOLOGY OF ORO-GENITAL AND ANAL HUMAN 




Oro-genital and anal cancers associated with HPV are increasingly reported among women in 
the general population, particularly, in developed countries [129, 373, 374]. The increased 
burden has been associated with changing sexual behaviours including oral and anal sex that 
make them vulnerable to HPV and other STIs [141, 375, 376]. It is evident from studies 
included in the systematic review presented in Chapter 2, that women in SSA frequently 
engaged in oral and anal sex with inconsistent use of protective barrier methods [157].  
 
The natural history of HPV infections as a causative agent of cervical cancer is well 
documented worldwide [377]. The persistence of HR-HPV infections is a necessary cause of 
HPV-associated cancers [29, 378]. A similar epidemiology of HPV infections has been reported 
in other genital and anal cancers [379, 380]. Nigeria has one of the highest burdens of cervical 
cancer in SSA and presently accounts for half of the total new cases per annum in the sub-
region of West Africa [7]. The most common of the 13 HR-HPV genotypes associated with 
cervical cancer in Nigeria are HPV -16, -18 and -35 [162, 163, 381-383]. In the last 20 years, 
the prevalence of cervical HPV infections ranged from 3.5% to 37.0% among the healthy 
population in the community, depending on the age, study population and associated co-
morbidities such as HIV infection [384-387]. There are no published studies on the prevalence 
of oral, vulvar and anal HPV infections among girls and women in Nigeria. 
 
In Nigeria, two studies have specifically reported on the prevalence of oral and anal sex among 
women in the general population [271, 335]. One study reported that 5.3% of 131 adolescent 
girls in schools had ever given oral sex [335]. Another study among 725 adult women in the 
community reported that only 3.0% had ever given and 4.6% ever received oral sex [271]. In 
this same study, 0.7% reported receiving anal sex from their partners [271]. However, none 
of these published studies explored any association between oral and anal sexual behaviours 
and the risk of HPV infection. The qualitative study in Chapter 3, oral and anal sexual 
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behaviours were reported by girls and women in the community in Ibadan, Nigeria. A number 
of participants believed these behaviours could be a risk factor for acquiring HPV infection.  
However, it is uncertain how these sexual behaviours are associated with the risk of HPV 
infection acquisition and transmission in both young and adult women in the community.  
 
Characterising the different sexual behaviours, including oral and anal sex, are important in 
order to fully understand the epidemiology of oro-genital and anal HPV infections in Nigeria. 
To address this gap in research, this study presents the results of the household survey on the 
prevalence of and risk factors associated with oral, cervical, vulvar and anal HPV infections 
among girls and women in the general population in Ibadan, Nigeria. In addition, an analysis 




4.2.1. Study design 
This was a cross-sectional, epidemiological study conducted among women from the general 
population that involves a household community survey and collection of biological samples. 
The survey was a two-stage design. The first stage involves selection of EAs from the study 
sites by probability proportional to size and the second stage was simple random selection of 
study participants from the sampling frame. 
The cross-sectional study was part of the SHINI study. The study investigates different sexual 
practices such as vaginal, oral and anal sexual behaviours, non-penetrative sexual practices, 
circumcision and intravaginal or penile cleansing. This analysis employed the data collected 
from females in the general population in Ibadan. 
 
4.2.2. Study setting  
The study was conducted in Moniya [population: 53,000] and Sasa [population: 25,000]. Both 
are contiguous peri-urban communities in the Akinyele local government authority (LGA) and 
Mokola [population: 77,000], a high-density urban community in Ibadan North LGA. These 
study settings were selected because they are heterogenous in culture, religion and socio-
economic/demographic profiles to determine the prevalence of HPV infections in these 
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diverse populations. Each community is comprised of smaller enumeration areas (EA). The 
2006 National Census EA maps for each of the selected study sites (Mokola, Moniya and Sasa) 
were updated during boundary delineation. The staff of the Nigerian Population Commission 
and office of the Surveyor General in Oyo State offered technical support to produce updated 
cadastral maps for each of the study sites (Figure 4.1: Cadastral maps of study sites at 




4.2.3. Study population  
The eligible participants were sexually active female adolescents and adults aged 18-45 years 
residing in Mokola and Moniya/Sasa communities. The study excluded young adolescents 
(<18 years), pregnant women, nursing mothers, people who were not resident at the study 
sites and those that declined participating in the study including biological sample collection. 
Figure 4.1: Cadastral maps of the SHINI study sites at Ibadan North and Akinyele LGAs 
4.1. A: Mokola community 4.1. B: Moniya community 
4.3.C: Sasa 
community 
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4.2.4. Sample size determination and power 
 The primary outcome of this study is the prevalence of oral, genital (cervix and vulva) and 
anal HPV infections. Previous studies of HPV prevalence in Nigeria reported a genital HPV 
infection prevalence of 10-50% in the female population [163, 381]. Data on oral and anal 
HPV prevalence from Nigeria are lacking. Prevalence estimates of oral HPV from a systematic 
review of studies elsewhere was 3 – 6% in relation to oral HPV [388].   
The precision of estimating the prevalence of HPV infection in the community will depend on 
the overall sample size and design effect. The design effect measures the effect of the 
multistage sampling design on the precision and this depends on the intra-cluster correlation 
coefficient (ICC). The ICC is likely to vary for different HPVs (genotypes and anatomical sites) 
and in the absence of preliminary data one cannot give a reliable estimate of the ICC and 
hence the design effect. Table 4.1 illustrates the precision with which the prevalence of HPV 
infection among the female population aged 18-45 years in the community can be measured 










 Assuming an alpha of 0.05 and a design effect of 2 owing to the clustered sampling design, a 
sample size of 300 would be able to estimate a prevalence of 3% with a precision of ± 2.7%.  
A prevalence of 20 % could be estimated with a precision of ± 6.4% and that of 50% with a 
precision of ± 8.0%. This sample size will also be able to detect differences between groups.  
For example, if the true prevalence of HPV infection in those aged 18-25 is two times the 




N Design Effects 
 1.5 2 2.5 3.0 
3.0 300 2.4 2.7 3.1 3.3 
5.0 300 3.0 3.5 3.9 4.3 
10.0 300 4.2 4.8 5.4 5.9 
20.0 300 5.5 6.4 7.2 7.8 
35.0 300 6.6 7.6 8.5 9.3 
50.0 300 6.9 8.0 8.9 9.8 
Table 4.1:  Table for sample size calculation 
 
Precision with which prevalence of HPV can be estimated with a sample size of 300 for different 
assumptions concerning HPV prevalence and the design effect of the survey 
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provided that the prevalence in older participants is at least 12% (Table 4.2).  This sample size 
will also be able to explore the association of risk factors regarding HPV infection. For 
example, assuming HPV prevalence is 20%, there will be at least 80% power to estimate an 
odds ratio of 2.5 or more, if the prevalence of the risk factor among those that are negative 












4.2.5. Study procedures 
The summary of study procedures is presented in Figure 4.2. 
Training of field staff and community entry 
After the recruitment of field staff, two-weeks training was conducted for the field 
(interviewers, data entry clerks and nurses) and laboratory staff members on good clinical 
practice, principles of research ethics and the research protocol, including the data collection 
tools. Another one-week training on the syndromic management of STIs and HIV counselling 
and testing was conducted for the research nurses. After the training, the research team 
visited the study site communities for advocacy meetings. Specifically, the research team met 
and discussed the objectives of the SHINI study with the administrative leadership of the local 
Prevalence of HPV 









1.5 2 2.5 
5% 150 15% 67% 54% 46% 
5% 150 20% 91% 81% 72% 
10% 150 30% 95% 89% 81% 
10% 150 40% >99% 99% 98% 
      
5% 300 15% 92% 83% 74% 
5% 300 20% >99% 98% 95% 
10% 300 30% >99% 99% 98% 
10% 300 40% >99% >99% >99% 
5% 150 15% 67% 54% 46% 
Table 4.2:  Table for power calculation1 
 
1- Power to detect the difference between two groups as regards the prevalence of HPV for 
different assumptions of prevalence in each group, sample size and design effect 
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government authority, health medical officers, social mobilisation committee members, 
traditional/religious leaders and landlord association officials in each LGA. 
 
Sampling of study participants 
A multi-stage sampling technique was used to select eligible participants at each study site. 
The first stage sampling involved random selection of four EAs each at Mokola and Moniya, 
and one EA at Sasa by probability proportional to size using the 2006 National Population 
Commission Census lists of the EAs [389]. Each individual house was assigned a unique 
identification number. Subsequently, the research assistants visited each house to list all 
adolescents and adults aged 18-45 years. The house listing data from each of the study sites 
were stratified into two age groups, female adolescents and adults (FAA - 18-25 years) and 
female adults (FAD - 26-45 years), to serve as a sampling frame for the study. The second 
stage sampling involved systematic random sampling of eligible participants from each 
sampling frame till the desired sample size of 310 was achieved. 
Participant enrolments 
The enrolment of randomly selected eligible participants occurred at home. The research 
assistants explained the objectives of the study to the potential participants. This explanation 
was buttressed by giving an information leaflet written in English or the local language 
(Yoruba). Interested potential participants were then given clinic appointments. Follow-up 
reminder phone calls were made at 72 hours and 24 hours prior to the clinic appointment, 
whilst a short message service was also sent to potential participants on the morning of their 
clinic appointment. Participants that declined an invitation during a home visit or were not 
met at home after two visits in a week were excluded from the study.  
	
Clinic visit, interview, sample collections and follow-up 
After confirming that a potential participant met the inclusion criteria, a written informed 
consent or witnessed consent was obtained at the clinic following a repeat explanation of 
study procedures, including collection of biological samples.  
 
Face-to-face interview 
The interview was conducted by a female research assistant in a private room at the clinic. 
The interview covered information on socio-demographics, sexual behaviours (vaginal, oral 
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and anal sex) and hygiene practices, intravaginal practices, alcohol, smoking/stimulant use in 
addition to history and current symptoms of STI/HIV (Annex 4.3: Female Case Report Form). 
Information on the history of HPV vaccination was not collected from the participants because 
the vaccine has not been introduced as part of routine immunisation and it is not universally 
available in Nigeria. However, information on the awareness of HPV vaccination was 
collected. The operational definitions of vaginal, oral and anal sex and other non-penetrative 
sexual behaviours were presented in the case report form in order to provide a clear 
understanding of the content of the questions that were asked. The research nurse always 
took the medical history aspect of the interview after the research assistant had concluded 
her own interview. The interview was conducted in English or in Yoruba for participants that 
could not speak English.  
 
Rapid HIV counselling and Testing 
After a face-to-face interview, a female nurse obtained consent for HIV counselling and 
testing with “opt-out” for individual participants if they did not wish to know their HIV status. 
A 5 ml venous blood was drawn into a sample bottle for serial rapid diagnostic HIV tests (RDT). 
The RDT involves testing of sample blood with Alere DetermineTM HIV-1/2 (Alere Medical Co. 
Ltd, Matsudo-shi, Chiba-ken, Japan). Participants found to be positive in relation to the 
Determine RDT kit had a further HIV test with Uni-GoldTM HIV-1/2 (Trinity Biotech 
Manufacturing Ltd; Ireland) RDT. Discordant results between Determine and Uni-Gold RDT 
were further tested with HIV 1/2 Stat-pak® (Chembio Diagnostic System, Inc. Medford, New 
York, USA) as a “tie-breaker” test to determine the final result. This HIV testing protocol was 
based on the National Guidelines for HIV Prevention Treatment and Care, Federal Ministry of 
Health, Nigeria[173]. Participants that did not wish to know their HIV test result had an 
anonymous RDT. They were not given their results (Annex 4.2: RDT HIV serial testing). 
 
Clinical examination and sample collection  
Two female research nurses at each clinic conducted clinical examinations and collected 
biological samples from specified anatomic sites (cervix, vulva, anal and oral). Overall, two 
samples each were collected from the oralcavity  and the cervix, vulvar and anus of each 
female participant. A set of four samples collected was shipped to ICO, Spain for HPV DNA 
analysis, while the other set of four samples was stored in a freezer as a back-up in Nigeria. If 
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a woman was menstruating, another appointment was given if she declined sample 
collection.  
 
Prior to collecting each sample, the nurse conducted a clinical examination by inspection. 
Then, an oral sample was collected using a 30 second oral rinse and gargle method with 10mls 
of Scope mouth wash (Procter & Gamble©). A nurse demonstrated the rinse and gargle 
procedure for individual participant to watch. The participant sample was collected into a 10 
ml labelled sample bottle and placed immediately into a cold box filled with ice-packs. To 
collect the vulvar sample, the labia were exposed with the participant in a dorsal position with 
legs apart. The tip of a Dacron swab was used to rub the introitus on either side of the vaginal 
orifice without touching the urethral orifice. The cervical sample was then collected by 
inserting a sterile Cusco speculum into the vagina to expose the cervix. The tip of a new 
Dacron swab was inserted into the cervical os and gently rotated 360 degrees to avoid trauma 
to the cervix and potential bleeding before removing it. An anal sample was collected with 
the participant in a left lateral position. A Dacron swab was inserted into the anal canal (about 
5-6 cm beyond the anal verge) and rotated 360 degrees with gentle pressure around the anal 
verge before removing it. Each of the samples collected with swabs were placed in separate 
2 ml cryotubes that were labelled and barcoded prior to being placed into a cold box filled 
with ice-pack. Samples stored in the cold box filled with ice-packs were transported every four 
hours to the SHINI study laboratory at the University College Hospital, Ibadan and 
immediately stored in a -800C freezer. 
 
Follow-up care and visit at the clinic  
Participants with symptoms and signs of STIs were offered free syndromic management and 
counselled for partner notification and treatment [390]. The HIV rapid test result was given 
to participants at the clinic and the research nurse offered individual post-test counselling 
irrespective of the outcome of the test result. Participants with positive rapid HIV test results 
were referred and linked to a free service specialist clinic for further counselling, repeat test 
and treatment based on the Nigerian National HIV Protocol [391]. Participants that had other 
medical complaints were referred to a hospital of their choice. Each participant was given 
health related incentives such as a bar of medicated soap, toothbrush and paste and also a 
soft drink and biscuit as refreshments and 1000 naira (3.0GBP) to cover transportation. 







Sample transport and storage 
All samples collected at the clinics were labelled with unique laboratory identification number 
barcodes to anonymise participants’ information. Samples were transferred in cold boxes at 
2-8oC to the SHINI laboratory at the University College Hospital, Ibadan, for daily sorting and 
storage in a freezer at a temperature of -80oC. After the fieldwork was completed, samples 
were shipped on dry-ice to the ICO, Barcelona, Spain. The back-up samples were stored at a 
temperature of -80oC in the freezer of the PI (IMB) in Nigeria. 
HPV DNA Sample analysis 
HPV genotyping of all samples was performed at the ICO, Spain that has extensive experience 
in HPV molecular diagnostics. HPV genotyping was completed using the Anyplex™ II HPV28 
(Seegene, Seoul, South Korea) assay; a validated PCR-based quantitative technique for the 
detection and genotyping of 28 HPV types [392]. Anyplex™ II HPV28 detection test 
distinguishes 28 HPV genotypes, including HR-HPV (HPV -16, -18, -31, -33, -35, -39, -45, -51, -
52, -56, -58, -59 and -68), LR-HPV (HPV -6, -11, -40, -42, -43, -44, -53, -54 and -70) and possibly 
carcinogenic genotypes (HPV-26, -61, -66, -69, -73 and -82).  
 
Figure 4.2: Summary of the study procedure in the community 
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DNA was extracted from the cervical, vulvar and anal swabs using the Maxwell 16 Buccal swab 
LEV DNA Purification kit, while DNA extraction from the mouthwash specimen was performed 
using the Maxwell® 16 LEV Blood DNA (United Kingdom) Kit as recommended by the 
manufacturer of Promega. The A set is a multiplex assay that permits simultaneous 
amplification of target DNA of 14 HR-HPV genotypes (16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 
59, 66 and 68), while the B set is a multiplex assay that permits the simultaneous amplification 
of target DNA of 5 high-risk (26, 53, 69, 73 and 82) and 9 low-risk (6, 11, 40, 42, 43, 44, 54, 61 
and 70) HPV types [393]. The process is conducted in two reactions by taking advantage of 
the five dyes that can be resolved on the CFX96™ real-time PCR instrument (Bio-Rad, Marnes-
la-Coquette, France) [392]. The Anyplex™ II HPV28 detection test was performed as 
recommended by the manufacturer with 5μl of DNA in each of the two reaction mixtures (20 
μl) with the A and B primers.  
 
Data recording and interpretation were automated with Seegene viewer software (Seegene, 
Seoul, South Korea), according to the manufacturer’s instructions (Figure 4.3). Viral load was 
semi-quantified in Anyplex based on specific catcher melting points: the viral titre is low (+) if 
there is a positive signal after 40 PCR cycles; medium (++) when a positive signal is between 
31 and 39 PCR cycles and high (+++) when there is a positive signal before 31 PCR cycles 
(Figure 4.3). The inclusion of internal control allows the entire process from DNA extraction 
to PCR amplification to be checked. Beta (β)-globin is used as the internal control to 
demonstrate the presence of human DNA in each sample. If the internal control was negative, 
but the test result was positive, the test result was considered valid. A sample that had a poor 
or no signal for β-globin was defined as an invalid sample.   





4.2.7. Data management 
Data from the field were received daily at the SHINI research office for quality checks and 
stored in a locked metal cabinet. The case report forms data were double entered into 
REDCap software (Vanderbilt University, Nashville Tennessee, USA)[394-396] that was hosted 
on the website of the College of Medicine, University of Ibadan, by two trained data entry 
clerks. The data manager resolved any inconsistences observed in the data set. Thereafter, 
the raw data were exported in CSV format and saved. Exported data were imported into 
STATA 16.0 (Stata 2019. Statistical Software: Release 16. College Station, TX: StataCorp LLC) 
software for analysis. Visual checks of the data were undertaken by IMB and the data 
manager. Frequencies of all variables were generated to check for any error, missingness or 
incorrect responses. The missing variables were reported in the descriptive analyses but were 
Figure 4.3: Interpretation of HPV results on automated Seegene viewer software 
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dropped in the test of associations and multivariable models. Data cleaning was performed 
by IMB.  
 
4.2.8. Statistical Analyses 
Participants’ selected descriptive variables were summarised using frequencies and 
proportions for the categorical variables and mean and standard deviations for the 
continuous variable – age (Tables 4.1, 4.2 and 4.3). 
 
4.2.8.1. Outcome variables 
The primary outcome of this study was the prevalence of any HPV infection. The prevalences 
of HR-HPV and LR-HPV infection and according to the 2009 IARC epidemiological oncogenic 
classification (Groups 1, 2a, 2b and 3) for each of the anatomical sites were calculated with 
their 95% confidence intervals. The trend of association between each classification of HPV 
and the age group of participants was calculated with ANOVA. The secondary outcomes were 
the prevalence of different sexual behaviours (oral and anal). However, the risk factor analysis 
was limited to oral sex alone for the reason that only one participant reported anal sex in the 
two study sites. 
 
4.2.8.2. Risk factor analysis for any HPV Infections 
A conceptual framework for the risk factor analysis of any HPV infection among women in the 
general population was developed after a review of the literature to answer the specific 
objectives in this study (Figure 4.4).


















Current marital status 
 
HPV INFECTION AT OTHER 
ANATOMIC SITES APART FROM 
OUTCOME MEASURE (Yes/No) 
SEXUAL BEHAVIOUR 
CHARACTERISTICS 
Age at 1st vaginal sex (year) 
Age difference between 1st vagina 
sex partner and participant (year) 
No of vaginal sex partners/three 
months 
Ever had oral sex (Yes/No) 




Female genital mutilation (Yes/No) 
Ever drank alcohol (Yes/No) 
Ever smoked cigarette (Yes/No) 
Ever taken Illicit drugs (Yes/No) OTHER RELATED FACTORS 
Ever had sexually transmitted 
infection 
Ever heard of human papillomavirus 
USE OF BARRIER METHODS  
Condom use during the last vaginal 
sexual act (Yes/No) 
UNDERLYING DETERMINANT 
(LEVEL 1 FACTORS) 
PROXIMATE DETERMINANT 
(LEVEL 2 FACTORS) 
BIOLOGICAL DETERMINANT 
(LEVEL 3 FACTORS) 
OUTCOME MEASURE 
HPV BY ANATOMIC SITES 
1) Any Cervical HPV 
2) Any Vulva HPV 
3) Any Anal HPV 
4) Any Oral HPV 
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Associations with any HPV infection were explored to determine independent risk factors for 
infection the detection of any HPV infection was treated as a binary outcome; each 
anatomical site – oral, cervical, vulvar and anal  - was analysed separately. Logistic regression 
was applied to obtain crude estimates for the association between any HPV infection and 
potential risk factors (Table 4.7, 4.8, 4.9 and 4.10). Adjusted estimates were obtained using a 
hierarchical modelling technique [397]. Age group and study sites were included in the 
adjusted estimates a priori. Level 1 (Figure 4.4) sociodemographic variables included 
ethnicity, religion, highest educational level, ever had Qur’anic education, current occupation, 
monthly income and current marital status. Each variable was added one by one to a model 
that included age and study site. P-values were obtained by likelihood ratio tests. Any variable 
that met a p value ≤ 0.10 was included in the adjusted model. All level 1 variables were 
adjusted.  
 
Level 2 (Figure 4.4) behavioural variables included age at first vaginal sex, age difference 
between first vaginal sex partner and the participant, lifetime number of vaginal sex partners, 
ever cleansed vagina, condom use during last vaginal sex, ever had oral sex (given or 
received), history of transactional sex, ever had mutual masturbation, history of female 
genital mutilation, alcohol use, illicit drug use, ever had sexually transmitted infection and 
ever heard of human papillomavirus. Each level 2 variable was added one by one to a model 
that included level 1 variables that met a p-value cut off of ≤ 0.1 after adjusting the ‘core 
variables’. Any level 2 variable that met a p value cut off of ≤ 0.1 was included   with the level 
1 core variables in the level 2 adjusted model. Level 3 (Figure 4.4.) biological variables were 
laboratory detection of concurrent HPV infection from the other three anatomical sites apart 
from the outcome measure. For example, if the outcome measure was to determine risk 
factor for any cervical HPV, concomitant detection in vulvar, anal and oral sites were included 
as explanatory variables.  
 
Each level 3 variable was added one by one to a model that included level 1 ‘core variables’ 
and level 2 factors that met a p value cut off of ≤ 0.1. Any level 3 variable that met a p-value 
cut off of ≤ 0.1 was included with the level 1 and level 2 ‘core variables’ in the level 3 adjusted 
model. This strategy allowed the effects of variables at each level of the framework to be 
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assessed, adjusted for more distal variables. The following variables were excluded in the 
model because of small number of observations: history of transactional sex, ever smoked 
cigarette and rapid HIV test results. 
 
The concordance of HPV between anatomic sites (oral, cervical, vulvar and anal samples) in 
individual study participants was defined as the presence of the same type of virus across the 
four sites. The proportion of concordance for specific HPV type was calculated as the number 
of each HPV type in all the four sites, any of three and any of two anatomical sites. In addition, 
the concordance of specific HPV genotype was calculated for each of the anatomical sites and 
the concordance between anogenital sites only, cervix and vulva only, cervix and anal sites 
only, cervix and oral sites only, vulva and anal sites only, oral and anal sites, as well as oral 
and vulva sites only. 
 
4.2.8.3. Risk factor analysis of oral sexual behaviour	
The conceptual framework in Figure 4.5 was developed to investigate the association of 
selected individual and behavioural factors as potential risk factors of oral sex among the 
females in the community.  
 




Figure 4.5. Conceptual Framework for the risk factor analysis of oral sex among females in two communities in Ibadan 
Sociodemographic factors 
Age group  
Ethnicity 
Religion 
Highest formal education 
Quranic education (Y/N) 
Other occupation 
Monthly income 
Current marital status 
Own media related materials – 
TV or Radio 
Prevalence of oral sex  
1 - Ever gave oral sex 
2 - Ever received oral sex 
Other related practices 
Previous mutual masturbation (Y/N) 
Female genital mutilation (Y/N) 
Social factors 
Ever drank alcohol (Y/N) 
Ever smoked cigarette (Y/N) 
Ever abuse substance (Y/N) 
Access to Information 
Previous HIV test (counselling) 
Ever heard of Human papillomavirus 
DISTAL FACTORS (LEVEL 1) PROXIMATE FACTORS (LEVEL 2) OUTCOME MEASURE 
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As there were few women in the general population who reported oral sex, a binary outcome 
for any oral sex that combined giving and receiving oral sex was used as the outcome variable. 
Logistic regression was used to obtain crude estimates for the association between any oral 
sex and potential risk factors (Table 4.13). Adjusted estimates were obtained using a 
hierarchical approach. Age and study sites were included in the adjusted estimates a priori 
(Figure 4.5).  Level 1 sociodemographic variables included ethnicity, religion, highest 
educational level, current occupation, ever had Qur’anic education, monthly income, owned 
a television and radio, as well as current marital status. Each variable was added one by one 
to a model that included age and study site. P-values were obtained by likelihood ratio tests. 
Any variable that met a p-value cut off of ≤ 0.10 was included in the adjusted model. All level 
1 variables were adjusted and shown in Table 4.13. Level 2 behavioural variables included: 
ever had other sexual partners, history of transactional sex, ever had mutual masturbation, 
history of female genital mutilation, alcohol use, illicit drug use, awareness of human 
papillomavirus and previous HIV screening. Each level 2 variable was added one by one to a 
model that included level 1 variables meeting a p value cut off of ≤ 0.10 after adjusting the 
‘core variables’. Any level 2 variable that met a p value cut off of ≤ 0.10 was included along 
with the Level 1 core variables in the Level 2 adjusted model. All level 2 variables were 
adjusted and exhibited in Table 4.12. 
4.2.9. Ethical considerations 
Ethical approvals were obtained from the Ethics Committee of the London School of Hygiene 
and Tropical Medicine, the University of Ibadan/University College Hospital Ethical 
Committee and the Oyo State Ethical Review Board (Annex 3.5: Ethical approvals). During 
enrolment, each participant was verbally informed about the study and given a copy of the 
information leaflet (Annex 4.2: Information leaflet) that provided a detailed description of 
the research.  At the clinic, a female research assistant obtained written informed consent 
from individual potential participants after a detailed explanation of the study objectives and 
participation in the study. The consent covered understanding the research objective, 
participation including samples collection and HIV counselling and testing, storage of samples 
for future studies, as well as dissemination of the results. The consent involved permission to 
transport  biological samples from Nigeria to ICO Spain for laboratory analysis. Additionally, 
witnessed consent was obtained for participants that were not literate. The research assistant 
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explained the study in the presence of a literate third party chosen by the prospective 
participant. After the participant agreed to participate, the witness signed and dated the 
consent form.  Participants that could not write placed a witnessed thumb print over the 
signature section of the consent form.  
 
The major part of the cross-sectional study on females focused on sexual behaviours and the 
collection of samples to measure HPV prevalence. The confidentiality of participant’s data 
was maintained to a high standard throughout the study. The enrolment register that 
contained personal identifier data (name, address and sex) was locked in a cabinet inside the 
principal investigator’s office (IMB) to prevent unauthorised access. The samples were 
collected by trained female research nurses at a private room in the clinic. Each participant 
had a unique code (identification number) comprising four numeric digits in each of the case 
reports and laboratory samples forms, besides the reports and administrative reports/forms 
to maintain confidentiality. The log files that contained an individual participant’s name and 
address without their identification number were stored in a separate locked cabinet away 
from the case report forms. Electronic data were password protected with access restricted 
to specific key staff members including the PI and data managers. Due to the sensitive nature 
of the study, research assistants were trained to maintain absolute confidentiality to minimise 
the risk of participants being stigmatised.  
 
4.3. RESULTS 
4.3.1. Descriptive results of study participants in the two communities 
A total of 930 potentially eligible females from selected households in two communities in 
Mokola, Ibadan North and Moniya/Sasa, Akinyele (480) LGAs were listed. The summary of the 
participant enrolment at the two study sites is shown in Figure 4.6. Out of the 450 potentially 
eligible females listed in Mokola, 304 participants were randomly selected and visited at 
home. Of those visited, 127 were not found at home after three home visits. Of the 177 (58%) 
participants found at home in Mokola and invited into the clinic, 157 (89%) consented to 
participate in the study, 13 (7%) were not eligible, and seven (4%) declined participation. In 
Moniya/Sasa, 480 potentially eligible females were listed, of which 297 were randomly 
selected. Of those visited, 138 females were not found at home after three visits. Of the 159 
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(54%) participants found at home in Moniya/Sasa and invited to the clinic, 153 (96%) 






















Figure 4.6: Female participant enrolment flow for the community survey 
 
 
Study population (N=310) 
930 Females 
Ibadan North LGA 
450 females listed 
Akinyele LGA 
480 females listed 
304 were randomly 
selected and visited 
at home 
297 were randomly 
selected and visited 
at home 
177 (58%) enrolled 
and invited to the 
clinic to participate 
159 (54%) enrolled 
and invited to the 
clinic to participate 
127 (42%) were not found 
at home after 3 visits  
138 (46%) were not 
found at home after 3 
visits  
157 (89%) 
participated in the 
study 
153 (96%) 
participated in the 
study 
7 (4%) refused participation 
13 (7%) ineligible 
participants 
2 (1%) refused 
participation 
4 (3%) ineligible 
participants 
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4.3.1.1. Socio-demographic characteristics 
The mean age of the participants was 29 years (SD=7). Participants in Moniya/Sasa (29 ± 8 
years) were slightly older than those in Mokola (28 ± 7 years) but this was not statistically 
significant. A third of participants were aged 18-24 years (Table 4.3). The distribution of some 
of the participants’ socio-demographic variables was the same in the two communities except 
for age group, ethnicity, religion, current marital status and items personally owned by the 
participant. There were more women aged 25-34 years and below in Mokola than 
Moniya/Sasa population (p=0.040). The proportion of participants in Moniya/Sasa that were 
from the Yoruba ethnic group was more than those in Mokola (p<0.001). There were more 
Christians (58%) than Muslims (41%) among participants in Mokola and more Muslims (68%) 
than Christians (32%) among participants in Moniya/Sasa community (p<0.001). There were 
more participants in Moniya/Sasa that owned a mobile phone (92% versus 79%; p = 0.001), 
television (80% versus 25%; p<0.001), radio (64% versus 17%; p<0.001), generator (40% 
versus 10%; p<0.001) and a house (9% versus 1%; p = 0.001) compared with those living in 
Mokola. 
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No current paid job (e.g. student, housewife) 
Unskilled worker (e.g. office assistant, food vendor) 
Semi-skilled worker (e.g. driver, tailor) 

















Income per month 
No income 
1 - 10,000N (1-28USD) 
10,001 - 20,000N (>28 – 56USD) 

















Current marital status 
Single and Living alone 
Married and living as married 















































4.3.1.2. Sexual relationships, partnerships and behaviours 
The participants at both research sites were significantly different in the number of lifetime 
partners for vaginal sex, reported condom use during the last vaginal sex, history of ever 
giving or receiving oral sex, number of lifetime partners oral sex were given or received, 
history of mutual masturbation and self-masturbation, alcohol use, illicit drug use and clinical 
evidence of female genital mutilation (Table 4.4.). The majority of participants had only one 
lifetime vaginal sex partner (53%). There was a higher proportion of this group of women in 
Moniya/Sasa (59%) than Mokola (47%) (p = 0.001). There was a higher number of women in 
Mokola (29%) that had three or more lifetime vaginal sex partners than those in Moniya/Sasa 
(14%). Although condom use during last vaginal sex was low (18%), a higher proportion of 
women in Mokola (24%) reported condom use during their last vaginal sex than women in 
Moniya/Sasa (12%) (p = 0.004).  
Thirty-five (11%) participants reported ever giving oral sex to a male partner. The majority 
were from Mokola compared to Moniya/Sasa (16% versus 7%) community (p = 0.009). Thirty-
six women (12%) reported having ever received oral sex from a male partner, whilst there 
were more women that reported ever receiving oral sex from a male partner in Mokola 
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relative to Moniya/Sasa (17% versus 7%; p = 0.006). Of all the participants interviewed at both 
study sites, only one participant in Mokola reported ever having heterosexual anal sex (data 
not shown). There were higher proportion of participants in Mokola that had had mutual 
masturbation compared to those in Moniya/Sasa (87% versus 63%; p < 0.001). However, 
higher proportion of people in Moniya/Sasa reported a history of self-masturbation than 
those in Mokola (67% versus 46%; p < 0.001). There were higher proportion of women in 
Moniya/Sasa that reported using water to cleanse inside their vagina (98% versus 79%; p < 
0.001) and had experienced female genital mutilation (61% versus 46%; p = 0.006) compared 
to women in Mokola. Participants from Mokola had higher proportions of those that ever 
drank alcohol (43% versus 11%; p<0.001) and engaged in illicit drug use (12% versus 2%; p = 
0.001) compared to those living in Moniya/Sasa. The most common illicit drugs ever taken 
include tramadol in 18(82%), Shisha in 8(36%) and codeine in 3(14%) by participants in the 
two communities. 
Table 4.4: Sexual relationships, partnerships and behaviours of sexually active females in two 




























Age of current main sexual partner1, years 





























Age of first vaginal sex partner3, years 
Mean (SD) = 274 
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Number of lifetime partners for vaginal sex 
Single vaginal partner 





































Age when the first oral sex was given to a 
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Age of partner when the first oral sex was 
given5, years 













Number of lifetime partners given oral sex 
None 
Single vaginal partner 














Condom use by male partner when last oral 































Age when the first oral sex was received 
from a male partner6, years 





























Number of lifetime partners you received 
oral sex from 
None 
Single vaginal partner 

















Any barrier methods used during last time 






























































































Female genital mutilation10    0.006 






4.3.1.3. Relevant medical history and clinical and laboratory diagnosis 
Table 4.5 depicts information on relevant medical history, clinical and laboratory diagnosis in women 
in the Mokola and Moniya/Sasa. Only 23 (7%) women from both communities had ever heard of HPV. 
There was no significant difference between the two study sites. There were more participants with a 
previous history of STI (18% versus 10%; p = 0.041), clinical diagnosis of vaginal discharge (16% versus 
9%; p = 0.046) and hypertension (8% versus 1%; p = 0.004) in Mokola compared to the community at 
Moniya/Sasa. All participants consented to rapid HIV diagnostic tests. Only 8(3%) of them were 
established to be HIV positive. 
 
Table 4.5: Relevant medical history and clinical and laboratory diagnosis among sexually 



























Sources of information on HPV 

























































































1-27 missing; 2- 6 missing; 3-36 missing; 4- Fisher’s exact test; -2- missing; 6-2 missing; 7-2 missing; 8- Mutual masturbation 
question was ‘have you or your partner ever touched each other’s genital area by hand? (Yes or No); 9- Cleansing of vagina was 
defined as using water or another substance to clean inside vagina by inserting half or whole finger; 10- Female genital mutilation 
was based on the clinical examination of the female external genitalia for evidence of genital circumcision by the research nurse 
at the clinic (Yes or No); 11-Illicit drugs are banned substances or drugs taken by participants for non-medical reasons in Nigeria;  
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Clinical diagnosis made at the clinic 
Vaginal discharge syndrome 
Pelvic Inflammatory Disease 
Genital ulcer disease 
Genital warts 

















































1.– Fisher’s exact test 
 
4.3.2. Prevalence of cervical, vulvar, anal and oral HPV Infection 
Three hundred and ten samples were collected from each of the anatomical sites - cervix, 
vulva, anal and oral cavity - of the participants at both research sites, making a total of 1,240 
samples. Out of these samples, twenty-four (7.7%) oral samples, seven (2.2%) anal samples, 
five (1.6%) cervical samples and one (0.3%) sample from the vulva were declared invalid 
samples in the laboratory due to the low amount of β globin portion of the DNA. All invalid 
samples were treated as missing.   
 
Overall, the prevalence of any detectable HPV infection among females in the general 
population was 68.0% (95 % CI, 62.4-73.1) in the vulvar samples, 59.7% (95% CI, 53.9-65.2) in 
the cervical samples, 56.8% (95 % CI, 51.0-62.4) in the anal samples and 16.1% (95% CI, 12.0-
12.9) in the oral samples (Table 4.6). Generally, the prevalence of any HPV was highest in each 
of the anatomical sites among participants aged 18-24 years, with the prevalence decreasing 
with the increasing age group of the participants. There was a significant inverse relationship 
between the age group of the participants and any HPV, any class 1, class 2B, class 3, and LR-
HPV, as well as multiple HPV infections (two or more different genotypes of HPV from a 
sample) in cervical samples. However, in the vulvar samples, a significant inverse relationship 
exists between the age group of participants and any class 1, any LR-HPV and multiple HPV 
infections. Similarly, there was also a significant inverse relationship between age group and 
the prevalence of any LR-HPV and multiple HPV infections in anal samples. Though, the 
observed prevalence of any oral HPV was highest among the youngest age group (18-24 
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years), this association was not statistically significant. Detection of any carcinogenic HPV 
genotypes (class 1), probable carcinogenic HPV genotypes (class 2A), possible carcinogenic 
HPV genotypes (class 2B) and unclassified HPV genotypes (class 3) was highest in the vulvar 
samples compared to the other three anatomical sites. For example, the overall prevalence 
of any carcinogenic HPV genotypes (class 1) was 48.2% (95% CI, 42.5-53.9) in the vulvar 
samples, 42.0% (95% CI, 36.4-47.7) in the cervical samples, 37.6% (95% CI, 32.1-43.3) in the 
anal samples and 10.1% (95% CI, 6.9-14.2) in the oral samples.  
 
Similarly, the prevalence of any HR-HPV and LR-HPV genotypes was highest in the vulvar 
samples compared to the other three anatomical sites. For example, the proportion of any 
HR-HPV genotypes was 51.1% (95% CI, 45.4-56.8) in the vulvar samples, 44.3% (95% CI, 38.6-
50.0) in the cervical samples, 39.3% (95% CI, 33.7-45.0) in the anal samples and 10.5% (95% 
CI, 7.2-14.6) in the oral samples. Detection of any LR-HPV types was 48.2% (95% CI, 42.5-53.9) 
in the vulvar samples, 40.3% in the cervical (95% CI, 34.8-46.1) and anal samples (95% CI, 34.7-
46.0) and 9.4% (95% CI, 6.3-13.4) in the oral samples. The proportion of multiple HPV infection 
detection in the vulvar, anal cavity, cervix and in the oral cavity was 40.8% (95% CI, 35.2-46.5), 
33.7% (95% CI, 28.4-39.3), 33.1% (95% CI, 27.9-38.7) and 4.5% (95% CI, 2.4-7.6), respectively 
(Table 4.6).    
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Table 4.6: Prevalence of Cervical, Vulvar, Anal and Oral Human papillomavirus infections among sexually active women from the general 
population in two communities in Ibadan, Nigeria (N=310) 
 
Variable Cervical Sample Vulvar Sample Anal Sample Oral Sample 
n/N1 Prevalence % 
[95% CI] 
n/N Prevalence (%) 
[95% CI] 
n/N Prevalence (%) 
[95% CI] 
n/N Prevalence (%) 
[95% CI] 
Any HPV genotype 
18-24 years 











































HPV classification by IARC2 
Class 1 – Carcinogenic3 
18-24 years 




Class 2A – Probable carcinogenic4 
18-24 years 




Class 2B – Possible carcinogenic6 
18-24 years 




Class 3 – Unclassified7 
18-24 years 





































































































































































































Any HR-HPV genotypes8 
18-24 years 











































Any LR-HPV genotype9 
18-24 years 











































Multiple HPV genotypes infection10 
18-24 years 












































 1-n/N – number of samples  with positive HPV infection as numerator and total samples with valid result as denominator; 2-IARC – International Agency for Research on Cancer (*- 
HPV genotypes in IARC classification that are not included in the Anyplex II HPV28 platform); 3- Class 1 IARC HPV -16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59; 4- Class 2A IARC HPV 
- 68; 5- Bartlett’s test for equal variances were significant (p< 0.05) ; 6- Class 2B IARC HPV - 5*, 8*, 26, 30*, 34*, 40, 42, 43, 44, 53, 54, 55*, 61, 66, 67*, 69, 70, 71*, 72*, 73, 81*, 
82, 83*, 84*, 85*, 97*, IS39* and CP6108*; 7- Class 3 IARC HPV -  6, 11; 8-  HR-HPV Group - Class 1 IARC HPV and Class 2A IARC HPV; 9- LR-HPV - Class 2b IARC and Class 3 IARC; 
10- Multiple HPV infection- Detection of two or more genotypes of HPV by Anyplex II HPV28 from a sample. All invalid samples were excluded from the descriptive analysis  
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The graphs in figures 4.7, 4.8, 4.9, 4.10 and 4.11 exhibited the distribution of HPV specific 
genotype prevalences with respect to the cervical, vulvar, anal and oral samples of the 
participants. The two most prevalent HR-HPV specific genotypes by anatomical site were HPV-
35 (8.5% [95% CI, 5.6-12.2]) and HPV-39 (7.2% [95% CI, 4.6-10.7]) in the cervical samples; HPV-
35 (8.7% [95% CI, 5.8-12.5]) and HPV-52 (8.1% [95% CI, 5.3-11.7]) in the vulvar samples; HPV-
52 (8.9% [95% CI, 6.0-12.7]) and HPV-45 (7.3% [95% CI, 4.6-7.3]) in the anal samples; and HPV-
51 (3.2% [95% CI, 1.5-5.9]) and HPV-18/35/39 (1.4% [95% CI, 0.4-3.5]) in the oral samples. 
HPV-42 was the commonest LR-HPV specific genotype detected in the anal (13.2% [95% CI, 
9.6-17.5]), vulvar (12.6% [95% CI, 9.1-16.9]), cervical (11.2% [95% CI, 7.8-15.2]) and oral (3.8% 
[95% CI, 1.9-6.8]) samples. HPV-6 was the second most prevalent LR type in the cervical (6.2% 
[95% CI, 3.8-9.6]), anal (8.9% [95% CI, 6.0-12.7]) and oral (3.2% [95% CI, 1.5-5.9]) samples, 
while HPV-66 (10.7% [95% CI, 7.5-14.7]) and HPV-54 (6.2% [95% CI, 3.8-9.6]) were the second 
most detected in the vulvar and cervical samples, respectively.   
 











































































































cervix vulva anal cavity oral cavity
Figure 4.7– Prevalence of specific HPV genotypes according to the four anatomical sites  
  














































RED triangle indicates HR-HPV point prevalence and BLACK BALL indicates LR-HPV point prevalence with lines indicating 95% CI 
Figure 4.8 – Prevalence of specific cervical HPV genotypes  
  
Figure 4.9– Prevalence of specific vulvar HPV genotypes  
  














































RED triangle indicates HR-HPV point prevalence and BLACK BALL indicates LR-HPV point prevalence with lines indicating 95% CI
Figure 4.10 – Prevalence of specific anal HPV genotypes  
  
Figure 4.11 – Prevalence of specific oral HPV genotypes  
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4.3.3. Risk factors associated with cervical, vulvar, anal and oral HPV Infection 
4.3.3.1. Risk factors associated with any cervical HPV Infection 
Overall, 182 (60%) out of 305 participants had any cervical HPV infection. The results of the 
multivariable analyses for cervical HPV are shown in Table 4.7. In the unadjusted analyses, 
only the age of participants among all the level 1 factors was associated with cervical HPV 
infection. After adjusting for other sociodemographic factors in the model, age of the women 
remained associated with cervical HPV infection. Women aged 26-34 years and 35-45 years 
had 0.81 (95% CI, 0.46-1.41) and 0.44 (95% CI, 0.25-0.78) odds of having cervical HPV 
infection, respectively, compared to those aged 18-24 years.   
 
For level 2 factors, the unadjusted analyses showed that number of lifetime vaginal sex 
partners, ever had oral sex (given or received), ever taken any illicit drugs and ever heard of 
HPV were associated with cervical HPV infection. After adjusting for confounders (level 1 core 
variables and Level 2 factors that were significant at p≤0.10), only the number of lifetime 
partner for vaginal sex remained significant. There was 1.54 (95%CI, 1.16-2.04) higher odds 
of having cervical HPV infection for a unit increase in number of lifetime partner for vaginal 
sex.  
 
In the unadjusted analyses of level 3 factors, concomitant vulvar, anal and oral HPV infections 
were associated with cervical HPV infections. After adjusting for possible confounding (level 
1 and 2 core variables, and any level 3 factors that were significant at p≤0.10), there was 
strong evidence that concomitant vulvar, anal and oral HPV infection remained associated 
with cervical HPV infection. The odds of detecting cervical HPV infections were 12.85 times 
(95%CI, 5.70-28.99), 4.37 times (95%CI, 1.50-12.71) and 3.48 times (95%CI, 1.74-6.96) in 
women that had concomitant vulvar, oral and anal HPV infections, respectively, compared to 
those with no HPV infections at these anatomical sites. 
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Table 4.7: Factors associated with cervical human papillomavirus infection among sexually active 
women from the general population in two communities in Ibadan, Nigeria 
Variable n/N (row, %) p-value1 
Crude OR (95%CI) 
p-value2 
Adjusted OR (95%CI)3 





















































Highest education level 















































Income per month6 
No income 
1 - 10,000N (1-28USD) 
10,001 - 20,000N (>28 – 56USD) 
















Current marital status 
Single7 














BEHAVIOURAL FACTORS (Level 2) n/N (row, %) Crude OR (95%CI) Adjusted OR (95%CI)8 
















Age difference between first vaginal sex 















Number of lifetime partners for vaginal sex  p=0.001 p=0.002 
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number of vaginal sex partners (mean (SD)) 1.91(1.41) 1.46(1.16-1.84) 1.54(1.16-2.04) 
























































































































BIOLOGICAL FACTORS (Level 3) n/N (row, %) Crude OR (95%CI) Adjusted OR (95%CI)15 










































1- p-values were obtained from Wald tests; 2 – p values were obtained from Likelihood Ratio tests; 3- Level 1 factors were adjusted for 
age and study site; 4– Hausa/Fulani, Igbo and other minorities; 5- Student, apprentice and no job; 6–N – Naira- currency of Nigeria; USD 
–United States Dollar; 7– Living alone; 8- Level 2 factors were adjusted for age and study site (core variables from Level 1) and number 
of lifetime vaginal sex partners, ever had oral sex, mutual masturbation, illicit drug and ever heard of human papillomavirus; 9- N=299 -
six participants did not provide information on age at first vaginal sex; 10- N=269 – 36 participants did not provide information to 
calculate the age difference between first vaginal sex partner and participant; 11- Cleansing of vagina was defined as using water or 
another substance to clean inside of vagina by inserting half or whole finger; 12- The mutual masturbation question was ‘have you or 
your partner ever touched each other’s genital area by hand? (Yes or No); 13- Female genital mutilation was based on the clinical 
examination of the female external genitalia for evidence of genital circumcision by the research nurse at the clinic (Yes or No); 14- Illicit 
drugs are banned substances or drugs taken by participants for non-medical reasons in Nigeria; 15-Level 3 factors were adjusted for 
(core variables from Level 1), Level 2 factors (number of lifetime vaginal sex partners, illicit drug and ever heard about human 
papillomavirus), and various biological factors, such as the detection of HPV genotype in the vulvar and anal and oral cavities of the 
participant; 16- N=298-seven participants did not have anal HPV results; 17- N=281-24 participants did not have oral HPV results 
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4.3.3.2. Risk factors associated with any vulvar HPV Infection 
Two hundred and ten women (68%) out of 309 had detectable HPV infection on their vulva.  
Table 4.8 shows the results of the regression model for vulva HPV infection. The unadjusted 
analyses of level 1 factors established that there was strong evidence of association between 
vulvar HPV infection and current marital status. After adjusting for possible confounders, 
there was still evidence of an association with current marital status of participants (p=0.02). 
There was a lower odds (aOR=0.49, 95% CI, 0.25-0.99) of vulvar HPV infection among married 
or living as married women relative to single women. 
 
The age difference between first vaginal sex partner and the participant, number of lifetime 
vaginal sex partners, history of ever drinking alcohol and illicit drug use were associated with 
detection of any HPV in the vulva in unadjusted analyses of level 2 factors (Table 4.8). After 
adjusting for possible confounders, the age difference between first vaginal sex partner 
(p=0.026) and the participant and the number of lifetime partners for vaginal sex partners 
(p<0.001) were still associated with vulvar HPV infection. Women whose age difference with 
their first vaginal sex partner  was six years and above had lower odds (aOR=0.51, 95% CI, 
0.29-0.90) of vulvar HPV infection compared to women who had five or less vaginal sex 
partners. The odds of having any vulvar HPV infection among women was 2.03 (95% CI, 1.38-
3.01) times higher with increasing  number of lifetime partners for vaginal sex. 
 
In the unadjusted analyses of level 3 factors, presence of concomitant HPV infection in the 
cervix, as well as the anal and oral cavities of participants were associated with detectable 
vulvar HPV infection. After adjusting for possible confounders, only the presence of 
concomitant cervical and anal HPV infection remained associated with vulvar HPV infection 
(p<0.001). Women with concomitant cervical (aOR=22.19, 95 %CI 7.85-62.72) and anal 
(aOR=6.68, 95% CI 2.44-18.26) HPV infection had higher odds of vulvar HPV infection relative 
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Table 4.8: Factors associated with vulvar human papillomavirus infection among sexually active 
women from the general population in two communities in Ibadan, Nigeria 
Variable n/N (row, %) p-value1 

























































Highest education level 















































Income per month6 
No income 
1 - 10,000N (1-28USD) 
10,001 - 20,000N (>28 – 56USD) 
















Current marital status 
Single7 














BEHAVIOURAL FACTORS (Level 2) n/N (row, %) Crude OR (95%CI) Adjusted OR 
(95%CI)8 
















Age difference between first vaginal sex 















Number of lifetime partners for vaginal sex  p<0.001 p<0.001 
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number of vaginal sex partners (mean (SD)) 1.91(1.41) 1.59(1.21-2.07) 2.03(1.38-3.01) 
























































































































BIOLOGICAL FACTORS (Level 3) n/N (row, %) Crude OR (95%CI) Adjusted OR 
(95%CI)15 




































1- p-values were obtained from Wald tests; 2 – p values were obtained from Likelihood Ratio tests; 3- Level 1 factors were adjusted for age, study 
site, monthly income and current marital status; 4– Hausa/Fulani, Igbo and other minorities; 5– Student, apprentice and no job; 6– N – Naira- 
currency of Nigeria; USD –United States Dollar; 7– Living alone; 8- Level 2 factors were adjusted for age, study site monthly income and current 
marital status (core variables from Level 1) and various behavioural factors - age difference between first vaginal sex partner and participant, 
number of lifetime vaginal sex partners, cleansed inside vaginal, alcohol and illicit drug; 9- N=303 -six participants did not provide information 
on age at first vaginal sex; 10- N=273 – 36 participants did not provide information to calculate age difference between first vaginal sex partner 
and participant; 11- Cleansing of vagina was defined as using water or another substance to clean inside of vagina by inserting half or whole 
finger;  12- The mutual masturbation question was ‘have you or your partner ever touched each other’s genital area by hand? (Yes or No); 13- 
Female genital mutilation was based on the clinical examination of the female external genitalia for evidence of genital circumcision by the 
research nurse at the clinic (Yes or No); 14- Illicit drugs are banned substances or drugs taken by participants for non-medical reasons in Nigeria; 
15- Level 3 factors were adjusted for (core variables from Level 1), Level 2 factors (age difference between first vaginal sex partner and 
participant, number of lifetime vaginal sex partners, cleansed inside vaginal, and illicit drug) and detection of HPV genotype in the cervical and 
anal cavity of participant; 16- N=305 – four participants did not have cervical HPV results; 17- N=302-seven participants did not have anal HPV 
results; 18- N=285-24 participants did not have oral HPV results 
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4.3.3.3. Risk factors associated with any anal HPV Infection 
Of the 303 women whose anal samples were analysed, 171 (56%) had detectable HPV 
infection. The results of the logistical regression models for anal HPV infection is shown in 
Table 4.9. Of the level 1 factors, study sites, monthly income and current marital status were 
associated with anal HPV infection in the unadjusted analyses, but none was significantly 
associated in the adjusted model.  
 
In the unadjusted analyses of level 2 factors (Table 4.9), age difference between first vaginal 
sex partners and participants, number of life time partners for vaginal sex, alcohol, illicit drug 
use, previous history of STI and ever heard of HPV were associated with any HPV infection. 
After adjusting for possible confounders, only age difference between first vaginal sex 
partners and participants (p=0.050) and number of lifetime partners for vaginal sex (p<0.001) 
remained associated with detection of anal HPV infection. Women whose age difference with 
her first vaginal sex partner was six years or more had lower odds (aOR=0.58, 95% CI 0.34-
1.00) of having anal HPV infection compared to women that had an age difference of five 
years and below. The odds of anal HPV infections were 1.92 (95% CI, 1.35-2.71) higher for 
each unit increase in number of lifetime partner for vaginal sex. 
 
The presence of concomitant HPV infection in the cervix, vulvar and oral cavity were found to 
be associated with detection of anal HPV infection in the unadjusted analyses. After adjusting 
for possible confounders, there was strong evidence of an association between concurrent 
cervical and vulvar HPV infection and any anal HPV infection. The odds of having anal HPV 
was higher in women with concomitant cervical (aOR=4.10, 95% CI, 1.85-9.11) and vulvar 
(aOR=5.47, 95% CI, 2.11-14.20) HPV infection compared with those without HPV infections at 
these anatomical sites.  
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Table 4.9: Factors associated with anal human papillomavirus infection among sexually active 
women from the general population in two communities in Ibadan, Nigeria 
Variable n/N (row, %) p-value1 
Crude OR (95%CI) 
p-value2 
Adjusted OR (95%CI)3 






















































Highest education level 















































Income per month6 
No income 
1 - 10,000N (1-28USD) 
10,001 - 20,000N (>28 – 56USD) 
















Current marital status 
Single7 














BEHAVIOURAL FACTORS (Level 2) n/N(row, %) Crude OR (95%CI) Adjusted OR (95%CI)8 
















Age difference between first vaginal sex 















Number of lifetime partners for vaginal sex  p<0.001 p<0.001 
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(Mean (SD)) 1.89(1.40) 1.50(1.19-1.90) 1.92(1.35-2.71) 
























































































































BIOLOGICAL FACTORS (Level 3) n/N(row, %) Crude OR (95%CI) Adjusted OR (95%CI)16 








































1- p-values were obtained from Wald tests; 2 – p values were obtained from Likelihood Ratio tests; 3- Level 1 factors were adjusted for 
age, study site, monthly income and current marital status; 4- Hausa/Fulani, Igbo and other minorities;  5– Student, apprentice and no 
job; 6– N – Naira- currency of Nigeria; USD –United States Dollar; 7– Living alone; 8- Level 2 factors were adjusted for age, study site 
monthly income and current marital status (core variables from Level 1) and various behavioural factors - age difference between first 
vaginal sex partner and participant, number of lifetime vaginal sex partners, alcohol and illicit drug; 9-N=297 -six participants did not 
provide information on age at first vaginal sex; 10- N=267 – 36 participants did not provide information to calculate age difference 
between first vaginal sex partner and participant; 11- Cleansing of vagina was defined as using water or another substance to clean 
inside of vagina by inserting half or whole finger;  12- The mutual masturbation question was ‘have you or your partner ever touched 
each other’s genital area by hand? (Yes or No); 13- Female genital mutilation was based on the clinical examination of the female 
external genitalia for evidence of genital circumcision by the research nurse at the clinic (Yes or No); 14- Cigarette smoking was excluded 
from the regression model because of small observations; 15- Illicit drugs are banned substances or drugs taken by participants for non-
medical reasons in Nigeria; 16- Level 3 factors were adjusted for (core variables from Level 1), Level 2 factors (age difference between 
first vaginal sex partner and participant, number of lifetime vaginal sex partners,ever heard about human papillomavirus ), and detection 
of HPV genotype in the cervix, and vulvar of participant; 17- N=298 – five participants did not have cervical HPV results; 18- N=302-one 
participant did not have vulvar HPV results; 19- N=280-23 participants did not have oral HPV results 
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4.3.3.4. Risk factors associated with any oral HPV Infection 
Forty-six (16.1%) out of two hundred and eighty-six participants had any oral HPV infection. 
Out of all Level 1 factors, study site was associated with any oral HPV infection in the 
unadjusted and adjusted analyses (Table 4.10). There were lower odds of having oral HPV 
infection in women in Moniya/Sasa (aOR=0.38, 95% CI, 0.19-0.74) compared to those in 
Mokola. None of the level 2 factors was established to be associated with oral HPV infection 
in both unadjusted and adjusted analyses.  
For level 3 factors, having a positive rapid HIV result and concomitant cervical, vulvar and anal 
HPV infections were all associated with having oral HPV infection in the unadjusted analyses. 
After adjusting for possible confounders, only concomitant cervical HPV infection was found 
to be associated with oral HPV infection. The odds of having oral HPV infection was 4.81 
(95%CI, 1.58-14.62) higher in women with concomitant cervical HPV infection than those with 
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Table 4.10: Factors associated with oral human papillomavirus infection among sexually active 
women from the general population in two communities in Ibadan, Nigeria 
Variable n/N(row, %) p-value1 
Crude OR (95%CI) 
p-value2 
Adjusted OR (95%CI)3 





















































Highest education level 















































Income per month6 
No income 
1 - 10,000N (1-28USD) 
10,001 - 20,000N (>28 – 56USD) 
















Current marital status 
Single7 














BEHAVIOURAL FACTORS (Level 2) n/N(row, %) Crude OR (95%CI) Adjusted OR (95%CI)8 
















Age difference between first vaginal sex 
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BIOLOGICAL FACTORS (Level 3) n/N(row, %) Crude OR (95%CI) Adjusted OR (95%CI)16 










































1- p-values were obtained from Wald tests; 2 – p values were obtained from Likelihood Ratio tests; 3- Level 1 factors were adjusted for 
age and study site; 4– Hausa/Fulani, Igbo and other minorities; 5– Student, apprentice and no job; 6– N – Naira- currency of Nigeria; USD 
–United States Dollar; 7– Living alone; 8- Level 2 factors were adjusted for age and study site (core variables from Level 1) only because 
none of the Level 2 factors had a Likelihood Ratio test p-value of ≤0.1; 9-N=281 -five participants did not provide information on age at 
first vaginal sex; 10- N=256 – 30 participants did not provide information to calculate age difference between first vaginal sex partner 
and participant; 11- Cleansing of vagina was defined as using water or another substance to clean inside of vagina by inserting half or 
whole finger; 12- The mutual masturbation question was ‘have you or your partner ever touched each other’s genital area by hand? (Yes 
or No); 13- Female genital mutilation was based on the clinical examination of the female external genitalia for evidence of genital 
circumcision by the research nurse at the clinic (Yes or No); 14 - Cigarette smoking was excluded from the regression model because of 
empty cells 15-Illicit drugs are banned substances or drugs taken by participants for non-medical reasons in Nigeria; 16- Level 3 factors 
were adjusted for (core variables from Level 1) and biological factor detection of HPV genotype in cervix of participant; 17- N=281-five 
participants did not have cervical HPV results; 18- N=285-one participant did not have vulvar HPV results; 19- N=280- six participant did 
not have vulvar HPV results 
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4.3.4. Concordance of genotype specific HPV infection 
Thirty one out of 310 women had concordance of any HPV in the four anatomical sites of the 
cervix, vulvar, anal and oral cavities. Moreover, 15 of these women had concordance of HR-
HPV genotypes (Table 4.11). Of those that had concordance of HR-HPV in the four anatomical 
sites, two women each had HPV-16, 18, 39, 51, 58 and 59 detected in all the four anatomical 
sites. Out of 16 participants that had concordance of LR-HPV genotypes in the four anatomic 
sites, HPV-42 was the most prevalent type detected in five women followed by HPVs-6, 40 
and 82 in two women each. Participants who had concordant HPV specific genotypes in any 
of the three anatomical sites, HPV-45, 39, 59 and 16 of HR types were found in twelve, eleven, 
ten and nine women, respectively. HPV-42 in 20 women, HPV-6 and 54 in 13 women and HPV-
66 in 10 women were LR group detected in three anatomical sites.  
 
The concordance of HPV genotype between any two anatomical site samples of participants 
(Table 4.12) showed that the concordance of HR-HPV was highest in the cervical and vulvar 
samples (116/309; 37.5%), followed by the anal and vulvar samples (104/310; 33.5%) and the 
cervical and anal samples (92/310; 29.7%). The lowest concordance of any HR-HPV genotype 
was between the oral and vulvar samples (21/309; 6.8%). The concordance of any LR-HPV 
genotype between two anatomical sites samples was also highest in the cervical and vulvar 
samples (123/305; 40.3%), followed by the cervical and anal samples (95/310; 30.6%) and the 
cervical and vulvar samples (95/310; 30.6%). The lowest concordance of any LR-HPV genotype 
was between the oral samples and the cervical samples (16/310; 5.2%). 
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Table 4.11: Proportion of HPV genotype specific concordance samples across the four 
anatomical sites of the cervix, vulvar, anal and oral cavities among sexually active women in 







the same HPV 
genotype in all 
the 4 sites (%) 
Women with 
the same HPV 
genotype in any 
3 sites (%) 
Women with 
the same HPV 
genotype in 
any 2 sites (%) 
Women with 
HPV genotype 
in 1 site only 
(%) 
Women with 
any HPV 16 
Yes (n=24) 2/24 (8%) 9/24 (38%) 2/24 (8%) 11 (46%) 
No (n=26) - - - - 
Women with 
any HPV 18 
Yes (n=25) 2/25 (8%) 4 /25(16%) 5 /25(20%) 14 /25(56%) 
No (n=19) - - - - 
Women with 
any HPV 31  
Yes (n=19) 0 5/19 (26%) 5/19 (26%) 9/19 (48%) 
No (n=15) - - - - 
Women with 
any HPV 33 
Yes (n=9) 0 3/9 (33%) 2/9 (22%) 4/9 (45%) 
No (n=8) - - - - 
Women with 
any HPV 35 
Yes (n=36) 1/36 (3%) 14/36 (39%) 9/36 (25%) 12/36 (33%) 
No (n=40) - - - - 
Women with 
any HPV 39  
Yes (n=30) 2/30 (7%) 11/30 (37%) 7/30 (23%) 10/30 (33%) 
No (n=36) - - - - 
Women with 
any HPV 45  
Yes (n=34) 0 12/34 (35%) 9/34 (27%) 13/34 (38%) 
No (n=33) - - - - 
Women with 
any HPV 51  
Yes (n=30) 2/30 (7%) 6/30 (20%) 5/30 (17%) 17/30 (56%) 
No (n=23) - - - - 
Women with 
any HPV 52 
Yes (n=40) 0 9/40 (23%) 10/40 (25%) 21/40 (52%) 
No (n=28) - - - - 
Women with 
any HPV 56 
Yes (n=23) 1/23 (4%) 6/23 (26%) 5/23 (22%) 11/23 (48%) 
No (n=20) - - - - 
Women with 
any HPV 58 
Yes (n=35) 2/35 (6%) 5/35 (14%) 7/35 (20%) 21/35 (60%) 
No (n=23) - - - - 
Women with 
any HPV 59 
Yes (n=25) 2/25 (8%) 10/25 (40%) 4/25 (16%) 9/25 (36%) 
No (n=30 - - - - 
Women with 
any HPV 68 
Yes (n=28) 1/28 (4%) 7/28 (25%) 8/28 (28%) 12/28 (43%) 
No (n=25) - - - - 
Women with 
any HPV 6  
Yes (n=43) 2/43 (5%) 13/43 (30%) 8/43 (19%) 20/43 (46%) 
No (n=40) - - - - 
Women with 
any HPV 11 
Yes (n=3) 0 0 2/3 (67%) 1/3 (33%) 
No (n=2) - - - - 
Women with 
any HPV 26  
Yes (n=6) 0 2/6 (33%) 1/6 (17%) 3/6 (50%) 
No (n=5) - - - - 
Women with 
any HPV 40 
Yes (n=28) 2/28 (7%) 9/28 (32%) 5/28 (18%) 12/28 (43%) 
No (n=29) - - - - 
Women with 
any HPV 42  
Yes (n=63) 5/63 (8%) 20/63 (32%) 6/63(9%) 32/63 (51%) 
No (n=61) - -  - 
Women with 
any HPV 43  
Yes (n=19) 0 9/19 (48%) 5/19 (26%) 5/19 (26%) 
No (n=23) - - - - 
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Women with 
any HPV 44 
Yes (n=18) 1/18 (6%) 8 /18(44%) 4/18 (22%) 5/18 (28%) 
No (n=23) - - - - 
Women with 
any HPV 53  
Yes (n=39) 0 9/39 (23%) 8/39 (21%) 22/39 (56%) 
N (n=26) - - - - 
Women with 
any HPV 54  
Yes (n=37) 0 13/37 (35%) 14/37 (38%) 10/37 (27%) 
No (n=40) - - - - 
Women with 
any HPV 61 
Yes (n=15) 0 0 7/15 (47%) 8/15 (53%) 
No (n=7) - - - - 
Women with 
any HPV 66 
Yes (n=37) 1/37 (3%) 10/37 (27%) 9/37 (24%) 17/37 (46%) 
No (n=32) - - - - 
Women with 
any HPV 69  
Yes (n=5) 0 1/5 (20%) 0 4/5 (80%) 
No (n=2) - - - - 
Women with 
any HPV 70  
Yes (n=11) 0 5/11 (45%) 1/11 (9%) 5/11 (45%) 
No (n=11)  - - - 
Women with 
any HPV 73  
Yes (n=14) 0 8/14 (57%) 2/14 (14%) 4/14 (29%) 
No (n=18) - - - - 
Women with 
any HPV 82  
Yes (n=18) 2/18 (11%) 5/18 (28%) 4/18 (22%) 7/18 (39%) 
No (n=20) - - - - 
 
 
1-Orange colour used to highlight HR-HPV genotypes; 2-Sky-blue colour used to indicate LR-HPV genotypes.  
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Table 4.12: Pattern of HPV concordance by means of anatomical sites among females in 
Ibadan, Nigeria (n=310) 
HPV Classification Anatomic sites Frequency 
 
Percentage 
Any HPV    
 Cervical, vulvar, anal and oral sites 31/310  10.0 
   
Any HR-HPV    
 Cervical, vulvar, anal and oral sites 19/310  6.1 
Cervical, vulvar and anal sites 90/310  29.0 
Cervical and vulvar sites 116/309 37.5 
Cervical and anal sites 92/310  29.7 
Cervical and oral sites 26/310  8.4 
Oral and anal sites 21/309  6.8 
Oral and vulvar sites 24/310  7.7 
Anal and vulvar sites 104/310  33.5 
Any LR-HPV    
 Cervical, vulvar, anal and oral sites 16/310  5.2 
Cervical, vulvar and anal sites 97/310  31.3 
Cervical and vulvar sites 123/305 40.3 
Cervical and anal sites 95/310  30.6 
Cervical and oral sites 16/310 5.2 
Oral and anal sites 19/309  6.1 
Oral and vulvar sites 16/310  5.2 
Anal and vulvar sites 95/310  30.6 
 
4.3.5. Factors associated with oral sexual behaviour 
Table 4.13 presents results of the factors associated with oral sexual behaviours among 
females in the community. For level 1, the unadjusted analyses showed that study sites, age 
group, highest level of education, ownership of a television and current marital status were 
associated with reported oral sex; however, after adjusting for possible confounders, none of 
the level 1 factors was found to be associated with oral sex. 
 
For Level 2 (Table 4.13), the unadjusted analyses showed that a history of ever having had 
transactional sex, the presence of female genital mutilation, ever drank alcohol and ever 
having taken illicit drugs were associated with reported oral sex. After adjusting for possible 
confounders, women with history of transactional sex (p=0.012), female genital mutilation 
(p=0.019), drinking alcohol (p=0.009) and illicit drug use (p=0.002) were associated with 
previous report of oral sex. 
women who reported ever having had touched each other’s genital area by hand with their 
sexual partner (‘mutual masturbation’) had 15.5 times the odds (95% CI 2.04-118.3) of 
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reported oral sex; women who reported having ever used illicit drugs (adjusted OR=3.74; 95% 
CI 1.30-10.76) and those that had female genital mutilation (aOR=2.22; 95% CI 1.07-4.61) had 
higher odds of reported oral sex compared to who those who did not. 
 
Table 4.13 –Factors associated with previous report of any oral sex among sexually active women 
from the general population in two communities in Ibadan, Nigeria (N=310) 
Variable n/N(%) p-value1 
Crude OR (95%CI) 
p-value2 
Adjusted OR (95%CI)3 
SOCIO-DEMOGRPAHICS (Level 1)    
Study site 



















































Highest education level 
None and primary  
Secondary 













































Income per month6 
No income 
1 - 10,000N (1-28USD) 
10,001 - 20,000N (>28 – 56USD) 








































Current marital status 
Single7  
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Divorced/Widowed/Separated7 2/16 (13%) 0.44(0.09-2.12) 0.45(0.09-2.34) 
BEHAVIOURAL FACTORS (Level 2) n/N(row) Crude OR (95%CI) Adjusted OR (95%CI)8 




























































































This study reported for the first time the prevalence of HPV infections in four anatomical sites 
of the cervical, vulvar oral and anal sites at the same time among sexually active women living 
in peri-urban and urban settings in West Africa. Generally, the prevalence of any HPV, any 
IARC Class 1, Class 2A, Class 2B and Class 3, any HR and any LR -HPV infections was highest in 
the vulva, followed by the cervical or anal and oral sites. In addition, multiple HPV genotype 
infections (≥two HPV types) were most prevalent in the vulvar, followed by the anal, cervix 
and oral sites. The age specific prevalence pattern of any HPV, any Class 1, Class 2A, Class 2B 
and Class 3, any HR-HPV and any LR-HPV infections exhibited an inverse relationship; the 
1- p-values were obtained from Wald tests; 2 – p values were obtained from Likelihood Ratio tests; 3- Level 1 factors were adjusted for 
age and study site; 4- LGA – Local government area; 5– Student, apprentice and no job; 6–N – Naira- currency of Nigeria; USD –United 
States Dollar; 7– Living alone;  8- Level 2 factors were adjusted for age and study site (core variables from Level 1) and ever had 
transactional sex, alcohol, illicit drug use and female genital mutation; 9- Participants that had other sexual partner(s) apart from her 
main sexual partner (12 participants gave no response and they were treated as missing); 10- Illicit drugs are banned substances or 
drugs taken by participants for non-medical reasons in Nigeria; 11- Awareness of HPV was defined as ever heard of the infection called 
human papillomavirus infection (Yes or No); Ever engaged in mutual masturbation and smoking were dropped from the model because 
of few observations. 
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highest reported prevalences were among adolescents and young females aged 18-24 years 
in the four anatomical sites compared with older females  Multiple HPV infections in the 
cervical, vulvar and anal samples also had an inverse relationship with age, with the highest 
prevalence in adolescents and young adults, but the prevalence of oral HPV infection 
increases with age group with the  highest among women aged 35-45 years.  The most 
common HR-HPV genotypes were HPV-35 in the cervix and vulva, HPV-52 in the anal cavity 
and HPV-51 in the oral sites.  In the four anatomical sites, the most common LR-HPV 
genotypes was HPV-42. The proportion of concordant HPV specific genotypes across the four 
anatomical sites was low, although the concordance rate increased when examined by three 
or two anatomic sites. The concordance proportion of any HR and any LR genotype was 
highest in the cervix and vulva. The most prevalent concordant specific HR-HPV genotypes 
were HPVs-16 and 18, whereas the low-risk types were HPVs-42 and 6. 
 
We observed almost double the prevalence of any HPV, HR and LR-HPV cervical infections in 
this study compared with previous studies in Nigeria. However, the pattern of age-specific 
prevalences were similar [162, 163, 381]. For example, a community survey two decades ago 
(1999-2000) among 932 women aged 15 years and above in Idikan, Ibadan, southwest 
Nigeria,  found prevalences of 26.3% for any HPV infection, 18.3% for any HR-HPV and 6.5% 
for any LR cervical HPV infections among the study population [381]. In 2012, another study 
conducted in Abuja, central Nigeria among 278 women who were 18 years and above, 
reported a prevalence of any HPV genotype of 37.0% and any HR genotype of 22.0% in their 
cervical samples [163]. The relatively high prevalence of cervical HPV infection in the present 
study may possibly be due to changing sexual behaviours across different generations, and 
furthermore, that the prevalence appears to be increasing with time. Watson-Jones et al. 
(2013), also established an unusually high prevalence (74.0%) of HPV infection among 334 
sexually active female adolescents and young adults (10-25 years) in Mwanza, Tanzania [398].  
Worldwide, the prevalence of cervical HPV in the general population is known to be high 
during the sexual debut and early adulthood stage and declines with age reaching a plateau 
by 40 years [7]. However, in Africa, Asia and Oceanian populations, there is typically a second 
peak of prevalence of cervical HPV infection in women aged 50 years and above [7]. The 
present study did not observe the second peak for the reason that it did not include females 
above 45 years of age. 
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The prevalence of anal HPV infection was lower than the reported prevalence of 67.1% among 
173 women (18-69 years) in Brazil [125]. There is a paucity of data on the prevalence of anal 
HPV infections among women in the general population in SSA. The few studies that reported 
anal HPV infection were mostly on the key affected populations [74, 122].  A Zimbabwean 
study (2014-2015) among 88 HIV positive adult women (≥18years) reported the prevalence 
of any anal HPV infection of 60.3% [122]. In South Africa, one study compared the detection 
of anal HPV by GeneXpert and Hybrid capture 2 methods in a population of 200 HIV positive 
women 18 years and above. This particular study ascertained anal HPV detection of 40.8% 
and 41.8% with GeneXpert and Hybrid capture 2 techniques, respectively [74].  
 
The data on the prevalence of vulvar HPV infection among women in the general population 
are limited compared to other anogenital sites. Studies that reported on vulvar HPV infections 
were typically conducted among women that had vulvar lesions and were not representative 
of general population prevalence estimates of vulvar HPV infections [399, 400]. Of the three 
studies that presented data on the prevalence of any vulvar HPV infection two (from China 
and UK) were population studies, while a study from the US was a review of medical records 
[131-133]. The Chinese study reported the low vulvar HPV prevalence of 13.3% for any HPV 
and 12.8% for any HR-HPV in vulvar samples of 2,327 adult women (18-55%) in the community 
[133]. A study in the UK among 3829 women aged 25 years and below reported that 34.6% 
had any HR vulvar HPV infection [132]. The reported prevalences in these two particular 
studies were lower than reported in the present study at 51.1%, although the UK study did 
not report the prevalence of LR types and the Chinese study included older women. The high 
prevalence of vulvar HPV infection relative to other genital sites had been associated with the 
hypothesis of viral shedding from infection of contiguous anatomical structures such as the 
cervix and anus.  
 
The prevalence of any or HR oral HPV infections was lower than for the other three anatomical 
sites. Oral HPV infections including HR genotypes were higher in this study than some 
previous studies [26, 45]. Specifically, the prevalence of any HPV and HR-HPV infections were 
three times higher than the global averages presented in two different systematic reviews 
that involved 26 studies among females that were 18 years and above  in 2018 (any HPV -
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5.5%; HR-HPV-2.3%) and 21 studies in 2019 (any HPV-3.8%; HR-HPV-2.6%) among healthy 
adolescents and adult women [26, 45]. However, in 2016, a study in Austria reported a 
prevalence of 18.1% on oral HPV infection among 310 adolescent and adult females (18-20 
years), which was similar to the findings in this study [401].  
 
HPV-35 was the most common HR genotypes in the cervix and vulva, HPV-52 in the anal and 
HPV-51 in the oral sites.  HPV-42 was the most common LR genotypes in the cervix, vulva, 
anal and oral sites of our study population. Studies in Nigeria had also reported HPV35 and 
42 as the most prevalent for cervical HPV infection [163, 381]. Studies in South Africa, 
Zimbabwe and Tanzania among women found HPV 16 as the most prevalent HR-HPV in the 
cervix, oral and anal cavities [74, 122, 402-404]. HPV-16 and -18 that are more associated with 
persistence and the progression of asymptomatic HPV infection than other HR-HPV infections 
in the pathogenesis of HPV-associated cancers was relatively low in prevalence in this study 
[405]. The concordance rate of HPV-16 and -18 was the highest in the four anatomical sites. 
Detection of HPV-16 and -18 could imply a higher risk of detection of similar genotypes in 
other genital and oral sites. Although, HPV-16 and -18 are the two most common genotypes 
associated with cervical cancer globally, the burden of other HR-HPV types is crucial in 
deciding which HPV vaccine should be adopted, besides other factors like the cost and 
availability of the vaccine.   
 
Risk factors associated with HPV infection in the four anatomical sites differed; the number 
of lifetime partner for vaginal sex was a common risk factor for high odds of cervical, vulval  
and anal HPV infections while the age difference of six years and above between the 
participants and her first vaginal sex partner compared to those with five years or less was 
associated with lower odds of vulvar and anal HPV infections; the presence of concurrent 
cervical HPV infections was commonly associated with high odds  of HPV infections in oral, 
vulvar and anal sites; concurrent vulvar HPV infection was associated with high odds of HPV 
infections in the cervix and anal sites while concurrent anal HPV infection was associated with 
high odds of HPV infection in the cervix and vulvar. Cervical HPV infections was also associated 
with age group with lowest odds among the older age group (35-45 years) relative to the 
youngest age group (18-24 years).  Married women had a lower odds of having vulvar HPV 
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infections compared to participants that were single. Participants living in the rural/peri-
urban community had a lower odds of oral HPV infection compared to those living in urban 
areas.   
 
All the risk factors associated with cervical, vulvar, anal and oral HPV infection had been 
previously reported [45, 79, 116, 132, 133, 406]. However, there are a number of other risk 
factors that were previously reported for specific anatomical sites that were not found to be 
associated or not considered in the analyses in this study [106, 407]. A meta-analyses of risk 
factors associated with oral HPV infection in 2018 reported mixed findings on the association 
between oral sex and risk of oral HPV infection [45]; while specific studies documented a 
strong association between oral sex and oral HPV, other studies did not[45].  In our study, the 
prevalence of oral sex was 11.0% and associated risk factors included transactional sex, 
female genital mutilation, ever drank alcohol and use of illicit drugs. However, none of these 
practices, including oral sex, was determined to be associated with oral HPV infection. 
Concomitant cervical HPV infection appeared as a constant risk factor for oral, vulvar and anal 
HPV infection in this study. In 2019, a meta-analysis of pooled data involving 13,427 women 
with paired cervical and anal samples showed that cervical and anal HPV infections were 
highly correlated, particularly in HR-HPV genotype specific infections [408]. Concomitant HPV 
infection in oral and genital sites may be due to sexual behaviour, autoinoculation or viral 
shedding with deposition in secretions at another site subsequently being detected as 
infection in that site.  The latter may be particularly substantial regarding the concurrent 
detection of vulvar and cervical HPV infections. 
 
The odds ratio of an association between an explanatory variable and outcome is a good 
approximation of a risk ratio (RR) when the prevalence of the outcome is low (≤10%)[409, 
410]. However, when the prevalence of the outcome is high (>10%), the odds ratio is not a 
good approximate of the risk ratio, and this can lead to misinterpretation of results. As 
prevalence increases, the odds ratio becomes larger than the risk ratio; therefore, if the odds 
ratio is misinterpreted as the risk ratio, it will be overestimated. This may lead to confusing 
messages during dissemination of research findings. [409, 411]. In this study, the prevalence 
of cervical HPV infection was very high among sexually active women from the general 
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population in two communities in Ibadan, Nigeria. Table 4.14 shows that if the prevalence 
was low (6%), the OR would have approximated the RR. However, the prevalence of cervical 
HPV infection was 60% (Table 4.15) - the crude OR was 4.12, and the RR was 1.46 – this could 
be interpreted as women that gave history of ever taken illicit drugs had 4.12 times the odds 
of having cervical HPV infection compared to those without illicit drug history. However, the 
interpretation in form of relative risk will be, the risk of cervical HPV infection was 1.46 times 
more likely among women that gave a history of ever taken illicit drugs than those without 
illicit drug history.    
 
Table 4.14: If the HPV prevalence is 6% (N=305) 
Ever taken illicit drugs HPV  Total 
Positive Negative 
Positive 2 18 20 
Negative 16 269 285 
Total 18 287 305 
 
OR = 1.87 
RR = 1.78 
 
Table 4.15: If the HPV prevalence is 60% (N=305) 
Ever taken illicit drugs HPV  Total 
Positive Negative 
Positive 17 3 20 
Negative 165 120 285 
Total 182 123 305 
 
OR = 4.12 
RR = 1.46 
 
 
One solution would be to present a risk ratio or prevalence ratio when the prevalence of an 
outcome is high. This topic has received attention of researchers in more than a decade. There 
are four different approaches that has been suggested: two are regression-based methods 
that directly estimate relative risk (the log-binomial model or Poisson regression with robust 
standard error)[412]. The other two methods indirectly estimate relative risk from logistic 
regression by substitution and standardization by estimating the odds ratio.  However, these 
alternative methods have substantial drawbacks that will be presented below[410, 413].  
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In logistic regression, the model is constrained to estimate the predicted probabilities 
between zero and one. In a log binomial model, the log risk is always constrained to be less 
than or equal to zero because the risk is between zero and one[412]. However, when the log 
binomial model is used, it actually estimates log probabilities since the modelling is done on 
log scale. This will lead to a problem of failed convergence if the model produces probabilities 
that are not within the permitted range. For example, log binominal often has problem of 
failed convergence when the data is sparse.  The Poisson regression model is one of the 
methods used to bypass the problem of data convergence in the log binomial model is used 
to estimate a risk ratio [410, 412, 413]. Poisson regression involves the log of expected counts 
and not the log of the probabilities, and it is therefore not constrained to be negative.  
However, when the data is dispersed or skewed, it usually leads to estimation of unrealistic 
risks ratio that may be greater than one[412]. The two logistic regression techniques for 
indirectly obtaining risk ratios from odds ratios generally produce biased estimates and 
narrowed confidence intervals when substitution method is used while the marginal or 
conditional standardization methods involves complex steps that may be difficult to 
interpret[412].  
 
While it is difficult to interpret, statistically, the odds ratio from logistic regression is a robust 
and valid effect estimate in a cross-sectional study even when the outcome is common. As 
stated, the issue is the correct interpretation of odds ratios provided that the results are 
interpreted in terms of the odds instead of reporting it as a risk[409].  
 
There are several potential limitations in this study. First, this study was unable to report on 
the prevalence of adults older than 45 years which is the period when the second peak 
prevalence of HPV infections is frequently reported. Second, the exclusion of sexually naïve 
females could also have accounted for the high prevalence of HPV. Third, the cross-sectional 
design of the study makes investigation of risk factors for persistence and the clearance of 
HPV infections impossible. The small observations of particular important explanatory 
variables did not allow for robust test of association. For example, only one participant 
reported anal sex. Hence, this practice could not be explored as a potential risk factor of anal 
HPV infection. The small sample size meant that it was not possible to test for association 
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between different types of oral sex (given or received) and oral HPV infection. The risk of oral 
HPV has been reported to be higher in individuals that received oral sex compared to those 
that give oral sex [45, 414] .  
 
Another source of limitation is the possibility of selection bias, which could compromise the 
generalisability of the research findings. The original design of the household survey was to 
select four EAs with probability proportionate to size in each of the two LGAs. After this, house 
listing would be conducted that involves a census of women (18 to 45 years) residing within 
the selected EAs.  A fixed number of individuals (18-45 years) ought to be selected by simple 
random sampling from a compiled list of adolescents and young adults (18-25 years) and 
adults (26-45 years) in each of the selected EAs. However, after the house listing, there was 
an error. The population of individuals listed from the selected EAs in each LGA were added 
together and stratified into 18-25 years and 26-45 years, to serve as the sampling frame. This 
unfortunately makes it impossible to weight the data and to calculate population level 
estimates for the results of the community survey among the women in the general 
population. 
 
In conclusion, this study provides a robust estimate of cervical, vulvar, anal and oral HPV 
prevalence among sexually active females in the general population in Nigeria and 
demonstrates how prevalent genital HPV infection is in these women. The risk factors for 
specific HPV infection of different anatomical sites were similar to findings in previous studies. 
Although HPV infection is transient, the relatively high HPV infection in all anatomical sites 
relative to previous studies may possibly be due to the changing sexual behaviour and 
increasing sexual risk practices in the general population, in addition to the study design and 
the characteristics of study population. The detection of HPV-35 -52 and -51 as the most 
prevalent HR-HPV types in the genital (cervix and vulva), anal and oral sites, respectively, may 
suggest the need to consider its coverage as regards the choice of HPV vaccine coverage in 
Nigeria. However, further studies are required including the design of longitudinal studies 
that will investigate the persistence of different HR-HPV infections to help policy makers make 
informed decisions with respect to the evidence-based prevention and management of HPV 
infection and associated cancers in the country. 
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CHAPTER 5: EPIDEMIOLOGY OF ORO-GENITAL AND ANAL HUMAN 
PAPILLOMAVIRUS INFECTIONS AMONG BROTHEL-BASED FEMALE SEX 




Evidence from the literature suggests that FSWs are more vulnerable to STIs than women in 
the general population due to behavioural, biological and structural risk factors [415, 416]. 
Worldwide, FSWs are known to engage in sexual risk behaviours including oral and anal sex 
[415, 417]. In addition, FSWs are occupationally exposed to multiple STIs which potentially 
increase their risk of acquiring or transmitting new STIs to clients [371, 415, 416]. Risk factors 
such as legal restriction, stigmatisation, poor organisational protection for commercial sex 
work and financial incentive for condomless sex with partners worsen their chances of 
engaging in safe sex [415, 416, 418].  
 
In SSA, FSWs engage in a variety of sexual risk behaviours with both their paying and non-
paying clients. According to the systematic review in Chapter 2 of this thesis, 0.3-24.1% of 
FSWs in Rwanda, Kenya and South Africa had engaged in oral sex, and 2.3-42.8% of FSWs in 
Rwanda, Cameroun, Kenya, South Africa and Uganda had received anal sex from clients. No 
studies from Nigeria were identified in this review. In 2019, a meta-analysis of 131 studies 
involving 74,426 FSWs worldwide reported that anal intercourse prevalence ranged between 
0.0 to 84.0% and a pooled estimate for reporting ever practiced anal sex of 15.7% (95% CI, 
12.2-19.3) [417]. The review also found a high proportion of condomless anal (46.1%) and 
vaginal (31.6%) sex among FSWs[417]. Findings from the SHINI qualitative study presented in 
Chapter 3 of this thesis showed that FSWs participants in the study understood the meaning 
of oral and anal sexual behaviours and majority of them engaged in both sexual behaviours. 
Condom use during vaginal sex among FSWs ranged between 20.0-25.0% with the lowest 
consistent use among brothel-based sex workers [419, 420].  Studies from different localities 
in Nigeria showed that FSWs had poor negotiation skills for condom use and this lack of skill 
make them vulnerable to STIs including HPV infections [419-423].  
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Despite reports of sexual risk behaviours and high-risk of STIs amongst Nigerian FSWs [419, 
424], no studies have investigated the association between HPV infections and sexual 
behaviours in this population. It is important to investigate the burden of HPV infection 
among FSWs in order to understand the epidemiology of HPV, associated risk factors and 
potential public health implications for FSW and the community. In addition to Nigeria, there 
is paucity of data on the prevalence of oral, anal and vulvar HPV among FSWs in the other 
countries in the West African sub-region. In this chapter, the prevalence of genital (cervical 
and vulvar), oral and anal HPV infections among brothel-based FSWs will be described, as well 
as the prevalence of oral and anal sexual behaviours and their association with the prevalence 
of HPV at these anatomic sites. 
 
5.2. METHODS 
5.2.1. Study design 
This cross-sectional survey was conducted among brothel-based FSWs as part of the SHINI 
study in Ibadan. The study involved advocacy, mapping and selection of brothels, sampling of 
FSWs and enrolment for study participation. 
 
5.2.2. Study setting 
This aspect of SHINI study was conducted at different brothel locations in Ibadan. The detailed 
description of administrative and geographical setting of Ibadan city in Oyo state and Nigeria 
has been described in Chapter one in this thesis. The brothel survey was conducted in six LGAs 
in Ibadan: Ibadan North, Northwest, Northeast, Southwest, and Southeast, and Akinyele. 
Ibadan has high number of brothels compared to other cities in Oyo State. A typical brothel 
in this part of Nigeria comprises of a building that has rooms occupied by FSWs and also a bar, 
television-viewing room, dancing room or club. Each brothel has three key officials that 
constitute a brothel management team: the managing director or director is the owner of the 
brothel, the manager who coordinates daily activities at the brothel, and a chairlady – the 
liaison or leader of FSWs. Most FSWs offer a 24-hour service in the brothels; however, the 
peak working time is at night, weekends, and on public holiday or during festive periods.  
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5.2.3. Study population 
For this study, eligible FSWs were women aged 18 to 45 years, living in a brothel and offering 
sex in exchange for money or goods [425]. The survey excluded female visitors to the brothel, 
and FSW that declined to consent or who were pregnant. 
5.2.4. Sample size determination 
The primary outcomes for this cross-sectional study were the prevalences of genital, oral, and 
anal HPV infections.  Studies of HPV prevalence in Nigeria reported a genital HPV infection 
prevalence of 10-50% in the female population [163, 381]. Data on oral and anal HPV from 
Nigeria are lacking; the range of the global prevalence estimates was 3 – 6% [388]. A study in 
Kenyan FSWs reported a prevalence of genital HPV infection of 56% [426]; estimates of anal 
and oral HPV infection prevalence in FSWs from Europe are 15% and 7%, respectively [427].  
The initial assumption was to sample 120 brothels of 3 FSWs per brothel or 60 brothels of 6 
FSWs per brothel from the six LGAs to be able to sample 300 FSWs (i.e. 80% of the total 
population). The anticipated refusal rate was 2 to 5%. Assuming an alpha of 0.05 and a design 
effect of 2 owing to the clustered sampling design, a sample size of 300 would be able to 
estimate a prevalence of 3% with a precision of ± 2.7%.  A prevalence of 20% could be 
estimated with a precision of ± 6.4% and that of 50% with a precision of ± 8.0%.  
 
5.2.6. Study procedures 
The summary of the study procedures is shown in figure 5.1. 
Training of field staff and advocacy visits 
After the recruitment of the field workers, a two-week didactic training including practical 
sessions were conducted. The training covered an online course on good clinical practice, 
lectures on clinical research, principles of research ethics, informed consent, and SHINI study 
procedures. There were sessions on the practical demonstration of face-to-face interview 
with the SHINI study case report forms. In addition, another one-week training was conducted 
for the research nurses and this covered how to take a clinical history and examination of the 
abdomen and pelvis. The clinical training also covered sample collection and syndromic 
management of STIs using the Nigerian protocol.   
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After the trainings, the research team including the project manager, female research 
assistants and two gatekeepers experienced on brothel related public health programme held 
the formal advocacy meetings with the administrative leadership of the six LGAs, the 
leadership of the Society Family Health office in Oyo State (http://www.sfhnigeria.org), the 
state officials of the association of brothel owners and the management team of each 
selected brothel. Specifically, the SHINI research team discussed the objectives of the study 
and sought permission to conduct the study from the leadership of the LGAs and brothel 
owners. These advocacy meetings were led by the project manager and supported by a 
female supervisor. During the advocacy visit to the SFH office, SHINI team discussed about 
the existing list of brothels in Ibadan, which the organisation shared with the research team.  
The list had the name, address and some had the number of FSWs per brothel. 
 
Mapping and selection of brothels 
After the advocacy meetings, the project manager, two female members of the SHINI 
research team (a supervisor and a research assistant) and two gatekeepers met to review the 
list of brothels from the six LGAs provided by the SFH team. The review included the current 
operational state of each brothel (functioning or closed), the number of FSWs in each brothel 
and their location/address. The list of brothels was also reviewed with an Assistant Director 
in charge of Reproductive Health programme in the Ministry of Health, Oyo State, to ascertain 
that all brothels were covered. 
 
After the review meetings, the research team comprising of a female research assistant and 
two gatekeepers conducted the mapping of brothels to confirm the list provided by SFH. This 
involves a visit to brothel with a checklist to confirm the name of the brothel, address, number 
of resident FSWs, availability of a room to the study, and safety of the area around the 
brothels, and to also identify newly established brothels in the locality (Annex 5.1: List of 
mapped brothels with number of selected participants). A second round of visit to individual 
brothel was conducted by two female research assistants to make a final arrangement and 
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Sampling of study participants in the brothel 
The 28 listed brothels were individually assigned a brothel identification number. Since the 
total number of the brothels and FSWs was less than the projected estimates, a modified 
sampling strategy was used to achieve the minimum required sample size. We sampled all 
FSWs in any brothel that had 10 or less resident sex workers. However, brothels that had 11 
or more resident FSWs, 90% of the FSWs were selected by a simple random sampling (Annex 
5.1: List of mapped brothels with number of selected participants). 
 
Participant enrolment 
An enrolment visit calendar was developed based on agreed dates with the management and 
participants at each brothel. During the enrolment visit, the female research assistant 
explained the objectives of the study to selected potential participants as a group in a 
prepared meeting room that accommodated everyone.  After the short meeting, all FSWs that 
were present at the meeting were also given a copy of information leaflets to read (Annex 
4.2: Information leaflet). Potential participants that indicated interest in the study had 
further discussion with a female research assistant in their individual room after ensuring 
there were eligible.  
 
After the discussion, potential participant that indicated interest to participate in the study 
was asked to sign a written informed consent or witnessed consent (if illiterate). The consent 
covered understanding the research objective, participation including samples collection and 
HIV counselling and testing, storage of samples for future studies, and dissemination of the 
results. A witnessed consent was obtained for participants that were not literate. The 
research assistant explained the study in the presence of a literate third party chosen by the 
prospective participant. After the participant agreed to participate, the witness signed and 
dated the consent form.  Potential participants that could not write placed a witnessed thumb 
print over the signature section of the consent form.  
FSWs that declined or who were not seen at the brothel after two visits in a week by the 








Interview, clinical examination, sample collection and follow-up 
The female research assistants and nurses conducted the research at the selected brothels. 
The research team was supported by the project manager (IMB) and a gatekeeper. 
Consenting participants had a face-to-face interview, clinical examination, sample collection 
and follow-up. All the activities took place inside the bed-room of the individual participant 
with their consent. 
 
Face to face interview 
The interview was conducted by a female research assistant. The interview covered 
information on socio-demographics, sexual behaviours (including oral and anal sex) and 
hygiene practices, intravaginal practices, alcohol, smoking/stimulant use, history of sex work 
and current symptoms of STI/HIV (Annex 4.3: Female Case Report Form and annex 5.2: 
additional questions for FSW). Information on history of HPV vaccination was not collected 
from the participants because the vaccine has not been introduced as part of routine 
immunisation and it is not universally available in Nigeria. However, information on the 
awareness of HPV vaccination was collected. Participants were asked questions about 
different sexual behaviours and each of these behaviours were clearly defined.  The interview 
was conducted in English or pidgin English. The research nurse always took the medical 
history aspect of the interview after the research assistant had concluded her own interview. 
 
Figure 5.1: summary of the study procedure in the community 
	
219 | P a g e  
 
Rapid HIV counselling and testing 
After a face-to-face interview, a female nurse obtained consent for HIV counselling and 
testing with “opt-out” for individual participants if they did not wish to know their HIV status. 
5 ml venous blood was drawn into a sample bottle for serial rapid diagnostic HIV tests (RDT). 
The RDT involves testing of sample blood with Alere DetermineTM  HIV-1/2 (Alere Medical Co. 
Ltd, Matsudo-shi, Chiba-ken, Japan). Participants found to be positive in relation to the 
Determine RDT kit had a further HIV test with Uni-GoldTM HIV-1/2 (Trinity Biotech 
Manufacturing Ltd; Ireland) RDT. Discordant results between Determine and Uni-Gold RDT 
were further tested with HIV 1/2 Stat-pak® (Chembio Diagnostic System, Inc. Medford, New 
York, USA) as a “tie-breaker” test to determine the final result.  
This testing algorithm followed the National Guidelines for HIV Prevention Treatment and 
Care, Federal Ministry of Health, Nigeria[173, 391].  An anonymous RDT was performed on 
participants that declined to know their HIV result. They were not given their results (Annex 
4.2: RDT HIV serial testing). 
 
Clinical examination and sample collection  
One female research nurse took the medical history and conducted clinical examinations and 
collected samples from specified anatomic sites (oral cavity, anal cavity, cervix and vulva).  
Two samples each were collected from the oral cavity, cervix, vulvar and anal cavities of each 
female participant. A set of four samples collected was shipped to ICO, Spain for HPV DNA 
analysis, while the other set of four samples was stored in a freezer as a back-up in Nigeria. 
The nurse conducted a clinical examination by inspection before samples were collected.  
 
An oral sample was collected using a 30 second oral rinse and gargle method with 10mls of 
Scope mouth wash (Procter & Gamble©). A nurse demonstrated the rinse and gargle 
procedure for individual participant to watch. The participant sample was collected into a 
10ml labelled sample bottle and placed immediately into a cold box filled with ice-packs. To 
collect the vulvar sample, the labia were exposed with the participant in a dorsal position with 
legs apart. The tip of a Dacron swab was used to rub the introitus on either side of the vaginal 
orifice without touching the urethral orifice. The cervical sample was then collected by 
inserting a sterile Cusco speculum into the vagina to expose the cervix. The tip of a new 
Dacron swab was inserted into the cervical os and gently rotated 360 degrees to avoid trauma 
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to the cervix and potential bleeding before removing it. An anal sample was collected with 
the participant in a left lateral position. A Dacron swab was inserted into the anal canal (about 
5-6 cm beyond the anal verge) and rotated 360 degrees with gentle pressure around the anal 
verge before removing it. Each of the samples collected with swabs were placed in separate 
2 ml cryotubes that were labelled and barcoded prior to being placed into a cold box filled 
with ice-pack. Samples stored in the cold box filled with ice-packs were transported every four 
hours to the SHINI study laboratory at the University College Hospital, Ibadan and 
immediately stored in a -800C freezer. 
 
Follow-up care and visit at the clinic  
Participants with symptoms and signs of STIs were offered free syndromic STI management 
and counselled for partner notification and treatment[390]. The HIV rapid test results were 
given to participants, and a research nurse offered post-test counselling irrespective of 
outcome. Participants with positive rapid HIV test results were referred and linked to a free 
service specialist clinic for further counselling, repeat test and treatment based on the 
Nigerian national HIV protocol [391].  Participants that had other medical complaints were 
referred to a hospital of their choice. Each participant was given health related incentives 
such as a bar of medicated soap, toothbrush and paste, and also, a toilet tissue paper, two 
packs of condoms and also a soft drink and biscuit as refreshments. 
 
5.2.7. Laboratory procedures 
Sample transport and storage 
All samples collected at the clinics were labelled with unique laboratory identification number 
barcodes to anonymise participants’ information. Samples collected were transferred in cold 
boxes at 2-8 0C to the SHINI laboratory at the University College Hospital, Ibadan for daily 
sorting and storage in a -800C freezer. After the field work was completed, samples were 
shipped on dry-ice to the ICO, Barcelona, Spain. The back-up samples were stored at a 
temperature of -80oC in the freezer of the PI (IMB) in Nigeria. 
 
HPV DNA Sample analysis 
HPV genotyping of all samples were performed at the ICO, Spain.   HPV genotyping was 
performed using the Anyplex™ II HPV28 Seegene assay (Seegene, Seoul, South Korea), a 
validated PCR-based quantitative technique for the detection and genotyping of 28 HPV 
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types.  Anyplex™ II HPV28 detection test distinguishes 28 HPV genotypes, including HR-HPV 
(HPV -16, -18, -31, -33, -35, -39, -45, -51, -52, -56, -58, -59 and -68), LR-HPV (HPVs -6, -11, -40, 
-42, -43, -44, -53, -54 and -70) and possibly carcinogenic genotypes (HPV-26, -61, -66, -69, -73 
and -82).  The details of sample handling, DNA extraction and HPV genotyping with Anyplex™ 
II HPV28 protocol has been described in detail in the Methods of Chapter 4.  
 
5.2.8. Data management 
Data collected from the field were received daily at the SHINI research office for quality checks 
and stored in a locked metal cabinet. Each brothel and individual participant were assigned 
unique four-digit numbers to maintain privacy and confidentiality. The unique code was 
written on all the pages of the case report and laboratory samples forms, reports and 
administrative reports/forms. The brothel enrolment register that contains personal 
identifiers (name and address) was locked in a cabinet inside the principal investigator’s office 
to prevent unauthorised access. The log files with participant’s name and brothel address did 
not have participant’s identification number. The log files were stored in a separate locked 
cabinet from other data collection forms.  Electronic data were password protected with strict 
access to staff members involved in data management. 
 
The case report forms data were double entered into the REDCAp software (Vanderbilt 
University, Nashville Tennessee, USA)[394-396] that was hosted on the website of the College 
of Medicine, University of Ibadan by two trained data entry clerks. After resolving the 
inconsistences observed by the data manager, the raw data were exported in CSV format and 
saved. The exported data were imported into STATA 16.0 software for analysis (Stata 2019. 
Statistical Software: Release 16. College Station, TX: StataCorp LLC). Visual checks were 
performed by IMB and the data manager. Thereafter, frequencies of all variables were 
generated to check for any error or missingness or implausible responses. Data cleaning was 
performed by IMB and descriptive tables were generated to further check for any incomplete 
responses and missing observations.  
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5.2.9. Statistical Analyses 
Participants’ socio-demographic information, sexual behaviour factors, social habits, 
information on sex work and clinical factors were summarised with frequencies and 
proportions for the categorical variables, and means and standard deviations for the 
continuous variables (Tables 5.1, 5.2, 5.3 and 5.4).  The missing variables were reported in the 
descriptive analyses but were dropped in the test of associations and multivariable models. 
 
5.2.9.1. Outcome variables 
The primary outcome of this study was the prevalence of any HPV infection. The prevalence 
of HR and LR HPV infection, and according to the 2009 IARC epidemiological oncogenic 
classification (groups 1, 2a, 2b and 3) for each of the anatomic sites were also calculated with 
their 95% confidence intervals. Associations between individual classification of HPV and the 
age group of participants were tested using the one-way ANOVA. Bartlett’s test was 
performed to test whether there were equal variances on variables before conducting a one-
way ANOVA. The secondary outcomes were the prevalence of different sexual behaviours, 
but the risk factor analysis was performed on oral sex alone because there were few 
participants that reported anal sex.  
 
5.2.9.2. Risk factor analysis for HPV Infections 
The risk factor analysis for any HPV infection was based on the conceptual framework (Figure 
5.2) that was from the review of literature to answer the specific objectives that were set out 
for this study. The conceptual framework guided the analysis using hierarchical statistical 
modelling. 























Occupation aside sex 
work 
Monthly income 
Current marital status 
SEX WORK RELATED FACTORS 
Age initiated to sex work (year) 
Duration in the sex work business (year) 
SEXUAL BEHAVIOUR CHARACTERISTICS 
Age at 1st vaginal sex (year) 
Age difference between 1st vagina sex 
partner and participant (year) 
No of vaginal sex partners/three 
months 
Ever gave oral sex (Yes/No); Ever 
received oral sex (Yes/No) 
Ever cleansed inside vaginal (Yes/No) 
Mutual masturbation (Yes/No) 
CULTURE/SOCIAL FACTORS 
Female genital mutilation (Yes/No) 
Ever drank alcohol (Yes/No) 
Ever smoked cigarette (Yes/No) 
Ever taken Illicit drugs OTHER RELATED FACTORS 
Ever had sexually transmitted infection 
Ever heard of human papillomavirus 
USE OF BARRIER METHODS  
Condom use during the last vaginal 
sexual act (Yes/No) 
RAPID HIV final test result 
 [Positive/Negative] 
HPV INFECTION AT OTHER 
ANATOMIC SITES APART 
FROM OUTCOME MEASURE 
(Yes/No) 
HPV BY ANATOMIC SITES 
1) Any Cervical HPV 
2) Any Vulva HPV 
3) Any Anal HPV 
4) Any Oral HPV 
UNDERLYING DETERMINANT  
(LEVEL 1 FACTORS) 
PROXIMATE DETERMINANT  
(LEVEL 2 FACTORS) 
BIOLOGICAL DETERMINANT 
(LEVEL 3 FACTORS) 
OUTCOME MEASURE 
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The association with any HPV infection was explored to determine independent risk factors 
for infection. The detection of any HPV infection was treated as a binary outcome; each 
anatomic site – cervical, vulvar, anal and oral - was analysed separately.  Logistic regression 
was used to obtain unadjusted estimates for the association between any HPV infection and 
potential risk factors, with a conceptual framework approach of three level factors: 
sociodemographic (level 1), behavioural (level 2)  and biological factors (level 3)[397].  Age 
was included in the adjusted estimates a priori. Level 1 sociodemographic variables included 
ethnicity, religion, highest educational level, ever had Quranic education, current occupation 
(other occupation apart from sex work), monthly income (total income that participant make 
in a month) and current marital status. Each variable was added one by one to a model that 
included age. P-values were obtained by likelihood ratio tests. Any variable that met a p value 
cut off of ≤ 0.1 was included in the adjusted model. All level 1 variables were adjusted.  
 
Level 2 behavioural variables included age at first vaginal sex, age difference between first 
vaginal sex partner and the participant, number of vaginal sex partners in the past three 
months, condom use during last vaginal sex, ever gave oral sex, ever received oral sex, age 
initiated to sex work business, Duration of years in sex work business, ever experienced 
mutual masturbation, history of female genital mutilation, alcohol use, illicit drug use, ever 
diagnosed with a sexually transmitted infection and ever heard of the infection called human 
papillomavirus. The variable measuring ever having cleansed inside the vagina was not 
included in the regression model because there were no observations. Each level 2 variable 
was added one by one to a model that included level 1 variables meeting a p value cut off of 
≤ 0.1 after adjusting ‘core variables’. Any level 2 variable that met a p value cut off of ≤ 0.1 
was included with the level 1 core variables in the level 2 adjusted model.  
 
Biological (level 3) variables were RDT final result and laboratory detection of concomitant 
HPV infection from the other three anatomic sites apart from the outcome measure. For 
example, if the outcome measure was to determine risk factor for any vulvar HPV, 
concomitant HPV detection in cervical, anal and oral sites were included as explanatory 
variables. Each level 3 variable was added one by one to a model that included level 1 ‘core 
variables’ and level 2 factors that met likelihood ratio p value cut off of ≤ 0.1. This strategy 
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allowed the effects of variables at each level of the framework to be assessed, adjusted for 
more distal variables. 
 
The concordance of HPV between anatomic sites (oral, cervical, vulvar and anal samples) in 
individual study participants was defined as the presence of the same type of virus across the 
four sites. The proportion of concordance for specific HPV type was calculated as the number 
of each HPV type in all the four sites, any of three and any of two anatomical sites. In addition, 
the concordance of specific HPV genotype was calculated for each of the anatomical sites and 
the concordance between ano-genital sites only, cervix and vulva only, cervix and anal sites 
only, cervix and oral sites only, vulva and anal sites only, oral and anal sites, as well as oral 
and vulva sites only. 
 
5.2.9.3. Risk factor analysis for oral sexual behaviour 
The conceptual framework in figure 5.3 was developed to investigate the association of 
selected individual and behavioural factors as potential risk factors for oral sex among the 
FSWs. This conceptual framework was based on an assumption that report of oral sexual 
practice (given or received) by a FSW with a male sexual partner could be influenced by both 
her individual and proximate factors. The conceptual framework guided the statistical 
modelling. 
 




Figure 5.3: Conceptual Framework of the risk factor analysis for oral sex among female sex workers 
Sociodemographic factors 
Age group  
Ethnicity 
Religion 
Highest formal education 
Quranic education (Y/N) 
Other occupation 
Monthly income 
Current marital status 
Own media related materials – TV 
or Radio 
Sex work related factors 
Age initiated to sex work 
Duration in sex work business 
Other related practices 
Previous mutual masturbation (Y/N) 
Female genital mutilation (Y/N) 
Social factors 
Ever drank alcohol (Y/N) 
Ever smoked cigarette (Y/N) 
Ever abuse substance (Y/N) 
Access to Information  
Previous HIV test (counselling) 
Ever heard of Human papillomavirus 
Prevalence of oral sex  
1 - Ever gave oral sex 
 
2 - Ever received oral sex 
OUTCOME MEASURE PROXIMATE FACTORS (LEVEL 2) DISTAL FACTORS (LEVEL 1) 
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The proportion of the brothel-based FSWs that ever gave and received oral sex were treated 
as a separate binary outcome measures for this analysis. Separate logistic regression models 
were used to obtain crude estimates for the association between each category of oral sexual 
behaviour (giving and receiving) and potential risk factors. Adjusted estimates were obtained 
for each category of oral sexual behaviour using a hierarchical approach. Age was included in 
the adjusted estimates a priori.  Level 1 sociodemographic variables included ethnicity, 
religion, highest educational level, other occupation apart from sex work, ever had quranic 
education, monthly income, owned a television and radio, and current marital status. Each 
variable was added one by one to a model that included age. P-values were obtained by 
likelihood ratio tests. Any variable that met a p value cut off of ≤ 0.1 was included in the 
adjusted model.  
 
All level 1 variables were adjusted and shown in Table 5.15 and 5.16 for giving and receiving 
oral sex, respectively. Level 2 behavioural variables included the age that the participant was 
initiated to sex work, duration in sex work business, ever had mutual masturbation, history 
of female genital mutilation, alcohol use, illicit drug use, awareness of human papillomavirus 
and ever having been tested for HIV. Each level 2 variable was added one by one to a model 
that included level 1 variables meeting a p value cut off of ≤ 0.1 after adjusting (‘core 
variables’). Any level 2 variable that met a p value cut off of ≤ 0.1 was included with the level 
1 core variables in the level 2 adjusted model. All level 2 variables were adjusted and shown 
in Tables 5.12 and 5.13. 
 
 
5.2.5. Ethical considerations 
Ethical approvals were obtained from three ethics committees including the London School 
of Hygiene and Tropical Medicine, London (LSHTM 9736-3), the University of Ibadan/the 
University College Hospital, Ibadan (UI/EC/16/005), and the Oyo State Government 
(AD13/479/712) (Annex 3.5. Ethical approvals). The consent also covered transportation of 
biological samples for analysis at ICO Spain. 
The research team maintained a high ethical standard including confidentiality at every stage 
of the study procedure.  
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5.3. RESULTS 
5.3.1. Descriptive results of study participants  
Out of the 31 brothels listed in six local governments of Ibadan city, two had stopped 
operating before the study commenced and the management of one of the selected brothels 
declined participation. Three hundred and forty-four eligible FSWs were listed from the 
remaining 28 brothels. Of those listed, 319 (93%) FSWs were randomly selected proportional 
to the brothel size and invited to participate in the study. Three hundred and fifteen FSWs 
























Figure 5.4 Brothel-based female sex workers enrolment flow for the survey 
 
 
31 brothels in 6 local 
government area listed and 
invited to participate 
28 brothels participated in 
the survey 
344 FSWs listed in 28 
brothels 
319 (93%) FSWs randomly 
selected and enrolled 
315 (99%) FSWs participated 
2 brothels closed  
1 brothel declined 
4 (1%) FSWs declined 
participation 
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The mean age of participants was 30 years (standard deviation, SD=7) and more than half 
(52%) were 25 to 34 years old.  Most were Christians (91%) and had no other job apart from 
sex work (72%). Most participants did not attend Quranic education (93%). Over two-thirds 
(62%) of participants were from other ethnic minorities in Nigeria, and more than half (56%) 
earned between 20,000 Naira and 40,000 Naira (56 – 112USD) a month (Table 5.1.).  
 
Table 5.1: Socio-demographic characteristics of brothel-based female sex workers in Ibadan, 
Nigeria (N=315) 










































Highest education level 
























No current paid job (e.g. student, apprentice, housewife) 
Unskilled worker (e.g. office assistant, food vendor) 
Semi-skilled worker (e.g. driver, caterer, tailor) 











Income per month3 
≤20,000N (≤56 USD) 
20,001 - 40,000N (>56 – 112USD) 









Current marital status 
Single4 

































The mean age of sexual debut of participants was 23.7 years (SD=6.0). The average age of the 
participants’ partners during first vaginal sex was 35 years (SD=7.0). Half of the participants 
had their vaginal sexual debut at the age of 17 years or less (50%). Most FSWs reported using 
condoms during their last the vaginal sex (94%).  The majority (72%) of participants had 
between 26-50 vaginal sex partners in the past three months (Table 5.2.)  
 
Sixty-one (19%) FSWs reported ever giving a male partner oral sex.  Among these women, the 
majority first gave oral sex to a male partner between 18-24 years and the mean age was 26 
years (SD=7.0). The mean age of the male partner they ever gave oral sex to was 30 years 
(SD=6.0) among those that knew the age of their partners.  Forty-one (71%) reported ever 
giving oral sex to only one male partner and thirty-six (59%) gave oral sex to one partner in 
the past three months. About 90% of participants reported giving oral sex to a male sexual 
partner who did not use a condom. One hundred and thirty-five FSWs (43%) reported ever 
receiving oral sex from a male partner. The mean age that the participants first received oral 
sex from a male partner was 27 years (SD=6.0). The average age of the first male partner that 
the participants received oral sex was 32 years (SD=6.0). Majority had ever received oral sex 
from a male partner (54%) and a little over a third (39%) had received oral sex in the past 
three months.  Almost all (99%) did not use any barrier methods when receiving oral. Only 
eight participants (3%) reported receptive heterosexual penile-anal sex. 
 
Most participants reported ever experienced mutual masturbation (97%) with a male partner, 
while about two third (68%) had practiced self-masturbation. Almost all participants had used 
their fingers to cleanse inside their vagina (Table 5.2).  Three quarter of the participants ever 
drank alcohol. About a third (32%) had smoked cigarettes and a quarter (24%) had used illicit 
drugs. The common illicit drugs that participants had ever used include: marijuhana in 47 
(61.8%), tramadol in 22 (29%), shisha in 17 (22%) and codeine in 11 (15%). 
1-Edo,	TIV,	Igbira;	2-N=313	–	two	participants	gave	no	response;	3- N – Naira-Nigeria currency; USD –United 
States Dollar; Living alone	
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Table 5.2: Sexual relationships, Partnerships and Behaviours of brothel-based female sex 
workers in Ibadan, Nigeria (N=315) 
Variable Frequency Percentage 














Age at first vaginal sex2, years 











Age of first vaginal sex partner3, years 








































Age at first ever experience of giving oral sex to a male partner5 
years 
















Age of partner when the first oral sex was given6, years  
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Age at first ever experience of receiving oral sex from a male 
partner 8, years (N=135) 




















Number of lifetime partners that participant ever received oral 



















































































































                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            
1-N=192-123 missing; 2-N=267-48 missing; 3-N=302-13 missing; 4-N=269-46 missing; 5-N=59-three missing; 6-N=52-Nine 
missing; 7-N=59-two missing; 8-N=128-Nine missing; 9-N=128-seven missing; 10-N=126-Nine missing; 11-N=130-five 
missing; 12- Mutual masturbation question was ‘have you or your partner ever touched each other’s genital area by hand? 
(Yes or No); 13- Cleansing of vagina was defined as using water or another substance to clean inside of vagina by inserting 
half or whole finger; 14- Illicit drugs are banned substances or drugs taken by participants for non-medical reasons in Nigeria 
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Only 14 (4%) participants had heard of HPV (Table 5.3).  The common sources of information 
about HPV were through the media (31%), hospital/clinics (15%) and friends (15%) among 
women who had heard of HPV (Table 5.3). A little over a third (35%) reported a history of STIs. 
Most (94%) participants had previously tested for HIV infection. Clinical evidence of female 
genital mutilation was found in 130 (41%) participants. Forty-two (13%) of the participants 
were HIV positive. The commonest clinical diagnosis that was made at the clinic was pelvic 
inflammatory disease (10%) and vaginal discharge syndrome (7%). 
Table 5. 3: Relevant medical history and clinical and laboratory diagnosis of brothel-based 
female sex workers in Ibadan, Nigeria (N=315) 
Variable Frequency Percentage 









Sources of information on HPV1 












































Clinical diagnosis made at the clinic 
Vaginal discharge syndrome 
Pelvic Inflammatory Disease 
Genital ulcer disease 
Genital warts 






















1-N=13 – one missing; 2-  3- Female genital mutilation was based on the clinical examination of the female external 
genitalia for evidence of genital circumcision by the research nurse at the clinic (Yes or No) 
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 Majority (77%) of participants had been in sex work business for more than a year (Table 5.4). 
The two most common reasons for engaging in sex work were to obtain money (96%) and 
lack of job (63%). About a third of participants were patronised by three  to four or five to six 
male clients for commercial sex daily, and majority (35%) reported that 11 to 20 men 
patronised them for sex weekly. One (11%) in nine participants gave history of ever allowing 
condomless vaginal sex; 16% had given oral sex and 1% had received oral sex without a barrier 
method from their fees paying male sex partners. The common reasons participants allowed 
condomless sex from their commercial sex partners include: lack of money (81%); out of love 
(39%); to hasten ejaculation (19%) and when under the influence of drugs (17%). Most (85%) 
participants gave a history of ever convincing their commercial sex partner to use condom.   
 
Table 5.4: Information on sex work history of brothel-based female sex workers in Ibadan, 
Nigeria (N=315) 
Variable Frequency Percentage 
Years in commercial sex activity 
<1 
1 - <3 












Reasons for engaging in sex work 
To get money 
To have fun 
To have a change of environment 
Because I have no job 
Because I lost or separated with my husband 
To join my friends/colleagues 
Cajoled/ deceived to join sex work 
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Yes 36 11% 



















Ever had unprotected sex (vaginal/oral/anal) in the last 











The last time participant engaged in an unprotected sex 
Today 
Less than a week ago 









Reasons for engaging in unprotected sex with 
commercial sex partners3 
To get more money 
Cajoled 
Forced 
Under the influence of alcohol 
Under the influence of drug (cocaine) 
For those that I like or love 
To hasten ejaculation 
To avoid sustained erection 
Commercial partner refused condom 
Because he is well known  
Fear of violence from the client 





























Any time participant convinced client that initially 











 Any experience of difficulty to negotiate condom use 
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5.3.2. Prevalence of cervical, vulvar, anal and oral HPV Infection 
Four biological (cervical, vulvar and anal swabs, and mouthwash) samples were obtained from 
each of the 315 women. Of the 1260 samples collected, two (0.6%) cervical, four (1.3%) anal 
swabs, and 33 (10.5%) mouthwash samples were declared as an invalid sample in the 
laboratory due to the low amount of β globin portion of DNA for the HPV genotyping analysis. 
These invalid samples were treated as missing in the analysis. The total biological samples 
analysed were 313 cervical samples, 315 vulvar samples, 311 anal samples and 282 oral 
samples. 
 
Overall, the prevalence of any detectable HPV among the FSWs was 87.9% (95% CI, 83.8-91.3) 
in the vulvar samples, 84.0% (95% CI, 79.5-87.9) in the cervical samples, 74.6% (95% CI, 69.4-
79.3) in the anal samples and 24.1% (95% CI, 19.2-29.5) in the oral samples (Table 5.5). The 
prevalence of the any Class 1 (carcinogenic), Class 2A (probable carcinogenic), Class 2B 
(possible carcinogenic) and Class 3 (unclassified) HPV genotypes by IARC classification was 
highest in the vulvar samples followed by cervical, anal and oral samples. Furthermore, 
detection of any HR-HPV and any LR-HPV genotypes was also found to be most prevalent in 
the vulvar samples, followed by the cervical, anal and oral samples. Any HR-HPV was found in 
75.2% (95% CI, 70.1-79.9) of the vulvar samples, 69.3% (95% CI, 63.9-79.8) of the cervical 
samples, 60.8% (95% CI, 55.1-66.2) of the anal samples and 14.9% (95% CI, 10.9-19.6) of the 
oral samples of the study participants. There were more multiple HPV genotypes detected in 
the vulvar samples (70.2% [95% CI, 64.8-75.2]) relative to the cervical (66.3% [95% CI,60.9-
71.7]), anal (55.3% [95% CI, 49.6-60.9]) and oral (9.6% [95% CI, 6.4-13.6]) samples.  
Generally, there was an inverse relationship between the age of participants and any HPV, 
HR-HPV, and multiple HPV infections at all anatomic sites. Specifically, there was a significant 
inverse association between any HPV infection and age of participants in the vulvar and 
cervical samples. Significant inverse association was also observed between any class 1 and 
2A HPV and the age of participants in cervical, vulvar and anal samples. The proportion of any 
HR-HPV and multiple HPV infection was found to be significantly highest among participants 
aged 18-24 years and reduced with age in the vulvar, cervical and anal samples. None of the 
HPV classification considered in this analysis was significantly associated with age in oral 
samples of the participants of this study (Table 5.5). 
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Table 5.5: Prevalence of Human papillomavirus infections among 315 brothel-based female sex workers in Ibadan, Nigeria 
Variable Cervical Sample Vulvar Sample Anal Sample Oral Sample 
n/N1 Prevalence (%) 
[95% CI] 
n/N Prevalence (%) 
[95% CI] 
n/N Prevalence (%) 
[95% CI] 
n/N Prevalence (%) 
[95% CI] 
Any HPV genotypes 
18-24 years 











































HPV classification by IARC3 
Class 1 – Carcinogenic4 
18-24 years 




Class 2A – Probable carcinogenic5 
18-24 years 




Class 2B – Possible carcinogenic6 
18-24 years 




Class 3 – Unclassified7 
18-24 years 
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Any HR-HPV genotypes8 
18-24 years 











































Any LR-HPV genotype9 
18-24 years 











































Multiple HPV genotypes10 
18-24 years 




















































1-n/N – number of samples  with positive HPV infection as numerator and total samples with valid result as denominator; 2- Bartlett’s test for equal variances were significant (p< 0.05); 
3-IARC – International Agency for Research on Cancer (*- HPV genotypes in IARC classification that are not included in the Anyplex II HPV28 platform); 4- Class 1 IARC HPV -16, 18, 31, 
33, 35, 39, 45, 51, 52, 56, 58, 59; 5- Class 2A IARC HPV - 68; 6- Class 2B IARC HPV - 5*, 8*, 26, 30*, 34*, 40, 42, 43, 44, 53, 54, 55*, 61, 66, 67*, 69, 70, 71*, 72*, 73, 81*, 82, 83*, 84*, 
85*, 97*, IS39* and CP6108*; 7- Class 3 IARC HPV -  6, 11; 8- 14 HR-HPV Group - Class 1 IARC HPV and Class 2A IARC HPV; 9- 14 LR-HPV - Class 2b IARC and Class 3 IARC; 10- Multiple 
HPV infection- Detection of two or more genotypes of HPV by Anyplex II HPV28 from a sample; All invalid samples were excluded from the descriptive analysis 
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The graphs in figures 5.5, 5.6, 5.7, 5.8 and 5.9 showed the pattern of HPV specific genotypes 
for cervical, vulvar, anal and oral samples of participants. The most prevalent HR-HPV 
genotype detected was HPV-35 in in all four anatomic sites: vulva (20.1% [95% CI, 15.8-25.0]), 
cervix (19.1% [95% CI,14.9-23.8]), anal cavity (18.2% [95% CI, 10.2-18.2]) and oral cavity (4.3% 
[95% CI, 1.7-6.4]). The second most common genotypes were HPV-68 in the vulvar (19.1% 
[95% CI,14.9-23.8]) and cervical (18.5% [95% CI, 14.4-23.3]) samples, HPV-51 in anal (12.5% 
[95% CI, 9.1-16.7]) and HPV-16 in oral (3.5% [95% CI, 1.7-6.4]) samples. HPV-53 was the most 
common LR-HPV genotypes detected in the vulvar (23.5% [95% CI, 18.9-28.6]), cervical (21.7% 
[95% CI, 17.3-26.7]) and anal (16.1% [95% CI, 12.8-21.3]) samples, and HPV-44 in oral (3.9% 
[95% CI, 2.0-6.9]) samples.  The second most common LR-HPV among the participants were 
HPV-54 in the vulvar (22.2% [95% CI, 17.8-27.2]) and cervical (19.2% [95% CI, 15.0-24.0]) 
samples, and HPV-42 in the anal (12.9% [95% CI, 9.4-17.1]) and oral (3.2% [95% CI, 1.5-6.0]) 
samples. 







































































































HPV specific genotypes Cervical Vulvar Anal Oral
Figure 5.5– Prevalence of specific HPV genotypes according to the four anatomic sites  
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RED triangle indicates HR-HPV point prevalence and BLACK BALL indicates LR-HPV point prevalence with lines indicating 95% CI 
 
RED triangle indicates HR-HPV point prevalence and BLACK BALL indicates LR-HPV point prevalence with lines indicating 95% CI 
Figure 5.6 – Prevalence of specific cervical HPV genotypes  
  
Figure 5.7 – Prevalence of specific vulvar HPV genotypes  
  




RED triangle indicates HR-HPV point prevalence and BLACK BALL indicates LR-HPV point prevalence with lines indicating 95% CI 












    
RED triangle indicates HR-HPV point prevalence and BLACK BALL indicates LR-HPV point prevalence with lines indicating 95% CI
Figure 5.8– Prevalence of specific anal HPV genotypes  
  
Figure 5.9– Prevalence of specific oral HPV genotypes  
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5.3.3. Risk factors associated with cervical, vulvar, anal and oral HPV Infection 
5.3.3. 1. Risk factors associated with cervical HPV Infection 
Two hundred and sixty-three (84.0%) FSWs had HPV detected out of 313 valid samples. Table 
5.6 shows results of the risk factor analysis for any HPV infection of the cervix. In the 
regression model, only age group was among the level 1 factors was associated with cervical 
HPV infection in both unadjusted and adjusted analyses. Participants whose age group were 
25-34 years (aOR=0.44, 95% CI, 0.15-1.31) and 35-45 years (aOR=0.26, 95% CI, 0.08-0.82) had 
lower odds of having cervical HPV infections compared to those that were 18-24 years.  For 
level 2 factors, age initiated into sex work and clinical evidence of female genital mutilation 
in the participants were the only factor found to be associated with cervical HPV in the 
unadjusted analyses. After adjusting for confounders, clinical evidence of female genital 
mutilation still remained associated. There were lower odds (aOR=0.48, 95% CI, 0.26-0.89) of 
cervical HPV infection in women that had clinical evidence of female genital mutilation than 
those without.  
 
Being HIV positive and having concomitant vulvar, anal and oral HPV infections were 
associated with cervical HPV infections in the unadjusted analyses of level 3 factors. After 
adjusting for confounders, HIV infection and concomitant vulvar HPV infections were still 
associated with cervical HPV infection. Participants who were HIV positive had 11.39 (95% CI, 
1.03-125.83) times the odds of having cervical HPV infection compared to those that were 
HIV negative, and those with concomitant vulvar HPV infection were 16.60 (95% CI, 5.08-
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Table 5.6: Factors associated with cervical human papillomavirus infection among brothel-
based female sex workers in Ibadan, Nigeria  
Variable n/N(row %) p-value1 




SOCIO-DEMOGRAPHICS FACTORS (Level 1)    








































Highest education level 











































Income per month7 
≤20,000N (≤56 USD) 
20,001 - 40,000N (>56 – 112USD) 













Current marital status 
Single8 










BEHAVIOURAL FACTORS (Level 2) n/N (row %) Crude OR (95%CI) Adjusted OR 
(95%CI)9 
















Age difference between first vaginal sex 
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>100 51/64 (80%) 1.31 (0.50-3.45) 1.05 (0.39-2.87) 








































































































































































BIOLOGICAL FACTORS (Level 3) n/N(row) Crude OR (95%CI) Adjusted OR 
(95%CI)17 
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5.3.3.2. Risk factors associated with vulvar HPV Infection 
The results of risk factor analysis for vulvar HPV infection are presented in table 5.7. Out of 
315 participants, 277 (88%) had HPV detected in the vulvar samples. The unadjusted analyses 
of level 1 factors showed that only age group of participants was associated with detection of 
vulvar HPV infection. After adjusting for confounders, age remained associated with having 
vulvar HPV infection. The odds of detecting vulvar HPV infection was lower with older age; 
women aged 25-34 years and 35-45 years had 0.16 (95% CI, 0.02-1.22) times and 0.07 (95% 
CI, 0.01-0.52) times lower odds of having vulvar HPV infection compared to those aged 18-24 
years. Regarding level 2 factors, age difference between first vaginal sex partner and 
participant and age initiated to sex work business were the only factors associated with vulvar 
HPV in the unadjusted analyses. After adjusting for confounders, none of the level 2 factors 
was found to be significantly associated with vulvar HPV infections.  
 
The detection of concomitant any cervical and any anal HPV infections were only Level 3 
factors found to be associated with vulvar HPV infection in unadjusted analyses and this 
association was also retained after adjusting for possible confounders. The odds of detecting 
vulvar HPV infection was higher among FSWs with   concomitant any cervical (aOR=6.48, 95% 
CI, 2.70-15.57) and any anal (aOR=8.88, 95% CI, 3.66-23.28) HPV infections compared to those 
with no infections in these anatomical sites. 
1-p-values were obtained from Wald tests; 2 – p values were obtained from Likelihood Ratio tests; 3- Level 1 factors were adjusted for 
age; 4-others – Igbo, Hausa/Fulani and other ethnic minorities; 5-no religion – one  participant said she had no religion; 6-others-
seamstress(tailor), petty trading and teaching; 7–N – Naira-Nigeria currency; USD –United States Dollar; 8– Living alone; 9- Level 2 factors 
were adjusted for age (core variable from Level 1) and female genital mutilation; 10-N=301 -12 participants did not provide information 
on age at first vaginal sex; 11- N=263 – 50 participants did not provide information to calculate age difference between first vaginal sex 
partner and participant; 12-N=267- 46 participants did not provide information on number of vaginal sex partners in past three months;  
13-N=312-one participant did not provide information on condom use during her last vaginal sex; 14-Mutual masturbation question was 
‘have you or your partner ever touched each other’s genital area by hand? (Yes or No); 15-Female genital mutilation was based on the 
clinical examination of the female external genitalia for evidence of genital circumcision by the research nurse at the clinic (Yes or No); 
16-Illicit drugs are banned substances or drugs taken by participants for non-medical reasons in Nigeria; 17-Level 3 factors were adjusted 
for core variable from level 1, female genital mutilation from level 2 and rapid HIV test result, concurrent detection of vulvar HPV 
infections; 18-N=309-four participants did not have anal HPV results; 19-N=280-33 participants did not have oral HPV results  
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Table 5.7: Factors associated with vulvar human papillomavirus infection among brothel-
based female sex workers in Ibadan, Nigeria  
Variable n/N(row %) p-value1 
Crude OR (95%CI) 
p-value2 
Adjusted OR (95%CI)3 
SOCIO-DEMOGRAPHICS FACTORS (Level 1)    








































Highest education level 











































Income per month7 
≤20,000N (≤56 USD) 
20,001 - 40,000N (>56 – 112USD) 













Current marital status 
Single8 










BEHAVIOURAL FACTORS (Level 2) n/N (row %) Crude OR (95%CI) Adjusted OR (95%CI)9 
















Age difference between first vaginal sex 
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BIOLOGICAL FACTORS (Level 3) n/N (row) Crude OR (95%CI) Adjusted OR (95%CI)17 
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5.3.3.3. Risk factors associated with anal HPV Infection 
Two hundred and thirty-two out of 311 (75 %) FSWs had detectable any anal HPV infection. 
Table 5.8 shows the multivariable analyses of risk factors associated with anal HPV infection. 
In the unadjusted analyses of level 1 factors, only age group and monthly income of FSWs was 
associated with having any anal HPV infection. After adjusting for possible confounders, age 
group and monthly income remained associated with detection of any anal HPV. The 
participants whose age were 25-34 years and 36-45 years had 0.39 (95% CI, 00.16-0.93) and 
0.37 (95% CI, 0.14-0.93) odds of having any anal HPV infection, respectively, relative to those 
aged 18-24 years. FSWs that earned between 20,001 to 40,000 Naira and more than 40,000 
Naira had 2.07 (95% CI, 1.11-3.86) times and 2.10 (95% CI, 1.09-4.04) times the odds of having 
any anal HPV infection compared to those that earned less than 20,000 Naira a month. The 
age difference between first vaginal sex partner and participants was the only level 2 factor 
associated with detection of any anal HPV in the unadjusted analyses. However, none of the 
level 2 factors was found to be associated after adjusting for possible confounders. For level 
3 factors, the unadjusted analyses showed that the presence of any concomitant cervical or 
vulvar or oral HPV infections were associated with detection of any anal HPV infection. 
However, only of the detection of any vulvar HPV infection remained associated with anal 
HPV infection after adjusting for possible confounders. FSWs that had vulvar HPV infections 
had higher odds (aOR=10.55, 95% CI, 3.67-30.31) of having any anal HPV infection than those 
with no vulvar HPV infection. 
1-p-values were obtained from Wald tests; 2 – p values were obtained from Likelihood Ratio tests; 3- Level 1 factors were adjusted for 
age; 4-others – Igbo, Hausa/Fulani and other ethnic minorities; 5-no religion – one  participant said she had no religion; 6-others-
seamstress(tailor), petty trading and teaching; 7–N – Naira-Nigeria currency; USD –United States Dollar; 8– Living alone; 9- Level 2 
factors were adjusted for age (core variable from Level 1) and ever given oral sex; 10-N=302 -13 participants did not provide 
information on age at first vaginal sex; 11- N=264 – 51 participants did not provide information to calculate age difference between 
first vaginal sex partner and participant; 12-N=269- 46 participants did not provide information on number of vaginal sex partners in 
past three months;  13-N=314-one participant did not provide information on condom use during her last vaginal sex; 14-Mutual 
masturbation question was ‘have you or your partner ever touched each other’s genital area by hand? (Yes or No); 15-Female genital 
mutilation was based on the clinical examination of the female external genitalia for evidence of genital circumcision by the research 
nurse at the clinic (Yes or No); 16-Illicit drugs are banned substances or drugs taken by participants for non-medical reasons in Nigeria; 
17-Level 3 factors were adjusted for core variable from level 1, ever given oral sex from level 2 and concurrent detection of cervical and 
anal HPV infections; 18-N=313-three participants did not have cervical HPV results; 19-N=311-four participants did not have anal HPV 
results; 20-N=282-33 participants did not have oral HPV results 
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Table 5.8: Factors associated with anal human papillomavirus infection among brothel-
based female sex workers in Ibadan, Nigeria  
Variable n/N (row %) p-value1 
Crude OR (95%CI) 
p-value2 
Adjusted OR (95%CI)3 
SOCIO-DEMOGRAPHICS FACTORS (Level 1)    








































Highest education level 











































Income per month7 
≤20,000N (≤56 USD) 
20,001 - 40,000N (>56 – 112USD) 

























BEHAVIOURAL FACTORS (Level 2) n/N (row %) Crude OR (95%CI) Adjusted OR (95%CI)9 
















Age difference between first vaginal sex 
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>100 52/62 (84%) 2.29 (0.86-6.10) 1.59 (0.55-4.61) 




































































































































































BIOLOGICAL FACTORS (Level 3) n/N (row %) Crude OR (95%CI) Adjusted OR (95%CI)17 
































252 | P a g e  
 
Yes 223/275 (81%) 12.87 (5.71-
28.99) 
10.55 (3.67-30.31) 



















5.3.3.4. Risk factors associated with oral HPV Infection 
Of the 282 FSWs with valid oral samples, 68 (24%) had detectable any HPV in the oral samples.  
None of the level 1 factors was associated with detection of any oral HPV infection in the 
unadjusted and adjusted analyses (Table 5.9). The only level 2 factor that was associated with 
any oral HPV in the unadjusted analyses was history of ever having heard of HPV and this 
factor remained associated after adjusting for possible confounders. The odds of detecting 
oral HPV was higher among FSWs that had ever heard of HPV (aOR=3.88, 95% CI, 1.19-12.64) 
compared to those with no information about HPV. In the unadjusted analyses of level 3 
factors, being HIV positive and having any concomitant anal and cervical HPV infections were 
associated with detection of any oral HPV. After adjusting for possible confounders, only 
being HIV positive remained associated with oral HPV among FSWs. FSWs that were HIV 
positive had 2.40 (95% CI, 1.12-5.14) times the odds of having any oral HPV infection 






1-p-values were obtained from Wald tests; 2 – p values were obtained from Likelihood Ratio tests; 3- Level 1 factors were adjusted for 
age and monthly income; 4-others – Igbo, Hausa/Fulani and other ethnic minorities; 5-no religion – one  participant said she had no 
religion; 6-others-seamstress(tailor), petty trading and teaching; 7–N – Naira-Nigeria currency; USD –United States Dollar; 8– Living 
alone; 9- Level 2 factors were adjusted for age (core variable from Level 1) and ever heard of human papillomavirus; 10-N=298 -13 
participants did not provide information on age at first vaginal sex; 11- N=260 – 51 participants did not provide information to calculate 
age difference between first vaginal sex partner and participant; 12-N=265- 46 participants did not provide information on number of 
vaginal sex partners in past three months;  13-N=310-one participant did not provide information on condom use during her last vaginal 
sex; 14-Mutual masturbation question was ‘have you or your partner ever touched each other’s genital area by hand? (Yes or No); 15-
Female genital mutilation was based on the clinical examination of the female external genitalia for evidence of genital circumcision 
by the research nurse at the clinic (Yes or No); 16-Illicit drugs are banned substances or drugs taken by participants for non-medical 
reasons in Nigeria; 17-Level 3 factors were adjusted for core variable from level 1, and concurrent detection of vulvar HPV infections; 
18-N=309-two participants did not have cervical HPV results; 19-N=278-33 participants did not have oral HPV results 
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Table 5.9: Factors associated with oral human papillomavirus infection among brothel-based 
female sex workers in Ibadan, Nigeria  
Variable n/N(row %) p-value1 
Crude OR (95%CI) 
p-value2 
Adjusted OR (95%CI)3 
SOCIO-DEMOGRAPHICS FACTORS (Level 1)    








































Highest education level 











































Income per month7 
≤20,000N (≤56 USD) 
20,001 - 40,000N (>56 – 112USD) 

























BEHAVIOURAL FACTORS (Level 2) n/N (row %) Crude OR (95%CI) Adjusted OR (95%CI)9 
Age at first vaginal sex, years10 















Age difference between first vaginal sex 
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BIOLOGICAL FACTORS (Level 3) n/N(row %) Crude OR (95%CI) Adjusted OR (95%CI)17 
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5.3.4. Concordance of genotype specific HPV infection 
Thirty-four FSWs had concordance of individual HR-HPV genotypes in all four anatomic sites 
(Table 5.10): the commonest genotype was HPV-35 in nine participants followed by HPV-51 
in four participants. HPV-16, 52 and 58 ranked third with three participants each. Among 38 
FSWs with the concordant LR-HPV genotypes in the four anatomic sites, HPV-42 was the 
commonest in seven participants, followed by HPV-44 in five, HPV-70 in four and HPV-
6/11/40/43 in three participants each. Two hundred and fifty-nine FSWs had concordance of 
the 13 HR-HPV genotypes in any of three of the four anatomic sites, and HPV-56 and HPV-52 
were the commonest found among 19 FSWs and 25 FSWs, respectively. Of the 218 FSWs that 
had the concordance of LR-HPV genotypes in any of three anatomic sites, HPV-53 was the 
most specific genotype found among 38 FSWs while the second most common was HPV-42 
in 25 FSWs. 
 
On the concordance of HPV genotypes between two anatomic sites of participants (Table 
5.11), the concordance of any HR-HPV was highest when cervical and vulvar samples 
(196/315; 62.2%) were compared, followed by between the anal and vulvar samples 
(173/315; 54.9%), and cervical and anal samples (157/315; 49.8%). Similarly, the highest 
concordance of LR-HPV was observed between the cervical and vulvar samples, followed by 
a similar rate of concordance between the cervical and anal samples (141/315; 44.8%), and 
1-p-values were obtained from Wald tests; 2 – p values were obtained from Likelihood Ratio tests; 3- Level 1 factors were adjusted for 
age; 4-others – Igbo, Hausa/Fulani and other ethnic minorities; 5-no religion – one  participant said she had no religion; 6-others-
seamstress(tailor), petty trading and teaching; 7–N – Naira-Nigeria currency; USD –United States Dollar; 8– Living alone; 9- Level 2 
factors were adjusted for age (core variable from Level 1) and number of vaginal sex partners in the past three months and ever heard 
of human papillomavirus; 10-N=270 -12 participants did not provide information on age at first vaginal sex; 11- N=235 – 47 
participants did not provide information to calculate age difference between first vaginal sex partner and participant; 12-N=240- 42 
participants did not provide information on number of vaginal sex partners in past three months;  13-N=281-one participant did not 
provide information on condom use during her last vaginal sex; 14-Mutual masturbation question was ‘have you or your partner ever 
touched each other’s genital area by hand? (Yes or No); 15-Female genital mutilation was based on the clinical examination of the 
female external genitalia for evidence of genital circumcision by the research nurse at the clinic (Yes or No); 16-Illicit drugs are banned 
substances or drugs taken by participants for non-medical reasons in Nigeria; 17-Level 3 factors were adjusted for core variable from 
level 1, ever heard of human papillomavirus from level 2 and rapid HIV test result; 18-N=278-four participants did not have anal HPV 
results; 19-N=280-two participants did not have cervical HPV results  
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the anal and vulvar samples (141/315; 44.8%). The lowest concordance rate for any LR-HPV 
genotype was between  oral and cervical sites (31/315; 9.8%). 
Table 5.10: Proportion of HPV genotype specific concordance samples across the four 
anatomic sites of cervix, vulvar, anal and oral cavities among brothel-based female sex workers 







FSW with the 
same HPV 
genotype in all 
the 4 sites (%) 
FSW with the 
same HPV 
genotype in 
any 3 sites (%) 
FSW with the 
same HPV 
genotype in 
any 2 sites (%) 
FSW with HPV 
genotype in 1 
site only (%) 
FSW with any HPV16  
 
Yes (n=72) 3/72 (4%) 18/72 (25%) 15/72 (21%) 36/72 (50%) 
No (n=60) - - - - 
FSW with any HPV 18 Yes (n=39) 2/39 (5%) 11/39 (28%) 10/39 (26%) 16/39 (41%) 
No (n=38) - - - - 
FSW with any HPV 31  Yes (n=50) 1/50 (2%) 23/50 (46%) 6/50 (12%) 20/50 (40%) 
No (n=55) - - - - 
FSW with any HPV 33 Yes (n=20) 2/20 (10%) 5/20 (25%) 8/20 (40%) 5/20 (25%) 
No (n=24) - - - - 
FSW with any HPV 35 
 
Yes (n=85) 9/85 (11%) 22/85 (12.4) 19/85 (10.7) 35/85 (19.7) 
No (n=93) - - - - 
FSW with any HPV 39  Yes (n=40) 2/40 (5%) 17/40 (42%) 8/40 (20%) 13/40 (33%) 
No (n=48) - - - - 
FSW with any HPV 45  Yes (n=54) 0 21/54 (39%) 10/54 (18%) 23/54 (43%) 
No (n=52) - - - - 
FSW with any HPV 51  Yes (n=65) 4/65 (6%) 17/65 (26%) 14/65 (22%) 30/65 (46%) 
No (n=60) - - - - 
FSW with any HPV 52 Yes (n=70) 3/70 (4%) 25/70 (36%) 16/70 (23%) 26/70 (37%) 
No (n=75) - - - - 
FSW with any HPV 56 Yes (n=89) 2/89 (2%) 38/89 (43%) 26/89 (29%) 23/89 (26%) 
No (n=158) - - - - 
FSW with any HPV 58 Yes (n=74) 3/74 (4%) 19/74 (26%) 16/74 (21%) 36/74 (49%) 
No (n=63) - - - - 
FSW with any HPV 59 Yes (n=48) 2/48 (4%) 17/48 (35%) 8/48 (17%) 21/48 (44%) 
No (n=48) - - - - 
FSW with any HPV 68 Yes (n=83) 1/83 (1%) 26/83 (31%) 22/83 (27%) 34/83 (41%) 
No (n=77) - - - - 
FSW with any HPV 6  Yes (n=54) 3/54 (6%) 8/54 (15%) 18/54 (33%) 25/54 (46%) 
No (n=43) - - - - 
FSW with any HPV 11 Yes (n=25) 3/25 (12%) 4/25 (16%) 10/25 (40%) 8/25 (32%) 
No (n=27) - - - - 
FSW with any HPV 26  Yes (n=13) 0 2/13 (15%) 7/13 (54%) 4/13 (31%) 
No (n=11) - - - - 
FSW with any HPV 40 Yes (n=50) 3/50 (6%) 17/50 (34%) 12/50 (24%) 18/50 (36%) 
No (n=55) - - - - 
FSW with any HPV 42  Yes (n=78) 7/78 (9%) 25/78 (32%) 22/78 (28%) 24/78 (31%) 
No (n=93) - - - - 
FSW with any HPV 43  Yes (n=42) 3/42 (7%) 12/42 (29%) 11/42 (26%) 16/42 (38%) 
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No (n=44) - - - - 
FSW with any HPV 44 
 
Yes (n=81) 5/81 (6%) 23/81 (28%) 24/81 (30%) 29/81 (36%) 
No (n=85) - - - - 
FSW with any HPV 53  Yes (n=89) 2/89 (2%) 38/89 (43%) 26/89 (29%) 23/89 (26%) 
No (n=108) - - - - 
FSW with any HPV 54  Yes (n=87) 2/87 (2%) 26/87 (30%) 25/87 (29%) 34/87 (39%) 
No (n=83) - - - - 
FSW with any HPV 61 Yes (n=17) 0 1/17 (6%) 4/17 (23%) 12/17 (71%) 
No (n=6) - - - - 
FSW with any HPV 66 Yes (n=37) 1/37 (3%) 11/37 (30%) 12/37 (32%) 13/37 (35%) 
No (n=37) - - - - 
FSW with any HPV 69  Yes (n=33) 2/33 (6%) 7/33 (21%) 2/33 (6%) 22/33 (67%) 
No (n=22) - - - - 
FSW with any HPV 70  Yes (n=57) 4/57 (7%) 20/57 (35%) 11/57 (19%) 22/57 (39%) 
No (n=63)     
FSW with any HPV 73  Yes (n=49) 2/49 (4%) 12/49 (24%) 16/49 (33%) 19/49 (39%) 
No (n=46) - - - - 
FSW with any HPV 82  Yes (n=43) 1/43 (2%) 12/43 (28%) 12/43 (28%) 18/43 (42%) 




Table 5.11: Pattern of HPV concordance by anatomic sites among brothel-based female sex 
workers in Ibadan, Nigeria (n=315) 
HPV Anatomic site Frequency 
 
Percentage 
Any HPV    
 Cervical, vulvar, anal and oral sites 54/315 17.1 
   
Any HR-HPV    
 Cervical, vulvar, anal cavity and oral sites 33/315 10.5 
Cervical, vulvar and anal sites 154/315 48.9 
Cervical and vulvar sites 196/315 62.2 
Cervical and anal sites 157/315 49.8 
Cervical and oral sites 36/315 11.4 
Oral and anal sites 36/315 11.4 
Oral and vulvar sites 36/315 11.4 
Anal and vulvar sites 173/315 54.9 
Any LR-HPV    
 Cervical, vulvar, anal and oral sites 30/315 9.5 
Cervical, vulvar and anal sites 141/315 44.8 
Cervical and vulvar sites 212/313 67.7 
Cervical and anal sites 141/315 44.8 
Cervical and oral sites 35/315 11.1 
Oral and anal sites 31/315 9.8 
Oral and vulvar sites 35/315 11.1 
Anal and vulvar sites 141/315 44.8 
1-Orange colour was used to highlight high-risk genotypes; 2-Sky-blue colour was used to indicate 
low-risk HPV genotypes;  
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5.3.5. Risk factors associated with oral sexual behaviours 
5.3.5.1. Risk factor analysis of ever having given oral sex (fellatio)  
The proportion of FSWs who ever gave oral sex to a male partner was 19% (61/315). Only the 
monthly income of FSWs among level 1 factors was found to be significantly associated with 
with report of ever giving oral sex in the unadjusted and adjusted model (Table 5.12). 
Participants whose monthly income was more than 40,000 Naira had 2.43 (95% CI, 1.20-4.91) 
odds of reporting ever given oral sex to a male client compared to those that earned 20,000 
or less Naira per month.  None of the level 2 factors was found to be significantly aassociated 
with report of ever given oral sex in both unadjusted and adjusted models.  
 
Table 5.12: Factors associated with ever gave oral sex among brothel-based female sex 
workers in Ibadan (N=315) 
VARIABLE Ever gave oral 
sex n/N(%) 
p-value1 
Crude OR (95%CI) 
p-value2 
Adjusted OR (95%CI)3 
SOCIO-DEMOGRAPHIC FACTORS 
 (LEVEL 1 ) 
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Income per month6 
≤20,000N (≤56 USD) 
20,001 - 40,000N (>56 – 112USD) 













Own television  p=0.525 p=0.861 






















Current marital status 
Single7  










BEHAVIOURAL AND OTHER FACTORS 
(LEVEL 2) 
Ever gave oral 
sex n/N(%) 
Crude OR (95%CI) Adjusted OR (95%CI)8 


























































































































1-p-values were obtained from Wald tests; 2 – p values were obtained from Likelihood Ratio tests; 3- Level 1 factors were adjusted for 
age, highest educational level, monthly income and ownership of a radio; 4- No religion – one participant had has no religion; 5– Other 
job titles petty trading, seamstress and teaching; 6–N – Naira-Nigeria currency; USD –United States Dollar; 7– Living alone;  8- Level 
2 factors were adjusted for age, highest educational level, monthly income and ownership of a radio (core variables from Level 1) and 
smoked cigarette; 9- Female genital mutilation was based on the clinical examination of the female external genitalia for evidence of 
genital circumcision by the research nurse at the clinic (Yes or No); 11-Illicit drugs are banned substances or drugs taken by participants 
for non-medical reasons in Nigeria 
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5.3.5.2. Risk factor analysis of ever received oral sex (cunnilingus) 
The proportion of FSWs that reported ever receiving oral sex from a male partner was 43% 
(135/135). The unadjusted model for level 1 factors showed that religion, highest level of 
formal education, quranic education, monthly income, ownership of a television andradio 
were associated with reports of ever receiving oral sex (Table 5.13). However, after adjusting 
for possible confounders, only current marital status was found to be associated with report 
of ever having received oral sex. Participants that were ever married had 0.56 (95% CI, 0.33-
0.95) odds of ever receiving oral sex compared to those that were single.   
 
In the level 2 factors, history of alcohol consumption and cigarette smoking and use of illicit 
drugs were found to be associated with report of ever having received oral sex in the 
unadjusted analyses. After adjusting for possible confounding, participants with history of 
illicit drug use had higher odds (aOR=1.91, 95% CI 1.02-3.57) of reporting ever receiving oral 
sex compared to those with no illicit drug use (Table 5.13). 
 
Table 5.13: Factors associated with ever received oral sex among brothel-based female sex 
workers in Ibadan (N=315) 
VARIABLE Ever received 
oral sex n/N(%) 
p-value1 
Crude OR (95%CI) 
p-value2 
Adjusted OR (95%CI)3 
SOCIO-DEMOGRAPHIC FACTORS 
(LEVEL 1) 
   








































Highest education level 
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Income per month6 
≤20,000N (≤56 USD) 
20,001 - 40,000N (>56 – 112USD) 





































Current marital status 
Single7  










BEHAVIOURAL AND OTHER FACTORS 
(LEVEL 2) 
  Adjusted OR (95%CI)8 




















































































































1-p-values were obtained from Wald tests; 2 – p values were obtained from Likelihood Ratio tests; 3- Level 1 factors were adjusted for 
age, religion, highest education level, quranic education, monthly income, ownership of  television and radio, and current marital status; 
4- No religion - one participant had has no religion; 5– Other job titles – petty trading, seamstress and teaching; 6–N – Naira-Nigeria 
currency; USD –United States Dollar; 7– Living alone;  8- Level 2 factors were adjusted for age, religion, quranic education, monthly 
income, ownership of  television and radio, and current marital status (core variables from Level 1) and illicit drug use; 9- Female genital 
mutilation was based on the clinical examination of the female external genitalia for evidence of genital circumcision by the research 
nurse at the clinic (Yes or No); 11-Illicit drugs are banned substances or drugs taken by participants for non-medical reasons in Nigeria 
 




This study showed a very high prevalence of vulvar, cervical and anal HPV infections, and a 
low prevalence of oral HPV among brothel-based FSWs in Ibadan, Nigeria. Specifically, HPV 
infection was most prevalent in the vulvar (87.9%) followed by the cervical (84.0%), anal 
(74.6%) and oral  (24.1%) samples. In addition, the prevalence of multiple HPV infections also 
followed similar patterns of distribution with the highest proportion in the vulvar samples. 
Generally, HPV prevalence was higher among FSWs who were between 18 and 25 years 
compared to other age groups. The commonest HR-HPV genotype was HPV-35 in the four 
anatomic sites and HPV-68 was as common as HPV-35 in the vulvar samples. The second most 
common genotypes were: HPV-58 in the vulvar samples; HPV-68 in the cervical samples, HPV-
51 in the anal samples and HPV-16 in the oral samples. HPV-16 was ranked fourth among the 
HR-HPV in the vulvar, cervical and anal samples. The most common LR-HPV genotypes was 
HPV-53 in the vulvar, cervical and anal samples and HPV-44 in the oral samples.  
 
The proportions of FSWs with oro-genital HPV infections in this study was, perhaps not 
surprisingly, higher than the prevalences by anatomical site reported among sexually active 
females in the general population in Ibadan, Nigeria, presented in Chapter 4.  Although 
studies on HPV infection among FSWs have been largely focusing on cervical HPV infections 
worldwide with fewer studies on anal, vulvar and oral HPV [96, 212, 428-434], most of these 
studies have reported a relatively lower prevalence of any HPV and HR-HPV infection 
compared to the present study. Until now, there was only a study published that presented 
data on five anatomic sites of cervical, vagina, vulvar, anal, and oral sites among 188 FSWs in 
Spain (2004); the study found HPV to be most prevalent in the cervical (27.8%), followed by 
the vaginal (26.1%), vulvar (22.9%), anal (15.0%) and oral (7.9%) sites[427].  In another study 
in Hungary (2013), three samples were collected from the cervical, anal and oral sites among 
34 FSWs and 52 women in the general population[435]. The prevalence of any HPV infection 
was significantly higher among FSWs compared to women in the general population for both 
cervical (64.0% versus 34.6%, p=0.006) and anal (50.0% versus 15.4%, p=0.001) samples 
except in the oral samples (20.6% versus 7.7%, p=0.103)[435]. In the same study, FSWs also 
had more HR-HPV and LR-HPV infections than women in the general population [435].  
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Two cross-sectional studies (one each from Togo and the Netherlands) among FSWs reported 
on the prevalences of anogenital HPV infections[429, 436]. The study conducted in Togo 
among 310 FSWs (21 – 32 years) found an infection rates of any HPV and any HR-HPV of 45.2% 
and 32.9% in the cervical, and 34.8% and 20.7% in the anal sites, respectively[429] . The 
observed higher prevalence in the cervical samples compared to anal samples among FSWs 
in the Togo study was similar to the present study[429]. However, another study from the 
Netherlands conducted among 304 FSWs (25-37 years) showed a slightly higher prevalence 
of any anal HPV of 80.0% and any LR anal HPV of 57.0%, but a lower prevalence of any HR 
anal HPV of 50.0% compared to this study [436]. The relatively high prevalence observed in 
the Netherlands study might be due to high proportion of FSWs with STI complaints whereas, 
the FSWs that were recruited in the Togo study did not present with STI complaints. STI had 
been shown to be a co-factor for HPV acquisition and it is also associated with slow clearance 
rate of HPV infection[437, 438].  
 
Two Kenyan studies estimated the prevalence of HR-HPV cervical HPV infection among FSWs. 
A study among 296 FSWs in Nairobi found an infection rate of 54%[434] whilst another study 
among 616 FSWs (≥ 18 years) in Western Kenya reported a prevalence of 57.7%  [96]. Both 
studies also reported multiple HPV infections of 28.0% in Nairobi and 32.8% in Western 
Kenya[96, 434].  Another study among 360 FSWs (16-54 years) in Burkina Faso showed a 
prevalence of cervical HPV of 66.1%[439]. Studies from Europe and Asia have reported a wide 
range of prevalences of cervical HPV prevalence among FSWs ranging from 25.0% to 
85.0%[93, 430, 432, 433, 440, 441]. The observed high prevalence of cervical HPV among this 
cohort of FSWs in Nigeria and the wide range of prevalence in previous studies in Europe 
might be due to differences in the age range of participants and HPV genotyping 
techniques[93]. The age cut-off in a number of previous studies were above 50 years 
compared with the upper age limit of 45 years used in this study.  
The data on oral HPV infection among FSWs in this study are the first coming from such 
population in SSA. Oral HPV infection was higher in this study than two previous studies that 
reported oral HPV in FSW; 7.6% among 185 FSWs (18-26 years) in Peru and 6.1% among 196 
FSWs (18-45 years) in Japan [212, 431]. The observed difference in oral HPV prevalence might 
be due to the sensitivity of diagnostic tests to detect HPV infection. 
 
264 | P a g e  
 
Just as in previous studies, the presence of concomitant HPV infection in other genital and or 
anal sites was a common risk factors for detection of HPV infection in a specific anatomical 
site [429, 436]. Concomitant vulvar HPV was associated with the detection of cervical and anal 
HPV infections, and vice versa. Association between anal and cervical or anal HPV infections 
had been previously reported[429].  The Togo study observed an increased risk of anal HPV 
infection among FSWs that were also positive to cervical HPV infection, particularly those with 
added premalignant lesion of the cervix[429].  The presence of concomitant vaginal HPV 
infection was found to be a risk factor for anal HPV infection in the study from the 
Netherlands, and vice versa [436]. As mentioned in Chapter 4, the risk of concomitant HPV 
infection has been explained by the concept of viral shedding between contiguous anatomic 
structures and autoinoculation that may be due to sexual risk behaviours or unhygienic 
practices [442].  The observed association of concomitant HPV infection between two or more 
anatomic sites has the benefit of providing a clinical suggestion to offer a screening protocol 
for multiple anatomic sites [442]. For example, an individual with positive HPV DNA with 
premalignant lesion of the cervix may also be offered opportunity to screen for premalignant 
lesions of the anus. 
 
HIV infection was another important risk factor that was common to cervical and oral HPV 
infections in this study. A number of other studies among FSWs have shown an increased risk 
of cervical and anal HPV infection among HIV positive compared to HIV negative  [429, 430]. 
The association between HPV and HIV is bi-directional and synergistic, HIV could be a risk 
factor for HPV acquisition and vice versa [443, 444]. It has been shown that HPV infection 
through the E7 protein could alter the integrity of epithelial lining by disrupting the epithelial 
adhesion molecules and cause alteration of the Langerhans cells, known to internalise HIV 
[443, 445, 446]. This cascade of events caused by HPV infection can make the host cell 
vulnerable to HIV infection [446]. Furthermore, HIV and HPV share similar risk factors for 
acquisition such as early age of first sexual activity, multiple sexual partners, condomless sex 
and presence of other STIs [444]. HPV infection acquisition, clearance, persistence, and 
disease progression to intraepithelial neoplasia and cancer may be increased in people with 
immunodeficiencies such as HIV infection [444, 447]. Furthermore, interventions that reduce 
HIV risks like male circumcision and anti-retroviral treatment had been associated with 
reduced rate of HPV acquisition [444, 447].  
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Another interesting finding was the reduced risk of cervical HPV infection among FSWs with 
clinical evidence of female genital mutilation. The reduced risk of cervical HPV infection 
among those with a history of female genital mutilation may be due to the reported reduced 
sexual activity from lack of sexual pleasure or orgasm and or increased sexual dysfunctions 
among such people [448, 449].  However, a large retrospective study of 2,398 women (18-90 
years) in Senegal observed an increased risk of invasive cervical cancer among women with 
evidence of female genital mutilation after adjusting for HIV infection, presence of HPV in the 
subjects and other benign and premalignant cervical lesions [450].  The increased risk of 
cervical cancer among women with history of female genital mutilation was ascribed to be 
due to  increased risk of chronic inflammation of structures around the areas affected by the 
mutilation[451]. Chronic inflammation could be a co-factor in the biology of HPV infection 
acquisition and persistence[451]. The real interaction of how genital mutilation is linked to 
chronic inflammation and subsequent HPV acquisition is not fully established.   The observed 
association between female genital mutilation and HPV infection could be confounded for the 
reason that genital mutilation tends to be common among women from low socioeconomic 
class, who live in rural community and those that lack access to health-related information 
[452].  
 
 In this study population, earning a relatively high monthly income was associated with the 
risk of anal HPV infection. It is possible that FSWs might be engaging in sexual risk behaviours 
in exchange for more money from their customers[371]. In the qualitative study that was 
presented in Chapter 3, the participants described how customers were offered high-risk 
sexual acts in exchange for increased money and sometimes, they also alluded that clients 
that desired anal sex are usually prepared to pay more money to them.   History of anal sex 
by FSWs was not associated with anal HPV infection in this study.  There is the possibility of 
under reporting of anal sex in this study because FSWs might found disclosure of anal sex to 
be embarrassing to them. It is also plausible to acquire anal HPV infection without a history 
of anal sex; anal HPV could be acquired from viral shedding or contiguous anatomic sites with 
HPV infection.   Other risk factors associated with the genital cervical and anal HPV infections 
in previous studies were  the presence of other STIs, sexual risk behaviours such as multiple 
sexual partner, age of regular sexual partner, age of first vaginal sex, inconsistent condom or 
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barrier methods, condomless vaginal and anal sex, intravaginal practices and illicit drug 
use[435, 441]. Oral HPV infection was also associated with oral sex and smoking in other 
studies [212, 435]. However, both oral sex and smoking were not associated with oral HPV in 
this study. Contrary to the previous reports that found HPV-16 or HPV-31, HPV-51 or HPV-58 
as the most frequent genotypes in the cervix and anus of FSWs [432, 433, 435], this study 
showed that HPV-35 was the commonest HR-HPV in the four anatomic site samples. 
Furthermore, HPV-35 was also the most common genotype with concordance in all four 
anatomic sites. Unfortunately, HPV-35 is not covered in any of the available HPV vaccine 
types. 
 
The proportion of FSWs that received oral sex (43%) from male sexual partners was higher 
than the proportions that had given oral sex (19%) to a male sexual partner, and majority did 
not use condom during the last episode of oral sex in this study. However, a study in Australian 
found that 25% of 1168 FSWs that admitted practicing fellatio did not always use condom 
consistently [453]. There is evidence that oral STIs are more efficiently acquired by fellatio 
compared to cunnilingus due to high risk of traumatic injuries to the soft palate and oedema 
in the area of contact, which could serve as a portal for the acquisition of infection[454, 455]. 
Association between history of ever given oral sex and income of FSWs confirmed the 
information provided during the FGDs and IDIs in chapter 3 that FSWs charge extra money to 
allow their male clients to have oral sex with them. The use of illicit drugs was found to be 
associated with cunnilingus in this study. A study in the USA has  shown that FSWs sometimes 
engage in oral sex in exchange for illicit drugs[456]. 
 
The major strength of this study was the collection of data for HPV genotyping from four 
anatomic sites at the same time, and this was probably the first largest study till date with 
such a diverse anatomic samples among FSWs. The study used a probability sampling to select 
study participants, and also limited her study population to a homogenous sample of brothel 
based FSWs. This was unlike previous studies that combined different sub-groups of FSWs 
from brothels, entertainment venues and streets, while other studies did provide information 
on the sub-group of FSWs that were recruited[96, 427, 429]. Some studies had demonstrated 
that sexual behaviours and associated risks among different sub-group of FSWs might not be 
the same [457-460]. A study in China found that street-based FSWs had more risk behaviours 
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than establishment-based FSWs, there was a higher report of inconsistent condom use and 
anal sex with clients among street-based FSWs relative to the establishment-based FSWs 
[457]. Another important strength of this study is the low refusal rate among the participants 
recruited.  
 
This study has some potential limitations.  This study was a cross-sectional design that cannot 
be used to explain causality of risk factors of HPV infection. The design cannot also explain 
the time of HPV acquisition, clearance and persistence. The age limit of 18 to 45 years used 
in this study excluded some FSWs from these analyses and this could introduce some 
selection bias, and potentially limit the generalisability of results. Although, the young age of 
the study population might have accounted for the observed high prevalence compared to 
other studies, but this is not clinically relevant given the transient nature of HPV infection. It 
is also possible that the selection of all FSWs at brothels that had less than 10 people could 
also introduce selection bias. However, the selection of participants from the sampling frame 
was almost exhaustive which could limit the risk of selection bias.   The history of STIs were 
obtained by the clinical nurses and participants found to have STIs were offered syndromic 
management of STIs. However, there was the possibility of missing asymptomatic STIs. There 




HPV infection was substantially higher among brothel-based FSWs in Ibadan, Nigeria 
compared to similar studies from other settings, and the commonest HR-HPV genotype (HPV-
35) in this study was similar to the type found among the female population in the community 
in Nigeria. It is recommended that future studies should include other categories of FSWs 
such as the streets and entertainment venues who might be more vulnerable to HPV 
infection, as well as, designing longitudinal studies that will be able to answer other critical 
issues of the epidemiology of HPV such as the incidence, clearance and persistence among 
this special group of women in the community.    
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CHAPTER 6: DISCUSSION 
 
PREAMBLE 
In this chapter a summary of key findings presented in the thesis will be given, followed by a 
review of the strengths and limitations of the studies, public health implications of the results 
including other important observations unrelated to HPV such as the female genital 
mutilation, recommendations and concluding statements.  
6.1. SUMMARY OF KEY FINDINGS OF THIS THESIS 
6.1.1. Knowledge, socio-cultural interpretations and different ways of learning 
sexual behaviours 
Data presented in this thesis showed that Nigerian adolescents and adults are knowledgeable 
about different sexual behaviours. The adult males, adolescent and young adult males and 
females and FSWs demonstrated a greater understanding of specific definitions or slang 
terms related to these behaviours compared with the adults or married women in the general 
population. The young people and FSWs were able to explain subtle differences between 
different sexual behaviours. For example, adolescents and young adult males and females 
were able to differentiate between “giving” or “receiving” oral sex and “insertive or 
receptive” anal sex, as well as explaining different sexual partnerships such as heterosexual 
and same sex partnerships.  
 
Generally, there were more robust discussions about oral sex than anal sex; participants 
associated oral sex with heterosexual sexual relationships while anal sex was described as 
either “foreign” or exclusively practiced by homosexuals. In addition, the notion that anal sex 
was not culturally acceptable was also demonstrated by FSWs who often considered that anal 
sex should not be openly discussed except among a trusted clique. Participants considered 
anal sex to be more stigmatising than oral sex, which is why it was being performed 
clandestinely. It is therefore not surprising that during the qualitative study, despite 
participants openly admitting that they had experienced anal sex, only one participant out of 
310 women in the general population face-to-face interview for the cross-sectional study 
admitted to any previous experience of anal sex. Similarly, only eight out of 315 FSW reported 
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ever practising anal sex, despite the assertions in this study and previous studies among FSWs 
that anal sex can be used to negotiate for more money from male clients [371, 461, 462]. 
Since financial incentives was the most common reason why women practiced sex work, one 
would have expected that many FSWs that participated in the SHINI study would have 
reported anal sex experience [419, 424]. It is also plausible that participants might be afraid 
to openly discuss anal sex because of the link between anal sex and homosexuality in the 
country. Nigeria has banned same sex marriage and made it a punishable offence [463].  
 
In this study, whilst the young people (18-25 years) freely described the sources of 
information they used to learn about different sexual behaviours, the adult participants were 
reluctant to discuss their sources of information pertaining to oral and anal sex. Generally, 
participants learnt oral and anal sex from watching pornographic films, sexual partners and 
friends. Similar sources of information have been reported in previous studies, with watching 
pornographic films being the most common [365, 464]. Watching sexually explicit films could 
generate curiosity [346], which may provoke interest in young people, as demonstrated in 
this study when some adolescents mentioned adventure as the sole reason for practising oral 
or anal sex [365, 464]. However, a study among 175 university students demonstrated that 
participants considered that learning about sexual activity through watching pornographic 
films was overrated among other sources of information and the majority believed that 
learning through peers was the most common method [465].                                                                                                                                                                                                                                                                                                                                                                                                                                       
 
6.1.2. Attitude, motivations, potential health risks and stigma for engaging in 
oral and anal sexual behaviour 
The motivation for engaging in oral and anal sex appeared to be driven by different gender 
perception and fear of poverty. Most women in the study reported reluctantly allowing their 
male sexual partners to practice oral and anal sex because of the fear of losing them to other 
competitors. Women appear to perceive the protection of their sexual relationship as their 
responsibility and some female participants allowed their partners to have oral and anal sex 
with them despite experiencing some discomfort or health related challenges such as severe 
pain or bleeding. A study in South Africa also found women engaging in heterosexual anal sex 
against their personal wishes in order to secure their sexual relationships [323]. Other reasons 
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for practising oral sex among women may possibly be to obtain or seek favours from men. 
This is further corroborated in the quantitative study in Chapter 4 where transactional sex 
was found to be associated with the report of ever engaging in oral sex among women.  
 
Understandably, the struggle for survival and fear of poverty was the most frequently 
mentioned reason for engaging in oral and anal sex among the FSWs. Negotiation for higher 
fees incentivised FSWs to engage in sexual risk behaviours such as condomless sex, as well as 
oral and anal sex with their male clients despite their knowledge of potential associated 
health risks [303, 304]. Similar reasons for engaging in oral sex could be deduced from the 
cross-sectional study. FSWs who earned better monthly pay had greater odds of ever having 
given or received oral sex. Previous studies from South Africa and in developed countries have 
documented that FSWs negotiate for increased fees in exchange for sexual risk behaviours 
[371, 466, 467]. In another study, FSWs had been reported to negotiate for unsafe sex in 
exchange for illicit drugs [468]. In this study, illicit drug use by FSWs was associated with nearly 
two times the odds of reporting ever receiving oral sex from a male client. However, sex in 
exchange for illicit drugs was not explicitly mentioned by FSWs in both the qualitative and 
quantitative SHINI studies.  
 
The majority of young people (18-25 years) and adults had good knowledge of associated 
health risks with oral and anal sex. In the qualitative study, women itemised more health-
related concerns with respect to oral and anal sex than men, whilst they also expressed more 
concern regarding their health, in conjunction with their social and emotional wellbeing. The 
health risks that were highlighted to be associated with oral and anal sex were STIs, HIV, HPV 
and cancer. There was also an anxiety around other possible diseases or infection that might 
not be known now but could cause problems for them in the future. This contrasts with a 
study in the UK among males and females that showed that participants were not concerned 
about contracting any disease from anal sex, although male participants were more worried 
about their personal hygiene from faecal soilage [469]. In the same study, male participants 
were also afraid of the social stigma associated with giving a female partner oral sex [470]. 
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6.1.3. Prevalence of oral, genital and anal HPV infections among women and 
FSWs 
The two SHINI cross-sectional studies presented one of the largest data on the epidemiology 
of HPV infection in the cervical, vulvar, anal and oral anatomic sites among sub-Saharan 
African women from the general population and from brothels. The study established a high 
prevalence of any HPV, HR-HPV, LR-HPV and multiple HPV infections among women in the 
general population and FSWs in all the four anatomical sites. As expected, there were higher 
prevalences of HPV infections among FSWs, although these prevalences followed the same 
pattern of the highest prevalence in the vulvar samples and lowest in the oral samples. 
Generally, FSWs are occupationally more exposed to sexual risk behaviours and at higher risk 
of STIs, including HPV infection, compared to women in the general population. 
The relative high prevalence of HPV among the youngest group (18-24 years) of participants 
in both population groups is not surprising; the incidence of HPV infections tends to be very 
high around the period of sexual initiation and genotype-specific infections typically clear over 
time. However, the high HPV prevalence among the adult population could suggest 
persistence, reactivation of old infections or new infections.  
 
The prevalence of cervical HPV among women in the general population in this study (59.7%) 
was higher than previous similar studies in Nigeria that reported cervical HPV prevalences of 
between 26.3 and 37.0% which were conducted 5-10 years ago[163, 381]. This may be due to 
a number of reasons. First, the age range of eligible participants in the SHINI study was 
narrower compared to previous Nigerian studies that included women with a wide age range 
including women aged 50 years and above. There were more younger participants in this 
study than previous Nigerian studies.  Second, HPV is becoming more prevalent due to 
changes in sexual behaviours, condom use and number of sexual partners.  Third, the HPV 
diagnostic tests that were used in the previous studies in Nigeria excluded LR-HPV and some 
HR-HPV genotypes. Several of the previous studies also used DNA primers that may not be as 
sensitive as the Anyplex II HPV28 [381, 382, 471-473]. A study showed that MY09/MY11 
consensus primers have a lower detection rate for HPV relative to the more recent PCR 
platforms [381, 471].   
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The prevalence of any anal HPV in this study (56.8%) is higher than the reported prevalence 
of 41.8% reported by GeneXpert and 40.8% from Hybrid capture techniques among HIV 
positive women in South Africa [74]. Both the Hybrid capture and GeneXpert methods detect 
lower numbers of HPV types per sample relative to the Anyplex II platform [474]. Additionally, 
the low prevalence of vulvar HPV reported in a Chinese study compared with this study could 
be due to the higher proportion of older women in the Chinese study [133].  
 
The high prevalence of vulvar HPV infection (87.9% versus 68.6%) compared to the cervical 
(84.0% versus 59.7%) and anal (74.6% versus 56.8%) HPV infections in both FSWs and women 
in the general population may possibly be due to any of these theoretical reasons. The vulva 
is the most externally sited anatomical structure of the three anatomical sites, making it at a 
high risk of contamination. It is also plausible that viral shedding from the cervix and anus can 
contaminate the vulvar area and be detected without this being true vulvar infection. The 
strong association between the risk of detecting vulvar HPV infection and the concomitant 
cervical and anal HPV infections observed in both FSWs and women in the community also 
confirms the possibility of a common source of HPV infections. 
 
6.1.4. Risk factors associated with HPV Infections in different anatomical sites 
The socio-demographic and behavioural factors associated with HPV infections in the two 
SHINI cross-sectional studies were different. The findings from SHINI study showed that 
participants that earned high monthly income had the higher odds of having anal HPV 
infection among FSWs compared to others. Anal HPV infection was associated with high 
number of multiple sexual partners, concomitant cervical, and vulvar HPV among women in 
the general population.  Anal HPV infection was also associated with vulvar HPV infection 
among FSWs. The observed strong association between concomitant oral and genital HPV 
infections or between two genital sites HPV infections have also been reported in several 
studies among women in Europe, USA and Australia [111, 128, 133, 475].  
 
273 | P a g e  
 
Although the qualitative study (Chapter 3) suggests that both women in the community and 
brothels engaged in receptive anal sex, the prevalence of reported anal sex in the two 
quantitative surveys was very low (1/310 in women in general population and 8/315 in FSWs), 
and this variable was not included in the risk factor analyses of anal HPV for chapter 4 and 
5.  Five published studies that explored association between receptive anal sex and HPV 
infection in women were reviewed [24, 125, 476-478]. Of these, two defined anal sex, one in 
Brazil and one in the United States (US) [125, 478]. The Brazilian study reported a unadjusted 
association between a reported history of ever having had anal sex and the presence of any 
anal HPV infection (Chi square; p=0.001) among women in Victoria[125]. The US (Hawaii) 
study reported an adjusted association between reported history of ever having anal sex and 
the presence of any anal HPV infection among women in Hawaii (AOR=1.79; 95% CI 1.10-
2.90)[478].  In this study, the ‘ever’ category was stratified into ‘current’ (defined as within 
the last three months) and ‘past’ (undefined) anal sex. There was a strong 
adjusted association between the reported current history of anal sex and presence of any 
anal HPV infection (AOR=3.13; 95% CI 1.28-7.66); however, the adjusted association between 
reporting a past history of anal sex and any HPV infection was much weaker (AOR=1.46; 95% 
CI 0.85-2.51)[478]. 
 
Cervical HPV infection among women in the general population was found to be associated 
with high multiple vaginal sex partners, concomitant vulvar, anal and oral HPV infections. 
Women aged 35 years and older had lower odds of cervical HPV. Previous studies conducted 
in Nigeria women in the community also showed an increase in risk of cervical HPV among 
women that are divorced or separated, who had no job or no monthly income and those that 
had no education [91, 163]. Other factors that were found to be associated with cervical HPV 
infections were early sexual debut, use of hormonal contraception, HIV infections, 
intravaginal practices, transactional sex, alcohol and cigarette smoking [10, 381, 479, 480]. 
Among FSWs in the SHINI study, cervical HPV infection was also associated with being HIV 
positive and having concomitant vulvar HPV infection. 
  
The strong evidence between oral HPV infection and HIV infection among women in the 
general population in this study has been previously reported [108]. The possible biological 
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explanation is that HIV can cause immunosuppression that makes an individual vulnerable to 
acquiring a new HPV infection, persistent infection and reduced rate of HPV clearance. The 
history of oral sex as a risk factor for oral HPV infection is mixed [107, 481]. Some studies 
reported a strong association between oral sex and oral HPV among females while others 
found no association [45, 107, 388]. A systematic review showed that oral HPV was 
significantly associated with having multiple oral sex, but not with the report of ever had oral 
sex[45]. Two meta-analyses of data in 2016 and 2018 involving 29 and 48 studies showed that 
women with history of smoking have higher risk of oral HPV than those without previous 
history of smoking [45, 108].   
 
Regarding the risk factors associated with vulvar HPV infections, women in the general 
population who were separated or divorced or currently married had lower odds of HPV 
infection relative to single women. Women whose age difference with their first vaginal sex 
partners was six years and above had lower odds of vulvar and anal HPV infections. In the 
general population and brothel participants of this study, concomitant cervical and anal HPV 
were found to be strongly associated with vulvar HPV. Association between genital sites HPV 
infections have also been reported among women in the general population and FSWs.  
 
6.1.5. The concordance of HPV genotype-specific infections in different 
anatomical sites 
The concordance rate of specific HPV genotype infection in two anatomical sites was higher 
than the comparison of HPV genotypes in three or four sites. Generally, the concordance rate 
in two anatomic sites among the FSWs was higher than the concordance rate among women 
in the general population. In both FSWs and women in the general population, the 
concordance rate was highest between cervical and vulvar samples, followed by the cervical 
and anal samples in FSWs and vulvar and anal samples in women in the community. The 
lowest concordance rate of HR-HPV was between oral and cervical samples in both 
populations. A similar pattern of concordance was observed for any LR-HPV genotypes in both 
population groups. 
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The observed high concordance rate between two contiguous anatomical sites is suggestive 
of a possible autoinoculation theory as there was no strong evidence of association between 
sexual behaviours of participants and HPV infections in any of these anogenital sites in this 
study. The concordance of HPV-16 infection in the cervical and anal samples was the highest 
of any HPV genotypes. This finding was also seen in a global meta-analysis that found a strong 
association between HPV-16 in the cervix and HPV-16 in the anus of the same individual [408]. 
In that study, the association of HPV-16 between the cervix and anus was found to be higher 
among HIV positive women than HIV negative. This could explain why a history of cervical, 
vulvar and vaginal cancers is a strong risk factors for HPV-associated anal cancers, in addition 
to immunosuppression, smoking and in men who have sex with men. Anal cancer is rare. It is 
more common in women than men [482]. It is now being advocated that anal cancer 
screening should be considered in women that have premalignant lesions of the cervix, 
particularly, when the associated HPV genotype is HPV-16. Although, there may be no data 
currently to back up similar observations between the vulva and cervix, the strong association 
between these two sites in this study suggest a need to always check for vulvar lesion among 
women with premalignant cervical lesions with positive HPV 16. 
 
 6.1.6. Implication of the specific HPV genotypes detected in the oral, genital 
and anal sites 
HPV-35 was the most prevalent HR-HPV genotype detected in the four anatomical sites 
among FSWs (4.3-20.1%) in addition to being the most concordant HR-HPV genotype in the 
four anatomical sites - cervical, vulvar, anal and oral - among FSWs. The most prevalent HR-
HPV genotypes among women in the general population was HPV 35 in the cervical (8.5%) 
and vulvar (8.7%) samples, HPV 52 (8.9%) in the anal samples and HPV 51 (3.2%) in the oral 
samples. HPV-16 was the most concordant HR-HPV genotypes in the four anatomical sites 
among women in the general population and the seventh concordant HR-HPV behind HPV-
35, -33, -51, -39, -18, -39 and -52 among FSWs.  HPV-16 and 18 are the most common 
genotypes in high-grade intra-epithelial lesions and invasive cervical cancer and Nigeria as 
well as in many countries in SSA and globally [162, 483, 484].  
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According to Okolo et al, HPV-16 accounted for 67.6% (95% CI, 55.2-78.5) of ICC, followed by 
HPV-18 in 10.3% (95% CI, 4.2-20.1) and HPV-35 in 5.9% (95% CI, 1.6-14.4) among 1,203 
samples of histologically confirmed ICC examined in Ibadan [162]. Data on HPV-associated 
anal, vulvar and oral cancers in Nigeria are rare. However, in 2019, a review of 738 cases of 
anogenital cancers from three referral hospitals in Rwanda found HPV-16 to be the 
commonest with a prevalence rate of 55.0%, 46.7%, 50.0% and 80.0% in the cervical, vulvar, 
vaginal and anal cancer samples, respectively [483]. Similarly, HPV-16 was also determined to 
be the most prevalent HR cervical HPV infections in women in West, East and Southern Africa 
[485-487]. The observed high prevalence of HPV-35, a genotype that is not covered by any of 
the three HPV licenced vaccines, may require further studies to compare its progression and 
clearance and persistence rates with HPV-16/18 among women. Persistence of HPV-35 could 
possibly increase the burden of a new variety of cervical cancer in the country.  
6.2. STRENGTHS OF THE THESIS 
The thesis included women in the general population and a section of a key affected 
population, brothel-based FSW, to document sexual behaviours and the epidemiology of HPV 
infections in Nigeria. The sequential mixed methods design offered a good opportunity to 
seek information from people in the community on the meaning, interpretations and 
reactions towards sexual behaviours during the qualitative study, whilst their valuable 
suggestions assisted in designing an acceptable tool to collect the quantitative data. For 
example, during the qualitative study, we learnt from the participants that a simple definition 
of oral and anal sex would be preferred and acceptable instead of using slang terminology.   
 
The SHINI project provides the first and the largest data on HPV epidemiology involving four 
different anatomical sample sites among sexually active women and FSWs in SSA. The studies 
explored the relationship between sexual behaviours and HPV infections and the different 
pattern of concordance rates were also analysed and presented. The study also offered 
information to compare the epidemiology of HPV women in the general population and FSWs.   
 
The studies had a low refusal rate for participation, particularly among FSWs, which 
potentially increases the representativeness of the findings. The high participation rate was 
probably due to the rigorous community engagement and advocacy visits that were employed 
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prior to the commencement of the study.  We worked with experienced individuals in the 
community as gatekeepers for both the household and brothel surveys to facilitate smooth 
access into the study sites. The research team also engaged the services of senior staff of Oyo 
State Government including the National Population Commission to have access to 
population data, identified study sites, and assisted in the boundary delineation. The use of 
gender matched research assistants and nurses to conduct interviews, clinical examinations 
and the collection of samples may possibly have also helped to reduce the chances of refusal 
among the participants. 
 
Another strength was the quality of information collected on oral and anal sexual behaviours 
among women in the general population and FSWs. In both the qualitative and quantitative 
studies of this thesis, a clear definition of different sexual behaviours was used to ensure case 
ascertainment. Participants during the FGDs and IDIs defined oral and anal sex and used these 
definitions to further discuss their experiences. Similarly, interviewers used simple definitions 
of different sexual behaviours to ask questions during the cross-sectional study to ensure 
accurate information was collected during the interviews. 
 
6.3. LIMITATION OF THE RESEARCH FINDINGS 
6.3.1. Generalisability issue 
The relatively small number of FGDs and IDIs conducted among FSWs during the qualitative 
study and the sampling strategy used during the quantitative study could limit the 
generalisability of the findings obtained in this thesis. Although a qualitative study does not 
require calculation of power to determine whether or not the sample size is adequate, it 
remains desirable that there should be adequate representation of potential participants to 
exhaustively discuss or answer the research question, depending on the theoretical concept 
[488, 489]. In this study, 18 FGDs and 39 IDIs were conducted among the people in the 
community compared to 2 FGDs and 5 IDIs among FSWs. The relatively small number of 
interviews and discussions among FSWs might not have exhaustively presented all views on 
sexual behaviours. For example, conducting an FGD among homogenous group of FSWs could 
have brought depth to some particular aspect of the discussion, which may not have 
materialised due to group dynamics. There are other FSWs who are not brothel based that 
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might provide a different perspective on the different sexual behaviours that were discussed. 
One more issue that can potentially affect generalisability was the error that occurred during 
the second stage sampling of female participants in the community in the quantitative cross-
sectional study in Chapter 4. The unfortunate error that occurred during the second stage 
sampling of potential participants in the community make it difficult to calculate population 
estimates.    
 
The SHINI study enrolled women aged 18-45 years in both cross-sectional studies and 
therefore there are no data on sexually active women who were outside this age range. 
Available data in Nigeria suggest that the average age of vaginal sex debut in females is 16 
years with variations across the six geo-political zones in the country [490, 491]. Women who 
are 45 years and above are sexually active and may also engage in sexual risk behaviours. 
Exclusion of women aged 45 years and over may be one of the reasons why a second peak of 
HPV prevalence was not observed in the SHINI study. The non-inclusion of young adolescents 
(<18 years) in this study is another potential source of limitation that could limit the 
generalisability of findings. It is plausible that young adolescents aged less than 18 years might 
have different behavioural pattern on sexual risk behaviour. 
6.3.2. Lack of information on causality 
The cross-sectional design of the two quantitative studies cannot provide data to establish 
temporal causality between any of the explanatory variables and HPV infection in the risk 
factor analyses. The design also means that there are no data on the incidence, persistence 
and clearance of new HPV infections among the study population. 
 
6.3.3. Social desirability bias 
The stigma around sexual behaviour is associated with social desirability bias which can 
negatively affect the quality of data collected. Social desirability bias could occur during FGDs 
and IDIs, or during the face-to-face interviews in the cross-sectional study, especially when 
sensitive issues are been discussed. A number of participants, both in the community and 
brothels, mentioned during IDIs that they only shared their anal sex experiences with “trusted 
friends or clique”.  
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The face-to-face interviews could cause under- or over-reporting of sexual behaviours by 
participants.  There is also a possibility of gender motivation bias during a face-to-face 
interview on sexual activity. Generally, males tend to exaggerate their sexual experience as a 
marker of their sexual maturity [492, 493]. Despite young people in the qualitative study 
discussing their experiences included of oral and anal sex, only one participant volunteered 
information on her experience of anal sex out of 310 participants sampled in the community 
and only eight people among the FSWs during the survey. Under-reporting of anal sex may 
well have occurred since both population groups had a high results of anal HPV infections 
despite very few participants reporting receptive anal sex. 
 
6.3.4. Important explanatory variables that were not measured 
There were some valuable explanatory variables that should have been included in the study 
but they were not included due to limitations with logistics and the budget. For example, an 
STI diagnosis was made following a clinical history and examination conducted by a research 
nurse without any laboratory tests. Laboratory evidence of reproductive tract infections, 
including bacterial vaginosis, would have provided more insight on the biological factors 
associated with the epidemiology of HPV infection in this study.  
 
The research did not provide information on the pattern of pre-malignant lesions in the study 
population. Studies have shown that the prevalence of HPV infection tends to be higher 
among subjects that have abnormal cervical cytology or histological evidence of microinvasive 
cancer than those with normal cytology [162, 494]. For example, in the Idikan study in Ibadan, 
Nigeria, the prevalence of cervical HPV infection was 24.8% and 40.9% in women with normal 
and abnormal cytology, respectively [381]. The study did not collect information on HPV 
vaccination history. Although Nigeria has not introduced routine HPV vaccination, some 
Nigerians have been purchasing HPV vaccine from private practitioners. A dose of HPV vaccine 
in Nigeria costs about 5.0 USD in Nigeria which is not affordable for many Nigerians.  
 
6.3.5. Sources of missing data in SHINI study 
There were certain variables with missing observations in the results. Missing observations 
typically bias results, especially when there is a significant difference in the characteristics of 
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participants with and without missing results. During the study, we conducted quality check 
to minimise this problem. Two of these quality checks were conducted in the field before 
participants left the clinic, while a third check was also conducted prior to data entry into the 
REDCap server (Vanderbilt University, Nashville Tennessee, USA)[394, 396]. Despite these 
measures, some data were still missing. In addition, participants that gave a response of “can’t 
remember” or declined to answer a question were also considered as missing observations. 
Furthermore, the biological samples that were categorised as invalid samples in the 
laboratory for HPV genotyping were also treated as missing observations. Although the 
number of invalid samples was relatively small in the anogenital samples, a high number of 
invalid samples were detected in oral samples, particularly among FSWs (33/315; 10.5%) 
compared to women in the community (24/310; 7.7%). Exclusion of these invalid samples can 
potentially bias the results of HPV prevalence.  
 
The Anyplex II assay does not detect all HPV genotypes and for this reason, it is possible that 
some HPV genotypes may have been missed in this study [495]. Roche Linear array technology 
that can detect 37 different HPV genotypes was not used because of the high cost of budget 
compared to the Anyplex II assay.   
  
6.4. PUBLIC HEALTH IMPLICATIONS OF THE RESEARCH FINDINGS 
The findings from this thesis have a number of public health implications for Nigeria and for 
SSA. Nigerian young people and some adults engage in different sexual risk behaviours and 
the poor risk perception and lack of necessary information that will encourage safe sexual 
behaviour among women will continue to increase the rate of acquisition and transmission of 
STIs including HPV in the community as they may not appreciate the health problems 
associated with these sexual behaviours. Despite the legal restriction on sexually explicit 
movies in Nigeria, the data from this study, like other previous studies, showed that 
pornographic films remained one of the most common sources of learning about sexual 
activity, particularly among the young people in the country [496-498].  Some Nigerian studies 
also reported that young people used internet on their mobile phones or computers and 
through television programme to watch pornographic film [496-498]. Watching pornographic 
films has been associated with sexual risk behaviours, including engaging in condomless 
vaginal, oral and anal sex in Nigeria [496-498]. 
281 | P a g e  
 
 
HPV awareness was low; only 4% among FSWs and 7% among women in the two communities 
had ever heard of HPV in a population that harboured a high prevalence of HPV infection. 
Nigeria has not yet introduced HPV vaccines. Previous studies among women of reproductive 
age groups in Nigeria have demonstrated poor knowledge of HPV, HPV vaccine and the 
associated morbidities [499, 500]. Studies in Nigeria showed that 4-10% of women were 
aware of HPV. Encouragingly, more than 80% of them were willing to allow their children to 
have the HPV vaccine if it was introduced [499, 501].  
 
Although the Nigerian Federal Ministry of Health launched a five-year strategic plan for cancer 
control last year and made the implementation of HPV vaccine a priority as part of the effort 
to eliminate cervical cancer, Nigeria no longer receives GAVI grant support to procure HPV 
vaccine at subsidised amounts due to the country’s weak health system and poor routine 
immunization indicators. HPV vaccination has been associated with a reduced burden of 
premalignant lesion and HPV-associated morbidities cervical cancer and genital warts [52, 
502]. The data has the potential to assist experts and policy makers to provide hard evidence 
for an urgent need to prioritise HPV vaccination, promote massive campaign on HPV and HPV 
vaccine awareness. The SHINI data can also offer useful information to plan a robust 
community engagement strategy to break the myth of misconceptions and cultural barriers 
against the acceptance of HPV vaccination in Nigeria. For example, engagement of religious 
leaders may be a useful approach to gain trust of people in the community because the role 
of religion in sexual activity was highlighted in the qualitative study in Chapter 3. 
 
Although the SHINI study did not provide information on the prevalence of pre-malignant 
lesions among participants, given the high prevalence of HPV in this setting and potential co-
infection with HIV, especially in vulnerable populations like FSW, it is beneficial to plan and 
screen individuals that may harbour persistent infections. Currently, cervical cancer is the only 
HPV-associated cancer that is recommended for population screening, although some 
professional associations have also recommended screening for anal cancer among MSM in 
USA and Australia [503-505]. The WHO recommends cervical cancer screening at least once 
in a lifetime for every woman in low income countries. The most appropriate time for this 
screening is between the ages of 30 and 49 (Figure 6.1) [66]. In Nigeria, the recommended 
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screening algorithm is HPV DNA testing and VIA or Pap smear, followed by colposcopy for 
those with abnormal results. This approach, if well implemented in relation to every woman 
that is eligible in Nigeria will help to drastically reduce the burden of HPV infection, associated 

















The high prevalence (41% in FSWs and 54% in the general population) of female genital 
mutilation observed among the study population underscores the importance of socio-
cultural beliefs in SSA. It is also interesting that women who were residing in a peri-urban 
environment had a significantly higher proportion female genital mutilation than those living 
Figure 6.1. Algorithm for Cervical cancer screening for low income countries 
Source: Comprehensive cervical cancer control: a guide to essential practice – 2nd Edition (WHO 2014) 
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in urban environment (61% versus 46%, p<0.001). This result is similar to the prevalence 
observed in the national demographic health survey and other similar studies in Nigeria that 
reported 40 to 50% of women undergoing genital mutilation [506, 507]. However, the SHINI 
study did not classify female genital mutilation based on the degree of the trauma. Female 
genital mutilation has been associated with poor sexual and reproductive health outcomes 
including post-traumatic stress disorders, sexual dysfunction and obstetric complications 
during childbirth [506, 508]. The observed association between female genital mutilation and 
the risk of HPV associated cancer may be confounded with socioeconomic factors – age, 
ethnicity, religious belief and wealth indices. The association between female genital 
mutilation and HPV associated cancer might be due to increase in sexual risk behaviours 
among those that had suffered from genital mutilation. For example, in this study, the odds 
of reporting a history of oral sex was two times greater among women in the general 




6.5.1. Sexual Health Education 
The emerging pattern of sexual risk behaviours and high burden of HPV infections, specifically 
among young people requires urgent steps to increase awareness on safe sexual practices. In 
2003, the Nigerian government introduced sexuality education labelled as Family Life and a 
HIV Education (FLHE) programme as a way to introduce health education to children and 
adolescents in schools [509]. The existing FLHE curriculum has been heavily criticised because 
of the narrow focus on abstinence alone [509]. It is recommended that the FLHE curriculum 
should be broadened to include other contextual sexual health related issues such as 
information about different sexual behaviours and associated health risks like HIV and HPV 
infections, as is currently being implemented in high-income countries. Some countries in 
Europe established youth friendly centres where sexual and reproductive health services 
including counselling for safe sexual practices are provided to the youths[510].  It is also 
important that provision should be made in the implementation of FLHE to cover out-of-
school children and the key affected populations such as the FSWs, MSMs and other groups. 
The Nigerian Broadcasting Commission, the agency in charge of monitoring media 
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transmission had banned all forms of pornographic films on local media stations including 
social media platforms in Nigeria[511]. The 2015 cybersecurity act in Nigeria also banned child 
pornography[512]. These laws would need to be enforced to reduce the circulation of sexually 
explicit movies among young people[511, 512]. Awareness creation in the communities 
through the engagement of community heads, religious organisations and opinion leaders as 
well as peer educators to discourage the use of telephone and other social media platforms 
to share or watch pornographic films in order to reduce the risk of sexual risk behaviours.  
 
6.5.2. Need to invest in HPV vaccination in Nigeria 
HPV vaccination is pivotal to the prevention of HPV associated morbidities, particularly, the 
associated cancers. First, it is necessary for the government to create awareness of HPV 
infection and its sequaelae as part of STI prevention programmes. The creation of awareness 
should involve the men, women and children in the community and the key affected 
population communities. Second, the high burden of HPV requires that in the Ministry of 
Health in Nigeria should invest in the purchase and distribution of the HPV vaccine. 
Worldwide, the most effective approach as regards the HPV vaccination programme is via 
schools [55, 513, 514]. Although vaccination of girls should be prioritised and quickly 
implemented on a national scale to achieve herd immunity, inclusion of boys will reduce the 
inequality and stigma associated with vaccinating girls alone [55, 513, 515]. However, Nigeria 
might need to modify this approach because of the high number of out of school children that 
will be eligible for HPV vaccination Two-third of the 10.5 million out of school children (5-14 
years) in Nigeria are girls[516]. It is also essential to consider catch-up vaccinations for those 
who could have been sexually exposed at an early age and before the recommended age for 
HPV vaccination [517, 518].  
 
6.5.3. Screening of other genital and anal sites? 
The high prevalence of HPV and concomitant rate between anal and genital sites, particularly 
between cervical and anal HPV infections. This finding is suggestive of multiple sites HPV 
infection among sexually active women in the community. It is recommended that  women 
with high intraepithelial neoplasia lesion of the cervix especially with HPV-16 should also be 
screened for anal lesions[519]. Anal cancer is rare in Nigeria with age standardised incidence 
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rate of 0.6 per 100,000 in women [158]. There is lack of data on anal dysplasia among women 
in Nigeria. However, a study in Abuja Nigeria among 424 MSM that were screened with anal 
cytology showed that 10.5% had low-grade squamous intraepithelial lesions while 6.3% had 
high-grade squamous intraepithelial lesions[520]. In the same study, two third of MSM with 
premalignant lesion of anal canal were HIV positive. Women with high-risk anal HPV, 
especially those infected HPV-16 and -18 should be monitored for any evidence of persistence 
infection with HPV DNA and anal cytology screening as first line methods and high resolution 
anoscopy as a second line. The cost effectiveness of population screening for anal 
premalignant lesions among women is yet to be ascertained. Recommendation to screen for 
anal premalignant lesions should be individualised based on risk factors and medical history. 
 
 
6.5.4. More scientific evidence on the epidemiology of HPV in Nigeria 
Due to the limitations associated with cross-sectional studies, it will be informative to conduct 
longitudinal studies among different age group of women to measure the incidence, 
clearance and persistence of HPV in the four anatomical sites. Inclusion of adolescent girls 
before they become sexually active and possibly acquire HPV in the study will provide 
information to guide in making decision for the appropriate age to introduce HPV vaccination 
in Nigeria. Information on the role of HPV vaccination will be important in future studies in 
order to understand the impact of the vaccine in the epidemiology of HPV in Nigeria. It will 
also be necessary to consider the inclusion of young adolescents that are less than 18 years, 
men, MSMs and other people of different sexual orientation. Further exploration of the 




This thesis has described the epidemiology of HPV infection among women and FSWs using 
data from both the qualitative and cross-sectional studies to determine and explain the 
observed high burden of HPV in each of the four anatomical sites – (cervix, vulva, anus and 
oral cavity) among women in the general population and FSWs in the brothels. The findings 
obtained by this thesis revealed that the prevalence of HPV is high. HPV-35 was found to be 
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the most prevalent HR-HPV in all the four anatomical sites in FSWs and in the cervical and 
vulvar sites of women in the general population. HPV 52 and HPV-51 were the most common 
HR-HPV genotypes detected in the anal and oral sites, respectively, among women in the 
community. The thesis also provided information on the meanings, interpretation and 
attitudes towards different sexual behaviours, including the possibility of under reporting of 
these behaviours. Young people of 18-25 years of age are particularly practicing different 
sexual behaviours and most of these sexual practices were learnt from watching pornographic 
films. The public health implications of these findings including recommendations covering 
the primary and secondary prevention strategies were discussed. A longitudinal study was 
recommended to further investigate the epidemiology and associated morbidities of HPV 
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ANNEXTURES 
ANNEX 3.1: FGD TOPIC QUIDE QUESTIONS 
 
GENERAL INSTRUCTIONS FOR THE MODERATOR 
Before you start each session of the FGD, please ensure that following issues are addressed: 
i. Make sure all the invited participants are seated and comfortable 
ii. Start by welcoming them to the session 
iii. Introduce yourself (name and your role in the project), and the note taker. Send round a data collection 
sheet to all participants to capture some of their demographic information. 
iv. Ensure every participant consented to the FGD by checking their consent form or verbally verify from 
those that opted for oral consent. 
v. Review the purpose of the FGD (i.e. the study objectives) and emphasise that we are hoping to learn 
from everyone through the discussion. Let them also know that the discussion is not about right or 
wrong answer or consensus; but every opinion is needed on issues that will be discussed.  
vi. Set some ground rules by allowing the participants suggest these rules (examples are: respect all 
opinion, do not abuse, listen when others are talking, allow your colleagues to hear their view, turn off 
mobile phones or put in silent mode etc) 
vii. Discuss other logistics such as location of the bathroom and refreshments. Tell them that the session 
will not exceed an hour 
viii. Finally, confirm that everyone is happy with recording equipment; turn it on when you are ready to 
start the session. 
SPECIFIC INSTRUCTIONS ON HOW TO MODERATE FGD 
a. Give time for participants to think before answering your questions. 
b. Do not rush to end discussion of questions, only move on to the next when you begin to hear repetition. 
c. Ensure that everyone participate by moderating those that are domineering and encourage the quiet 
members to speak. 
d. Try to generate further discussions with follow-up probes on issues that are not mentioned or that you 
think are not clearly discussed.  
e. Summarise what you think are the key messages after each question has been exhaustively discussed, 
and ask participant again whether your summary captured their thought 
FGD QUESTIONS 
The following questions will guide the discussion in an open way. 
1. Let us start with this question; how do people learn about sexual behaviours generally? Do the ways 
people learn these sexual behaviours differ?  
a. Probe for sources of knowledge or information (friends/peers, family, religious group, TV/radio, 
Literature/school, internet or films etc) 
b. Probe whether sources of information might influence what type of sexual behaviour people 
learn 
c. How about you, how did you learn about oral/anal sex? 
2. What does oral sex mean to you?  
a. Probe for when a man (boy) is giving oral sex to a woman (girl) (i.e. when a man use his mouth 
or tongue to touch the private part of a woman) 
b. Probe for when a woman (girl) is giving oral sex to a man (boy) (i.e. when a woman use her 
mouth or tongue to touch the penis of a man) 
c. Probe for same sex oral sex (i.e. man to man or woman to woman) 
	
320 | P a g e  
 
3. What does anal sex mean to you?  
a. Probe for when a man (boy) is giving anal sex to a woman (girl) (i.e. when a man put his penis 
inside the anus of a woman)  
b. Probe for when a man (boy) is giving anal sex to another man(boy) (i.e. when a man put his 
penis inside the anus of another man) 
4. People use different names (terms) to describe types of sexual behaviours in the community, and these 
names might have different meanings or interpretations.  What are the various names (terms) including 
slang that are used to describe oral sex? (Ascertain whether there is any difference between formal or 
local names, terms by health professionals and slang for oral sex)? 
a. Probe for when such names or slangs are usually used? 
b. Probe for how people feel when such names or slangs are used (acceptability) in the 
community?  
c. Probe for whether people understand the meaning of those names or slang when they are used 
to describe oral sex?  
d. Probe for which of these names (terms) that people will be happy to see in the questionnaire if 
we are to ask men or women about oral sexual behaviours in the community? 
5. Like I said earlier when we were talking about oral sex, people use different names (terms) to describe 
types of sexual behaviours, what are the various local names including slang that are used to describe 
anal sex? (Ascertain whether there is any difference between formal or local names,  terms by health 
professionals and slang  for anal sex) 
a. Probe for when such names or slangs are usually used? 
b. Probe for how people feel when such names or slangs are used (acceptability) in the 
community? Probe: Might anyone find these terms offensive? 
c. Probe for whether people understand the meaning of those names or slangs when they are 
used to describe anal sex?  
d. Probe for which of these names (terms) that people will be happy to see in the questionnaire if 
we are to ask men or women about anal sexual behaviours in the community? 
6. What are the reasons why some people engage in oral or anal sex, and why others do not?  
a. Probes for reasons e.g. because it is pleasureable, to avoid HIV, to avoid pregnancy, because 
they feel obliged or are forced, because they wish to do the same things as their friends report 
doing or because of money or benefit etc   
b. Probe for  reasons for oral sex  
c. Probe for reasons tor anal sex  
7. We’ve talked about some of the reasons why people do or do not engage in different behaviours. Are 
there any other advantages or disadvantages, in your opinion?  
a. Probe for oral sex 
b. Probe for anal sex 
c. Probe for risks if not covered in discussion so far 
d. Probe for knowledge of common sexually transmitted infections including human 
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ANNEX 3.2: IDI TOPIC QUIDE QUESTIONS 
GENERAL INSTRUCTIONS FOR THE INTERVIEWER 
Before you start each IDI session, please ensure that following issues are addressed: 
ix. Make sure the participant is comfortable with the venue 
x. Thank and welcome participant to the session  
xi. Introduce yourself (name and your role in the project). Ask the participant to fill in his or her 
demographic information into a data collection sheet (age, sex religion, ethnicity and marital status).  
xii. Ensure that the participant consented (written or verbal depending on their choice)  
xiii. Review the purpose of the IDI (i.e. the study objectives) and emphasise that we are hoping to learn 
from the participant’s experience.  
xiv. Finally, confirm that the participant is happy with the recording equipment; turn it on when you are 
ready to start the interview. 
SPECIFIC INSTRUCTIONS ON HOW TO CONDUCT IDI 
f. Give time for participant to think before answering your questions 
g. Do not rush to move on to the next question until you begin to hear repetition 
h. Try to generate further discussions with follow-up probes on issues that are not mentioned or that 
you think are not clearly discussed  
i. Summarise what you think are the key messages after each question has been answered, and ask 
participant again whether your summary captured their thought 
IDI QUESTIONS 
The interview will involve structured and open questions on the following topics: 
A.) GENERAL SEXUAL BEHAVIOUR QUESTIONS 
8. Let me start with this question; how do people learn about sexual behaviours generally? Do the ways 
people learn these sexual behaviours differ?  
a. Probe for sources of knowledge or information (friends/peers, family, religious group, 
TV/radio, Literature/school, internet or films etc) 
b. Probe whether sources of information might influence what type of sexual behaviour people  
learn 
c. How about you, how did you learn about oral, how did you learn about anal sex? 
9. What does oral sex mean to you?  
a. Probe for when a man (boy) is giving oral sex to a woman (girl) ( i.e. when a man use his 
mouth or tongue to touch the private part of a woman) 
b. Probe for when a woman (girl) is giving oral sex to a man (boy) (i.e. when a woman use her 
mouth or tongue to touch the penis of a man) 
c. Probe for same sex oral sex (either man to man or woman to woman) 
10. What does anal sex mean to you?  
c. Probe for when a man (boy) is giving anal  sex to a woman (girl) (i.e. when a man put his 
penis inside the anus of a woman)  
d. Probe for when a man (boy) is giving anal sex to another man(boy) (i.e. when a man put his 
penis inside the anus of another man) 
 
B.) SPECIFIC INTERVIEW GUIDE 
Only for those with previous oral sex experience [I will like to seek further clarifications on your experience 
about oral sex].  
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11. In your opinion, what will you say are the reason(s) that motivates or make you avoid oral sex with 
your partner now? 
a. Probe for fear of pregnancy 
b. Probe for perception of risk (may be its less riskier) 
c. Probe for partner pressure or transactional benefits (money or favour) 
12. Do you see any risks in having oral sex? 
a. Probe for knowledge of any health risks (sexually transmitted infection; HIV and human 
papillomavirus etc) 
b. Probe for any previous experience (stigma, discrimination, injury etc) 
 
Only for those with previous anal sex experience  
[I will like to seek further clarifications on your experience about anal sex].  
13. In your opinion, what will you say are the reason(s) that motivates or make you avoid anal sex with 
your partner? 
a. Probe for what motivated then, how about now? 
b. Probe for fear of pregnancy 
c. Probe for perception of risk (may be its less riskier) 
d. Probe for partner pressure or transactional benefits (money or favour) 
14. Do you see any risks in having anal sex? 
a. Probe for knowledge of any health risks (sexually transmitted infection; HIV and human 
papillomavirus etc) 
b. Probe for any previous experience (stigma, discrimination, injury etc) 
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ANNEX 3.3: INFORMATION SHEET AND INFORMED CONSENT FORM 
FOR FGD 
Investigators: Dr. Imran O. Morhason-Bello, & Prof. Isaac F. Adewole 
 
Organization:  University of Ibadan 
 
Sponsor:   University of Ibadan 
 
You are being invited to take part in a research study.  Before you decide it is important for you to understand, 
why the research is being done and what it will involve.  Please take time to read the following information 
carefully and to talk to others about the study, if you wish.  Ask us if there is anything that is not clear or if you 
would like more information.  Take time to decide whether or not you wish to take part. 
 
1. What is the purpose of this study?  
We think that sexual behaviour may be changing in Nigeria, and we would like to document this so we can 
develop policies and programmes that help people to have healthy lives in Nigeria. We will try to learn from your 
perceptions and understanding of different types of sexual behaviours from what you know, learn and practiced. 
We are conducting this study in men and women aged 18-45 years living in selected communities in Ibadan. This 
project is being undertaken in part fulfillment for the award of research degree (PhD) at the London School of 
Hygiene and Tropical Medicine, London. 
 
2. Why have I been chosen?  
We are inviting men and women who are 18-45 years living in selected communities in Ibadan to participate in 
this study. We have asked you to participate because you are an adult representative of people in your 
community/workplace and we hope that you can offer us some useful information about different sexual 
behaviours. 
 
3. What will happen if I join this study? 
We will ask you to join other people of the same age range and gender to participate as a group. The focus group 
will involve 6 – 10 participants. The discussion will be moderated by an experienced moderator who is of the 
same gender with you, and it will take an average time of 45 – 60 minutes. The discussion will be conducted in 
a private venue that is convenient to you and other members of the group. 
The research team member will provide detailed explanation to all your questions and concerns regarding your 
participation in this study. After satisfactory explanation, you will be asked to sign or thumbprint on this consent 
form. You will also be asked if you mind that the discussion is recorded. The discussion will be casual and you 
will be encouraged to talk freely about anything you feel is related to the questions. We will be interviewing 
people for about three months on this subject. You will only be asked to participate in this study once, although 
a few people may be asked to attend an additional interview later.  
 
4. Will I be paid to be in this study? 
We will compensate you with 1000 naira (£3.5) as stipend for transport and time spent for participating in the 
focus group discussion. We will also give you light soft drink and biscuit after the discussion.  
 
5. What are the risks or discomforts of the study? 
You may feel shy or embarrassed by the questions that we will be asking you. You may decide to refuse to answer 
any question if you feel uncomfortable. To minimize the possibility of feeling embarrassed, our study has a 
trained staff member who will help you deal with any bad feelings or embarrassing questions. We do not think 
there are any other risks involved in your taking part in this study. However, if you do feel that you have suffered 
harm as a result of taking part in the study then you should discuss this with this principal investigator:  
Dr. Imran Morhason-Bello, Department of Obstetrics and Gynaecology, College of Medicine, University College 
Hospital/University of Ibadan, Oritamefa, Ibadan. Tel:+2347034784402. 
 
6. Are there any benefits to being in the study?  
We will use the information gained to improve the quality of the large household survey we are planning to 
conduct at another community in Ibadan, Nigeria.   
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7. How will my privacy be protected?  
We will do everything we can to protect your privacy while you participate in this study. The group discussion 
will be held in private place and will be led by a trained research team member. Your personal records (e.g. your 
name, or place of residence) will only be available to the staff involved in this study. The copy of the digital 
recording will not have your name attached to it. We will be preparing a report about this study and we may 
quote some of the words you tell us in the report. In this report any words that you have told us during the 
interviews will not have your name attached to them. To keep your information confidential all recordings and 
forms will be kept safe and locked in the principal investigator’s office at the University College Hospital, 
Oritamefa, Ibadan. The signed consent form by you gives your permission that your records may be reviewed by 
the institutional review board (IRB) or institutional ethics committee (IEC) who protect the rights of human 
volunteers. However, no reports about this study will identify you in any way.  
8. What will happen to the results of the research study? 
We will analyse the results without including your name and any other information that could potentially breach 
your privacy. Findings from this study will be used to design questions that will be used in the survey that will 
plan to conduct immediately after this study. The result will also be presented for the defense of a PhD 
programme at the London School of Hygiene & Tropical Medicine, London. We will share our experience from 
the study by presenting our findings at conferences and submit to journals for scientific publication 
9. What will happen if I don’t want to carry on with the study? 
Your participation in this study is voluntary. It is your choice whether you want to take part in the study or not. 
You can decide not to participate in the study at any time, even after you have given verbal consent or after we 
have signed on your behalf this written Informed Consent Form, or even during the group discussion. You do 
not have to give a reason for wanting to stop being part of the study.  
10.  What if something goes wrong? 
If you have a concern about any aspect of this study, you should ask to speak to the researchers who will do 
their best to answer your questions. If you remain unhappy and wish to complain formally, you can do this 
through The Provost, College of Medicine, University College Hospital, Oritamefa, Ibadan, Oyo state. If you are 
harmed due to someone’s negligence, then you may have grounds for a legal action.  Regardless of this, if you 
wish to complain, or have any concerns about any aspect of the way you have been treated during the course 
of this study then you should immediately inform the Principal Investigator; Dr Imran Morhason-Bello, 
Department of Obstetrics and Gynaecology, College of Medicine, University College Hospital/University of 
Ibadan, Oritamefa, Ibadan. Tel:+2347034784402 
10. Who is organizing and funding the research? 
This research is being conducted as part of requirement for the award of PhD at the London School of Hygiene 
& Tropical Medicine, London. Funding for this research was provided by the management of University of Ibadan 
as part of scholarship award for the PhD programme.  
11.  Who has reviewed the study? 
The research study has been approved by the ethics committees of the Oyo State Government, State Secretariat, 
Ibadan, University of Ibadan/University College Hospital, and the London School of Hygiene & Tropical Medicine, 
London. These committees make sure that the study is carried out in the safest way possible. 
12. Who do I contact if I have any questions? 
If you want to talk to anyone about this research study because you think you have not been treated fairly or 
think you have been hurt by joining the study, or you have any other questions about the study, you should 
contact the people below:  
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Dr Imran O. Morhason-Bello,  
Department of Obstetrics and Gynaecology, College of Medicine, University College 
Hospital/University of Ibadan, Oritamefa Ibadan. Tel:+2347034784402 
 
Professor Isaac F. Adewole 
Gynecological Oncology Unit,Department of Obstetrics and Gynaecology 
College of Medicine, University College Hospital/University of Ibadan, Oritamefa, Ibadan 
 
If you have any questions about your rights as a research study participant, you can contact the following people:  
1. Professor C Falade, Chair, University of Ibadan/University College Hospital, Ethics Committee, 
University College Hospital, Oritamefa, Ibadan, Oyo State. 
Telephone: +234 22 413 922  
2. Director of Secondary Health Care, Chair, Oyo State Research Ethics Review Committee, State 
Secretariat, Ibadan, Oyo State.  
Telephone: +2348036555092 
You will be given a copy of the information sheet and a signed consent form to keep. 
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INFORMED CONSENT FORM FOR FOCUSED GROUP DISCUSSION 
 
Name of Principal Investigator:  Imran Morhason-Bello 
 Please 
initial box 
1. I confirm that I have read and understand the participant information sheet dated 8th 
April 2016 (version 2.0.) for the above study.  I have had the opportunity to consider 
the information, ask questions and have had these answered fully. 
 
2. I understand that my participation is voluntary and I am free to withdraw at any 
time, without giving any reason, without my medical care or legal rights being 
affected. 
 
3. I understand that sections of my medical notes and data collected during the study 
may be looked at by responsible individuals from the London School of Hygiene & 
Tropical Medicine, the Oyo State research ethics review committee, and the 
University of Ibadan/University College Hospital Joint ethical committee research.  I 
give permission for these individuals to access my records. 
 









 Signature/Thumbprint  Date 




 Signature  Date 
Principal Investigator 
 
 Signature  Date 
 
The participant is unable to sign.  As a witness, I confirm that all the information about the study was 




Name of Impartial Witness 
(if required) 
 Signature  Date 
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ANNEX 3.4: INFORMATION SHEET AND INFORMED CONSENT FORM 
FOR IDI 
Investigators: Dr. Imran O. Morhason-Bello & Prof. Isaac F. Adewole 
 
Organization:  University of Ibadan 
 
Sponsor:   University of Ibadan 
 
You are being invited to take part in a research study.  Before you decide it is important for you to understand, 
why the research is being done and what it will involve.  Please take time to read the following information 
carefully and to talk to others about the study, if you wish.  Ask us if there is anything that is not clear or if you 
would like more information.  Take time to decide whether or not you wish to take part. 
1. What is the purpose of this study?  
We think that sexual behaviour may be changing in Nigeria, and we would like to document this so we can 
develop policies and programmes that help people to have healthy lives in Nigeria. We will try to learn from your 
perceptions and understanding of different types of sexual behaviours from what you know, learn and 
practiced.We are conducting this study in men and women aged 18-45 years living in selected communities in 
Ibadan. This project is being undertaken in part fulfilment for the award of research degree (PhD) at the London 
School of Hygiene and Tropical Medicine, London. 
2. Why have I been chosen?  
We are inviting men and women who are 18-45 years living in selected communities in Ibadan to participate in 
this study. We have asked you to participate because we want to learn from previous experience on any of the 
sexual behaviours and also your age is within our target population. We hope that you can offer us some useful 
information about different sexual behaviours. 
3. What will happen if I join this study? 
We will conduct an in-depth interview with you especially to learn from your previous experience on different 
types of sexual behaviours including oral and anal sex.  The interviewer will be a trained and highly experienced 
person of the same gender with you.  The interview will take an average time of 45 – 60 minutes. The interview 
will be conducted in a private venue that is convenient for you.The research team member (interviewer) will 
provide detailed explanation to all your questions and concerns regarding your participation in this study. After 
satisfactory explanation, you will be asked to sign or thumbprint on this consent form. You will also be asked if 
you mind that the interview is recorded. The interview will be casual and you will be encouraged to talk freely 
about anything you feel is related to the questions.  We will be interviewing people for about three months on 
this subject. You will only be asked to participate in this study once.  
4. Will I be paid to be in this study? 
We will compensate you with 1000 naira (£3.5) as stipend for transport and time spent for participating in the 
in-depth interview. We will also provide for you soft drink and biscuit after the interview.  
5. What are the risks or discomforts of the study? 
You may feel shy or embarrassed by the questions that we will be asking you. You may decide to refuse to answer 
any question if you feel uncomfortable. To minimize the possibility of feeling embarrassed, our study has a 
trained staff member who will help you deal with any bad feelings or embarrassing questions. We do not think 
there are any other risks involved in your taking part in this study. However, if you do feel that you have suffered 
harm as a result of taking part in the study then you should discuss this with the principal investigator:  Dr Imran 
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Morhason-Bello, Department of Obstetrics and Gynaecology, College of Medicine, University College 
Hospital/University of Ibadan, Oritamefa, Ibadan. Tel:+2347034784402 
6. Are there any benefits to being in the study?  
We will use the information gained to improve the quality of the large household survey we are planning to 
conduct at another community in Ibadan, Nigeria.   
7. How will my privacy be protected?  
We will do everything we can to protect your privacy while you participate in this study. The interview will be 
held in private place and will be conducted by a trained research team member. Your personal records (e.g. your 
name, or place of residence) will only be available to the staff involved in this study. The copy of the digital 
recording will not have your name attached to it. We will be preparing a report about this study and we may 
quote some of the words you tell us in the report. In this report any words that you have told us during the 
interviews will not have your name attached to them. To keep your information confidential all recordings and 
forms will be kept safe and locked in the principal investigator’s office at the University College Hospital, 
Oritamefa, Ibadan.The signed consent form by you  gives your permission that your records may be reviewed by 
the institutional review board (IRB) or institutional ethics committee (IEC) who protect the rights of human 
volunteers. However, no reports about this study will identify you in any way.  
8. What will happen to the results of the research study? 
We will analyse the results without including your name and any other information that could potentially breach 
your privacy. Findings from this study will be used to design questions that will be used in the household survey 
that we plan to conduct immediately in another community within Ibadan. The result will also be presented for 
the defense of a PhD programme at the London School of Hygiene & Tropical Medicine, London. We will share 
our experience from the study by presenting findings at conferences and submit to journals for scientific 
publication 
9. What will happen if I don’t want to carry on with the study? 
Your participation in this study is entirely voluntary. It is your choice whether you want to take part in the study 
or not. You can decide not to participate in the study at any time, even after you have given verbal consent or 
after we have signed on your behalf this written Informed Consent Form, or even during the interview. You do 
not have to give a reason for wanting to stop being part of the study.  
10.  What if something goes wrong? 
If you have a concern about any aspect of this study, you should ask to speak to the researchers who will do 
their best to answer your questions. If you remain unhappy and wish to complain formally, you can do this 
through The Provost, College of Medicine, University College Hospital, Oritamefa, Ibadan, Oyo state. If you are 
harmed due to someone’s negligence, then you may have grounds for a legal action.  Regardless of this, if you 
wish to complain, or have any concerns about any aspect of the way you have been treated during the course 
of this study then you should immediately inform the Principal Investigator; Dr Imran Morhason-Bello, 
Department of Obstetrics and Gynaecology, College of Medicine, University College Hospital/University of 
Ibadan, Oritamefa, Ibadan. Tel:+2347034784402. 
10. Who is organizing and funding the research? 
This research is being conducted as part of requirement for the award of PhD at the London School of Hygiene 
& Tropical Medicine, London. Funding for this research was provided by the management of University of Ibadan 
as part of scholarship award for the PhD programme.  
11.  Who has reviewed the study? 
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The research study has been approved by the ethics committees of the Oyo State Government, State Secretariat, 
Ibadan, University of Ibadan/University College Hospital, and the London School of Hygiene & Tropical Medicine, 
London. These committees make sure that the study is carried out in the safest way possible. 
12. Who do I contact if I have any questions? 
If you want to talk to anyone about this research study because you think you have not been treated fairly or 
think you have been hurt by joining the study, or you have any other questions about the study, you should 
contact the people below:  
Dr Imran O. Morhason-Bello,  
Department of Obstetrics and Gynaecology, College of Medicine, University College Hospital/University of 
Ibadan, Oritamefa Ibadan. Tel:+2347034784402 
 
Professor Isaac F. Adewole 
Gynecological Oncology Unit,Department of Obstetrics and Gynaecology 
College of Medicine, University College Hospital/University of Ibadan, Oritamefa, Ibadan 
 
If you have any questions about your rights as a research study participant, you can contact the following people:  
1. Professor C Falade, Chair, University of Ibadan/University College Hospital, Ethics Committee, 
University College Hospital, Oritamefa, Ibadan, Oyo State. 
Telephone: +234 22 413 922  
2. Director of Secondary Health Care, Chair, Oyo State Research Ethics Review Committee, State 
Secretariat, Ibadan, Oyo State.  
Telephone: +2348036555092 
You will be given a copy of the information sheet and a signed consent form to keep. 

















330 | P a g e  
 
 
INFORMED CONSENT FORM FOR IN-DEPTH INTERVIEW 
 
Name of Principal Investigator:  Imran Morhason-Bello 
 Please initial box 
1. I confirm that I have read and understand the participant information sheet 
dated 8th April 2016 (version 2.0) for the above study.  I have had the 
opportunity to consider the information, ask questions and have had these 
answered fully. 
 
2. I understand that my participation is voluntary and I am free to withdraw at 
any time, without giving any reason, without my medical care or legal rights 
being affected. 
 
3. I understand that sections of data collected during the study may be looked 
at by responsible individuals from the London School of Hygiene & Tropical 
Medicine, the Oyo State research ethics review committee, and the 
University of Ibadan/University College Hospital Joint ethical committee 
research.  I give permission for these individuals to access my records.. 
 









 Signature/Thumbprint  Date 




 Signature  Date 
Principal Investigator 
 
 Signature  Date 
 
The participant is unable to sign.  As a witness, I confirm that all the information about the study 




Name of Impartial Witness 
(if required) 
 Signature  Date 
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ANNEX 4.1: INFORMATION SHEET AND INFORMED CONSENT FORM 
FOR CROSS-SECTIONAL STUDY 
 
Investigators: Dr. Imran O. Morhason-Bello & Prof Rasheed Bakare 
 
Organization:  University of Ibadan 
 
Sponsor:   University of Ibadan 
You are being invited to take part in a research study.  Before you decide it is important for you to understand 
why the research is being done and what it will involve.  Please take time to read the following information 
carefully and to talk to others about the study if you wish.  Ask us if there is anything that is not clear or if you 
would like more information.  Take time to decide whether or not you wish to take part. 
1. What is the purpose of the study?  
The purpose of this research is to learn about different types of sexual behaviours and how these behaviours 
make it easier or harder to become infected with infections such as human Immunodeficiency virus (HIV) and 
human papillomavirus (HPV) infections. You may have heard about infection that could occur during sexual 
activity without any protection between two people. These are called sexually transmitted infections. HIV and 
HPV are common examples of sexually transmitted infections. HPV infection is an infection that can cause cancer 
of the cervix, vagina, vulva, anus, mouth and throat in women. It can also cause cancer of penis, anus, mouth 
and throat in men. HPV infections do not present with any symptoms and this infection may go on in the body 
without any knowledge of it. We think that sexual behaviour may be changing in Nigeria, and we do not know 
whether these changes could make it easier or harder to get human papillomavirus infection. We would like to 
document this so that we can better develop policies and programme that help people to have healthy lives in 
Nigeria. The information gathered will also assist us to have knowledge on how to prevent and treat any health-
related problems that are identified. We are conducting this study in men and women aged 18-45 years living in 
selected communities in Ibadan. This project is being undertaken in part fulfilment for the award of research 
degree (PhD) at the London School of Hygiene and Tropical Medicine, London. 
2. Why have I been chosen? 
Men and women who are 18-45 years living in selected communities within Ibadan are expected to participate 
in this study. Pregnant women or recently delivered mothers (less than 6weeks after childbirth) will not be able 
to participate. At each selected community, we will first randomly select houses.  Thereafter, we will then 
randomly select from list of men and women who are 18-45years living selected houses.  You are not selected 
because we have any information about you or that you may have human papillomavirus infection. Participation 
in the study involves face-to-face interview by a member of our research team (same gender with you) and 
collection of some samples by the research nurse. |For men, we will collect samples from the mouth, penis and 
anus. Samples from women will be collected from mouth, cervix, vulva, and anus. Samples will be collected in 
the clinic by an experienced research nurse. Your decision to participate means you have understood every 
aspect of the study and agree for interview and samples collection. We will be enrolling 900 individuals to 
participate in the study from different communities.   
3. What will happen if I join this study? 
If you chose to participate we will ask you sign a consent form to confirm this decision. Thereafter, you will be 
interviewed, and some samples will be collected from you either at where you live, or clinic located close to your 
environment. We will collect contact details from you and seek date and time that is convenient for you between 
8.00 – 16.00hours any day of the week to participate in the study.   
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On the day of the appointment, members of our research team will visit you.  During this visit, you will be 
required to participate in some activities which will be coordinated by our research team. First, you will be asked 
some questions by a member of the research team on awareness, knowledge and practice of sexual behaviours. 
Some of these questions may sound very personal and sometimes sensitive. We will appreciate if you could 
answer in a very honest way. After this interview, the second activity is collection of some samples. These 
samples will be collected from your blood, mouth, private parts and anus. A trained nurse will collect these 
samples after explaining in detail the procedures. The blood test is to check for your HIV status and this will 
involve collecting about 5 ml of blood from your arm into a bottle that is labelled with a specific code.  This code 
will make the research team identify each sample. A rapid HIV test will be performed. Everyone will be given 
their result of rapid HIV test before leaving the clinic.  Anyone that is HIV positive according to the national 
guidelines will be referred to treatment site for a repeat test and care. However, if a person does decide s/he 
does not want to know their HIV test results, we will collect their blood sample for anonymous rapid HIV testing 
(the result will not be linked to the individual).  After this, the nurse will collect samples from other sites using a 
small stick with cotton tip (Dacron swabs) placed into separate sample bottles. The Dacron swab is safe, and it 
will not cause any pain to you apart from little discomfort during insertion especially into your anus. If the nurse 
noticed any sign of sexually transmitted infections (STI), such individual will be offered treatment according to 
the symptoms and signs (syndromic management of STIs). If you want at the end, the nurse will check your pulse 
rate, blood pressure and test your urine for protein and sugar. The essence is to screen you for other medical 
conditions which are often neglected. If the result shows any abnormal result, the nurse will counsel you and 
refer you to see any health care provider of your choice.  Everyone that participated in the research will be 
informed about the result of tests conducted. We will deliver the result through our research team personally 
to you in a sealed envelope which will not contain your personal details. For those that will be required to see 
us due to the nature of their result, we will include date, time and venue of such appointment.  
4. What will the research team do with my blood and swabs samples?  
The oral rinse samples, blood and swabs samples will be taken to the minus 80-degree freezer at the University 
College of Hospital for storage.  We will use the blood to do HIV test and swabs from the mouth, private part 
and anus will be tested for human papillomavirus infection. Frozen oral rinse and dacron swabs from private 
parts and anus will be taken to Catalan Institute for Oncology in Barcelona Spain for storage and HPV DNA 
testing. The left-over sample will be used for future studies that will examine different infections at these sites. 
5. Will it cost me anything to be in this study? 
You will not pay any money for participation and all screening as well a possible treatment for those that will 
require such is free. 
6. Will I be paid to be in this study?  
We will compensate you with 1000 naira (£3.5) as stipend for transport and time spent for participating in all 
stages of the study. We will also give you an item from some of these health-related incentives – soap, tooth 
paste and brush, and a soft drink and biscuit refreshment after sample collection.  
7. What are the risks or discomforts of the study? 
There is no any envisaged physical injury for participating in this study aside discomfort of needle stick pain and 
during introduction of swab stick into your anal cavity. However, you may feel embarrassed by answering some 
of the interview questions on sexual behaviour. We have a team of trained research staff that will support you 
and they will reassure you that your response will be kept confidential. We are only collecting a small amount 
of blood from you. Most people do not have any problems after having a blood test but you may feel a slight 
pain or faintness when the blood is taken. Occasionally pain and bruising may occur where the needle goes into 
your arm but this is very unusual. You may also feel embarrassed or uncomfortable during the genital 
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examination and sample collection. For women, you may feel slightly uncomfortable when speculum is passed 
into your private part for genital (cervix) sample collection may associated with some slight disc. There is no any 
envisaged problems with other sample collection methods. In the event that your samples shows a positive 
result for either HIV or HPV infection, this could make you to be unhappy and possibly get upset. Our staff will 
show understanding and further counsel you on the next line of action including linking you treatment center.  
8. Are there any benefits to being in the study? 
The following might be of benefit to you if you participate in the study:  
(1) You will have free HIV and HPV infection testing with follow-up counseling  
(2) You will be offered free treatment if there is any evidence of sexually transmitted infection 
(3) We will provide screening and counseling for some common non-communicable diseases through urine 
testing for protein and glucose, and checking of your vital signs (Pulse and Blood pressure) 
(4) You will also be able to ask question on any health-related question and possible advice from the study nurse.  
If you decide to take part in the study, it will help us to understand different sexual behaviour. We hope that 
this will help us to develop better ways to protect people HIV and other sexually transmitted infections. 
9. How will my privacy be protected? 
We assure you that everything possible will be done to protect your privacy including linking your information 
with you. To guide against any breach of your privacy, we will conduct interview and examination in a private 
room. There will be no name in the data collection form and result sheets that will be brought to the point of 
interview. However, we will have your name and mobile number on a separate register to contact you when the 
results of various tests are ready. Only selected members of the research team involve with this will have access 
to this personal information. All documents related to this study will be kept safe and locked in the principal 
investigator’s office at the University College Hospital, Oritamefa, Ibadan. 
10. What will happen to the results of the research study? 
We will analyse the results without including your name and any other information that could potentially breach 
your privacy. Your test results will be given to you in a sealed envelope. If you need follow-up counselling or 
care, we will make arrangement with you for other necessary service. The result will also be presented for the 
defense of a PhD programme at the London School of Hygiene & Tropical Medicine, London. We will share our 
experience from the study by presenting our findings at conferences and submit to journals for scientific 
publication.  
11. What will happen if I don’t want to carry on with the study? 
You do not have to join as your participation is entirely voluntary. If you choose to participate, you will be 
required to sign a consent form before our research team can proceed. However, if you decided not to 
participate at any stage of the study, we will respect this decision and terminates the study with you.  
12. What if something goes wrong? 
If you have a concern about any aspect of this study, you should ask to speak to the researchers who will do 
their best to answer your questions. If you remain unhappy and wish to complain formally you can do this 
through The Provost, College of Medicine, University College Hospital, Oritamefa, Ibadan, Oyo state. If you are 
harmed due to someone’s negligence, then you may have grounds for a legal action.  Regardless of this, if you 
wish to complain, or have any concerns about any aspect of the way you have been treated during the course 
of this study then you should immediately inform the Principal Investigator; Dr Imran Morhason-Bello, 
Department of Obstetrics and Gynaecology, College of Medicine, University College Hospital/University of 
Ibadan, Oritamefa, Ibadan. Tel:+2347034784402 
13. Who is organising and funding the research?   
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This research is being conducted as part of requirement for the award of PhD at the London School of Hygiene 
& Tropical Medicine, London. Funding for this research was provided by the management of University of Ibadan 
as part of scholarship award for the PhD programme.  
14. Who has reviewed the study? 
The research study has been approved by the ethics committees of the Oyo State Government, State Secretariat, 
Ibadan, University of Ibadan/University College Hospital, and the London School of Hygiene & Tropical Medicine, 
London. These committees make sure that the study is carried out in the safest way possible. 
15. Who do I contact if I have any questions? 
Please feel free to talk to any of the following people in the event of any unsatisfactory conduct of our 
research team members towards you.  
You can speak to: 
Dr Imran O. Morhason-Bello,  
Department of Obstetrics and Gynaecology,  
College of Medicine, University College Hospital/University of Ibadan, Oritamefa Ibadan. Tel:+2347034784402 
 
Professor Rasheed Bakare, 
Department of Medical Microbiology, 
College of Medicine, University College Hospital/University of Ibadan, Oritamefa, Ibadan 
 
If you have any questions about your rights as a research study participant, you can contact the following 
people: 
Professor C Falade, Chair, University of Ibadan/University College Hospital, Ethics Committee, University 
College Hospital, Oritamefa, Ibadan, Oyo State. 
 
Telephone: +234 22 413 922  
Director of Secondary Health Care, Chair, Oyo State Research Ethics Review Committee, State Secretariat, 
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INFORMED CONSENT FORM FOR CROSS-SECTIONAL STUDY 
Name of Principal Investigator:                                     Imran Morhason-Bello  
1. I confirm that I have read and understand the participant information sheet dated 20th March 
2018 (version 4.0) for the above study.  I have had the opportunity to consider the 
information, ask questions and have had these answered fully. 
 
2. I understand that my participation is voluntary, and I am free to withdraw at any time, 
without giving any reason, without my medical care or legal rights being affected. 
 
3. I understand that sections of my medical notes and data collected during the study may be 
looked at by responsible individuals from the London School of Hygiene & Tropical Medicine, 
the Oyo State research ethics review committee, and the University of Ibadan/University 
College Hospital Joint ethical committee research.  I give permission for these individuals to 
access my records. 
 
4. I agree for my photo/quote/recording/other to be used in the publication or report released 
on the study. 
 
5. I agree for any remaining tissue samples to be retained, stored at SHINI laboratory, Ibadan, 
and used for future research, subject to further ethical approval 
 
6. I agree to take part in the above study.  
 
Name of Participant  
(printed) 
 Signature/Thumbprint  Date 
Name of Person taking consent 
 
 Signature  Date 
Principal Investigator  Signature  Date 
 
The participant is unable to sign.  As a witness, I confirm that all the information about the study was given and 
the participant consented to taking part. 
 
Name of Impartial Witness 
(if required) 
 Signature  Date 
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CASE REPORT FORM 
 
Sexual Behaviour and HPV Infection In 
Nigerians In Ibadan (SHINI) Project 
 
[Version 5.0_April 2018] 
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SECTION 1: BACKGROUND CHARACTERISTICS 
READ: Thank you very much for sharing your time to participate in this study. There are different sections in this interview. We implore you to be 
transparent and honest in your response to questions asked. I will read through each question and wait for your response. Please take as long as you 
need to remember or think about your answer. If a question is unclear, please ask me to repeat or explain it. Again, I will like to assure you that your 
response/answers are confidential, and they will not be traceable to you. I will start the interview by asking you some questions about yourself. 







Please tell me your date of birth 
[Ejowo e so fun mi ojo ibi yin?]  
[If participant can not remember; 
use the common local 
events/activity to estimate the 
nearest year. If participant can 
not remember the dates and 
month use the middate of the 
month for the expected date 
(15th) and mid-month of the year 
for the expected month (June)] 
[Record in Date/Month/Year] 
 
 
              |___|___| |___|___||___|___|___|___| 
DD           MM              YYYY 





How old were you at your last 
birthday? [Omo odun melo ni 
yin?] [Assist participant in 
estimating best answer by using 
common local events/activity in 
the area] 
Age in completed years 
 [Ojo ori ni pipe] 
                                          Don’t know[Nko mo] = 88 






Where were you born? 
[Nibo ni a bi o si?] [If the age of 
the participant is < 18years, 
explain to her that she is not 
eligible and terminate the 
interview. Write the code for the  
response in the box]  
                                                                         Ibadan = 01                                                                                                   
[Ibadan]  
    Other town in Oyo state = 02                                                                                      
                      [Ilu miiran ni ipinle oyo]  
                                 Town outside Oyo state, but in Nigeria = 03 
                          [Ilu miiran ti kii se Ipinle oyo sugbon ni naijiria]  
                                                            Town outside Nigeria = 04                                                                                                       
                                                                                 [Ilu lehin odi]  





             
Q104 
fsch 
Have you ever attended a formal 
school?[N je oti losi ile iwe ri?] 
[Write the code for the  response 
in the box] 
Yes [Beeni] = 01 






 QUESTIONS AND FILTERS RESPONSE COLUMN 
Q001 
doi 
Date of interview 
[Write the date in days/month/year] 
|___|___| |___|___||___|___|___|___| 




Research assistant initials 
[Write your 3 digits initials in upper case in the box] |____|____|____| 
Q003 
hwin 
Healthworker’s initials  
[Write your 3 digits initials in upper case in the box] |____|____|____| 
Q004 
qccin 
Quality Control Checker initials 
[Write your 3 digits initials in upper case in the box] |____|____|____| 
Q005 
lga 
Local government area code 
[Check the code guide that was provided to identify the appropriate code for the 




Community code  
[Check the code guide that was provided to identify the appropriate code for the 




Enumeration area  
[Check the code guide that was provided to identify the appropriate code for the EA] 




House identification number  
[Check the code guide that was provided to identify the appropriate house ID 




Time interview begin [Write in hours minutes] 
|____|____| |____|____| 
 




What is the highest level of 
formal school you have 
completed? 
[Iwe melo ni o ka?] 
[Only one response is required] 
[Write the code for the  response 
in the box] 
                                                                       Some Primary =  01 
                                                      [Iwe alakobere die]                                                          
                                                               Completed Primary=  02                                                                                 
                                                               [Alakobere]  
                               Junior Secondary or some secondary =  03  
                                                                    [Iwe girama kekere] 
                      Completed Senior Secondary/High School=   04  
                                                                          [Iwe girama agba] 
  Any Tertiary Education =  05 







How many years of formal 
education have you completed 
up till now? [Odun melo ni oti fi 
kawe titi di akoko yii?] 
[Assist participant to calculate 
number of completed years] 
 
Indicate number of years completed  






Did you ever attend a Quranic 
school at all? [Nje o losi ile kehu 
ri?][Write the code for the  
response in the box] 
Yes [Beeni] = 01 






How long have you lived in this 
community or area?[Bi odun 
melo ni o ti ngbe ni adugbo 
tabi agbegbe yii?][Assist 
participant to calculate number of 
completed years] 
Indicate number of years  
[Daruko iye odun]  
Record ‘00’ If less than 1 year  








What is your religion?[Esin wo 
ni o n sin? Tabi kini esin re?] 
[Write the code for the  response 
in the box] 
None [Ko si] = 00 
Christian [Omoleyin jesu] = 01 
Islam [Musulumi] = 02 
Traditional [Elesin abalaye] = 03 










What is your ethnic group? 
[Eya wo ni o?] 
[Write the code for the  response 
in the box] 
Hausa/Fulani [Awusa/Fulani] = 01 
Igbo [Ibo] = 02 
Yoruba [Yoruba] = 03 
Other Nigerian, specify [Eya miiran ni naijiria jo mo] __ =04 









Which of these categories best 
describes your marital status at 
the moment? [Ewo ninu awon 
ipele wonyi ni o salaye ni o 
salaye igbeyawo re?] 
[Prompt by reading each option 
for the participant. Write the code 
for the  response in the box] 
Single (no current partner) = 01 
                                       [Omidan (ti ko ti loko tabi ni olubadore)] 
              Single (Has boyfriend/lover but not living together) = 02 
                              Omidan (ti ko ti loko ti ko gbe plu olubadore)] 
                                     Single (living with a boyfriend/lover) =  03 
                                      [Omidan ti ko ti loko, gbe pelu ololufe re)] 
                                                                   Currently married = 04 
                                                                                [Sese loko]                                                                                                           
                                                                        Divorced = 05                                                                        
                                                                 [Mo ti pinya pelu oko mi]     
                                                                        Widowed = 06    [Opo]                                                                                             
                                                                             Separated=  07                                                                                                                                                                                
[Dalemosu]   












What is your current occupation? 
[Iru ise wo ni o nse] 
[Classify the occupation after 
participant has responded. Write 
the code for the response in the 
box] 
Name of the occupation [Oruko ise] ______________________ 
                                                                                  Student =  01    
                                 [Omo ile-iwe/akeko]   
No current paid job [e.g.housewife] = 02 
                [Mi o nise ti on mun owo wole] 
Unskilled workers [Messenger/Food Vendors/) = 03 
                                                      [Ise ti a ko(ojise/olounje)] 
Semi-skilled worker [e.g. Drivers/catering/ 
                                food vendor/Tailor/hairdresser /Trader) = 04 
  [onise owo (awako,aranso,aserunloso,olutaja)] 
Skilled worker Teacher/Technicians] = 05 
           [akosemose oluko/onimo kekere] 
            Highly skilled worker [e.g.Doctor/Lawyer/ Engineer/ 
                                                                           Accountant] = 06      
[onimo ijinle(apeer dokita,agbaejoro,onimo ero agba,olusiro 
owo]  
Armed forces (military/police etc) = 07 
           [omo ologun/olopa ati beebee lo] 













What is your average income per 
month after tax?[Elo lo n wole 
fun o losu leyin owo ori?] 
[Assist participant to calculate in 
Naira] 
 




Do you own a mobile telephone? 
[N je o ni ero ibanisoro 
Alagbeka?][Write the code for 
the  response in the box] 
Yes [Beeni]= 01 





Do you own a television? 
[N je o ni eromohunmaworan?] 
[Write the code for the  response 
in the box] 
Yes [Beeni] = 01 




Do you own a radio?[N je o ni 
ero asoromagbesi(redio)?] 
[Write the code for the  response 
in the box] 
Yes [Beeni] = 01 




Do you own a generator? [N je o 
ni ero amunawa?][Write the 
code for the  response in the 
box] 
 Yes [Beeni] = 01 





Do you own your own house? 
[N je o ni ile ti ara re?] 
[Write the code for the response 
in the box] 
Yes [Beeni] = 01 
No [Beeko] = 02 |____|____| 
 
 
SECTION 2: ALCOHOL, SMOKING, LOCAL STIMULANTS AND ILLICIT DRUG USE 
READ: I am going to ask you some questions about your use of alcohol, tobacco, and other drugs. Thank you. 








Recall in your whole life up till now, 
have you ever drunk alcohol?[Mofe ki 
o se iranti boya o ti mu oti lile ri?] 
[Write the code for the  response in 
the box] 
Yes [Beeni] = 01 
No [Beeko] = 02 
 
|____|____| 




How often do you have a drink 
containing alcohol? [Bawo ni o se 
maa nmu oti lile si?] 
[Allow the participant to state the frequency 
and if you are unsure, probe for each option. 
Write the code for the response in the box] 
Never [rara] = 00 
Monthly or less [osoosu tabi din] = 01 
2-4 times per month [emeji si emerin losu] = 02 
2-3 times per week [emeji si meta lose] = 03 








How many units of alcohol do you 
drink on a typical day when you are 
drinking?[O maa nto bii igo oti melo 
ti o maa n mu lojumo?] 
[Allow the participant to state the number of 
units,  and if you are unsure, probe further. 
Write the code for the response in the box] 
[Half pint is equal to a bottle of beer or 
alcohol] 
1-2 [Eyokan si meji] = 00 
3-4 [Meta si merin] = 01 
5-6 [Marun si mefa] = 02 
7-9 [Meje si mesan] = 03 







How often have you had 6 or more 
units of alcohol on a single occasion in 
the last year?[Bawo ni e se nmu bii igo 
mefa tabi jube lo ni ijoko ekan ni odun 
ti o koja si?] [Allow the participant to 
state the frequency and if you are 
unsure, probe for each option. Write 
the code for the response in the box]  
Never [Rara] = 00 
Less than a month [Odin ni osu] = 01 
Monthly [Ososu] = 02 
Weekly [Osose] = 03 







In your whole life up to now, have you 
ever smoked cigarettes or any locally 
made tobacco? [Lati igba ti e ti daye 
titi di akoko yi, n je e ti mu siga ri 
tabi taba ti ibile ri?] [Allow the 
participant to state the frequency and 
if you are unsure, probe for each 
option. Write the code for the  
response in the box] 
Yes [Beeni] = 01 
No [Beeko] = 02 
 
|____|____| 
If 02 Skip 
to Q207 
 




How often do you smoke now? [Bawo 
ni o se maa n mu siga si?][Allow the 
participant to state the frequency and 
if you are unsure, probe for each 
option. Write the code for the  
response in the box] 
 
                        Daily =  01 
                       [Lojojumo]  
Less than daily, but regularly= 02 
                            [Ko ki n se ojojumo sugbon o wopo] 
 Occasionaly [e.g. special occasions] = 03  
  [Ni ekokan(fun apeere nigbati o se Pataki bi ayeye)] 





















Some people have tried a range of 
different types of substance (drugs), 
which of the following, if any, have you 
ever used when it was not prescribed 
by a medical person?[Awon kan ti 
gbinyanju lati lo oniruru oogun,ewo 
ninu awon wonyi  ti o ba wa ni o ti 
lo nigbati  osise.ilera ko ko fun o pe 
ki o lo?] 
 [Please read out each of these 
substances and ask if she is taking 
any of them. Wirte “01” for YES  and 




Snuff (Ifinmu) [Sinofu]  
Marijuana (weed) [Igbo]   
Heroine [Eroin]                   
Cocaine [Kokeni]                   
Glue/Gum[Gulu]                        
Pethidine [Petidin]                 
Pentazocine(Fortwin) [Petasosin] 
Amphetamines [Amafetamin]        
Codeine [Kodini]                   
Rochi(Rophynol) [Rosi]   
Tramadol [Tiramado]  
Shisha [shisha]              
































Have you used any of these 
substances or drugs in the last 3 
months when you did not need them 
medically? 
[Nje o ti lo eyikeyi ninu awon oogun 
yii nigbati ilera re ko nilo re?] 
[Please read out each of these 
substances and ask if she is taking 
any of them. Wirte “01” for YES  and 
“02” for  NO; Multiple responses are 
possible] 
 
                                                      Sniff (Ifinmu [Sinofu] 
                                                Marihuana (weed) [Igbo]    
                                                                Heroine[Eroin]                                     
                                                             Cocaine[Kokeni]                                                                                                     
Glue/Gum[Gulu]                                               
                                                           Pethidine[Petidin]                                 
                                    Pentazocine(Fortwin) [Petasosin] 
                                            Amphetamines[Amafetamin]               
                                                             Codeine[Kodini]                                     
                                                 Rochi(Rophynol) [Rosi]     
                                                       Tramadol[Tiramado]  
Shisha [shisha]                                         
















SECTION 3: HUMAN PAPILLOMAVIRUS INFECTION 
READ: I will now ask you some specific questions to understand your knowledge about the infection called “human papillomavirus” 






Before we told you about this 
infection, had you ever heard of the 
infection called “human 
papillomavirus”? [ Ki a to so fun o 
nipa kokoro papilloma yii , nje o ti 
gbo nipa re ri?][Write the code for 
the  response in the box] 
Yes [Beeni] = 01 











Where did you first hear about human 
papillomavirus infection? [Nibo ni oti 
koko gbo nipa kokoro 
papilloma?][If participant did not 
mention any of the options, probe for 
it. Write the code for the  response in 
the box] 
 
Hospital or clinic= 01    
                                                            [Ile-iwosan]      
Media (TV/Radio/Newspaper/Magazine) = 02 
       [Lori ero mohunmaworan/asoro ma gbesi/iwe iroyin] 
  Internet= 03 
            [Lori ero ayelukara] 
Friends/peer= 04 
                                                                               [Ore/akegbe] 
Other, specify [Omiiran, salaye]_____________ = 05  


















Do you know how people catch 
human papillomavirus infection? [N je 
o mo bii awon eeyan se maa nko 
kokoro papilloma yii?] 
 [Please read out each of these 
options and ask if she knows any of 
them. Write “01” for YES if she 
knows and “02” for NO if not; 
Multiple responses are possible] 
 
Through anal sex[Ibi iho ile igbonse]   
Through oral sex[Ibalopo lati enu]   
Through Vaginal sex [Ibalopo lati oju ara]   
Touching a dirty surface [Fifi owo kan ibi ti o doti] 
Touching a toilet seat [Fifi owo kana wo ijoko ile igbonse]  
After touching the genital area [Leyin fifi own kan ayika oju  ara]  
After touching the anus [Leyin fifi ow obo idi]  


























Do you know what diseases are 
associated with human papillomavirus 
infection? [Nje o mo awon arun ti o 
romo kokoro papilloma?][Please 
read out each of these options and 
ask if she knows any of them. Write 
“01” for YES if she knows and “02” 
for NO if not; Multiple responses are 
possible] 
Cervical cancer [jejere enu ile omo] 
Vulva cancer[Jejere oju ara] 
Oral (mouth/throat) cancer [Jejere ona ofun/enu] 
Anal cancer [Jejere idi] 
Head and neck cancer [Jejere ori ati orun] 
Abdominal cancer [Jejere inu] 
Blood cancer [Jejere eje] 

























Do you know whether any of these 
actions could prevent  people from 
catching human papillomavirus 
infections? [Nje o mo boya eyikeyi 
ninu awon igbese yii le dena nini 
kokoro papilloma?] 
[Please read out each of these 
options and ask if she knows any of 
them. Write “01” for YES if she 
knows and “02” for NO if not; 
Multiple responses are possible] 
 
Abstain from sex [Yiyera fun ibalopo] 
Use condom during casual sex [Liloroba idabobo lasiko 
ibalopo] 
Have sex with one partner [Nini olubalopo eyokan] 
Avoid multiple sex partners [Yera fun olubalopo pupo] 
Vaccine [Gbigba abere ajesara] 
Avoid blood transfusions [Year fun eje gbigba] 
Avoid mosquito bites [Maje ki efon je e] 
Use antibiotics [Lilo oogun adena kokoro arun] 
Use of condom or other barrier methods [Lilo roba idabobo 
ati awon miiran lati daabobo ara] 
Washing of vagina after sex [Fifo oju ara leyin ibalopo]  













SECTION 4: SEXUAL RELATIONSHIPS, PARTNERSHIPS AND BEHAVIOURS  
READ: I am now going to ask you some questions on your sexual relationships. By this, I mean any relationship that may involve kissing and 
touching your partner to sexually stimulate vagina, oral and anal sex.  





Are you currently involve in a sexual 
relationship? [N je o ti nni ibalopo?][Write 
the code for the  response in the box] 
Yes [Beeni] = 01 
No [Beeko] = 02 
 
|____|____|   




Who is your current main sexual partner? 
[Tani olubase re nipa ibalopo?] 
[Allow participant to mention their main 
sexual partner. Write the code for the  
response in the box] 
 
No main sexual partners [Ko si awon 
olubalopo] = 01 
Boyfriend [Orekunrin] = 02 
Husband [Oko] = 03 
Only casual sexual partners [Olubalopo kan 







Is your current main sexual partner 
circumcised? [Se won dabe fun olubalopo 
re?][Write the code for the  response in the box] 
Yes [Beeni] = 01 
No [Beeko] = 02 






How old is your husband or current main 
sexual partner? 
[Omo odun melo ni oko re tabi olubalopo 
re?] 
[Write the code for the  response in the box] 
Indicate age in years [so ojo ori  odun] 








Does your husband or current main sexual 
partner have other wives or girl friends? [Nje 
oko re tabi olubalopo re lowolowo ni aya 
miran tabi awon orebiriin?]  
[Write the code for the  response in the box] 
Yes [Beeni] = 01 
No [Beeko] = 02 








Do you have other sexual partners besides 
your husband or current main sexual 
partner(s)? [se oni olubalopo miiran yato 
si oko re tabi olubalopo re lowolowo?] 
[Write the code for the  response in the box] 
Yes[Beeni]  = 01 





READ: I will now ask you some personal questions about your previous and present sexual experiences. Please remember that your name is not 
on this questionnaire and all information you provide will be kept confidential. What is most important is that you answer such questions as fully 




Have you ever had vaginal sex before? By 
this I mean  when a man (boy) puts his penis 
in your vagina)[Nje o ti ni ibalopo lati oju 
ara ri?][ 
Yes[Beeni]   = 01 









How old were you when you first had vaginal 
sex?[Omo odun melo ni o nigba ti o ni 
ibalopo lati oju ara obinrin fun igba 
akoko?][Write the code for the  response in 
the box] 
Indicate age in years [So ojo ori re ni odun] 


















Think back to the first time you had vagina 
sex, what was the main reason why you had 
your first vaginal sex?        [Ronu si igba 
akoko ti o ni ibalopo lati oju ara, kini idi 
Pataki ti o fi se ?] 
[Please read out each of these options and 
ask if she knows any of them. Write “01” for 
YES if she knows and “02” for NO if not; 
Multiple responses are possible] 
 
In love [Nipa ife] 
Got married [Mo ti laya] 
To have fun/pleasure [Fun igbadun]  
For money /seek favours [Fun owo ati lati wa 
oju rere] 
To get pregnant [Lati ni oyun] 
Rape or forced [Ifipa ba ni lo/fi dandan] 
Drunk [Mu yan imuti para] 
Cajoled or Pressured [Etan tabi Iyo lenu]  














How old was the person that you first had 
vaginal sex with? [Kini ojo ori eni ti o koko 
ni ibalopo lati oju ara pelu?] [Write the 
code for the  response in the box] 
Indicate age in years [So ojo ori ni odun] 






Throughout your whole life up until now, how 
many different people have you had vaginal 
sex with? [Lati igba ti oti daye titi akoko yii 
awon eyan melo ni o ti ni ibalopo pelu?] 
[Including current partners, past partners, 
spouse and all other kinds of partner. Write 
the code in the box] 
 
Indicate number [So iye won] 







How many different people in the last 12 
months have you had vaginal sex with?[ 
Eeyan melo ni o ni ibalopo pelu lati oju 
ara ni osu mejila seyin] 
[Including current partners, past partners, 
spouse and all other kinds of partner. Write 
the code in the box] 
Indicate number[So iye won] 







How many different people in the last 3 months have you 
had vaginal sex with? 
[Eeyan melo ni o ni ibalopo pelu lati oju ara ni osu meta 
seyin] 
[Including current partners, past partners, spouse and all 
other kinds of partner. Write the code in the box] 
Indicate number[So iye won] 








When did you last have vaginal sex? [Igba 
wo nie ni ibalopo lati oju ara gbeyin?] 
[Allow participant tell you  and fit it into the 
options. Write the code for the  response in 
the box] 
 
Today = 01 
[Oni] 
Less than a week ago = 02                                                                                   
[Ko ti to ose kan] 
      Within the last 3 months but more than a week 
ago = 03 
  arin osu meta sugbon ju osu kan lo]  
Within the last 6 months but more than 3 months 
ago = 04       
      [Laarin osu mefa sugbon ju osu meta lo] 
Within the last 12 months but more than 6 months 
ago = 05 
  [Laarin osu mejila ti o koja sugbon oju osu 
mefa lo] 
      More than one year ago = 06 








Did you or your partner used condom during 
your last vaginal sex? [Se iwo tabi 
olubalopo re lo roba idabobo nigba ti e ni 
ibalopo gbeyin?] 
[Write the code for the  response in the box]  
Yes [Beeni] = 01 
No [Beeko] = 02 
 
|____|____| 










What were the  main reasons for using 
condoms during your last vaginal sex? [Kini 
awon idi ti o fi lo roba idabobo lasiko ti o 
ni ibalopo gbeyin?] 
[Allow participant tell you  and fit it into the 
options. Write “01” for YES if she knows and 
“02” for NO if not; Multiple responses are 
possible] 
To prevent pregnancy [Lati dena oyun]  
To prevent STI [Lati dena arun ibalopo]  
To prevent HIV [Lati dena arun kogboogun]  
Partner insisted [Olubalopo mi fi dandan]  
Don’t trust partner [Olubalopo mi o nigbekele 
ninu]  








ORAL SEXUAL INTERCOURSE EXPERIENCE 
Q417 
evergos 
Have you ever give oral sex to a man/boy? 
By this I mean when you used your mouth or 
tongue to touch the penis or other genital 
area like the scrotum or anus of a man/boy. 
[Nje o ti ni ibalopo lati enu agbalagba 
okunrin/omode? Nipa fifi enu tabi ahon 
kan nkan omokunrin tabi ni ayika ojuara 
okunrin bii idi tabi koropon okunrin.] 











How old were you when you  first gave oral 
sex to a man/boy? [Omo odun melo ni e 
nigbati o koko ni ibalopo lati enu pelu 
Indicate the age in years [So ojo ori ni odun] 
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okunrin?] [Write the code for the  response 















Think back to the first time you had oral sex, 
what was the main reason why you gave oral 
sex to a man/boy for the first time?[Ronu si 
igba akoko ti o koko ni ibalopo lati enu 
,kini idi ni pato ti o fi ni iru ibalopo bee fun 
igba akoko?]  
[Please read out each of these options and 
ask if she knows any of them. Write “01” for 
YES if she knows and “02” for NO if not; 
Multiple responses are possible] 
 
In love [Nipa ife] 
Got married [Mo ti loko] 
To have fun/pleasure [Fun igbadun] 
For money /seek favours [Fun owo/lati wa oju 
rere]  
To get pregnant [Lati loyun] 
Rape or forced [Ifipa bani lopo] 
Drunk [Imuti para] 
Cajoled or Pressured [Etan/Iyo lenu] 
To avoid pregnancy [Lati dena oyun nini] 
During menstruation [Lasiko nkan osu] 
















How old was the man/boy that you first gave 
oral sex to?) [Omo odun melo ni 
agbalagba/omode okunrin ti o koko ni 
ibalopo lati enu pelu?] 
[Write the code for the  response in the box] 
Indicate age in years[So ojo ori ni odun] 






Throughout your whole life up till now, how 
many men/boys have you given oral sex? [Ni 
gbogbo igbesi aye re titi di asiko yii awon 
okunrin melo ni o ti ni ibalopo lati enu 
pelu?] [Including current partners, past 
partners, spouse and all other partner; 
write the number] 
Indicate number [So iye won] 







How many men (boys) have you given oral 
sex in the last 12 months? 
[Awon okunrin melo ni o ti ba se ibalopo 
lati enu ni osu mejila seyin?] 
[Including current partners, past partners, 
spouse and all other kinds of partner; write 
the number] 
Indicate number[So iye won] 







How many men (boys) in the last 3 months have you given 
oral sex to? 
[Okunrin melo ni o ti ba se ibalopo lati enu ni osu meta 
seyin?][Including current partners, past partners, spouse 
and all other kinds of partner; write the number] 
Indicate number[So iye won] 









When was the last time you gave oral sex to 
a man/boy? 
[Igba wo ni o se ibalopo lati enu pelu 
okunrin gbeyin?] 
[Allow participant tell you  and fit it into the 
options. Write the code for the  response in 
the box] 
 
Today = 0 
Less than a week ago = 02                                                                                   
[Ko ti to ose kan] 
 Within the last 3 months but more than a week 
ago = 03 
      [Laarin osu meta sugbon ju osu kan lo]  
   Within the last 6 months but more than 3 
months ago = 04       
                 [Laarin osu mefa sugbon ju osu 
meta lo] 
Within the last 12 months but more than 6 months 
ago = 05 
             [Laarin osu mejila ti o koja sugbon oju 
osu mefa lo] 
More than one year ago= 06 









Did you or your partner use condom or any 
other barrier method during the last time you 
gave oral sex to a man/boy? [Se iwo tabi 
olubalopo re eyikeyi ninu awon ona 
idabobo lati dabobo ara re nigbati o ni 
ibalopo lati enu?] 
[Write the code for the response in the box] 
Yes [Beeni] = 01 















What were the main reasons for using 
condoms or any other barrier method during 
the last time you gave oral sex to a man/boy? 
[Kini awon idi ti o fi lo roba idabobo tabi 
awon ona idena miiran ni asiko ti o ni 
ibalopo lati enu?] 
 [Allow participant tell you. Write “01” for 
YES if she knows and “02” for NO if not ; 
Multiple responses are possible] 
To prevent pregnancy [Lati dena oyun] 
To prevent STI [Lati dena arun ibalopo] 
To prevent HIV [Lati dena arun kogbooogun] 
Partner insisted [Olubalopo mu mi ni dandan] 
Don’t trust partner [Mi o ni igbekele ninu 
olubalopo mi] 











Have you ever received oral sex from a 
man/boy? By this, I mean when a man/boy 
put his mouth or tongue on your genital area 
either outside or inside your vagina or anus. 
Yes [Beeni]= 01 




If 02 skip 
to Q437 
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[Nje o ti ni ibalopo lati enu pelu agbalagba 
okunrin/odokunrin?] 
[Write code for the  response in the box] 
Q428 
agefros 
How old were you when you first received 
oral sex from a man/boy?  
[Omo odun melo ni e nigba ti o koko ni 
ibalopo lati enu pelu agbalagba okunrin 
tabi odokunrin?] 
[Write the age in the box] 
Indicate age in years [So ojo ori ni odun] 







How old was the man/boy that you first 
received oral sex from? [Omo odun melo ni 
agbalagba okunrin/odokunrin ti o koko ni 
ibalopo lati enu pelu re?] 
[Write the code for the  response in the box] 
Indicate age in years [So ojo ori ni odun] 


















Think back to the first time you had oral sex, 
what was the main reason why you received 
oral sex from a man/boy for the first time? 
[Ronu pada seyin si igba akoko ti o ni 
ibalopo lati enu ki ni idi Pataki ti o fi se 
ibalopo lati enu pelu agbalagba okunrin 
tabi odokunrin fun igba akoko?]. 
[Please read out each of these options and 
ask if she knows any of them. Write “01” for 
YES if she knows and “02” for NO if not; 
Multiple responses are possible] 
 
In love [Nipa ife] 
Got married [Mo ti loko] 
To have fun/pleasure [Fun igbadun] 
For money /seek favours [Fun owo/lati wa oju 
rere]  
To get pregnant [Lati loyun] 
Rape or forced [Ifipa bani lopo] 
Drunk [Imuti para] 
Cajoled or Pressured [Etan/Iyo lenu] 
To avoid pregnancy [Lati dena oyun nini] 
During menstruation [Lasiko nkan osu] 
Other, specify 















Throughout your whole life up till now, how 
many men/boys have had oral sex with you? 
[Ni gbogbo igbesi aye re di akoko yii, 
agbalagba tabi odokunrin melo ni o ti ba 
ni ibalopo lati enu?] 
[Including current partners, past partners, 
spouse and all other kinds of partner; write 
the number] 
Indicate the number [So onka won] 






How many men/boys in the last 12 months 
have had oral sex with you? Agbalagba 
okunrin tabi odokunrin melo ni o ti ni 
ibalopo lati enu pelu re ni osu mejila 
seyin? [Including current partners, past 
partners, spouse and all other kinds of 
partner; write the number] 
 
 
Indicate the number[So onka won] 






How many men/boys in the last 3 months 
have had oral sex with you? 
[Agbalagba okunrin tabi odokunrin melo 
ni o ti ni ibalopo lati enu pelu re ni osu 
meta seyin?][Including current partners, past 
partners, spouse and all other kinds of 
partner; write the number] 
Indicate the number [So onka won] 






When was the last time you received oral 
sex from a man/boy?[Igba wo ni o ni 
ibalopo lati enu gbeyin?] 
[Allow participant tell you and fit it into the 
options. Write the code for the response in 
the box] 
 
Today = 01 
[Oni] 
Less than a week ago = 02                                                                                   
[Ko ti to ose kan] 
 Within the last 3 months but more than a week 
ago = 03 
      [Laarin osu meta sugbon ju osu kan lo]  
   Within the last 6 months but more than 3 
months ago = 04       
                 [Laarin osu mefa sugbon ju osu 
meta lo] 
Within the last 12 months but more than 6 months 
ago = 05 
            [Laarin osu mejila ti o koja sugbon oju 
osu mefa lo] 
 More than one year ago = 06 








Did you or your partner use any barrier 
method during the last time that you received 
oral sex from a man/boy?[Se iwo tabi 
olubalopo re lo eyikeyi nkan idabobo 
lasiko ti e ni ibalopo lati enu pelu okunrin 
tabi odokunrin?] 
[Write the code for the  response in the box] 
Yes [Beeni]= 01 
No [Beeko]= 02 
 
|____|____| 






What were the main reasons for using 
condom or barrier methods when you last 
received oral sex from a man/boy? [Kini 
awon idi ti o fi lo roba idabobo tabi awon 
To prevent pregnancy [Lati dena oyun] 
To prevent STI [Lati dena arun ibalopo] 
To prevent HIV [Lati dena arun kogbooogun] 














ona idena miiran ni asiko ti o ni ibalopo 
lati enu pelu obirin?] 
[Allow participant tell you. Write “01” for YES 
if she knows and “02” for NO if not ; Multiple 
responses are possible] 
Don’t trust partner [Mi o ni igbekele ninu 
olubalopo mi] 




ANAL SEXUAL INTERCOURSE EXPERIENCE 
Q437 
everras 
Have you ever had anal sex? (By that I mean 
where a man (boy) puts his penis inside your 
anus) 
[Nje o ti ni ibalopo lati iho ile igbonse ri?] 
[Write the code for the  response in the box] 
Yes [Beeni]= 01 
No [Beeko]= 02 
 
|____|____| 




At what age did you first had anal sex?[Bii 
omo odun melo ni e nigbati o ni ibalopo 
lati iho ile-igbonse fun igba akoko?] 
[Write the code for the  response in the box] 
Indicate the number [So onka] 







How old was the man (boy) that first had anal 
sex with you? [Omo odun melo ni 
agbalagba okunrin(odokunrin) ti o koko ni 
iru ibalopo pelu fun igba akoko?] 
[Write the code for the  response in the box] 
Indicate age in years [So ojo ori re] 


















Think back to the first time you had anal sex, 
what was the main reason why you had your 
first anal sex with your man/boy? 
 [Ronu pada seyin igba akoko ti o ni iru 
ibalopo bayi, kini awon idi Pataki ti o fi se 
pelu agbalagba okunrin/odokunrin?] 
[[Please read out each of these options and 
ask if she knows any of them. Write “01” for 
YES if she knows and “02” for NO if not; 
Multiple responses are possible] 
In love [Nipa ife] 
Got married [Mo ti loko]  
To have fun/pleasure [Fun igbadun] 
For money /seek favours [Fun owo/lati wa oju 
rere] 
To get pregnant [Lati loyun] 
Rape or forced [Ifipa bani lopo] 
Drunk [Imuti para] 
Cajoled or Pressured [Etan/iyo lenu] 
To avoid pregnancy [Lati dena oyun nini] 
During menstruation [Lasiko nkan osu] 
Other, specify [Omiiran] ___________________   
















Did you or your partner use condom during 
your first anal sex? [Se iwo ati olubara lo 
roba idabobo lasiko ti o koko ni ibalopo 
lati ibi iho ile-igbonse?] 
 [Write the code for the response in the box] 








Throughout your whole life up till now, how 
many men (boys) have had anal sex with 
you? [Lati igba ti oti daye titi di asiko yii, 
awon okunrin agbalagba (awon 
odokunrin) melo ni o ti ni ibalopo pelu 
won lati ibi iho ile-igbonse?] 
[Include current partners, past partners & 
spouse; write the number] 
Indicate the number [So onka won] 








How many men (boys) in the last 12 months 
have had anal sex with you? 
[Awon agbalagba okunrin(awon 
odokunrin) melo ni o ti ibalopo pelu won 
lati ibi iho ile igbonse ni osu mejila 
seyin?][Include current partners, past 
partners & spouse; write the number] 
 
Indicate the number [So onka won] 







How many men (boys) in the last 3 months 
have had anal sex with you? 
[Awon agbalagba okunrin(awon 
odokunrin) melo ni o ti ibalopo pelu won 
lati ibi iho ile igbonse ni osu meta seyin?] 
[Include current partners, past partners & 
spouse; write the number in the box] 
Indicate the number [So onka won] 







When was the last time a man (boy) put his 
penis inside your anus? [Igba wo ni 
agbalagba okunrin(odokunrin) ti nkan 
omokunrin bo oju iho ti o tin se igbonse 
gbeyin?] 
[Allow participant tell you and fit it into the 
options. Write the code for the  response in 
the box] 
 
Today = 01 
[Oni] 
Less than a week ago = 02                                                                                   
[Ko ti to ose kan] 
 Within the last 3 months but more than a week 
ago = 03 
      [Laarin osu meta sugbon ju osu kan lo]  
  Within the last 6 months but more than 3 months ago =  
04       
   [Laarin osu mefa sugbon ju osu meta lo] 
Within the last 12 months but more than 6 months 
ago = 05 
   [Laarin osu mejila ti o koja sugbon oju osu mefa lo] 
More than one year ago = 06 








Did you or your partner use condom or any 
other barrier method during the last time you 
Yes [Beeni]= 01 
No [Beeko]= 02 
 
|____|____| 
If 02 skip 
to Q448 
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received anal sex from a man? [Se iwo tabi 
olubalopo re lo roba idabobo tabi ona 
idabobo miiran lasiko ti o ni ibalopo lati 
oju iho ti o ti n se igbonse pelu okunrin?] 










What were your main reasons for using 
barrier methods during the last time you 
received anal sex from a man/boy? [Kini 
awon idi Pataki ti o fi lo awon ona idabobo 
lasiko ti o ni ibalopo pelu okunrin loju iho 
ti oti n se igbonse?][Allow participant tell you. 
Write “01” for YES if she knows and “02” for NO if 
not; Multiple responses are possible] 
To prevent pregnancy [Lati dena oyun]= 01 
To prevent STI [Lati dena arun ibalopo] = 02 
To prevent HIV [Lati dena arun kogboogun] = 
03 
Partner insisted [Olubalopo mi fi dandan] = 04 
Don’t trust partner [Mi o nigbekele ninu 
olubalopo mi] = 05 











Have you ever had sex because he gave 
you, or told you that he would give you gifts, 
cash, or anything else? [This includes oral, 
anal or vaginal sex] 
[N je o ti ni ibalopo pelu enikan nitori pe o 
fun e ni nkan tabi so fun e wipe oun a fun 
e ni ebun owo tabi ohunkohun?] 
 [Write the code for the  response in the box] 
Yes [Beeni] = 01 








In the past 12 months, how many men (boys) 
have you had sex with because he gave you 
or told you he would give you gifts, cash, or 
anything else? [Ni bii osu mejila seyin, 
obinrin agbalagba (odokunrin) melo lo ti 
ni ibalopo pelu re nitoripe o fun e tabi so 
fun e pe oun yoo fun e ni ebun owo tabi 
ohunkohun?][This includes oral, anal or vaginal 
sex][Write the code for the  response in the box] 
 
Indicate the number [So onka won] 
  
Can’t remember [Mi o le ranti] = 77 
 






In the past 3 months, how many men (boys) 
have you had sex with because he gave you 
or told you he would give you gifts, cash, or 
anything else? [Ni osu meta seyin, okunrin 
agbalagba (odokunrin) melo lo ti ni 
ibalopo pelu re nitoripe o fun e tabi so fun 
e pe oun yoo fun e ni ebun owo tabi 
ohunkohun?] 
[This includes oral, anal or vaginal sex][Write 
the code for the  response in the box] 
Indicate the number [So onka won] 







When was the last time you had 
sex with anyone because he 
gave you or told you he would 
give you gifts, cash, or anything 
else? [Igbawo ni o ni ibalopo 
pelu enikan nitori pe o fun e ni 
nkan tabi so fun e wipe oun a 
fun e ni ebun owo tabi 
ohunkohun?] 
 [This includes oral, anal or vaginal 
sex] [Allow participant tell you and fit 
it into the options. Write the code for 
the  response in the box] 
Today = 01 
   [Oni] 
Less than a week ago = 02 
        [Ko ti to ose kan] 
 Within the last 3 months but more than a week ago = 03 
[Laarin osu meta sugbon ju osu kan lo] 
  Within the last 6 months but more than 3 months ago = 04       
        [Laarin osu mefa sugbon ju osu meta lo] 
Within the last 12 months but more than 6 months ago = 05 
     [Laarin osu mejila ti o koja sugbon oju osu mefa lo] 
       More than one year ago = 06 










During the time you had transactional sex, 
did you use a condom? [Lasiko igba ti o ni 
ibalopo,nje o lo roba idabobo?] 
[Write the code for the  response in the box] 
Yes [Beeni] = 01 
No [Beeko] = 02 







SECTION 5: NON-PENETRATIVE SEXUAL PRACTICES 
READ: Some people derive sexual pleasure including orgasm by touching parts of body especially genital area without intercourse (vaginal, oral 
or anal). They perform these act themselves (self-masturbation) or on their partner (mutual masturbation). In this interview, we mean vulva and 
vagina as female genital area, and penis and scrotal area as male genital area.   







Have you ever touched your genitals or inserted 
your finger(s) into your vagina or anus? [Nje o 
ti fi owo kan ayika oju ara re ri tabi ki o ti ika 
kan tabi meji bo oju ara re ri tabi iho ti o ti  n 
se  igbonse?] 
[Write the code for the  response in the box] 
Yes [Beeni] = 01 
No [Beeko] = 02 








How old were you when you first touched your 
genitals or inserted your finger(s) into your 
vagina or anus? [Omo odun melo ni e nigba ti 
o koko fi owo ka nayika oju ara re tabi ti ika 
bo oju ara re tabi iho ile igbonse re?] 
[Write the code for the  response in the box] 
Indicate the age in years [So ojo orire] 









Have you ever inserted another object into your 
vagina? [Nje o ti ti nkan miiran bo oju ara re 
ri?] 
[Write the code for the  response in the box] 
Yes [Beeni] = 01 
No [Beeko] = 02 
Can’t remember [Mi o ranti] = 77 
 
|____|____| 






What objects have you ever inserted into your 
vagina? [Nkan wo ni o ti tibo oju ara re ri?] 
[Write the code for each that participant 
mentioned in the box] 
Hand [Owo]= 01 
Vibrator [Irinse ti o maa ngbon]= 02 
Candle [Abela] = 03 








Do you put saliva in your hand before you touch 
your genital area? [Se o maa nfi ito sowo ki o 
to fi owo kan oju ara re?] 
[Write the code for the  response in the box] 
Yes [Beeni] = 01 
No [Beeko] = 02 






Have you or your partner ever touch each 
other’s genital area by hand (mutual-
masturbation)? [N je iwo tabi olubalopo re ti fi 
owo kan ayika oju ara yin ri pelu owo?] 
 [Write the code for the  response in the box] 
Yes [Beeni] = 01 
No [Beeko] = 02 
Can’t remember [Mi o ranti] = 77 
 
|____|____| 





Have you ever had a man (boy) put his fingers 
inside your vagina? [N je agbalagba 
okunrin(odokunrin) Kankan ti ti ika bo oju 
ara re ri?] [Write the code for the  response in 
the box] 
Yes [Beeni] = 01 
No [Beeko] = 02 







Have you ever put your hands on a man’s (boy) 
penis? [N je o ti fi owo kan nkan omokunrin 
ri?][Write the code for the  response in the box] 
Yes [Beeni] = 01 
No [Beeko] = 02 





SECTION 6: CIRCUMCISION & INTRAVAGINAL PRACTICES 
READ: I would now also like to ask you about other behaviours and practices concerning the genitals. 
 





Have you been circumcised? [Se won ti 
dabe fun e ri?] 
[Write the code for the  response in the box] 
Yes[Beeni]= 01 
No[Beeko]= 02 






Many women cleanse inside the vagina. 
Cleansing is defined as cleaning inside the 
vagina with water or another substance. Do 
you ever cleanse inside the vagina? By that 
I mean cleansing by inserting half a finger 
or a whole finger? [Opolopo obinrin lo 
maa nfo inu oju ara.fifo tumo si oju ara 
fifo pelu omi tabi eroja miiran.n je o ti fo 
inu oju ara re ri? Nkan ti o tumo si nipe 
fifi idaji ika tabi odidi ika fo inu oju ara] 
[Write the code for the  response in the box] 
Yes[Beeni]= 01 
No[Beeko]= 02 











How often do you cleanse inside the 
vagina?[Bawo ni o se maa nfo nkan Oju 
Ara re si?] [Write the code for the  
response in the box] 
Every day [Ojojumo] = 01 
Few days a week [Awon ojo die laari nose] = 02 














When do you usually cleanse inside the 
vagina? Igba wo ni o saba ma nfo nkan 
oju ara re? 
[Please read out each of these options and 
ask if she knows any of them. Write “01” 
for YES if she knows and “02” for NO if 
not. Multiple responses are possible] 
Anytime I use the toilet  
               [Nigbakugba ti moba lo si ile igbonse] 
When bathing 
                      [Ti moba n we] 
Before sexual intercourse 
                  [Ki nto ni ibalopo] 
After sexual intercourse 
                      [leyin ibalopo] 
        Anytime I perceive an odour from my vagina        
[Nigbakugba ti moba gbo oorun lati oju ara mi] 
During or after completing my menstruation 
[Lasiko ati leyin nkan osu] 
To remove vaginal discharge 
    [Lati fo nkan ti o n jade lati oju ara mi] 















Time Interview Completed [Ipari 
iforowanilenuwo] 
[Write in hours:minutes] 
 
|______|_____|:|______|______| 




The  interview completed? 
 [Se iforowanilenuwo pari?] 
[Write the code in the box, “01” for YES 
and “02” for NO] 
Yes [Beeni] = 01 
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SECTION 8: MEDICAL HISTORY 
This section will be handled by the healthcare worker that will also be responsible for taking the biological samples. All the samples will be collected by 
the trained research nurse READ:  I will now ask you some questions about your general health, and thereafter, examine and collect samples from your 
blood, mouth, genital area (vulva and cervix) and anus. Our staff will refer people whose results of tests requires further evaluations or treatment.  











Do you have any of the following 
chronic health problems? [Nje eni 
ikankan ninu awon ailera wonyi?] 
[Write 01 in the box for each chronic 
medical problem that the participant 
have; Write 02 in the box of 
participant did not have this diseae;88 
for if the participant did not know] 
Asthma [Iko gbofungbofun]  
Hypertension (High blood pressure) Eje riru(ifunpa giga) 
Diabetes mellitus[Ito suga] 
Any cancer, specify [Eyikeyi jejere, salaye] ______________ 










Have you ever been tested for HIV 
infection? [N je o ti se ayewo fun arun 
kokoro (HIV/AIDS) ri?][Write the code 
for the  response in the box] 
Yes [Beeni] = 01 
No [Beeko] = 02 
 
|____|____| 






If YES to Q802, what was the 
outcome of your last HIV test?[Ti 
idahun ibeere 802 ba je beeni, kini 
abajade ayewo HIV ti o se koja?] 
[Write the code for the response in 
the box] 
Positive [O wa nibe]= 01 
Negative [Ko si nibe]= 02 
Inconclusive [Ko ti yanju]= 03 




ART clinic  
Q804 
arv 
Are you on Anti-Retroviral Treatment 
now? [N je o wa lori oogun itoju HIV?] 








If YES to Q804, how long have you 
been on Anti-Retroviral Treatment? 
[Ti o baje beeni si ibeere 804, o ti to bi 
igba wo ti o ti wa lori oogun itoju yii?] 
[Write the code for the  response in 
the box] 
Less than 6 months [Odin ni osu mefa] = 01 
6-12 months [Osu mefa si mejila] = 02 
More than 1 year [O ju odun kan lo] = 03 
















Do you have any of the following 
symptoms now? [N je o ni ikankan 
ninu awon apeere arun wonyi bayii] 
Please read out each of these options 
and ask if she knows any of them. 
Write 01 for YES if she has any of the 
symptoms and 02 for NO if not; 
Multiple responses are possible] 
 
 
Fever [Ara gbigbona]  
Abdominal pain [Inu rirun] 
  Pain during vaginal sexual intercourse [Irora lasiko ibalopo]  
Vaginal itching [Oyun lati oju ara] 
Foul smell from the genitals [Oorun lati ayika oju ara] 
Abnormal vaginal discharge [Eje jijade lati oju ara] 
Vaginal sores/blisters [Egbo lati oju ara] 
Abnormal vaginal bleeding [Eje jijade lati oju ara] 
Lumps in genital area [Oju ara lile]   
 Other Specify [Omiiran, salaye] _____________ 














SECTION 9: CLINICAL EXAMINATION 
READ: I will conduct some physical and clinical examinations, and also, collect samples from your blood, mouth, genital area (vulva and 
cervix) and anus. The blood sample is to test for HIV infection while other samples (mouth, genital area and anus) are to screen for human 
papillomavirus infection. Please remember your name will not be written on this form. Your results will only be shared with you alone. Our 
staff will refer people whose results requires further evaluations or treatment. This section will be handled by the healthcare worker that will 
also be responsible for taking the biological samples. All the samples will be collected by the trained research nurse. 
 QUESTIONS AND FILTERS CODING CATEGORIES RESPONSE COLUMN SKIP 
Q901 Part 1: Physical and Clinical Measurements   
Q901A 
wt 
Weight [W] Weight (Kg) |____|____|____|  
Q901B 
ht 
Height[H] Height (Metres) |____|____|____|  
Q901C 
pr 
Pulse rate [PR] PR |____|____|____|  
Q901D 
sbp 
Blood pressure [BP] Systolic BP (mmHg) |____|____|____|  
Q901E 
dbp 
 Diastolic BP (mmHg) |____|____|____|  
Q901F 
uriclt 
Indicate whether urine sample has 
been collected or not 
Yes = 01 






If YES, place the duplicate barcode 
for urine sample 
 








Urinalysis [Instruct participant to 
collect a midstream urine as in SOP 
and use a multistix to assess the 






nil  +  ++   +++    ++++ 
nil  +  ++   +++    ++++ 
nil  +  ++   +++    ++++ 
nil  +  ++   +++    ++++ 
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Q902 [Conduct a pre-test counselling for HIV test; take permission to collect blood sample from the participant at this point; conduct 
Rapid HIV Screening according to the SOP & conduct a post-test counselling] 
Q902A 
bldsclt 
Indicate whether blood sample has 
been collected or not.  
Yes = 01 






If YES, place the duplicate barcode 
for the blood sample  





Determine HIV Rapid test result 
[Take a small sample of whole blood with 
capillary tube and perform HIV rapid test 
with determine kit as per protocol. Indicate 
the result as either ‘positive’ or ‘negative’ in 
the response box] 
 
HIV positive = 01 













Uni-Gold HIV Rapid test result 
[ Perform if the result of Q902C is 
positive]  
[Take a small sample of whole blood with 
capillary tube and perform HIV rapid test 
with Uni-gold kit as per protocol. Indicate 
the result as either ‘positive’ or ‘negative’ in 
the response box] 
 
HIV positive = 01 






If the result is 
the same with 





Statpack HIV Rapid test result 
 [Take a small sample of whole blood with 
capillary tube and perform HIV rapid test 
with Statpack kit as per protocol. Indicate 
the result as either ‘positive’ or ‘negative’ in 
the response box] 
 
HIV positive = 01 








Indicate the final result of Rapid HIV 
screening test. [Write “01” for YES 
and “02” for N0 according to the 
SOP]  
HIV positive = 01 










Indicate whether oral sample has 
been collected or not. 
Yes = 01 






If YES, place the duplicate barcode 
for the oral sample 
 
Paste the ORAL SAMPLE barcode here 
 
Q904 Part 3. Examination of the external genital area. 
Reaffirm from the study participant that you will need to examine her genital area.  Briefly, tell her that you will inspect the genital area  
before collecting the sample from vulva, cervix and anus.  
Ensure you take permission from the participant before you start. 
Q904A 
ocircum 
Has she been circumcised? 
[Write the code for the  response in 
the box] 
Yes = 01 






Any ulceration or sores in the genital 
area? [Write the code of your finding 
in the box] 
Present = 01 
Absent = 02 
 
|____|____| 







Where are the ulcers/sores/vesicles? 
[Write 01 if wart is  present in any of 













Any genital warts in the external 
genital area?[Write the code of your 
finding in the box] 
Present = 01 
Absent = 02 







Location of genital warts? 
[Write 01 if wart is  present in any of 















Indicate whether vulva sample has 
been collected with Dacron Swab 
Yes = 01 






If YES, place the duplicate barcode 
for the vulva sample 
 
 
Paste VULVA SAMPLE barcode here 
 
 Part 4. Speculum Examination Reaffirm with the study participant that you will need to pass a 
speculum into their private part to examine the cervix and also take a sample. 
 





Check for colour of vaginal secretions 
and Record in code in the response 
box. [Write the code of your finding in 
the box] 
 
Normal (clear/mucoid) = 01 
White & curdlike = 02 
White & homogenous = 03 
Bloody = 04 
Yellow = 05 





Q907 Examination of the CERVIX [Make sure you can visualise the cervix, and record your findings]  
 





Cervix seen?[Write the code of your 
finding in the box] 
Yes = 01 








[[Write the code of your finding in the 
box] 
None/Normal (clear/mucoid) = 01 
White & curdlike = 02 
White & homogenous = 03 
Bloody = 04 
Yellow = 05 








[Write the code of your finding in the 
box] 
Yes = 01 










Other cervical findings 
[Write 01 if lesion is present in any of 




Suspicious growth in the cervix 
(?cancer) 







 [Take permission from the participant to collect cervical sample at this point with a Dacron 





Indicate that Cervical sample taken 
with Dacron Swab 
Yes = 01 






If YES, place the duplicate barcode 
for the cervical sample 
 
Paste CERVICAL SAMPLE  barcode here 
 
Q908 Part 5: Examination of the PERI-ANAL AREA and RECTUM 




Any discharge from the anus? 
[Write the code of your finding in the 
box] 
Yes = 01 






Any ulcer in the peri-anal area? 
[Write the code of your finding in the 
box] 
Yes = 01 






Anal warts?  
[Write the code of your finding in the 
box] 
Yes = 01 









Any other lesions around the anus? 
Write 01 if lesion is  present in any of 
the anatomic sites; 02 if it is not 
present] 
Haemorrhoids 






 [Take permission from the participant to collect anal sample at this point with a Dacron swab 




Indicate that anal sample has been 
collected with Dacron swab 
Yes = 01 




If YES, place the duplicate barcode 
for the anal sample 
 








Record all samples that were 
collected  
 
[Write “01” for YES, collected and 















Make a diagnosis of Vaginal 
Discharge Syndrome [Write “01” for 
YES  and “02” for NO] 
Yes = 01 
No = 02 
 
|____|____| 





Make a diagnosis of Pelvic 
Inflammatory Disease: Female 
Abdominal Pain [Write “01” for YES  
and “02” for NO] 
Yes = 01 
No = 02 
 
|____|____| 





Make a diagnosis of Genital Ulcer 
Disease 
[Write “01” for YES and “02” for NO] 
Yes = 01 
No = 02 
 
|____|____| 





Make a diagnosis of Genital Warts 
[Write “01” for YES and “02” for NO] 
Yes = 01 
No = 02 
 
|____|____| 





Make a clinical diagnosis of 
suspicious cervical cancer growth 
[Write “01” for YES  and “02” for NO] 
Yes = 01 
No = 02 
 
|____|____| 




Make a diagnosis of Hypertension if 
BP is 140/90mmHg and above 
[Write “01” for YES  and “02” for NO] 
Yes = 01 
No = 02 
 
|____|____| 








Make a diagnosis of 
glycosuria 
[Write “01” for YES and “02” 
for NO] 
Yes = 01 
No = 02 
 
|____|____| 






Make any other diagnosis 
[Write “01” for YES and “02” 
for NO] 
Yes = 01 








Time Medical History & 
Examination Completed  
[write in hours: minutes] 
 
|______|______|:|______|______| 





The interview completed?                 
  [Write the code in the box] 
 
Yes = 01 
No = 02 





Use the National STI Treatment Guideline to prescribe drugs according to the diagnosis. Circle the REGIMEN that is 
prescribed. 
VAGINAL DISCHARGE SYNDROME 






Metronidazole 2 g orally in a single 
dose PLUS Nystatin Vaginal 
pessaries 100,000 units inserted 
every night for 14 days  
 Metronidazole 2g orally in a single dose AND 
Clotrimazole vaginal pessaries 100mg inserted 
every night for 6 days 
 Tinidazole orally stat 
as a single dose AND 
Tioconazole 300mg 






Azithromycin 2g orally stat only 
AND Doxycycline 100mg tab. 
Orally twice daily for 7 days 
Ceftriaxone 250mg IM as a single oral dose OR 
Ofloxacin 400mg tabs orally as a single dose AND 
Erythromycin 500mg tab. Orally four times a day for 
7days 
Azithromycin 2g orally 
stat  
OR Erythromycin base 
500mg tab. Orally four 
times a day for 7 days 
PELVIC INFLAMMATORY DISEASE: FEMALE LOWER ABDOMINAL PAIN  





Azithromycin 2 g orally once  
Metronidazole  2g orally once  
 
IM Ceftriaxone 250 mg once  
Tinidazole 2g once 
 
In pregnancy, Patients 




parenteral therapy    
GENITAL ULCER DISEASE 
COMMON 
CAUSES 










Benzathine Penicillin 2.4million units IM 
once 
PLUS 
Azithromycin 2 g orally once weekly for 
3weeks   
Procaine Penicillin 2.4million units IM once daily for 
10 – 14days 
 
Erythromycin base 500 mg orally 3 times a day for 
21 days   
For penicillin-allergic 
non-pregnant patients 
only;  Doxycycline 100 
mg orally 2 times a 
day for 14 days OR 
Tetracycline 500 mg 







Acyclovir 400 mg orally 3 times a day for 
7-10 days OR 
200 mg orally 5 times a day for 7-10 
days  
Famciclovir18 250 mg orally 3 times a day for 7-10 
days OR 






Podophyllin 0.5% gel application 
OR Acyclovir 400 mg orally 3 times a day 
for 7-10 days OR 
200 mg orally 5 times a day for 7-10 
days 
Podophyllin 0.5% gel application 
OR Famciclovir18 250 mg orally 3 times a day for 7-
10 days OR 
Valacyclovir 1 g orally 2 times a day for 7-10 days 
 
This is the end of the interview, examination and sample collection. Thank the participant for their time and remind them if there is 




Record the Number of Contact Slips: |_____|_____| 
DATE OF FIRST FOLLOW-UP VISIT |_____|_____|/|____|_____|/|____|____|____|_____| 
         DD                  MM                   YYYY 
DATE OF SECOND FOLLOW-UP VISIT |_____|_____|/|____|_____|/|____|____|____|_____| 
             DD              MM                       YYYY 
 











SECOND DATA ENTRY VERIFICATION 
INITIALS     
DATE     
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BIN – Brothel Identification Number
S/N BIN Local Government 
Area/Code 
No of Participants 
Listed 
No of Participant 
Interviewed 
1 0022 Ibadan South West /005 4 4 
2 0020 Ibadan South West /0020 3 3 
3 0025 Ibadan South East /006 6 6 
4 0026 Ibadan South East /006 4 4 
5 0028 Ibadan South East /006 9 9 
6 0011 Ibadan North East/003 3 3 
7 0010 Ibadan North East/003 7 7 
8 0003 Ibadan North/001 9 9 
9 0017 Ibadan North West /004 3 3 
10 0016 Ibadan North West /004 4 4 
11 0014 Ibadan North West /004 7 7 
12 0030 Ibadan North West /004 5 5 
13 0019 Ibadan North West /004 3 3 
14 0013 Ibadan North West /004 5 5 
15 0031 Ibadan North West/004 13 11 
16 0015 Ibadan North West /004 2 2 
17 0018 Ibadan North West /004 6 6 
18 0005 Akinyele/002 13 11 
19 0007 Akinyele/002 17 15 
20 0008 Akinyele/002 13 11 
21 0006 Akinyele/002 9 9 
22 0001 Ibadan North/001 22 20 
23 0009 Akinyele/002 15 14 
24 0027 Ibadan South East/006 18 15 
25 0002 Ibadan North/001 34 31 
26 0023 Ibadan South West/005 20 17 
27 0024 Ibadan South West/005 16 13 
28 0004 Ibadan North/001 75 68 
   344 315 
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ANNEX 5.2:  ADDITIONAL QUESTIONS FOR FEMALE SEX WORKERS ONLY  
SECTION 7: INFORMATION ON SEX WORK ACTIVITY 
READ: I will now ask you some personal questions in relation to your work.  Please remember that your name and other means of identity is well 
protected. Thank you. 





How long have you been involved in 
commercial sex work activity? [o 
tito bii odun melo ti e ti n se ise 
yii] [Assist participant to calculate 
number of completed years] 
Indicate number of years 
[So iye odun] 
Record ‘00’ if less than 1 year 















What were your main reasons for 
engaging in commercial sex work? 
[kini awon idi ti e fi n se ise yii] 
[Allow participant to tell you her 
reason(s) Write “01” for YES if she 
knows and “02” for NO if not; 
Multiple responses are possible] 
 
To get money [lati ri owo] 
To have fun [fun igbadun] 
To have a change of environment [lati yii agbegbe pada] 
Because I have no job [to ripe mi oni ise miiran] 
 Because I lost or separated with my husband [toripe mo 
padanu                                                                                                                   
oko mi] 
To join my friends/colleagues [lati darapo mo awon ore/elegbe 
mi] 
Cajoled/deceived to join sex work [Se won tan yi tie fi darapo 
mo ise yi] 
Forced to join sex work [se won fi ipa mun yin mo ise yi] 















On average, how many men pay you for vagina, oral or anal sex 
every week? [ti e ba fi oju da, o maa nto bii okunrin melo ti e 
man ri ni aarin ose kan fun ibalopo oju ara tabi enu tabi lati 
enu oju ile igbonse?] [Assist participant to calculate number of 
sex partners] 
 
Indicate the number 






On average, how many men pay 
you for vagina, oral or anal sex 
every day? [ti e ba fi oju da, o maa 
nto bii okunrin melo ti e man ri ni 
ojo kan fun ibalopo oju ara tabi 
enu tabi lati enu oju ile igbonse?]  
[Assist participant to calculate 
number of sex partners] 
 
Indicate the number 






Have you ever allowed unprotected 
vagina sex with men that pay you 
but refuse to use condom? [nje e ti 
ni ibalopo lati oju ara yin pelu 
onibara yin okunrin ti won ko lati 
lo roba idabobo pelu yin?] [Write 
the code for the response in the 
box] 
Yes [Beeni] = 01 
 








Have you ever give oral sex to men 
that pay you but refuse to use 
condom?  [nje e tigba ri ki e fi enu 
yin tabi ahon yin kan oko onibara 
yin nigbati eni ibalopo pelu won, 
sugbon ti won ko jale lati lo roba 
idabobo pelu yin?] [Write the code 
for the response in the box] 
Yes [Beeni] = 01 
 








Have you ever received oral sex 
from men that pay you but did not 
use mouth gag or any protection?  
[nje e ti gba ri ki onibara yin 
okurin fi enu won kan oju arayin 
nigba ti eni ibalopo pelu won 
sugbon ti won ko lai lo idabobo 
kankan?] [Write the code for the 
response in the box] 
 
Yes [Beeni] = 01 
 









Have you ever received 
unprotected anal sex from men that 
pay you but refused to use 
condom?  [nje e ti gba ri ki 
onibara yin okurin bayin ni 
ibalopo lati enu ile iyagbe yin 
nigbati f ti won ko  lai lo idabobo 
kankan?] [Write the code for the 
response in the box] 
 
Yes [Beeni] = 01 
 












Have you provided any unprotected 
sexual activity (vagina or oral or 
anal sex) to men that pay you in the 
past 3 months? [nje e ni ibalopo 
lai lo roba idabobo pelu inibara 
yin ni osu meta seyin?] [Write the 
code for the response in the box] 
Yes [Beeni] = 01 











When was the last time you 
provided unprotected sex to any 
man that pay you? By this I mean, 
vaginal or oral or anal sex. [igba 
wo ni eni ibalopo lai lo roba 
idabobo pelu onibara yin gbeyin? 
Ibalopo lati oju ara tabi enu tabi 
iho ile igbonse] [Allow participant 
to tell you and fit it into the options. 
Write the code for the response in 
the box] 
                                                                                   Today = 01                                                                                                              
[Oni] 
                                                          Less than a week ago = 02 
                                      [Ko ti to ose kan] 
             Within the last 3 months but more than a week ago= 03                                     
                    [Laarin osu meta sugbon ju osu kan lo] 
        Within the last 6 months but more than 3 months ago = 04                                   
               [Laarin osu mefa sugbon ju osu meta lo] 
       Within the last 12 months but more than 6 months ago = 05                            
       [Laarin osu mejila ti o koja sugbon oju osu mefa lo] 
      More than one year ago = 06 


























What were your main reasons (s) 
for engaging in an unprotected sex 
with your commercial sex partner? 
[kini awon idi Pataki ti e fi ni 
ibalopo lai lo roba idabobo pelu 
awon onibara yin?] 
[Please read out each of these 
reasons for the partcipant. Write 
“01” for YES if she knows and 
“02” for NO if not; Multiple 
responses are possible] 
 
To get more money [lati ri owo] 
Cajoled [pelu etan] 
Forced [pelu ipa] 
Under the influence of alcohol [oti mimu yo] 
Under the influence of drug (cocaine) [ogun oloro lilo] 
For those that I like or love [nipa ife] 
To hasten ejaculation [lati le jeki nkan omokunrin tete wa] 
To avoid sustained erection [lati je ki oko onibara ti wala] 
Commercial partner refused condom [kiko jale onibara mi] 
Because he is well known to me [nitori o je eni mimo mi] 
Fear of violence from the client [nitori o won fi ipamumi] 
Fear of losing the client [nitori lati padanu awon oni bara mi] 
No money to buy condom [ko si owo lati ra roba idabobo] 
I don’t like to use condoms [ni tori pe mi o feran lati lo roba 
idabobo]  





















Have there been times when a man 
refused to use a condom, but you 
convinced him to use it? [n je oti ni 
igba ti oni bara okunrin ti yari lati 
lo roba idaabobo sugbon ti e pe 
arowa fun lati loo] [Write the code 
for the response in the box] 
 
Yes [Beeni] = 01 
 







Was it difficult for you to negotiate 
condom use with clients when you 
move to a new place? [nje oni ra 
fun yin lati beere lowo onibara 
yin lati lo roba idaabobo nigbati 
esese de ibi] [Write the code for 
the response in the box] 
 
Yes [Beeni] = 01 
 






What is your average income per 
week from sex work? [elo lo n wole 
fun yin ni ise yi] [Assist participant 
to calculate in Naira]  
Monthly income (Naira) [Owo osu(naira]: |____|____|____|____|____|____|  
720 
tc 
Time Interview Completed [Ipari 
iforowanilenuwo] 
[Write in hours:minutes] 
 
|______|_____|:|______|______| 




The interview completed? 
 [Se iforowanilenuwo pari?] 
[Write the code in the box, “01” for 
YES and “02” for NO] 
Yes [Beeni] = 01 
No [Beeko]= 02 
 
 
|____|____| 
 
